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SUMMARY 
 
Main trends and new developments 
 
• In April 2001 the Irish Government approved the National Drugs Strategy 
2001-2008. The new Strategy endorses the Irish Government's existing 
approach to tackling the drugs issue. The four 'pillars' of the new Strategy - 
supply reduction, prevention (including education and awareness), 
treatment (including rehabilitation and risk reduction), and research - focus 
on the same four issues as in the Government's previous Drugs Strategy.  
 
• To sharpen the focus of the National Drugs Strategy 2001-2008 specific 
objectives and key performance indicators for each of the four pillars were 
specified. In addition, 100 individual actions to be taken across the full 
range of Departments and Agencies involved in the delivery of drugs 
policy have been developed.  The actions are designed to address specific 
gaps in the current strategy, to strengthen each of the four pillars which 
underpin it and to ensure that the foregoing objectives are met thus driving 
the new strategy forward. 
 
• According to the results of the second national survey of Drug-Related 
Knowledge, Attitudes and Beliefs in Ireland (commissioned by the Drug 
Misuse Research Division in 2000 and carried out as part of the 2000 Irish 
Social Omnibus Survey, unpublished) concern about the drug problem in 
Ireland remains high, especially regarding the threat to young people from 
the availability of illegal drugs. There is also growing concern regarding the 
availability of drugs in local neighbourhoods. Public support for harm 
reduction strategies (including availability of medically-subscribed heroin 
substitutes and the provision of syringes and needles free of charge) 
continues to increase. 
 
• After alcohol and tobacco, cannabis is the most commonly used drug in 
the general population in Ireland, followed to a much lesser extent by 
amphetamine and ecstasy use.  
 
• A main development is the stabilising and decreasing drug use among 
young people at school.  The lifetime experience of cannabis use, in 
particular in the general population of young people in Ireland, is one of 
the highest in Europe, but recent results show a levelling off of use.  
 
• Misuse of solvents among young people is relatively high at around one-
fifth of the population.  
 
• There is evidence of polydrug use from a number of sources – treatment 
data, information on intoxicated drivers, death statistics. 
 
• A survey to investigate factors underlying international variations in youth 
drug use undertaken in five cities including Dublin, found that sporting 
activities by young people were linked with low rates of drug use. 
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• It is now recognised at official level that homeless young people are 
seriously at risk of becoming involved in drugs, prostitution and crime.  As 
a result a strategy on youth homelessness has been drawn up. 
 
• Services need to be developed for drug users in the prison setting that 
take account of the particular nature of the prison environment.  They also 
need to address the needs both of those who continue to engage in drug 
use and the associated risk behaviours; and those who wish to cease their 
drug use while incarcerated. 
 
• Studies indicate the need for more imaginative education initiatives in 
harm reduction interventions.  Greater attention needs to be paid to the 
social context of injecting drug use and the sharing of injecting equipment.  
Outcomes of harm reduction interventions could be improved by exploring 
the perceptions surrounding unsafe injecting practices.   
 
• Treatment demand monitoring, the most developed of the five key 
indicators of drug misuse in Ireland, has been adversely affected in 2000, 
mainly due to lack of commitment/priority given to data collection by drug 
treatment service providers. 
 
• As a result of growing concern over the over-prescribing of 
benzodiazepines a Committee was established in 2000 by the Minister for 
Health and Children to explore the nature and extent of benzodiazepine 
prescribing in Ireland. This Committee will examine current trends and 
make recommendations on good prescribing practices, paying particular 
attention to the management of drug users. The Committee is due to make 
its report to the Minister at the end of 2001. 
 
• There are more seizures of cannabis than any other drug in Ireland.  
However, in 2000 while the number of cannabis seizures increased, the 
quantity dropped very significantly.  This may be due to a change in the 
nature of the cannabis market, which now seems to involve a larger 
distribution network trafficking in smaller amounts of the drug.   
 
• Special studies need to be undertaken to explore issues, such as 
availablility, sources of supply and trafficking patterns, involved in drug 
markets in Ireland.   
 
• The emphasis on rehabilitation has received a more focused approach in 
recent years, particularly within the Eastern Regional Health Authority 
(ERHA) area. A ‘blueprint’ was drawn up in 2000 to guide the development 
of rehabilitation services within the remit of the ERHA.  Central to the 
measures set out in the aforementioned blueprint, was the creation of "re-
integration centres" in the three health board areas under the ERHA. It 
was proposed that these centres would provide a base for integration 
workers to support individual clients towards re-integration into 
mainstream social activity. In pursuit of this aim the centres would provide 
career guidance and counselling, personal skills development, and 
educational/training opportunities. 
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• Aftercare and reintegration progressively come to the fore as key areas of 
intervention in the drug field.  For example, FAS the key statutory training 
agency in training people for employment offered a substantial number of 
'special FAS training schemes' for former drug users seeking reintegration. 
In addition a number of community projects under the Local Drug Task 
Forces provided aftercare and reintegration services.  
 
• Interventions aimed at reducing the harmful consequences of drug misuse 
were also key to the demand reduction field. In this regard the provision of 
needle exchange, an increase in outreach services and the placing of 
mobile clinics in areas badly affected by the drug issue have been some 
of the key developments during the year.  
 
• A key recommendation included in the National Drugs Strategy 2001-08 is 
the creation of a number of Regional Drug Task Forces (RDTFs) in each 
of eleven regional health board areas. The RDTFs will consist of 
representatives from the statutory, voluntary and community sectors. It is 
anticipated that the RDTFs will be place by the end of 2001.  
 
• Northside Partnership an area-based company working for the social 
inclusion of marginalised groups have developed a number of innovative 
initiatives that aim to assist ex-drug users in the process of re-integration. 
For example, The Labour Market Inclusive Project (LIP) provides work 
placements for ex-drug users that in some cases have led to longer-term 
employment.  
 
• An emerging trend from the National Drug Treatment Reporting System 
(NDTRS) data shows employment among drug treatment contacts 
increasing from 14% in 1997, to 20% in 1998 with 26% roughly one in four 
treatment contacts reporting to be in 'gainful employment' in 1999.  
 
• A Drug Court was established in January 2001 on a pilot basis in one area 
of Dublin City. The purpose of the court is to provide a scheme for 
rehabilitation of offenders who are before the court on drug offences of a 
minor nature. To date 44 offenders have bee referred to the Drug Court, 
from this group 15 were either deemed unsuitable or failed to comply with 
the court's direction, the remainder are currently before the court.  
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Part 1 
 
National and Local Policies & Legal Frameworks 
 
1. Developments in Drug Policy and Responses 
 
1.1  Political framework in the drug field – Hamish Sinclair and 
Brigid Pike 
 
(a) Objectives and priorities of the national drug policy 
 
In April 2000, the Cabinet Committee on Social Inclusion requested that a 
review of the current national drugs strategy be undertaken. The overall 
objective of the review was to identify any gaps or deficiencies in the existing 
strategy and to develop revised strategies and, if necessary, new 
arrangements through which to deliver them. A sub-group of the Inter-
Departmental Group on Drugs and the National Drugs Strategy Team – 
known as the Review Group – managed and oversaw the process.  
 
The review set out to identify the latest available data on the extent and 
nature of drug misuse in Ireland as a whole and attempt to identify any 
emerging trends and pinpoint the areas with the greatest levels of drug 
misuse. The review also involved extensive consultations through invited 
written submissions (189 received), discussions with key players in the state, 
voluntary and community sectors, and a series of eight public regional 
consultative fora (attended by approximately 600 people) held throughout the 
country during June 2000. In addition, a total of 34 agencies and 
organisations were invited to make detailed presentations to further assist in 
the identification of any gaps or deficiencies in the current strategy.  To be as 
comprehensive as possible, the review also looked at international trends, 
developments and best practice models. 
 
The resulting Report of the Review Group was adopted by the Government in 
April 2001 and the National Drugs Strategy 2001-2008 “Building on 
Experience” was launched in May 2001 (Department of Tourism, Sport and 
Recreation 2001).  
 
The overall strategic objective of the National Drugs Strategy 2001-2008 is: 
 
to significantly reduce the harm caused to individuals and 
society by the misuse of drugs through a concerted focus 
on supply reduction, prevention, treatment, and research 
 
The new Strategy endorses the Irish Government's existing approach to 
tackling the drugs issue. The four 'pillars' of the new Strategy - supply 
reduction, prevention (including education and awareness), treatment 
(including rehabilitation and risk reduction), and research - focus on the same 
four issues as in the Government's previous Drugs Strategy. 
 
The new National Drugs Strategy, however, seeks to strengthen the strategy 
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and sharpen its focus, by: 
 
• welcoming the Government's positioning of the National Drugs Strategy 
within the wider Social Inclusion policy and the strong commitment to 
areas of disadvantage in the NDP 2000 - 2006. The Review Team 
recognises that the best prospects for communities affected by the drugs 
problem, in the longer term, rest with a Social Inclusion strategy which 
delivers much improved living standards to areas of disadvantage 
throughout the country; and  
 
• requiring all state agencies involved in delivering the National Drugs 
Strategy to specify annual targets in terms of outputs and desired 
outcomes for their respective programmes and initiatives. 
 
With these broad considerations in mind, the Strategy has identified seven 
overall aims: 
 
• to reduce the availability of illicit drugs; 
 
• to promote throughout society a greater awareness, understanding and 
clarity of the dangers of misuse; 
 
• to enable people with drug misuse problems to access treatment and 
other supports in order to re-integrate into society; 
 
• to reduce the risk behaviour associated with drug misuse; 
 
• to reduce the harm caused by drug misuse to individuals, families and 
communities; 
 
• to have valid, timely and comparable data on the extent and nature of 
drug misuse in Ireland; and 
 
• to strengthen existing partnerships in and with communities and build 
new partnerships to tackle the problem of drug misuse. 
 
To sharpen the focus, the National Drugs Strategy 2001-2008 specifies 
objectives and key performance indicators for each of the four pillars – supply 
reduction, prevention, treatment, and research. These are outlined below: 
 
Supply Reduction 
 
The objectives in relation to supply reduction are: 
 
• to significantly reduce the volume of illicit drugs available in Ireland, to 
arrest the dynamic of existing markets and to curtail new markets as they 
are identified; and 
 
• to significantly reduce access to all drugs, particularly those drugs that 
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cause most harm, amongst young people especially in those areas where 
misuse is most prevalent. 
 
The key performance indicators in relation to supply reduction are: 
 
• increase the volume of opiates and all other drugs seized by 25% by end 
2004 and by 50% by end 2008 (using 2000 seizures as a base); 
 
• establish a co-ordinating framework in relation to drugs policy in each 
Garda District by end 2001; and  
 
• increase the level of Garda resources in Local Drugs Task Force areas by 
end 2001, building on lessons emanating from the Community Policing 
Forum model; 
 
• strengthen and consolidate existing coastal watch and other ports of entry 
measures designed to restrict the importation of illicit drugs; 
 
• co-operate and collaborate fully, at every level, with law enforcement and 
intelligence agencies, in Europe and internationally, in reducing the 
amount of drugs coming into Ireland. 
 
Prevention 
 
The objectives in relation to prevention are: 
 
• to create greater social awareness about the dangers and prevalence of 
drug misuse; and 
 
• to equip young people and other vulnerable groups with the skills and 
supports necessary to make informed choices about their health, personal 
lives and social development. 
 
The key performance indicators in relation to prevention are: 
 
• bring drug misuse by schools-goers to below the EU average and, as a 
first step, reduce the level of substance misuse reported to ESPAD by 
school-goers by 15% by 2003 and by 25% by 2007 (based on 1999 
ESPAD levels as reported in 2001); 
 
• develop and launch an ongoing National Awareness Campaign 
highlighting the dangers of drugs, the first stage to commence by end 
2001; 
 
• develop formal links at local, regional and national levels with the National 
Alcohol Policy, by end 2001 and ensure complementarity between the 
different measures being undertaken; 
 
• publish and implement a policy statement specifically relating to education 
supports for Local Drugs Task Force areas, including an audit of the level 
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of current supports, by end 2001; 
 
• nominate an official from the Department of Education and Science to 
serve as a member of each of the Local Drugs Task Forces by end 2001; 
 
• prioritise Local Drugs Task Force areas during the establishment and 
expansion of the services of the National Educational Welfare Board; 
 
• have comprehensive substance misuse prevention programmes in all 
schools and, as a first step, implement the “Walk Tall” and “On My Own 
Two Feet” Programmes in all schools in the Local Drugs Task Force areas 
during the academic year 2001/02; 
 
• complete the evaluation of the “Walk Tall” and “On My Own Two Feet” 
Programmes by end 2002; and 
 
• deliver the SPHE Programme (Social, Personal & Health Education) in all 
second level schools nation-wide by September 2003. 
 
Treatment 
 
The objectives in relation to treatment are: 
 
• to encourage and enable those dependent on drugs to avail of treatment 
with the aim of reducing dependency and improving overall health and 
social well being, with the ultimate aim of leading a drug-free lifestyle; and 
 
• to minimise the harm to those who continue to engage in drug-taking 
 
• activities that put them at risk. 
 
The key performance indicators in relation to treatment are: 
 
• have immediate access for drug misusers to professional assessment and 
counselling by health board services, followed by commencement of 
treatment as deemed appropriate, not later than one month after 
assessment; 
 
• have access for under-18s to treatment following the development of an 
appropriate protocol for dealing with this age group; 
 
• increase the number of treatment places to 6,000 places by end 2001 and 
to a minimum of 6,500 places by end 2002; 
 
• continue to implement the recommendations of the Steering Group on 
Prison-Based Drug Treatment Services as a priority and implement 
proposals designed to end heroin use in prisons during the period of the 
Strategy; 
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• have in place, in each Health Board are a, a service user charter by end 
2002; 
 
• have in place, in each Health Board area, a range of treatment and 
rehabilitation options as part of a planned programme of progression for 
each drug misuser, by end 2002; and 
 
• provide stabilised drug misusers with training and employment 
opportunities and, as a first step, increase the number of such 
opportunities by 30% by end 2004. 
 
Research 
 
The objectives in relation to research are: 
 
• to have available valid, timely and comparable data on the extent of 
drug misuse amongst the Irish population and specifically amongst all 
marginalised groups; and 
 
• to gain a greater understanding of the factors which contribute to Irish 
people, particularly young people, misusing drugs. 
 
The key performance indicators in relation to research are: 
 
• eliminate all major research gaps in drug research by end 2003; and 
 
• publish an annual report on the nature and extent of the drug problem 
in Ireland and on progress being made in achieving the objectives set 
out in the Strategy. 
 
Although not designated one of the 'pillars' of the National Drugs Strategy, key 
performance indicators relating to the establishment of an efficient and 
effective framework for implementing and evaluating the Strategy are 
identified. They include establishing an effective regional framework to 
support the measures; completing an independent evaluation of the 
effectiveness of the overall framework; requiring each agency to prepare a 
critical implementation path for each of the actions listed in the Strategy that 
are relevant to their remit; and reviewing the membership, workload and 
supports required by the National Drugs Strategy Team to carry out its terms 
of reference. 
 
Apart from specifying objectives and key performance indicators the Review 
Group also recommended 100 individual actions to be taken across the full 
range of Departments and Agencies involved in the delivery of drugs policy.  
The actions are designed to address specific gaps in the current strategy, to 
strengthen each of the four pillars which underpin it and to ensure that the 
foregoing objectives are met thus driving the new strategy forward.  Their 
implementation will be overseen by the Inter-Departmental Group on Drugs in 
consultation with the National Drugs Strategy Team.  Six monthly progress 
reports will be made to the Cabinet Committee on Social Inclusion. 
  14  
 
(b) Basic elements of drug policy at national, regional, local level 
 
At national level, the policy and co-ordination tasks in relation to the drugs 
issue overlap with the mechanisms to promote Social Inclusion in general in 
Ireland. Foremost among these mechanisms is the Cabinet Committee on 
Social Inclusion, which gives political direction to the Government's Social 
Inclusion policies, including the National Drugs Strategy. Chaired by the 
Taoiseach, this committee receives input on the drugs issue from the 
Department of Tourism, Sport and Recreation, the Inter-Departmental Group 
on Drugs (IDG) and the National Drugs Strategy Team (NDST). 
 
The Department of Tourism, Sport and Recreation has responsibility for the 
overall co-ordination of national policy to tackle drug misuse, including 
implementation of the National Drugs Strategy 2001-2008. The Department 
works in partnership with government departments, state agencies and the 
community and voluntary sectors, through the IDG and NDST. The 
Department's co-ordinating responsibilities also include the establishment of 
an evaluation framework for the National Drugs Strategy. The Department of 
Tourism, Sport and Recreation also has responsibility for local development, 
and the implementation of the Integrated Services Process (ISP). The aims of 
the ISP include the development of a more focused and better co-ordinated 
response by the statutory authorities to the needs of communities with the 
greatest levels of disadvantage. The ISP is aimed at developing an integrated 
framework within which ongoing programmes can be rationalised and 
enriched to do a better job of making services available to communities. 
 
In early 2001 the Government launched the RAPID (Revitalising Areas by 
Planning, Investment and Development) Programme, under the aegis of the 
Department of Tourism, Sport and Recreation. RAPID is a focused initiative 
by the Government targeting the twenty-five most concentrated areas of 
disadvantage in the country. The targeted areas will be prioritised for 
investment and development in relation to health, education, housing, 
childcare and community facilities including sports facilities, youth 
development, employment, drug misuse and policing. The programme is 
based on ISP principles, involving an implementation team (comprising state 
agency personnel, the local Area Partnership and residents of the local 
community) and a co-ordinator. Under the National Development Plan, up to 
Ir£15 billion / E19.5 billion has been earmarked for Social Inclusion measures, 
and the RAPID programme will prioritise the twenty-five targeted areas and 
front-load a significant share of this money to them over the next three years. 
 
The Department also has continuing responsibility for providing accessible, 
positive alternatives to drug misuse through the YPFSF, through arts and 
culture youth programmes, the schemes run by the Irish Sports Council and 
the facilities provided under the Sports Capital Programme. The National 
Drugs Strategy 2001-2008 states that LDTF areas should be prioritised and 
specific efforts made to ensure that the groups who are most at risk of drug 
misuse are actively engaged in recreational activities at local level. 
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The National Drugs Strategy Review Group noted that, in other countries, 
responsibility for co-ordinating drugs strategies usually resides either in the 
Department of the Prime Minister or the Department of Health. While the 
advantages of both these options were acknowledged (in terms of political 
authority, budget size and service-provision experience), the Review Group 
recommended retaining the responsibility in Tourism, Sport and Recreation. 
The Team considered that the Department of Tourism, Sport and Recreation 
can be objective in relation to all the thematic areas covered by the national 
policy. Moreover, given this Department's role in local development and co-
ordination of a number of different programmes relating to Social Inclusion, 
and given the correlation between drug misuse and social exclusion, it was 
considered that it was strategically well placed to take the lead role in co-
ordination. In other words, it can bring a holistic and integrated approach to 
the drugs issue. 
 
The Inter-Departmental Group on Drugs (IDG) plays a key role on overseeing 
the implementation of the National Drugs Strategy. Strengthened under the 
National Drugs Strategy 2001-2008 to comprise senior level representatives 
from government departments, and the chair of the NDST, and to be chaired 
by the Minister of State at the Department of Tourism, Sport and Recreation, 
the IDG, inter alia, will advise the Cabinet Committee on Social Inclusion on 
critical matters of a public policy nature relating to the National Drugs 
Strategy; ensure timely and effective input by relevant Departments and 
agencies into emerging operational difficulties or conflicts; and approve the 
plans and initiatives of the LDTFs and the proposed Regional Drugs Task 
Forces - RDTFs, and monitor and evaluate the outcomes of their 
implementation, in conjunction with the NDST. By the end of 2001, the IDG, in 
conjunction with the NDST, is to develop formal links at local, regional and 
national levels with the National Alcohol Policy, to ensure complementarities 
between the different measures being undertaken. 
 
The National Drugs Strategy Team (NDST) includes representatives from 
relevant government departments and agencies, and also two non-
government representatives, one each from the community and the voluntary 
sectors, making the NDTS a partnership between the statutory, community 
and voluntary sectors. Members of the NDTS play a central role in overseeing 
the implementation of the Government's National Drugs Strategy by ensuring, 
inter alia, effective co-ordination between departments, agencies and the 
community and voluntary sectors, in delivering LDTF and the proposed RDTF 
plans; reviewing the need for LDTFs in disadvantaged urban areas 
(particularly having regard to evidence of localised heroin misuse); identifying 
and considering policy issues and ensuring that policy is informed by the work 
of and lessons from the LDTFs; overseeing the establishment of the proposed 
RDTFs; drawing up guidelines for the operation of, and evaluating the action 
plans of, LDTFs and RDTFs. The NDTS has joint monthly meetings with the 
IDG, and they jointly report to the Cabinet Committee on Social Inclusion 
every six months. 
 
The National Drugs Strategy 2001-2008 identifies the need for an Oireachtas 
Committee on Drugs. The Strategy includes an action to establish a dedicated 
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drugs sub-committee of the existing Select Committee on Tourism, Sport and 
Recreation. This Oireachtas committee would meet at least three times a 
year. 
 
A number of government departments and agencies play lead roles in 
developing and implementing policy to tackle the drugs issue in Ireland. Their 
roles and responsibilities are outlined under the four pillars - supply reduction, 
prevention, treatment, and research. 
 
Supply Reduction  
 
Department of Justice, Equality and Law Reform 
 
The Department of Justice, Equality and Law Reform has overall 
responsibility for policy and legislation relating to the reduction of the supply of 
drugs. In recent years Ireland has put in place one of the strongest legislative 
frameworks in Europe for countering drugs. Key pieces of legislation include 
the Criminal Justice Act 1994, the Criminal Justice (Drug Trafficking) Acts 
1996 and 1999, the Criminal Assets Bureau Act 1996, and the Proceeds of 
Crime Act 1996. 
 
The National Drugs Strategy 2001-2008 tasks the Department with 
overseeing the establishment of a framework to monitor the number of 
successful prosecutions, arrests and the nature of the sentences passed; 
establishing, after consultation, best-practice guidelines and approaches for 
community involvement in supply control activities with the law enforcement 
agencies; reviewing the ongoing effectiveness of crime legislation in tackling 
drug-related activity; and working with regional health boards in considering 
how best to integrate child-care facilities in treatment and rehabilitation 
centers and in residential treatment settings. 
 
An Garda Síochána 
 
An Garda Siochána has responsibility for the State security services and all 
traffic and criminal law enforcement functions, including those laws related to 
drug offences. Special units have been integrated into the organizational 
structure of An Garda Siochána in an effort to address the drugs issue. In 
each of the country's twenty-seven Garda Divisions, there is a specialised 
Drug Unit, which has responsibility for the enforcement of drugs legislation. 
There may also be a Drug Unit in a District where drugs present particular 
problems. 
 
The Garda National Drugs Unit (GNDU) was established in 1995 with specific 
responsibility for drug law enforcement. The primary focus of the GNDU is to 
target major drug traffickers, as well as monitoring, controlling and evaluating 
all drug intelligence and policies within the force. As part of its focus on the 
national and international aspects of drug trafficking, the GNDU maintains 
close liaison with police forces from other jurisdictions, through various police 
networks and operational exchange programmes (An Garda Síochána, 1999). 
In 1996 the Criminal Assets Bureau was set up as an inter-agency response, 
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including An Garda Síochána, the Office of the Revenue Commissioners and 
the Department of Social, Community and Family Affairs, to target the 
proceeds of crime, especially drug trafficking. At a community level 
Community Policing Fora have been established on a pilot basis in several 
LDTF areas. The Garda have also been instrumental in implementing a 
number of operations addressing supply reduction, including Cleanstreet, 
Nightcap, Rectify, Tap and Dóchas. Under the National Drugs Strategy 2001-
2008 it is intended to extend, and enhance the efficiency of, all the above 
initiatives - adding resources to existing drug units, and establishing drug units 
in areas where they don't exist; establishing a co-ordinating framework for 
drugs policy in each Garda District to liaise with the community and act as a 
source of information for parents and members of the public; increasing the 
level of Garda resources in LDTF areas, building on the lessons learned from 
the Community Policing Fora, and extending the Community Policing Forum 
model to all LDTF areas, if the evaluation of the pilot is positive. 
 
Office of the Revenue Commissioners 
 
The Office of the Revenue Commissioners includes the Customs and Excise 
Service. Customs have primary responsibility for the prevention, detection, 
interception and seizure of controlled drugs, intended to be smuggled or 
imported illegally into the State. 
 
In 1992 a Customs National Drugs Team was established, with the principal 
role of directing the work of Customs on the prevention of drugs smuggling 
and the enforcement of legislative provisions regarding the import and export 
of controlled drugs and other substances. The Team's units are strategically 
located around the coast of Ireland in an effort to prevent drug trafficking. 
 
In 1996 a Memorandum of Understanding was agreed between Customs and 
Excise and An Garda Síochána regarding drugs law enforcement. As a result, 
a joint task force comprising Customs, Garda and the Naval Service was 
established, and personnel are exchanged at national level, and liaise at local 
level. Customs also liaise with the Garda National Drugs Unit and the Criminal 
Assets Bureau. Customs have also entered into agreements with trade 
associations and individual companies regarding detection of illegal drug 
smuggling, and developed a Coastal Watch Programme, which enlists the 
help of coastal communities and seagoing personnel in reporting suspicious 
activities. At an international level, the customs services of all EU member 
states are linked electronically to facilitate quick and effective exchanges of 
information. A Customs official has been assigned to the Irish Embassy in 
London, and appointments are to be made to Europol in The Hague.  
 
Under the National Drugs Strategy 2001-2008, these initiatives are to be 
strengthened and consolidated. Close liaison and collaboration, both 
nationally and in conjunction with enforcement and intelligence agencies in 
Europe, are to be developed; coastal watch and other port-of-entry measures 
to restrict importation of illicit drugs are to be strengthened; and a Customs 
official is to be assigned to the Europol National Unit. The Customs and 
Excise Service is also to develop benchmarks, in conjunction with the Gardaí, 
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against which seizures of heroin and other drugs can be evaluated under the 
EU Action Plan on Drugs (Commission of the European Communities, 1999), 
in order to establish progress on a yearly basis. 
 
Prisons Service 
 
The Prisons Service has responsibility for the provision and maintenance of a 
secure, efficient and progressive system of containment and rehabilitation for 
offenders committed to custody. This role is undertaken in a co-operative and 
co-ordinated way with prisoners, their families, the community, other 
Government Departments and statutory agencies. However, serious capacity 
problems have, in the past, led to overcrowding, particularly in Mountjoy 
prison, which was, until recently, the main committal prison in the State. This 
severely undermined the development of prison-based treatment services in 
the past. However, the current prison building programme will alleviate this 
situation and will, accordingly, facilitate the on-going development of these 
services. In the past year, two new prisons have come on stream, Cloverhill 
Prison in Clondalkin and the Midlands Prison in Portlaoise. In addition, 
extensive redevelopment work is planned for Cork, Limerick and Mountjoy 
prisons. In this regard, approx. 1,000 extra prison places have been provided 
and 1,000 more are planned. 
 
Department of the Environment and Local Government 
 
Under the 1997 Housing Act, the Department of the Environment and Local 
Government provides financial support to local authorities for housing 
management activities and other initiatives, on local authority estates, which 
are associated with problems of drug-related crime and anti-social behaviour. 
 
Prevention  
 
Department of Education and Science 
 
The Department of Education and Science plays a role in relation to 
prevention, operating mainly through the formal education system. Its 
initiatives to combat drug use, such as 'Walk Tall' for primary level and 'On My 
Own Two Feet' for secondary level, and more recently the Social, Personal 
and Health Education (SPHE) programme, are linked to its overall package of 
measures to combat educational disadvantage. The National Drugs Strategy 
2001-2008 stipulates that the Department is to ensure that every second-level 
school is to have an active programme to counter early school-leaving, with 
particular focus on areas with high levels of drug misuse.  
 
In the non-formal education sector, the Department of Education and Science 
works closely with FÁS on joint-funded initiatives such as Youthreach, and in 
the running of workshops aimed at increasing drug awareness in areas where 
acute drug problems are apparent. In relation to LDTFs, the role of the 
Department of Education is to be strengthened under the National Drugs 
Strategy 2001-2008. The Department is to publish and implement a policy 
statement on education supports in LDTFs, including an audit of current 
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supports, by the end of 2001, and to nominate a departmental official to serve 
on each LDTF. 
 
Department of Health and Children 
 
The Department of Health and Children also places considerable emphasis 
on the need for education and prevention. The National Health Promotion 
Strategy, approved by the Government in 2000, has a strategic aim “to 
endeavour to reduce the numbers engaging in drug misuse”. The Health 
Promotion Unit (HPU) promotes a multi-faceted approach to drug awareness, 
education and prevention. A range of activities are supported, for example: 
 
• life-skills programmes; 
• award programmes for schools; 
• initiatives in the youth service; 
• the dissemination of resource material; 
• and local campaigns in ERHA areas. 
 
The HPU also formulates preventative policies. However, the implementation 
of these policies on the ground is very much a matter for the regional Health 
Boards, as the Department’s role – at the policy level – has been to monitor 
and oversee implementation and to provide resources. The Department 
situates its policy responses in the context of UN efforts to combat drugs 
through establishing targets to be achieved by 2008. 
 
An Garda Síochána 
 
The Gardaí are also active in prevention, particularly in relation to young 
people involved in, or at risk of becoming involved in, drugs and crime. 
Initiatives include the Garda Youth Diversion Projects, generally managed by 
Foróige and/or the City of Dublin Youth Service Board; the Drug Awareness 
Programme for communities; Garda Schools Programmes; the Garda Mobile 
Anti-Drugs Unit; and the Juvenile Diversion Project. Garda Juvenile Liaison 
Officers are also assigned throughout the country. The National Drugs 
Strategy 2001-2008 identifies an opportunity for enhanced co-ordination, 
whereby incidences of early use of alcohol or drugs by young people coming 
to Garda attention are followed up by the Community Police and/or the health 
and social services, so that problem-drug misuse may be diagnosed/halted 
early on. 
 
Young People's Facilities and Services Fund 
 
In 1998, the Young People's Facilities and Services Fund (YPFSF) was set up 
to develop youth facilities, including sport and recreational facilities, and 
services in disadvantaged areas where a significant drug problem exists or 
has the potential to develop. The primary focus of the Fund is on LDTF areas 
and selected urban areas (i.e. Galway, Limerick, South Cork City, Waterford 
and Carlow) where a serious drug problem exists or has the potential to 
develop. A sum of £102 million has been provided under the National 
Development Plan (2000 – 2006) to support measures under the Fund, of 
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which approx. £46 million has been allocated to date in the first round of 
funding. 
 
In establishing the Fund, the Cabinet Committee set up a National 
Assessment Committee to (i) prepare guidelines for the development of 
integrated plans in the target areas, which meet the overall aims and 
objectives of the Fund; (ii) facilitate the establishment of the local structures 
charged with developing plans; (iii) assess the plans emanating from each of 
the target areas and (iv) make recommendations on funding to the Cabinet 
Committee on Social Inclusion. The National Assessment Committee is 
responsible for monitoring on-going progress in implementing the plans and 
strategies approved and addressing any difficulties or issues arising. It is also 
overseeing an external evaluation of the Fund, in conjunction with the 
Department of Education and Science, which will provide a comprehensive 
and independent assessment of the Fund, taking account of its overall aims 
and objectives. The evaluation of the Fund commenced in April 2001. 
 
Local Drug Task Forces 
 
The Local Drug Task Forces  (LDTFs), in the context of implementing their 
Action Plans, are delivering a range of measures in the education, prevention 
and awareness areas. Initiatives include community-based drug awareness 
programmes in schools, youth clubs and other places where young people 
congregate; drug awareness programmes for parents, teachers etc; peer 
education programmes and projects to prevent early school-leaving. 
 
Treatment  
 
Department of Health and Children 
 
The Department of Health and Children has overall policy and legislative 
responsibility for health, social services and child welfare in Ireland, as well as 
various responsibilities for aspects of drug policy, principally treatment and 
rehabilitation services. In developing its policy on drug misuse, the 
Department has adopted a health promotion approach. The Department’s 
national policy on the treatment of alcohol and drug misuse stresses the need 
for community based interventions rather than specialist in-patient 
approaches. These services include family support and community medical 
and social services. 
 
Responsibility for the provision of treatment and rehabilitation services for 
drug misusers is vested with the ten Regional Health Boards. The Health 
Boards also provide support and training for community groups which are 
involved in drug - related prevention or rehabilitation activities, as both the 
community and voluntary sectors play a significant part in the provision of 
drug related services, especially in the LDTF areas. The Health Boards have 
appointed Regional Drug Co-ordinators and many have also established 
Regional Drug Co-ordinating Committees comprising representatives of the 
relevant Health Board, An Garda Síochána, Education Services and the 
community and voluntary sectors. There is regular contact between the NDST 
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and the Regional Drug Co-ordinators. 
 
Growth in drug-related problems throughout the country has resulted in the 
need for many of the Health Boards to formulate a specific drug strategy for 
their region. This is especially the case in the area of development of 
services, which are local and tailored to the needs of particular communities. 
The majority of these strategies are being developed at present in accordance 
with emerging trends which are specific to the individual regions. Perhaps not 
surprisingly, the emphasis in many Health Boards outside of the Eastern 
region has been on education and prevention initiatives. However, because of 
the nature of the drug problem in the Eastern catchment area, the Eastern 
Regional Health Authority (ERHA) has been involved in a significant degree of 
activity and expansion of treatment services within its area. The expansion of 
services in the ERHA area has been a priority in order to protect the health of 
misusers themselves, to prevent the spread of infectious diseases and to 
reduce the effect of chaotic behaviour on certain neighbourhoods. 
 
Prison Service 
 
In October 2000, the Government approved in principle the implementation of 
the recommendations contained in the Report on Prison-Based Drug 
Treatment Services which was produced by a Steering Group, established by 
the Director General of the Prison Service. These proposals will result in a 
major overhaul of prison-based drug treatment services and should make a 
major contribution to breaking the cycle of drug dependency, crime and 
imprisonment which are inextricably linked at present. Perhaps the main 
conclusion of the report is that the Prisons Service must replicate in prison, 
the level of medical and other supports available in the community for drug 
dependent people, to the maximum extent possible. 
 
In addition, the report proposes a multi-disciplinary approach to the drug 
problem in prisons and the appointment of a senior figure from the ERHA to 
co-ordinate the overall treatment service in the Dublin prisons, as well as 
drugs counsellors and extra nurses, psychologists and probation service staff. 
All staff in the relevant institutions will receive training in drugs-related issues 
and refresher courses every year thereafter. Links are also being established 
with local community and voluntary groups, through liaison committees, to 
enhance the throughcare and aftercare arrangements for prisoners in receipt 
of drug treatments in custody. Implementation of the recommendations of the 
report are progressing at present.  
 
Probation and Welfare Service 
 
The Probation and Welfare Service, although not a primary drug treatment 
agency, co-ordinates a range of drug treatment initiatives, in co-operation with 
a number of rehabilitation agencies and the community. 
 
Drug Court 
 
A Drug Court was established in January 2001 in the North Inner City of 
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Dublin. It has as its primary aim “the reduction of crime through rehabilitation 
of the offender but not excluding punishment should the circumstances so 
warrant”. Rehabilitation and structured supervision will be used to help 
participants to escape the cycle of offending with the ultimate objective of 
ending all criminal activity. It is hoped that best practice will be identified to 
allow for expansion, as appropriate. 
 
FÁS 
 
FÁS, the state training agency, operates specific drug-related programmes, 
including the Special Drugs Community Employment Programme, on which 
1,000 places have been assigned for recovering drug misusers. Trained staff 
are available to work with stabilised drug misusers, to help them access 
employment or further training. Similarly, advocates, located in severely 
disadvantaged areas, provide a mentoring service to young people 
experiencing drug problems. 
 
Acknowledging that the FÁS Community Employment Programme has been 
an important element of the existing approach to rehabilitation, the National 
Drugs Strategy 2001-2008 sets a target for increasing the number of training 
and employment opportunities for drug misusers by 30 per cent by the end of 
2004. The Strategy also identifies the need to examine the potential to involve 
recovering drug misusers in Social Economy projects, and in other forms of 
vocational training. 
 
Department of the Environment and Local Government 
 
Special high support hostel accommodation is necessary for homeless people 
with drug dependence problems. Under the Homeless Strategy, funding has 
been provided by the Government for the provision of two high support 
hostels in Dublin for people with drug and alcohol dependence problems. In 
view of the number of people with such problems in Dublin, Dublin 
Corporation and the ERHA are taking the lead role in drawing up and 
implementing suitable proposals. 
 
Voluntary Drug Treatment Network 
 
The Voluntary Drug Treatment Network provides a framework for a number of 
voluntary drug groups working in the area of treatment to meet, share issues 
of concern and develop more comprehensive responses to the prevention and 
treatment of problem drug use. The Network is an umbrella group that aims to 
challenge drug misuse and related issues in a creative, caring and 
motivational way. It provides a comprehensive range of drug treatment 
methods that range from harm reduction intervention through to long-term 
residential drug-free programmes. There are two core strands to the 
composition of the Network. These are localized community-based treatment 
responses, that have emerged from local residents and individuals seeking to 
respond to issues in their areas and regional responses that provide treatment 
at national and, occasionally, at EU level. 
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The Network has representatives on the National Aids Strategy Committee, 
the NDST and the National Advisory Committee on Drugs (NACD). They are 
also members of the Community Platform that forms part of the Community 
and Voluntary Pillar of the Social Partnership. However, the Network itself 
does not have a national remit to represent all the voluntary drug treatment 
organizations in the country. It is primarily for the Dublin based organisations 
which deal with drug misuse but some of its members do have a national 
focus in terms of treatment and training. The Network engages with various 
Government Departments and Regional Health Boards who assist in the 
funding of its services. 
 
Research  
 
Drug Misuse Research Division 
 
The Drug Misuse Research Division (DMRD) of the Health Research Board 
was established in 1989 and is responsible for operating the National Drug 
Treatment Reporting System (NDTRS) which is the main source of 
information on drug misuse in Ireland. The NDTRS is an epidemiological 
database, which provides data on people who avail of treatment services for 
problem drug use, on a nationwide basis. This provides information on the 
current patterns and trends of treated drug use and drug addiction in Ireland. 
Data is provided to the NDTRS through centers or service locations where 
drug misuse is treated. 
 
The Government has designated the DMRD as the central point to which all 
research data and information should be channelled. In order to deliver on the 
role assigned to it, the DMRD is developing a National Documentation Centre 
which policy-makers and other interested parties can use to access all 
relevant and up-to-date information and research in the field of drug misuse in 
Ireland and internationally. In addition to existing data, all future research and 
information will be channelled or, as appropriate, its existence notified and 
recorded in a way which facilitates ease of retrieval by policy-makers and 
other interested parties. The Documentation Centre will build on the existing 
resources of the DMRD and will capitalise on its position as the National Focal 
Point for the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). 
 
National Advisory Committee on Drugs 
 
The National Advisory Committee on Drugs (NACD) was established in July 
2000 to advise the Government in relation to the prevalence, prevention, 
treatment and consequences of problem drug use in Ireland, based on the 
Committee's analysis and interpretation of research findings and information 
available to it. The Committee is overseeing the delivery of a three year 
prioritised programme of research and evaluation on the extent, nature, 
causes and effects of drug misuse in Ireland, identifying the contribution which 
can be made by all the relevant interests. Its membership reflects statutory, 
community, voluntary, academic and research interests as well as 
representation from the relevant Government Departments. The Committee 
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operates under the aegis of the Department of Tourism, Sport and 
Recreation. 
 
Health Promotion Unit of the Department of Health and Children 
 
The Health Promotion Unit (HPU) of the Department of Health and Children is 
also involved in the publication and dissemination of information and literature 
which promotes the avoidance of drug misuse. In this regard, the National 
Health Promotion Strategy sets clear aims and objectives to support best 
practice models which promote the non-use of drugs and, where they are 
used, the minimisation of the harm done by them. 
 
Conclusion 
 
Ireland's National Drugs Strategy 2001-2008 has been developed in the 
context of various international and EU agreements, for example the Political 
Declaration on the Guiding Principles of Drugs Demand Reduction (UN 
Special Session on Drugs, held in New York, 1998)1, the UN Conventions on 
Narcotic Drugs and Psychotropic Substances2, the EU Action Plan on Drugs 
2000 – 2004 (Commission of the European Communities, 1999), and the EU 
Drugs Strategy 2000 - 2004 (CORDROGUE 64, 1999). Development of the 
strategy has also involved extensive consultation, including public fora in a 
number of centers throughout the country. 
 
The main changes and new directions in Irish drugs policy, strategies, 
implementation and evaluation can be summarised as follows: 
 
• publication of a major review of the National Drugs Strategy; 
• adoption of the promotion of Social Inclusion as one of the priorities of the 
National Development Plan 2000-2006, and the situation of the drugs 
issue within this context; 
• adoption of National Drugs Strategy for 2001-2008; 
• greater devolution of power to regional structures, with which existing 
structures in the drugs area will co-operate; 
• continued adoption of an integrated, inter-agency response to the drugs 
problem involving local communities; 
• continued involvement of local communities in the development and 
implementation of drugs policy; 
• increasing role of voluntary and community sectors; 
• continued development of a culture of evaluation and increased resources 
of knowledge infrastructure to support same; and 
• development of drug-related research and information capability. 
                                                     
1 At a UN Special Session on Drugs, held in New York in 1998, a Political Declaration on the Guiding 
Principles of Drug Demand Reduction was adopted. It put an onus on every member state to have in 
place a comprehensive drugs policy and an outline of how targets are to be achieved over the period 
2000 to 2008. 
2 Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol Amending the Single 
Convention on Narcotic Drugs, 1961; the Convention on Psychotropic Substances, 1971; and the UN 
Convention against the Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. The 
conventions may be accessed through the website - www.incb.org/e/conv/ 
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1.2 Policy implementation, legal framework and prosecution - 
Mary O’Brien 
 
a) Law and regulations  
 
Recent changes in legislation 
 
Responsibility for the making of laws for the Republic of Ireland is vested in 
the Oireachtas (Parliament) subject to the obligations of European Union 
Membership as provided in the Constitution of Ireland. The Oireachtas 
consists of the President and two Houses, Dáil Eireann (House of 
Representatives) and Seanad Eireann (Senate).  The Irish Statute Book3 is 
made up of Acts of the Oireachtas and Statutory Instruments (S.I.).   
 
The legislation is drawn up by relevant government departments: Health & 
Children; Justice, Equality & Law Reform; and Environment and Local 
Government.  It is implemented by An Garda Siochana (the Irish Police 
Force), the Revenue Commissioners and Customs authorities. 
 
 The Misuse of Drugs Acts 1977 and 1984 are the two central pieces of 
legislation under which the majority of prosecutions in relation to drug 
misusers are made.  A brief description of these Acts and the relevant listing 
of Regulations can be found at Appendix 1. These Acts provide for a wide 
range of controls over drugs, which are liable to be misused. They include 
controls relating to cultivation, licensing, administration, supply, record 
keeping, prescription writing, destruction and safe custody.  These laws also 
include provisions designed to deal with the irresponsible prescribing of 
controlled drugs by medical practitioners.  
 
 In the past few years a number of changes have been made to the legislative 
framework surrounding drug issues.   The Criminal Justice Act, 1999 makes 
amendments to the Misuse of Drugs Act, 1977 to provide for a new drug 
related offence.  The new section (15A) creates a new offence related to the 
possession of drugs, with a value of IR£10,000/ Euro12,700 or more, for the 
purpose of sale or supply.  A person found guilty of such an offence may be 
imprisoned for up to life and be subject to an unlimited fine.  The Act also 
provides for a mandatory minimum sentence of ten years in prison.  However, 
where it is found that addiction was a substantial factor leading to the 
commission of the offence, the sentence may be reviewed after half of the 
mandatory period, at which time the court may suspend the remainder of the 
sentence on any condition it sees fit. 
 
 The Housing (Traveller Accommodation) Act, 1998, which is the legislative 
framework within which housing authorities provide for the accommodation 
needs of Travellers, is a key element in the Government’s efforts to promote 
social inclusion and equality and to counter discrimination.  This law applies 
                                                     
3 Electronic versions of the Irish Statute Book (Acts of the Oireachtas and Statutory Instruments) 1922-1998 may be viewed at 
the website of the Attorney General’s Office  www.irlgov.ie/ag/default.htm.  Hard copies may be purchased from the 
Government Publications Sales Office, Sun Alliance House, Molesworth Street, Dublin 2.  
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relevant sections of the Housing (Miscellaneous Provisions) Act, 1997 in respect 
of the control of anti-social behaviour, such as drug dealing, to halting sites 
provided by local authorities or by voluntary bodies.   
 
 New legislation in relation to mental health, which is being drawn up, 
proposes that addiction will be excluded from the scope of the definition of 
mental disorder in the legislation.  Although in practice it is not invoked, under 
current legislation (Mental Treatment Act, 1945) addiction remains on the 
statute books as a criterion for non-voluntary committal to a psychiatric 
hospital.  It is now considered unacceptable to detain by law, people whose 
primary problem is addiction. 
  
 Regulations introduced in 1999 (Misuse of Drugs (Amendment No. 1) 
Regulations, 1999) gave authority to certain officials of the Department of 
Agriculture to possess cannabis hemp, lawfully, in the course of their duties 
for monitoring and sampling in the production of hemp fibre.   
 
 In 2000 new regulations (Customs-free Airport (Extension of Laws) 
Regulations, 2000) were introduced to extend drug controls under the Misuse 
of Drugs Acts, 1977 and 1984, and the Irish Medicines Board Act, 1995, to 
include the Customs free area at Shannon airport.  This instrument covers a 
loophole in the legislation and allows the Irish Medicines Board to inspect any 
company within the customs free area at Shannon Airport. 
 
 An order has been drafted (Misuse of Drugs Act, 1977 (Controlled Drugs) 
(Declaration) Order, 1999) to extend the list of substances controlled under 
the Misuse of Drugs Acts.  The need to do this arose out of Ireland’s 
obligations under the United Nations Conventions on Narcotic Drugs, 
Psychotropic Substances and Precursor Chemicals4, but also because of 
concerns about the abuse of amphetamine-type substances, and the use of 
certain drugs in sport.   The drugs to be controlled include substances 
associated with ecstasy misuse (4-MTA, ketamine, ephedrine and 
pseudoephedrine), as well as a number of substances which are on the 
current International Olympics Committee list of prohibited substances in an 
effort to prevent doping in sport.   This order is due to be brought into force 
before the end of 2001.   
 
Health and social drug-related issues  
 
Social and health drug-related issues have arisen, particularly in relation to 
the implementation of two pieces of legislation.  The first is a health issue in 
relation to the Criminal Law (Sexual Offences) Act, 1993. A study carried out 
by the Women’s Health Project in Dublin (O’Neill and O’Connor 1999) found 
that the legislation dealing with prostitution is having a negative impact on the 
lives of prostitutes.  The researchers comment that increasing complaints 
from local residents and the requirements of the legislation, that anyone 
‘loitering for the purposes of prostitution’ be directed from the area, has 
resulted in sex workers going underground and working in increasingly unsafe 
environments. Consequently, it is becoming more difficult for health workers, 
                                                     
4 The conventions may be accessed through the website – www.incb.org/e/conv/.   
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with the aim of providing healthcare and preventing HIV, to reach the women.  
This has serious implications for public health policy.  The authors of the study 
recommend that a review of the current legislation be undertaken as soon as 
possible.   
 
The second is a social and health issue in relation to housing legislation 
(Housing (Miscellaneous Provisions) Act, 1997) and its effect on drug users.  
This law allows public housing authorities to initiate an excluding order 
procedure against occupants of local authority housing who are ‘involved in 
anti-social behaviour’.    A study of the impact of the legislation (Memery and 
Kerrins 2000) found that it gave local authorities the political go-ahead to evict 
tenants and to use indirect means, such as encouraging other family 
members to exclude the individual, to remove those considered to be involved 
in anti-social behaviour much of which was drug-related.  People excluded 
from access to public housing can find themselves also discriminated against 
in seeking hostel accommodation because of their drug use.  The exclusion of 
the individual involved in anti-social behaviour from the home, results in the 
loss of essential family supports, as well as removal from community based 
drug services.  This report states that ‘street homelessness resulting from 
exclusion leads to open drug taking and riskier drug taking practices’ (p 33).  
Such behaviour will increase the risk of contracting infectious diseases. 
Outreach workers from one local drug project are experiencing difficulty in 
contacting intravenous drug users because they have gone ‘underground’ for 
fear of local anti-drug activists (personal communications with drug project 
workers).  A study of out-of-home drug users (Cox and Lawless 1999) 
suggests that the housing legislation has contributed to the rise in homeless 
among drug users.  
 
Other aspects of drug legislation were criticised at the public National Forum 
on Crime held in 1999.  One such issue, is the provision under the Criminal 
Justice (Drug Trafficking) Act, 1996, which allows the police to detain a 
person accused of drug trafficking for a period of seven days.  Some 
contributors to the Forum considered that this provision could prove to be 
counterproductive, resulting in more convictions of drug users and small-time 
dealers rather than curbing the activities of large-scale drug traffickers.  
Another was the then proposal (now law - Criminal Justice Act, 1999) to 
provide for a new drug offence related to the possession of drugs, with a 
value of IR£10,000 or more, for the purpose of sale or supply, and for a 
mandatory minimum sentence of ten years in prison.  It was criticised ‘both on 
grounds of principle relating to mandatory sentences generally and because 
of the difficulty of establishing the actual value of a seizure’ (National Crime 
Forum Report 1998, p. 72).  
 
Barry (2000) in a discussion paper writes that the supply of drugs and the 
legal framework in which drug policy is formulated in Ireland require 
examination.  He poses the question as to what the benefits and 
disadvantages of current drug laws are to the health of the population.  He 
suggests that posing such questions usually meets a blanket response of no 
softening of the laws on drugs.  He also comments that there does not seem 
to be an acknowledgement of the fact that there is not necessarily a link 
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between whether something is legal, and whether it is good or not good for 
one.  He proposes that the time is right to have an honest debate on the 
current legislative basis of drug policy in Ireland; and though such a debate 
may not be welcomed, he posits that it is necessary. 
 
b) Prosecution policy, priorities and objectives in relation to drug 
addicts, occasional users, drug-related crime 
 
All criminal prosecutions are taken under the authority of the Director of Public 
Prosecutions (DPP).  It is a function of the Garda Siochana (police) not alone 
to investigate crime but also to initiate prosecutions and in summary cases 
(where an offence is a minor one chargeable by way of a summons, tried 
before a judge)  to prosecute offenders to verdict.  Consequently most 
prosecutions are taken by the police, usually the Garda who investigated the 
matter, under the name of the DPP.   
 
Sections 3 and 15 of the Misuse Drugs Act, 1997, are the sections most 
frequently used in drug prosecutions.  Section 3 covers the possession of any 
controlled drug, and Section 15 concerns trafficking of controlled substances. 
The use per se of a drug, other than opium, is not a criminal offence. 
 
In addition to custodial measures there is a range of non-custodial options 
available to sentence those who plead or are found guilty.  The decision of the 
court in relation to sentencing may be influenced by a Pre-Sanction Report.  
This report is compiled by the Probation and Welfare Service and includes 
information on factors that may have contributed to the individual’s offending, 
such as addiction to drugs.  Non-custodial options include : 
 
• Probation Order (Probation of Offenders Act, 1907) – this is to secure the 
rehabilitation of the offender, to protect the public and to prevent the 
offender from committing further offences.  It is used, inter alia, for drug 
users where conditions may include attendance for treatment and the 
provision of urine for analysis.  This is the preferred procedure in the 
District Court when dealing with drug users. 
• Order of Recognisance (Misuse of Drugs Act, 1977, Section 28 as 
amended by the Misuse of Drugs Act, 1984) – This is an order requiring an 
offender to undergo treatment for drug addiction in a residential centre or 
in the community.  This is an important non-custodial option for drug users 
who offend in Ireland. However, in practice this Order is not generally used 
by the courts since the provision of a statutory place of treatment has 
always been problematic, inter alia.  
It has been recommended that the necessary Courts’ Rules and Regulations 
be updated by the various Court Rules Committees (Final Report of the 
Expert Group on the Probation and Welfare Services, 1999).   
c) Any other important project of law or other initiative with political 
relevance to drug related issues 
While the legislative framework requiring an individual to undergo treatment 
for drug addiction as a non-custodial option in sentencing exists, in practice it 
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is rarely used by the courts.  A Drug Courts system, initially on a pilot basis in 
Dublin, under the jurisdiction of the District Court, was established in January 
2001.  These courts are treatment oriented, where people with a drug problem 
and who are charged with non-violent offences, are diverted to treatment 
programmes rather than to prison.  This development is likely to have major 
implications for treatment services and the success of the initiative will depend 
on the formulation and implementation of cohesive treatment and 
rehabilitation programmes.   
The Medical Bureau of Road Safety at the Department of Forensic Medicine, 
National University of Ireland, Dublin, in collaboration with the Garda 
Siochana (police) has undertaken a study to examine the level and type of 
drug use among drivers and its contribution to accidents.  All samples 
submitted between 1 July and 31 December 1999, which were under the legal 
limit for alcohol, were tested.  Preliminary results from 338 samples showed 
that cannabis was most frequently found (34%), followed by benzodiazepines 
(25%).  Cocaine was the drug least commonly found at 4% of the sample 
(Moane et al. 2000).    
 
 
1.3 Developments in public attitudes and debates – Hamish 
Sinclair and Brigid Pike 
 
a) Public perceptions of the drug issues and public debates carried 
out by civil society, national Parliament, organizations, NGO’s 
 
The first national survey of Drug-Related Knowledge, Attitudes and Beliefs in 
Ireland was published by the Drug Misuse Research Division of the Health 
Research Board in September 2000. The questionnaire on which the research 
was based constituted a module of the 1998 Irish Social Omnibus Survey. A 
total of 1,000 adults 18 years and over, randomly selected from the 1997 
Register of Electors for Ireland, took part in the study. Data was collected 
using face-to-face interviews between February and April 1998. 
 
A second national survey of Drug-Related Knowledge, Attitudes and Beliefs in 
Ireland was commissioned by the Drug Misuse Research Division in 2000 and 
carried out as part of the 2000 Irish Social Omnibus Survey.  A total of 1,000 
adults 18 years and over, randomly selected from the 2000 Register of 
Electors for Ireland, took part in the study. Data was collected using face-to-
face interviews between November and December 2000. 
 
Some of the main changes in the public’s drug related attitudes and beliefs 
between 1998 and 2000 are summarised below. 
 
Concern about the drug problem in Ireland remains high, especially regarding 
the threat to young people from the availability of illegal drugs (Table 1.3a). 
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Table 1.3a.  Changes in the perceived extent and nature of the drug problem in Ireland, 
1998 and 2000 
 
Statement 
Survey year 
(number of 
responses) 
Agree 
 
(%) 
Disagree 
 
(%) 
Don’t 
Know 
(%) 
1998 (n = 998) 56.1 30.5 13.4 Alcohol abuse causes more problems in 
society than drug abuse 2000 (n = 999) 54.8 25.5 19.7 
1998 (n = 999) 46.9 38.7 14.3 Drugs are not really a problem to us here in 
this neighbourhood 2000 (n = 996) 36.8 46.0 17.2 
1998 (n = 998) 91.0 5.2 3.8 Most people are concerned about the drug 
problem in Ireland 2000 (n = 1000) 88.3 8.6 3.1 
1998 (n = 996) 75.0 15.1 9.9 The drug problem in Ireland is out of control 
2000 (n = 998) 74.4 13.2 12.3 
1998 (n = 998) 94.4 2.0 3.6 Drug related crime is a major problem in 
Ireland today 2000 (n = 996) 88.6 6.1 5.3 
1998 (n = 995) 94.4 2.1 3.5 The availability of illegal drugs poses a great 
threat to young people nowadays 2000 (n = 995) 96.9 0.3 2.8 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
Concern regarding the availability of drugs in local neighbourhoods has 
increased, with only 36.8% of respondents in 2000 agreeing with the 
statement that drugs were not really a problem in their neighbourhood 
compared with 46.9% in 1998. 
  
Sympathy for drug-addicted individuals has grown, with fewer people (30.4% 
in 2000 compared to 39.7% in 1998) agreeing that many drug addicts 
exaggerate their troubles to get sympathy and fewer (43.4% in 2000 
compared to 52.5% in 1998) agreeing that almost all drug addicts are 
dangerous (Table 1.3b). However, while 45.6 per cent disagree that they 
would see drug addicts more as criminals than as victims in 2000, a growing 
proportion (61.7% in 2000 compared to 56.9% in 1998) agree that people who 
end up with a drugs problem have only themselves to blame.  
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Table 1.3b.  Changes in the attitudes towards drug addicts, 1998 and 2000 
 
Statement 
Survey year 
(number of 
responses) 
Agree 
 
(%) 
Disagree 
 
(%) 
Don’t 
Know 
(%) 
1998 (n = 999) 42.6 45.2 12.1 I would see drug addicts more as criminals 
than victims 2000 (n = 998) 37.8 45.6 16.6 
1998 (n = 999) 71.1 21.6 7.3 I would tend to avoid someone who is a drug 
addict 2000 (n = 998) 69.0 21.8 9.1 
1998 (n = 999) 30.5 50.7 18.8 Drug addicts are not given a fair chance to get 
along in society 2000 (n = 995) 30.1 48.6 21.3 
1998 (n = 999) 56.9 33.9 9.2 People who end up with a drugs problem have 
only themselves to blame 2000 (n = 998) 61.7 26.0 12.3 
1998 (n = 997) 66.4 26.0 7.6 Drug addicts really scare me 
2000 (n = 999) 61.1 29.9 12.1 
1998 (n = 998) 39.7 29.1 31.3 Many drug addicts exaggerate their troubles to 
get sympathy 2000 (n = 995) 30.4 36.9 32.8 
1998 (n = 998) 52.5 34.7 12.8 Almost all drug addicts are dangerous 
2000 (n = 997) 43.4 42.6 13.9 
1998 (n = 995) 69.9 22.4 7.6 It would bother me to live near a person who is 
a drug addict 2000 (n = 998) 63.0 24.0 12.9 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
Social avoidance and fear of drug addicts remains high in 2000, with around 
two thirds of respondents agreeing that they would tend to avoid someone 
who is a drug addict (69%), that it would bother them to live near a person 
who is a drug addict (63%), and that drug addicts really scare them (61.1%). 
 
The results summarised in Table 1.3c indicate that  societal attitudes towards 
those who use or misuse illegal drugs still tend to be negative, with 64.8% of 
respondents in 2000 believing Irish society is too tolerant towards drug users 
compared to 70.1% in 1998. The proportion believing tougher sentences for 
drug misusers are the answer to the drugs problem still remains about half.  
 
Table 1.3c.  Changes in the attitudes towards those who use or misuse illegal drugs, 
1998 and 2000 
 
Statement 
Survey year 
(number of 
responses) 
Agree 
 
(%) 
Disagree 
 
(%) 
Don’t 
Know 
(%) 
1998 (n = 998) 70.1 21.1 8.7 Our society is too tolerant towards 
drug users 2000 (n = 995) 64.8 23.6 11.6 
1998 (n = 998) 75.5 19.1 5.4 I would be nervous of someone who 
uses illegal drugs 2000 (n = 999) 70.0 19.1 10.9 
1998 (n = 998) 51.3 37.7 11.0 Tougher sentences for drug misusers 
- is the answer to the drugs problem 2000 (n = 998) 49.4 35.4 15.2 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
Support for drug prevention strategies remains high (Table 1.3d), though 
there was a slight drop in the proportion agreeing with the statement that 
‘money well spent in the prevention of drug use, is money well spent’. 
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Table 1.3d.  Changes in the support for drug prevention strategies, 1998 and 2000 
 
Statement 
Survey year 
(number of 
responses) 
Agree 
 
(%) 
Disagree 
 
(%) 
Don’t 
Know 
(%) 
1998 (n = 997) 91.6 4.1 4.3 Money spent in the prevention of drug 
use, is money well spent 2000 (n = 998) 87.3 3.8 8.9 
1998 (n = 996) 94.5 2.3 3.2 Drugs education in school should start 
at primary level 2000 (n = 999) 93.5 2.9 3.6 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
While support for treatment being available to all drug addicts according to 
their needs remains high (90.5% in 2000), Table 1.3e reveals that support for 
the statement that ‘treatment should only be given to drug addicts who intend 
to give up drugs for good’ has increased by over 9 per cent, from 64.5% in 
1998 to 73.8% in 2000. 
 
Table 1.3e.  Changes in the support for drug treatment strategies, 1998 and 2000 
 
Statement 
Survey year 
(number of 
responses) 
Agree 
 
(%) 
Disagree 
 
(%) 
Don’t 
Know 
(%) 
1998 (n = 999) 64.5 27.3 8.2 Treatment should only be given to 
drug addicts who intend to give up 
drugs for good 
2000 (n = 997) 73.8 18.4 7.8 
1998 (n = 999) 90.2 3.7 6.1 Treatment should be available to all 
drug addicts, according to their needs 2000 (n = 999) 90.5 3.1 6.4 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
Support for harm reduction strategies (including availability of medically-
subscribed heroin substitutes and the provision of syringes and needles free 
of charge) has increased to over 70 percent.  
 
Table 1.3f.  Changes in the support for harm reduction strategies, 1998 and 2000 
 
Statement 
Survey year 
(number of 
responses) 
Agree 
 
(%) 
Disagree 
 
(%) 
Don’t 
Know 
(%) 
1998 (n = 933) 64.8 16.1 19.1 Medically prescribed heroin 
substitutes [such as 
methadone/physeptone] should be 
available to drug addicts 1 
2000 (n = 963) 70.9 14.3 14.7 
1998 (n = 998) 66.7 17.3 15.9 Society should provide syringes and 
needles free of charge to drug addicts 
to avoid the spread of HIV/AIDs 
2000 (n = 998) 72.3 14.4 13.2 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
1.Question only applies to those who had heard of heroin 
 
b) Media presentation and imaging drug use 
 
NO INFORMATION AVAILABLE 
Note no research has been carried out in this area on a national basis in 
Ireland. 
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1.4 Budget and funding arrangements – Hamish Sinclair 
 
a) Funding (figures) at national level  
 
The cost of drug misuse at a societal level is extremely difficult to quantify as 
it encompasses areas like the public health costs of disease associated with 
drug dependence, the cost of acquisitive crime and associated losses and 
insurance costs which are borne by both business and individuals. The level 
of State spending on drugs-related issues is also difficult to estimate and is 
complicated by the fact that expenditure is spread across a number of 
Departments, Local Authorities, Agencies and other statutory organisations. 
Even within Departments and Agencies, it is difficult to arrive at an accurate 
estimate of costs associated specifically with drug misuse as services such as 
An Garda Síochána, the Prisons, the Courts and Probation and Welfare 
Services and the various health agencies deal with drugs issues as part of 
their wider daily services. 
 
Bearing these limiting factors in mind it is estimated that the development, co-
ordination and delivery of the National Drugs Strategy approximated to 183 
million Euros in 2000. This is broken down by Departments and Agencies in 
Table 1.4. 
 
Table 1.4. Direct public expenditure on the National Drugs Strategy in 2000 
Department/Agency Expenditure (Euros) 
Dept. of Justice, Equality & Law Reform 123.2 
Dept. of Health & Children 32.0 
Dept of Enterprise, Trade & Employment 6.0 
Dept of Education & Science 7.5 
Dept of Tourism, Sport & Recreation 11.6 
Revenue Commissioners (Customs and Excise) 1.9 
State Laboratory 0.5 
Total 182.7 
 
Notes: The expenditure for the Department of Education and Science includes 
the YPFSF. The expenditure for the Department of Tourism, Sport and 
Recreation is mainly for the implementation of the LDTF action plans and is 
paid through the implementing Departments and Agencies. The expenditure 
figure for the Department of Enterprise, Trade and Employment represents 
funding for the Special Drugs Community Employment Programme run by 
FÁS for recovering drug misusers. Expenditure for the Department of Health 
and Children comprises the additional funding granted to Health Boards from 
1996 to 2000 plus the 2000 funding allocated (from other sources as well as 
the Department of Health and Children) to the DMRD. 
 
No detailed breakdown of national expenditure relating to drugs in the 
requested areas i.e. law enforcement, epidemiological research, 
prevention and treatments, evaluation, quality and training is available. 
 
b) Geographical differences 
 
Geographical differences in the nature and extent of drug misuse exist in 
Ireland.  Problematic drug use, in particular the heroin problem is 
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concentrated in inner city areas of our larger cities.  Consequently the major 
policy programmes and financial resources are targeted at these areas of 
need. 
 
No complete and comprehensive breakdown of national expenditure 
relating to drugs by geographical area is currently available. 
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PART 2 
 
EPIDEMIOLOGICAL SITUATION 
 
2. Prevalence, Patterns and Developments in Drug Use  
 
2.1 Main developments and emerging trends – Mary O’Brien 
 
The following is a summary of the main developments and emerging trends in 
drug use in Ireland.  Supporting data and references are included in 
subsequent sections of the report. 
 
a) Overview of most important characteristics and developments of 
drug situation 
 
After alcohol and tobacco, cannabis is the most commonly used drug in 
Ireland, followed to a much lesser extent by amphetamine and ecstasy 
use.  
A main development is the stabilising and decreasing drug use among 
young people at school.  The lifetime experience of cannabis use, in 
particular in the general population of young people in Ireland, is one of 
the highest in Europe, but recent results show a levelling off of use. 
Explanations are speculative and many factors are likely to be involved.  
For example, the impact of drug prevention policies or the availability of 
cannabis at street level could be factors associated with the decrease in 
prevalence.   
Misuse of solvents among young people is relatively high at around one-
fifth of the population.  
There is evidence of polydrug use from a number of sources – treatment 
data, information on intoxicated drivers, death statistics. 
Drug use is most prevalent among young Dublin males. 
Heroin is the least used illicit drug in the general population, but it is the 
most problematic from a health and social point of view. 
Problem heroin use is mainly confined to the Dublin area but there are 
pockets of heroin use in other urban areas of the country. 
Injecting drug use continues to be a problem in Dublin and surrounding 
areas, and is one of the main risk categories to which new HIV positive 
cases are attributed each year. 
The profile of the typical problematic drug user is young, unemployed 
male, leaving school at an early age and living in a socially and 
economically disadvantaged area.   
On a positive note the level of employment among problem drug users in 
treatment has increased considerably. 
A significant proportion of prisoners, who have a history of drug use, 
continue to engage in illicit drug use once incarcerated. 
A survey to investigate factors underlying international variations in youth 
drug use undertaken in five cities including Dublin, found that sporting 
activities by young people were linked with low rates of drug use. 
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It is now recognised at official level that homeless young people are 
seriously at risk of becoming involved in drugs, prostitution and crime.  As 
a result a strategy on youth homelessness has been drawn up. 
Services need to be developed for drug users in the prison setting that 
take account of the particular nature of the prison environment.  They also 
need to address the needs both of those who continue to engage in drug 
use and the associated risk behaviours; and those who wish to cease their 
drug use while incarcerated. 
There are indications of increasing homelessness among young drug 
users. 
There has been a decrease in high-risk behaviours – needle sharing 
decreased and safe sex (use of condoms) practices increased among 
clients attending a needle exchange programme over an eight-year period.  
This could be due to increase in service provision and the freer availability 
of clean needles and condoms 
Women are more at risk than men, but while women tend to be involved in 
more risky behaviours than male drug users, they do present earlier for 
treatment  
Patterns of problem drug use are changing.  Over a number of years 
(1990-1996), among those presenting to treatment for the first time, there 
was a trend towards the smoking, rather than injecting, of heroin.  
Smoking seems to have been the preferred route for young people starting 
to use heroin, at least in the initial year or so of their drug careers.  
However, trends since 1997 show that the route of administration for 
heroin is tending again towards injecting.  The explanation is likely to be a 
complex one, involving many factors such as the availability of heroin, 
fluctuations in the price of heroin, but it may be that young people who 
originally preferred to smoke heroin are now no longer reluctant to inject. 
Studies indicate the need for more imaginative education initiatives in 
harm reduction interventions.  Greater attention needs to be paid to the 
social context of injecting drug use and the sharing of injecting equipment.  
Outcomes of harm reduction interventions could be improved by exploring 
the perceptions surrounding unsafe injecting practices.   
 
b) Emerging trends  
 
Changing patterns  
Patterns of drug use are changing.  Over a number of years, among those 
presenting to treatment for the first time, there was a trend towards the 
smoking, rather than injecting, of heroin.  Smoking seems to have been 
the preferred route for young people starting to use heroin, at least in the 
initial year or so of their drug careers.  However, trends since 1997 show 
that the route of administration for heroin is tending again towards 
injecting.  The explanation is likely to be a complex one, involving many 
factors such as the availability of heroin, fluctuations in the price of heroin, 
but it may be that young people who originally preferred to smoke heroin 
are now no longer reluctant to inject. 
There has been a decrease in high-risk behaviours – needle sharing 
decreased, safe sex (use of condoms) practices increased among clients 
attending a needle exchange programme over the eight-year period 1990-
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1997.  This is probably due to increases in service provision and the freer 
availability of clean needles and condoms. 
While the decrease in risk behaviours is a welcome development, 
nonetheless studies indicate that there is a need for more imaginative 
education initiatives if harm reduction intervention outcomes are to be 
further improved. 
The quantity of cannabis seized fell significantly in 2000, while the number 
of seizures rose, and has been rising over several years. The number of 
seizures is usually a better indicator of trends at user level, suggesting an 
increasing use of cannabis.  Although it is too early to indicate a trend, 
there are anecdotal suggestions of a shift in the nature of the cannabis 
market, which now seems to involve a greater number of individuals 
trafficking smaller amounts of the drug.  
 
New user groups  
In the absence of research and information based evidence there are no 
up-to-date indications of new drug using groups emerging.   
 
New drugs 
There are no indications of the use of new drugs among drug users in 
Ireland.  Apart from seizures of MDMA, and relatively small amounts of 
MDEA, MDA, ephedrine and ketamine, which are sold as ecstasy, there is 
no evidence of the use of new drugs, such as 4MTA or MBDB.   
 
New problems 
There is no evidence of the emergence of new problems related to drug 
misuse. 
The prevalence of Hepatitis C among injecting drug users over the past 
decade has been consistently high.   
Women are more at risk than men, but while women tend to be involved in 
more risky behaviours than male drug users, they do present earlier for 
treatment. 
 
c) Analysis of drug trends in wider social context 
 
Several factors, including the media, can influence society’s perspective on 
drug use and drug users, and research evidence can sometimes be at 
variance with what is perceived in society at large.  When discussing drug 
issues ‘It is important to look beyond the stereotypes or reliance on the media-
fed explanations of phenomena’ (NicGabhainn and Walsh 2000, p. 2).  
 
The KAB study (Bryan et al. 2000, p. xv) on the knowledge, attitudes and 
beliefs of the general public in Ireland found that: 
Irish people have a good general awareness of commonly used illegal 
drugs.  However, their perception of the general harmfulness of these 
drugs indicated a lack of accurate knowledge about the different effects of 
different types of drugs. 
Societal attitudes to drugs were mostly negative.  Younger members of 
society and those with personal experience of someone with a drug 
problem tended to have less negative attitudes.  
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The public generally perceived drug taking to be common among young 
people, and there was a high level of concern about the current drug 
situation in Ireland.   
 
Not many qualitative studies have been carried out in the general population 
of young people in Ireland.  Such studies to date have tended to concentrate 
on problematic drug use.  It is important that there is a general awareness, 
and in particular awareness among policy makers of the social context of 
young people’s drug taking if suitable and appropriate prevention measures 
are to be adopted (see Section 2.2c for a summary of the results from one 
such study).     
 
The lifetime experience of drug use in the general population of young people 
in Ireland is widespread but this does not necessarily mean they continue to 
use drugs after an initial experience, or go on to become regular users.  A 
sizeable minority of young people have tried cannabis at some time in their 
lives. Media reports tend to concentrate on such figures without any reference 
to what is meant by lifetime prevalence.  Drug use in the past year or the past 
month is more indicative of recent use but such distinctions tend to be ignored 
in media reports of drug use.   
 
The authors of the KAB study recommend that accurate information of a non-
sensationalist type on the relative known risks associated with different types 
of drugs, should be made available to all age groups of people; and that more 
positive attitudes towards those who misuse drugs should be promoted.  This 
is important to the social integration of problem drug users and their 
willingness to avail of treatment.  
 
2.2 Drug use in the population – Mary O’Brien 
 
a) Main results of surveys and studies 
 
Historically there has been little information available in Ireland on drug use 
among the general population.  The first nation-wide survey of drug use 
among adults was carried out in 1998.  Information on drug use among school 
pupils is more readily available but most of the studies have been conducted 
at regional level and use different methodologies, different sample sizes, 
different questionnaire designs, different age groups, etc.. In addition, 
differences in theoretical approaches (health behaviours, health promotion, 
education/prevention, problem drug use behaviours) reflecting different 
perspectives can preclude meaningful comparisons of survey results.  
 
What is evident from survey results (SLÁN; HBSS; Rhatigan and Shelley 
1999; Kiernan 1995; Hibell et al. 1997; Hibell et al. 2001) is that alcohol and 
tobacco are the most widely used drugs in Irish society.  Cannabis is the most 
commonly used illicit drug, followed to a much lesser extent by amphetamine 
and ecstasy use, and their use is widespread (see Sections 2.2c and 2.2b 
below).  Where there is evidence from general population survey data (Table 
2.2c), it seems that cannabis use is decreasing.  Among young people of 
school-going age this is also the case.  The relatively high lifetime prevalence 
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of cannabis use (37%) among 15-16 year old school pupils in 1995 (Hibell et 
al. 1997), had decreased to 32% in 1999 (Hibell et al. 2001).   
 
From the available general population survey data it is apparent that, 
generally speaking, young men in urban areas are the most likely to have 
misused drugs, mainly cannabis.  However, a distinction must be made 
between the adult population and young people.  Among adults aged 18 years 
and over, after cannabis, amphetamines and ecstasy are the drugs most 
commonly used, though to a much lesser extent.  On the other hand, among 
young people there is some disparity between different age groups.  For 
example, among young people in general (ages 9-18) after cannabis, solvents 
are the most widely used substances.  However, adolescents between 11-14 
years of age are more likely to use solvents (see Section 2.2c).  Anecdotal 
evidence suggests that the recreational use of cocaine is on the increase.  
Heroin, which is generally considered to be the drug that causes the most 
problems for individuals, communities and society, is the drug least used in 
the general population (see Section 2.3).  
 
b) General population 
 
In 1998, a general population Survey of Lifestyle, Attitudes and Nutrition 
(SLÁN) was undertaken for the Department of Health and Children by the 
Department of Health Promotion, National University of Ireland, Galway 
(results of module on drug use unpublished).  This is the largest study 
undertaken in Ireland to date in which drug use prevalence was measured.  
The sampling frame was the electoral register, the target population thus 
being adults of 18 years and over.  A proportionate random sampling design 
was used to select the survey sample.  The questionnaires were posted to 
respondents and were self-administered. The sample size of the drug module 
of the survey was 10,415.  The response rate was 62.2% (n=6,539) (Friel, 
personal communication).   
 
Cannabis was the most commonly used drug, followed to a much lesser 
extent by amphetamines and ecstasy (Tables 2.2a and 2.2b).  The use of 
amphetamines was just slightly higher than ecstasy use.  Cocaine use is quite 
rare at 3% among 18 to 34 year-olds. Heroin use was found to be the drug 
least used (less than one percent) in the general population.  
  40  
 
Table 2.2a.  Ireland 1998. SLÁN Survey. Last 12 months prevalence.  Type of drug by 
age groups.  Percentages 
 Age Groups 
Type of Drug 18-64 18-34 18-24 
    
Cannabis 9.4 17.7 26.0 
Amphetamines 2.6 5.4 8.8 
Ecstasy 2.4 4.9 8.1 
LSD 1.4 2.9 5.1 
Cocaine 1.3 2.6 3.4 
Hypnotics and sedatives* 1.2 1.4 2.1 
Solvents 0.3 0.8 1.4 
Heroin 0.3 0.7 0.8 
Source: SLÁN, Dept. Health Promotion, NUI, Galway 
*includes benzodiazepines 
 
The highest prevalence rate for cannabis use was found among 18-24 year 
olds: 33.4% had used cannabis at some time in the past; 26.0% during the 
last 12 months; and 15.3% in the last 30 days. The rates were lower in older 
age groups.   
 
Table 2.2b.  Ireland 1998.  SLÁN Survey.  Lifetime, last 12 months, last 30 days 
prevalence of cannabis use by age groups. Percentages 
 Age Groups 
Prevalence 18-64 18-34 18-24 
    
Lifetime 19.9 30.0 33.4 
Last 12 months 9.4 17.7 26.0 
Last 30 days 5.1 9.7 15.3 
Source: SLÁN, Dept. Health Promotion, NUI, Galway 
 
Young men under 25 were the most likely to have used drugs.  This was the 
case for all drug types in the 18-24 age group (see EMCDDA 2000 Standard 
Table 1a). In the older age groups women were slightly more likely to have 
used hypnotics and sedatives which include benzodiazepines.  Interestingly, 
there were no gender differences in the 55-64 year olds for cannabis use 
during the past year and the past month, although the rates were small at 
0.5%.  Geographically, drug users were more likely to live in an urban 
location. 
 
In the same year (1998) a general population survey (KAB1 survey), using a 
much smaller sample (n=1,000), was undertaken by the Drug Misuse 
Research Division, Health Research Board (Bryan et al. 2000).  The fieldwork 
was carried out by an independent research organisation as part of a broader 
social omnibus survey.  The aim of the survey was to investigate the attitudes 
of the general public towards drug use and drug users, and to determine the 
extent of cannabis use. As in the SLÁN study, the sampling frame was the 
register of electors, target population adults aged 18 years and over.  The 
sampling procedure was a two-stage proportionate to size random sample.  
The questionnaires were administered face-to-face in the respondents’ 
homes. The final sample size was 1,000 (response rate was 64.5%).  
Prevalence information on lifetime use of cannabis only was collected.   
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A follow-up to this survey - KAB2 - was carried out in 2000, for which 
preliminary results are available.  The findings of KAB1 were quite similar to 
those found in SLÁN, particularly so in the case of the 18-24 age group.  As 
mentioned above, SLÁN found that lifetime prevalence of cannabis use 
among 18-24 year olds was 33.4% (Table 2.2b), the KAB1 figure was 32.3% 
(Table 2.2c).  This was not the case in KAB2 where the lifetime prevalence of 
cannabis use among the same age-group had fallen to 21.5% (Table 2.2c). 
 
Table 2.2c.  Ireland 1998 & 2000.  KAB Surveys. Lifetime prevalence of cannabis use by 
age groups. Percentages 
 Age Groups 
Prevalence 18-64 18-34 18-24 
    
KAB1 – 1998 
Lifetime 
 
14.2 
 
26.2 
 
32.3 
KAB2 – 2000 
Lifetime 
 
11.4 
 
19.8 
 
21.5 
Source: Knowledge Attitudes & Beliefs Surveys, Drug Misuse Research Division, Health Research Board 
 
c) School and youth population 
 
There is more information available on drug use among school pupils, than 
among adults in the general population in Ireland.  However, most of the work 
has been carried out at regional level.  The survey studies vary in a number of 
ways; objectives, methodologies, focus of data collection, questionnaire 
design, age groups studied etc..  Differences in theoretical approaches, for 
example health behaviour, health promotion, education, prevention, problem 
drug use behaviour, reflect different perspectives.  This affects interpretations 
of survey results and can preclude meaningful comparisons.  Therefore, 
comparisons below are tentative and must be viewed with these variations 
borne in mind.   
 
A survey of substance use among adolescents of school-going age (12-18 
year olds) was conducted in the Western Health Board area (WHB) (Kiernan 
1995).  A sample of early school-leavers was also included in this study.  
Cannabis and solvents were the drugs most likely to have been used (Table 
2.2g below). 
 
In 1995 nation-wide school surveys of 15-16 year old (born in 1979) post-
primary pupils (ESPAD95) were carried out in a number of European 
countries (Hibell et al. 1997, p. 12).  The Irish lifetime prevalence rate for 
cannabis use was found to be 37%.  This was among the highest of the 
countries participating in the study – UK was higher at 40%.  However, this 
relatively high rate has not been found in subsequent surveys.   
 
A follow-up to this survey (ESPAD99) was conducted in 1999 in schools 
throughout Ireland (Hibell et al. 2001).  Cannabis, which is by far the most 
commonly used illicit drug, was down in 1999 as compared to 1995.   
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Table 2.2d.  Ireland 1995 & 1999. Schools Surveys - ESPAD.  Lifetime, Last Year, and 
Last Month Prevalence of cannabis use by Gender.  Percentages 
 Lifetime Last Year Last Month 
 M F Total M F Total M F Total 
          
ESPAD95 42 31 37 39 27 33 25 12 19 
ESPAD99 35 29 32 31 22 26 18 11 15 
Source: Hibell et al. 1997, 2001 
 
Lifetime use of cannabis, as well as more recent use, in the past year or the 
past month, among both males and females all show downward trends (Table 
2.2d).  Lifetime use was down by 5% (from 37% in 1995 to 32% in 1999); use 
in last year was down from 33% to 26%; and use in the last month had 
decreased by 4% - from 19% to 15%.   
 
Use of other drugs is also decreasing: LSD fell from 13% to 5%; ecstasy from 
9% to 5%; and hypnotics from 7% to 5% (Table 2.2g). The use of less popular 
drugs, such as heroin and cocaine is stablilising, with 1999 lifetime rates 
remaining similar to those of 1995 at around 2 % (Table 2.2g).  Lifetime use of 
solvents was the exception: according to the results of ESPAD 1999 the 
lifetime use of solvents had increased slightly, from 19% in 1995 to 22% in 
1999.   
 
Similarly high levels of solvent use (19%) were found in a local survey of 
adolescent drug use in the north-east of the country (Department of Public 
Health 1999).  The geographic area covered by this survey is located just 
north of Dublin.  The survey was conducted in 1997 among 1,516 young 
people between 13 and 19 years of age (Table 2.2g).  The stratified (by 
county and type of school) sample of 21 schools was randomly selected from 
a total of 57 schools in the area. Three classes were selected from each 
school.   
 
Lifetime prevalence of cannabis use was less, at 25%, than the national figure 
of 32% found in ESPAD99.  Other drugs used did not show such a difference.  
For example, national and local ecstasy prevalence was quite similar at 6% 
and 5%; in both cases LSD was 5%, cocaine was 2% and heroin 2%.   
 
This survey was unusual in that it included a qualitative element to the 
research, which gave an interesting insight to young peoples’ views about 
different aspects of drug use.  It found that while young people seem to be au 
fait with illicit drugs, in fact knowledge about drugs was often vague and 
inaccurate, suggesting that current educational methods are falling short of 
getting the message across.  Young people are not impressed with 
educational strategies currently in operation.  The study concluded that ‘the 
views and ideas of young people should form an integral part of future drug 
strategies’ (Department of Public Health 1999, p. 585).  The central messages 
emanating from the study were as follows: 
So called ‘soft’ drug use was not a problem for most young people in the 
north-east.  Those who were involved in illicit drug use felt in control of 
                                                     
5 Can be viewed at website: www.nehb.ie      
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their drug use.  Under-age drinking is the area of concern where both 
parental and professional attention should be directed. 
Young people do not see drugs as being on a continuum from soft to hard 
drug use. 
Drug use was not considered to be an isolated part of young peoples’ 
lives, but one of a number of ordinary and unremarkable activities, which is 
part of growing up in contemporary Ireland. 
Current drug education strategies were deemed irrelevant because they 
do not reflect young peoples’ realities.  
 
A survey, to investigate factors underlying international variations in youth 
drug use, was undertaken in five cities – Bremen, Dublin, Groningen, 
Newcastle-upon-Tyne and Rome (McArdle et al. 2000).  The findings showed 
a higher level of drug use in the English-speaking compared to the continental 
populations.  The authors also found a number of factors associated with drug 
use: peer affiliation, family structure and individual anti-social behaviour.  
Sporting activities were linked with low rates of drug use, supporting the view 
that when activities that include sport are increased in urban districts there is 
significant decline in problem behaviour in general (ibid.) 
 
A survey was carried out in 1996 to examine lifestyles of second level 
students in the Midland Health Board area (MHB).  The results were 
presented in a short report entitled Report on school survey of second level 
students in the Midland Health Board area (unpublished). Unfortunately, a 
detailed description of the methodology was not provided. Twelve schools 
were randomly selected and 1,654 pupils completed a questionnaire in the 
classroom.  Cannabis was the most widely used drug, followed by solvents 
(Table 2.2g).   
 
A national survey was conducted in 1998 (Irish Health Behaviours in Schools 
Survey [HBSS], Department Health Promotion, NUI Galway, unpublished) 
(Tables 2.2e and 2.2f).  All types of schools were sampled – primary and post-
primary schools - from Department of Education & Science lists.  Pupils were 
selected using two-stage random sampling within health board regions and 
classrooms. The sample size was 8,497; the response rate was 73%.  
Respondents ranged in age from 9-18 years old.  Lifetime prevalence of 
cannabis use was found to be much less (21.7% for 15-16 year olds) than the 
ESPAD findings of 1995 (37%) or 1999 (32%) (Tables 2.2d, 2.2e). 
 
Table 2.2e.  Ireland 1998. Schools Survey - HBSS.  Prevalence of cannabis use by age 
groups.  Percentages 
 Age Groups 
Prevalence 11-12 13-14 15-16 17-18 
     
Lifetime 3.0 8.0 21.7 28.5 
Last 12 months 2.3 6.5 18.3 24.0 
Last 30 days 1.3 4.3 10.5 11.0 
Source: Irish Health Behaviours in Schools Survey (HBSS),  Department Health Promotion, NUI, Galway 
 
The highest prevalence was among 17-18 year olds; 28.5% had used 
cannabis at some time in the past (lifetime prevalence); 24% had done so in 
the past twelve months and 11% had used cannabis recently (in past 30 
  44  
days).  All drug types were more likely to be used by males.  However, in the 
case of lifetime use of cannabis among this (17-18) age group there was very 
little gender difference – male 28.7%, female 28.5% (EMCDDA 2000 
Standard Table 2a).  Details on different types of drugs were not provided for 
drug use experience in the past 12 months.  
 
Among young people in general (ages 9-18) after cannabis, solvents are the 
most commonly used substances (Table 2.2f).   
 
Table 2.2f.  Ireland 1998. Schools Survey - HBSS.  Last 30 days prevalence.  Type of 
drug by age groups.  Percentages 
 Age Groups 
Type of Drug 11-12 13-14 15-16 17-18 
 
9-18 
Cannabis 1.3 4.3 10.5 11.0 5.9 
Amphetamines 0.7 0.9 2.4 4.9 1.6 
Ecstasy 0.6 0.9 1.9 3.7 1.3 
LSD 0.8 0.9 1.7 3.7 1.3 
Hypnotics & sedatives* 0.8 1.4 1.9 2.1 1.4 
Cocaine 1.9 1.6 1.5 1.8 1.7 
Solvents 2.9 5.7 5.9 4.1 4.8 
Heroin 0.8 0.8 1.0 2.0 0.9 
Source: Irish Health Behaviours in Schools Survey (HBSS), Department Health Promotion, NUI, Galway 
*includes tranquilisers or sedatives without prescription (barbs, jellies, downers) 
 
Among 17-18 year olds (Table 2.2f) prevalence of recent cannabis use 
(11.0%) was followed by amphetamine use (4.9%).  Solvents (4.1%) were the 
next most commonly used substances, and not ecstasy (3.7%) as might be 
expected.  The prevalence of LSD use was the same as that of ecstasy use at 
3.7%.  The picture which emerged among younger age groups was quite 
different.  Among 15-16 year olds the use of cannabis (10.5%) and solvents 
(5.9%) was followed by amphetamine use (2.4%).  Solvents were the 
substances most commonly used by 11-14 year olds; followed by cannabis in 
the case of 13-14 year olds.  Surprisingly, among 11-12 year olds, use of 
solvents (2.9%) was followed by cocaine use (1.9%), even before cannabis 
use (1.3%).  Cocaine use was in fact highest among 11-12 year olds (1.9%).  
Heroin use seems higher than would be expected, especially among 17-18 
year olds at 2%.  
 
In 1998 also, a school survey was conducted in the eastern region (Eastern 
Health Board (EHB), now Eastern Regional Health Authority, area) of the 
country (Rhatigan and Shelley 1999) to study the health behaviours of school 
pupils.  Again, as above, the sampling frame was the schools’ list of the 
Department of Education & Science.  A random sample of schools stratified 
by county and school type was selected.  The response rate was 78.2%.  The 
sample size was 6,081 pupils aged between 10-18 years.  Cannabis was the 
drug most commonly experienced at least once (lifetime) followed by solvents 
(Table 2.2g below).  These data – lifetime use of cannabis (21%), solvents 
(13%); and recent use of cannabis (11%), solvents (7%) – are somewhat 
higher than results from HBSS (Health Behaviours in Schools Survey).  This 
could be expected given that the sample was drawn from the most urbanised 
eastern region, including Dublin.  Prevalence rates (both lifetime and recent) 
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for cocaine use among the whole group are the same, both in the HBSS and 
the EHB surveys, at 2%.  
 
Tables 2.2g and 2.2h below illustrate the difficulties involved in making 
comparisons between different studies.  Attempting to compare youth surveys 
for different geographic locations where different methodologies are used 
must be done with considerable caution.  Drug use prevalence among young 
people also varies quite considerable according to the age groups examined.  
As an example of the disparity in results - in the HBSS the prevalence of 
cannabis use for the whole sample (9-18 year olds) was 12% whereas for the 
15-16 year olds it was 22%, and for those aged 17-18 it was 29% (Table 
2.2e).  
 
Table 2.2g.  Ireland 1995-1999. Comparison of school/youth surveys of drug use.  
Lifetime prevalence of drug use by type of drug.   
Survey / 
Year 
 
 
ESPAD 
1995  
National 
 
WHB 
1994 
Local 
MHB 
1996 
Local 
HBSS 
1998  
National 
EHB 
1998 
Local 
NEHB 
1997 
Local 
ESPAD 
1999 
National 
Sample size 1,849 2,762 1,654 8,497 6,081 1,516 2,277 
Age group 15-16 13-18 16-18 9-18 10-18 13-19 15-16 
Cannabis 37% 16% 26% 12% 21% 25% 35% 
Amphetamine 3% 2% 5% 3% 5% 6% 3% 
Ecstasy 9% 2% 7% 2% 3% 6% 5% 
LSD or other 
hallucinogens  
13% 9% 9% 4% 3% 5% 5% 
Hypnotics & sedatives 7% 2% 4% 3% 3% - 5% 
Cocaine  2% 1% na 2% 2% 2% 2% 
Crack 3% na na na na - 2% 
Solvents/inhalants 19% 14% 17% 10% 13% 19% 22% 
Heroin 2% 1% na 1% 1% 2% 2% 
na=not available 
 
The results from the 1999 ESPAD survey show lower lifetime prevalence 
rates for most drug types (cannabis, ecstasy, LSD, and hypnotics).  The 
exception was solvents.  While the rate for these substances was the same in 
the ESPAD95 and 1997 NEHB surveys (19%), it increased slightly in the 1999 
ESPAD study to 22%.  Amphetamine use was slightly higher in the north east 
of the country at 6% (Table 2.2g) (Department of Public Health 1999).  
Cocaine use remained stable at the low rate of 2%.  
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Table 2.2h.  Ireland 1995-1999. Comparison of school/youth surveys of drug use.   
Recent prevalence (past 30 days) of drug use by type of drug.   
Survey / 
Year 
 
 
ESPAD 
1995  
National 
 
WHB 
1994 
Local 
MHB 
1996 
Local 
HBSS 
1998  
National 
EHB 
1998 
Local 
NEHB 
1997 
Local 
ESPAD 
1999  
National 
 
Sample size 1,849 2,762 1,654 8,497 6,081 1,516 2,277 
Age group 15-16 13-18 16-18 9-18 10-18 13-19 15-16 
Cannabis 19% 9% Na 6% 11% 10% 15% 
Amphetamine Na 1% Na 2% 3% 1% Na 
Ecstasy Na 1% Na 1% 3% 2% Na 
LSD Na Na Na 1% 2% 1% Na 
Hypnotics & sedatives Na na Na 2% 2% - Na 
Cocaine  Na 1% Na 2% 2% 0% Na 
Solvents/inhalants Na Na Na 5% 7% 2% 4% 
Heroin Na 0% Na 1% 1% 0% Na 
* Na=not available 
 
More recent use, for which very little comparable information is available, also 
seems to be decreasing.  Cannabis was down from 19% in 1995 to 15% in 
1999 ESPAD.   
 
The explanation for the decrease in the prevalence of drug use is likely to be 
a complex one.  For example, anecdotal information from street level sources 
suggests that in the past year there is less cannabis available at street level 
than formerly.  The impact of drug prevention policies could also be a factor.  
In the absence of research on drug markets, availability, trafficking patterns, 
etc., it is difficult and unwise to speculate on explanations for changes in 
trends, such as the decrease in cannabis use.   
 
What is very apparent is the importance of carrying out research, such as 
population surveys on the use of all types of illicit drugs.  This should be done 
at regular intervals using comparable methodologies, if meaningful 
comparisons and interpretations are to be made.  It should include information 
on lifetime use (ever used), and recent use (past 30 days/past month) of 
drugs – the latter being a better indication of the current situation.  Also 
qualitative research studies, such as drug use and its social context, the 
perceptions of drug users, would enhance the findings of survey work by 
providing insight for the formulation of effective drug policies, particularly in 
relation to prevention interventions and the reduction of demand for drugs.  
 
d) Specific groups – Mary O’Brien & Lucy Dillon 
 
Homeless people: It has been suggested that the extent of drug use among 
the homeless population ‘is substantially higher than it is among the rest of 
the population’ (Costello and Howley 2001, p. v).  Holohan (2000) found that 
the lifetime prevalence of drug use among homeless people in Dublin was 
28%, which compares with 20% in the general population (see Table 2.2b).  
Costello and Howley (2001) carried out a feasibility study to explore the idea 
of setting up a direct-access hostel in Dublin for drug users who sleep rough, 
using a qualitative methodology.  Fifteen in-depth interviews were carried out 
with homeless drug users exploring their contact with services, their drug use, 
physical and mental health and accommodation alternatives.  A number of 
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personal reasons were cited, such as family and domestic problems, as 
precipitating their homeless state, as well as drug use itself which forced 
some to leave home.  All of their experiences were against a backdrop of 
social disadvantage and exclusion.  While no attempt was made to measure 
the extent of homeless drug users in Dublin, the study did identify a gap in 
homeless services for people using drugs.  It concluded that '‘without the 
committed and consistent challenging of barriers to housing for people who 
are homeless and using drugs, efforts of homeless services are severely 
limited'’ (Costello and Howley 2001, p. 70).  
 
A small scale pilot study examined the health status of 14 families with 31 
children in Dublin.  The families were living in a transitional housing project 
(O’Brien et al. 2001).  Only two of the families had both parents, the other 
twelve were headed by mothers alone.  The aim of the study was to examine 
the mental health status of homeless children and their families.  The findings 
show that the study group were socially isolated and lacked support from 
fathers and wider family members.  High addiction levels and poor parenting 
skills were other features of the group.  Heroin addiction was the main reason 
cited for four of the families’ homelessness.  The authors concluded that there 
should be targeted services to support vulnerable families.  A comprehensive 
and integrated approach by housing, childcare, education and family support 
services is needed to address the need of homeless families.   
 
As a result of recognition at official level that homeless young people are 
seriously at risk of becoming involved in drugs, prostitution and crime, a 
strategy on youth homeless has been drawn up, stressing the need for a 
cross-sectoral approach involving health boards, education and local 
authorities, voluntary organisations and local communities.  (Department of 
Health and Children 2001).  
 
Ethnic Minorities :  Research in Ireland continues to be limited in the area of 
drug use among minority groupings.  However, one study has been carried 
out on drug use among the Travelling Community (Hurley 1999).  Data were 
collected using a range of data collection methods that focussed on exploring 
perceptions of members of the Travelling Community on the extent and nature 
of drug use among the Travelling Community. The study does not in fact 
provide information on prevalence rates. It does however, report a number of 
interesting findings on the perceptions of drug use: 
The main drug used by young members of the Travelling Community was 
perceived to be cannabis rather than alcohol, ‘and is normalised and not 
perceived to be an illegal activity’ (Hurley 1999, p. 41) 
Heroin use was perceived to be a problem for ‘a minority of Travellers’ 
(Hurley 1999, p. 41) 
Travellers who either mixed with members of the settled community or had 
spent time in prison were perceived to be particularly at risk of becoming 
involved in illicit drug use.  
 
Recent years have seen a significant change in the migration profile of 
Ireland.  Net migration in Ireland has gone from 8,000 in 1996 to an estimated 
20,000 for the year 2000.  Furthermore, there has been a large increase in the 
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numbers of people applying for asylum in Ireland.  In 1992 there were only 39 
applications made, whereas for 2000 the figure had increased to 10,938 
(Table 2.2i below). 
 
Table 2.2i.  Ireland 1992-1999 (30/11).   Total number of applications for asylum in 
Ireland. 
1992 1993 1994 1995 1996 1997 1998 1999  2000 
         
39 91 362 424 1,179 3,883 4,626 7,724 10,938 
Source: Department of Justice, Equality and Law Reform 
 
However, there is no evidence-based information on drug use among the 
immigrant population.  A change in the nationality profile of people presenting 
for treatment is not evident from data recorded in the National Drug Treatment 
Reporting System.  For example, in 1999 only 36 of the total number of first 
treatment contacts (N=1852) were non-nationals (other than Irish).  Twenty-
five of these were from Great Britain.   
, 
There is, therefore, a need to explore drug use in this context.  It is important 
that the necessary information be available to facilitate Irish services to 
address any specific needs that drug users from minority groups may have, 
and to offer services in a way that will encourage these users to access them. 
 
Prisoners: Research has found that a significant proportion of Ireland’s 
prison population has a history of drug use, and that a number of prisoners 
continue to use drugs while incarcerated. Two studies (Allwright et al. 1999; 
Long et al. 2000) concerned with the prevalence of HIV, hepatitis B and 
hepatitis C among the Irish prison population, explored the related risk 
behaviours and drug use engaged in by prisoners. Allwright et al. (1999) 
found that of 1,205 respondents, 630 (52.3%) reported that they had used 
heroin and 43.2% reported that they had ever injected drugs. Furthermore, 
the authors concluded that “drug use within prison was common” (Allwright et 
al. 1999, p. 18). Forty-five percent of the 334 respondents who reported that 
they had a history of drug use and had been in prison for longer than three 
months, reported that they had injected drugs in the previous month. Thirty 
one percent (n=103) reported that they had injected between 1 and 19 times 
in the previous month, while 14% (n=48) said they had injected more than 20 
times in the previous month (Allwright et al. 1999). The subsequent study of a 
sample (n=604) of committal6 prisoners found lower rates of prisoners 
reporting drug use (Long et al. 2000). Thirty five and a half percent of the 
sample reported that they had ever smoked heroin and/or injected drugs, 29% 
reported that they had ever injected drugs. Both of these studies suggest that 
there is a significant proportion of prisoners who have a history of drug use 
and, furthermore, a significant proportion continues to engage in illicit drug 
use once incarcerated. 
 
 
                                                     
6 Committal prisoners were defined as “prisoners who have been admitted to the prison within the preceding 48 hours, accused 
or guilty of a new crime, excluding those on temporary release or transferred from another prison. The committal population 
includes individuals entering on remand, following sentence, committed as a result of a bench warrant, and non-nationals without 
valid documentation” (Long et al 2000). 
  49  
2.3 Problem drug use – Mary O’Brien 
 
a) National and local estimates 
 
NO NEW INFORMATION FOR NATIONAL OR LOCAL ESTIMATES OF 
PROBLEM DRUG USE IS AVAILABLE. 
 
The National Advisory Committee on Drugs [NACD] has issued a call for 
expressions of interest in conducting a study of opiate users in Ireland.  The 
aim of the study is ‘to provide data on a number of aspects of opiate use in 
Ireland which can be used to develop multipliers for use in assessing changes 
in the prevalence of opiate use’7.  The specified methodologies are to be 
network analysis or nomination technique.  The final report is expected in 
2003.    
 
Studies on national and local prevalence estimates of problem drug use are 
quite limited in Ireland.  An exploratory study was carried out (Comiskey 1998) 
to estimate the prevalence of problematic opiate use.  Using the capture re-
capture methodology with three samples of data (methadone treatment list, 
hospital inpatient data and police record data), this local study  in Dublin 
estimated that there were between 10,655 and 14,804 opiate users in Dublin 
in 1996.  There were difficulties with the samples used in this study - 12% of 
the Garda (police) sample contained ambiguous data (7% were non-opiate 
users; and 5% were identified by unspecified means).  The Garda data were 
originally collected for a study to examine drug-related crime (Keogh 1997), 
with different definitions to those used in the prevalence study.  Prevalence 
studies such as this should be regarded as an exploratory exercise in the 
development of methodologies to estimate the prevalence of problem drug 
use, and the resultant estimates of opiate use should be viewed in this light. 
 
Another local area prevalence study was carried out in north-east inner city 
Dublin, an area with higher than average levels of social and economic 
disadvantage. This study (Coveney et al. 1999) collected data from four 
sources: five treatment and support agencies; agency waiting lists; a 
residents’ street survey and two general practitioners. Of the 1,657 individuals 
identified, 477 were residents of the Dublin 1 postal district (north inner city). It 
was estimated that the prevalence rate of heroin use was 2.0 percent of the 
population of that area. This is surprisingly low, given that it is considered to 
be a high-risk area, but is probably a reflection of the methodology used in the 
study. 
  
More problematic drug use is represented by the treated population of drug 
users.  This information is collected by the Drug Misuse Research Division, 
Health Research Board for the National Drug Treatment Reporting System 
(NDTRS) and refers to people who receive treatment for problem drug use.  In 
recent years there has been an extensive increase in the services provided 
for problem drug users. Compared to ten years ago services are now de-
centralised and have become more diversified and dispersed both locally and 
nationally.  Data collected by the National Drug Treatment Reporting System 
                                                     
7 Tender for network analysis study 
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give a good profile of the characteristics of clients, patterns of use and trends 
over time (see Section 3.1a). Problematic opiate use, mainly heroin, continues 
to be concentrated in the Dublin area, in localities with high levels of social 
and economic disadvantage.  Pockets of heroin use are being reported in 
recent times in a number of areas throughout the country.   
  
b) Risk behaviours and trends 
 
Risk behaviours are very important in the transmission of HIV infection; 
injecting with shared equipment is the crucial transmission route among 
injecting drug users; sexual contact is likely to be the most common 
transmission route to the wider population.  A retrospective examination of 
data from the Needle Exchange Programme (NEP) in the Eastern Health 
Board area was carried out to identify the factors associated with high-risk 
behaviours (Mullen and Barry 1999, 2001).  The NEP was set up in 1989. 
Drug users who attended for the first time between 1990-1997 were included 
– 6025 in total. The number of first attenders increased from 350 in 1990 to 
1039 in 1997. Four needles, on average, were distributed to first attenders; all 
were offered condoms, 45% accepted.  First-time attenders were 
predominantly male, but over the eight-year period the proportion of women 
increased from 18% in 1990 to 24% in 1997 - this increase was particularly 
noticeable in young women under 20 years of age.  The mean number of 
years of injecting drug use of the study group was 4 years.  The overall 
prevalence of needle sharing in the year prior to attendance was 39%, but 
women (44%) were more likely to share than men (38%).  Women (51%) 
were also more likely to engage in unsafe sex than men (44%).  Young 
injectors under 20 years old, were just as likely as all attenders to share 
injecting equipment (39%).  Those who did not share injecting equipment 
were more likely to use condoms, than those who did share.  Young attenders 
under 20 years old, were less likely to be involved in unsafe sex than the 
overall group (Table 2.3).   
 
Table 2.3.  Eastern Health Board area. Characteristics and Risk Behaviours of Needle 
Exchange Attenders 1990-1997.  
Characteristics All attenders Young attenders  
     <20 years 
Total N 6025 1224 
Gender ratio:   
      Overall Male:Female 80:20 75:25 
       1990   Male:Female 82:18 86:14 
       1997   Male:Female 76:24 68:32 
Mean age 25 18.6 
Risk behaviour:   
  Injecting-mean no. years 4 <1 
  Sharing prevalence-past year: 
       Total 
 
39%  
 
39% 
        Male 38%  Na 
        Female 44%  Na 
   Unsafe sex:   
         Male 44% 36% 
         Female 51% 48% 
Source: Mullen and Barry (1999)  
*  Na=not available 
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Trends over the time period 1990-1997 showed a significant decrease in high-
risk behaviours – needle sharing practices fell and safe sex (use of condoms) 
practices increased.  Women engage in more risky behaviours, and with the 
proportion of women increasing over time this has serious health implications.  
Young injecting drug users are a particularly at-risk group. However, they do 
seem to present quite early in their drug using careers to needle exchange 
programmes. The authors state that ‘it is crucial that young people do not 
encounter barriers to protecting themselves, such as parental permission, 
mandatory treatment, and statutory notification’ (Mullen and Barry 1999, 
p.29).   The authors argue that this would defeat the purpose of a low 
threshold service, to which young people are more likely to present.  The 
profile of the attenders at the NEP highlights the importance of providing 
prevention and early intervention programmes particularly for young people.  
The authors recommend that more in-depth/qualitative research is needed to 
increase understanding of injecting drug users – ‘the issues surrounding drug 
use, risk management and sexual relationships’ (ibid. p. 25) – in order to 
make prevention strategies more effective.   
 
While the Mullen and Barry study did not provide details on the sharing of 
injecting equipment, another study in Dublin did examine the frequency of 
syringe borrowing among young intravenous drug users (Smyth et al. 2001).  
The study was carried out between September 1997 and June 1999 in a 
number of treatment settings in Dublin.  Consecutive new attenders, who had 
injected in the preceding 6 months, were eligible to participate in the study.  
The perception of danger involved in borrowing syringe equipment was 
measured using ‘a 100-mm visual analogue scale’ (Smyth et al. 2001, p. 719). 
Three-hundred-and-ten candidates were identified, and 294 participated.   
 
Sixty percent of the participants were male; heroin was the primary substance 
injected in 97% of cases.  Cocaine (in 30% of cases) and benzodiazepines (in 
60% of cases) were injected as secondary drugs.  Over half (56%) had on 
average re-used ones own syringe; 70% had borrowed a syringe or needle; 
and 87% had borrowed spoons or filters from other intravenous drug users. 
All indicating a high level of recent unsafe behaviours, and also explaining the 
very early acquisition of hepatitis C infection by IDUs in Dublin.  The study 
found that poly-drug users are more likely to inject unsafely; and that those 
who inject benzodiazepines in addition to heroin appear to be a particularly 
high-risk group.  Social factors such as early school leaving and parental 
unemployment were associated with increased reporting of syringe borrowing.  
While social deprivation and social exclusion are generally accepted to be 
associated with increased occurrence of drug use and general health risk 
behaviour, this study found that these social markers are predictors of current 
unsafe injecting within populations of intravenous drug users. The authors 
suggest that greater attention needs to be paid to the social context in which 
individuals inject and share equipment, and that exploration of perceptions of 
unsafe injecting practices could prove to be a useful area of focus for harm 
reduction interventions.    
 
Another study also highlights the fact that women, although in a minority, are 
a very at-risk group among drug users (Geoghegan et al. 1999).  Taking a 
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somewhat different perspective and focusing on gender differences the 
research study carried out at the Merchants’ Quay Project (a voluntary agency 
providing a needle exchange service), explored patterns of drug use, risk 
behaviour, health and well-being among 934 new attenders.  Data were 
collected, between May 1997 and April 1998, from all new clients.   A sizeable 
minority was female (25%) and notable gender differences were found.  
Women were younger than men and were more likely to: 
have a sexual partner who was an injecting drug user 
be living with an injecting drug user 
share injecting equipment with their sexual partner 
report recent sharing of injecting paraphernalia 
report having problems finding an intravenous site 
report having abscesses and to be suffering from weight loss 
report depression, unable to cope, feeling isolated and having suicidal 
tendencies 
have attended a GP in the previous 3 months 
have a medical card.   
 
Heroin was the preferred drug of choice of all the study participants. A 
majority (86%) of the overall group reported that they had smoked heroin prior 
to injecting – no gender difference was found.  However, women had 
significantly shorter smoking careers and were more likely to present sooner 
in their injecting careers to treatment services, than men.  The authors 
conclude that this research illustrates that it is important to recognise that 
women drug users do exist and that they ‘are more likely than their male 
counterparts to engage in risk behaviour which has a detrimental effect on 
their mental and physical health’ (Geoghegan et al. 1999, p. 135).   
 
Data from the National Drug Treatment Reporting System (NDTRS) were 
used in a study (Smyth et al. 2000) to examine trends in treated opiate use 
and to identify factors associated with the route of administration of heroin.  
Dublin clients presenting for the first time for treatment of an opiate problem 
over the six-year period 1991-1996 were included.  The study population was 
3981.  Over the period there was a three-fold increase in the number of new 
clients and the proportion of females increased.  The mean age of first opiate 
use declined and users began presenting for treatment earlier in their opiate-
using careers. There was an increase in the proportion who were using heroin 
as distinct from other opiates, such as morphine sulphate tablets.  There was 
a dramatic increase in heroin smoking after 1994 when it became the most 
common route of heroin use.  Heroin was most likely to be smoked by young, 
employed people who were using heroin for less than three years.   
 
The reasons for the increase in chasing (heroin smoking) are not clear.  It is 
suggested that while awareness of AIDS and the risks of injecting may be a 
factor, it would be simplistic to assume that this alone accounts for the change 
in the pattern of heroin use (Smyth et al. 2000).  In a later study of first time 
attenders at a needle exchange programme between May 1997 and February 
1998, a comparative analysis of the risk behaviour of younger and older 
injectors, i.e. under 25 and over 25 years of age, was carried out.  It was 
found that the younger group (under 25 years old) were significantly more 
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likely to have smoked illicit drugs prior to injecting and to report using heroin 
as their primary drug (Cassin et al. 1998).  It may be that smoking is the 
preferred route for young people starting to use heroin, particularly for those 
reluctant to inject.  The more acceptable nature of chasing, it was suggested, 
may attract increasing numbers to use heroin and concern was expressed 
that ‘chasing may prove to be a dragon in sheep’s clothing’ (Smyth et al. 
2000, p. 1223).  
 
Data from the NDTRS for 1997-1999, suggest that these concerns were 
warranted.  The data show (EMCDDA Standard Table 4) that between 1990 
and 1996 the proportion of all treated drug users who injected their main drug 
decreased from 66% to 37%.  However, since then the proportion who inject 
has increased a little, from 45% in 1997, to 49% in 1998 and 51% in 1999.  
The explanation is likely to be a complex one, involving many factors (sub-
group norms, availability, price of drugs, etc.) but it may be that the young 
people who preferred to smoke heroin initially are no longer reluctant to inject.  
In other words they have ‘progressed’ to injecting. 
 
In a qualitative study of a group of prisoners (n=29) it was found that moving 
from smoking to injecting heroin was motivated by a more efficient use of a 
scarce commodity.  Because of the limited quantity of heroin available in 
prison, drug-using prisoners managed their drug use in order to ensure that 
the maximum number of people were facilitated by the heroin which could be 
accessed.  Since smoking was considered to be wasteful this meant that 
injecting rather than smoking the heroin was more acceptable.  Furthermore, 
injecting was perceived to give a better ‘buzz’ than smoking, once an 
individual had become an habitual user (Dillon 2001).   
 
A study of 77 drug-using women (O’Neill and O’Connor 1999) involved in 
prostitution found them to be a very at-risk group:  
45 percent started working in prostitution between 13 and 19 years old, 
mainly to earn money for drugs 
83 percent had injected in the past month. A quarter of these (n=16) had 
shared needles in the past month 
less than one-third had been screened for sexually transmitted diseases. 
 
Compared to similar research carried out in 1996 (in O’Neill and O’Connor 
1999, p. 9) the women in the 1999 study: 
tended to be younger 
their children were more likely to be cared for by someone else 
they were more likely to be homeless. 
The women in the latter study were found to be a particularly vulnerable and 
marginalised group who engaged in high-risk behaviours.  
 
The importance of more imaginative education initiatives in harm reduction 
interventions was demonstrated by a study conducted in a specialised 
treatment setting (Smyth et al. 1999b).  The level of knowledge of intravenous 
drug users regarding hepatitis C (HCV) and the factors influencing this 
knowledge were assessed using an instrument developed by the research 
team.  The results showed that there were prominent misconceptions about 
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the cause of transmission and natural history of HCV infection.  Contact with 
services did not lead to any significant gain in understanding.  The authors 
concluded that current education approaches in specialist treatment centres 
and by general practitioners are deficient.  They recommend a move away 
from the ‘typical didactic model of fact provision’ (ibid. p. 263) to a more 
explorative approach where misconceptions are more likely to emerge, 
thereby providing the opportunity to correct and educate.  
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3. Health Consequences – Mary O’Brien   
 
3.1 Drug treatment demand  
 
NO NEW INFORMATION AVAILABLE FOR THIS SECTION 
TREATMENT DATA FOR 2000 NOT YET AVAILABLE (Oct 2001) 
 
a) Characteristics of clients, patterns of use and trends 
 
People encountering very serious problems with drug misuse will more than 
likely eventually come into contact with treatment services.  The treated 
population of drug users is well represented in the National Drug Treatment 
Reporting System (NDTRS).  Analysis of the characteristics of clients 
presenting to treatment for the first time, gives a good overview of trends over 
time.   
 
Drug use patterns in Ireland vary according to geographic location.  Problem 
opiate use, mostly heroin, is mainly confined to the Dublin area. This is 
beginning to change, with pockets of heroin use now becoming apparent in a 
number of urbananised areas in regional locations. While the profile of the 
typical problematic drug user – young, unemployed male, leaving school at an 
early age and living in a socially and economically disadvantaged area – has 
not varied much over the years, there has been a change in some trends over 
the past five years.   
 
Data on clients presenting for treatment for the first time are presented in 
Table 3.1 below.  Gender distribution has not changed much over the five-
year period, and the mean age has remained fairly stable at around 22 years.  
Over 70% of those presenting for treatment for the first time are under 25 
years old.  This is younger than in other EU countries and is a reflection of the 
demographic situation in Ireland where the median age of the Irish population 
is much younger than the EU average.  Nearly half the population in Ireland 
(47%) is under 30 years of age, whereas the median age in other EU 
countries is between 35 and 40 years of age.  
 
Table 3.1.   Ireland 1995-1999.  New clients presenting for treatment.  Characteristics 
and patterns of use. Percentages.   
Characteristics 1995 1996 1997 1998 1999* 
Valid N 1886 2014 1465 1621 1852 
Gender ratio   Male:Female 80:20 73:27 72:28 74:26 73:27 
Mean age 21.1 21.3 22.0 22.1 23.3 
Living status – with parental family 78.9 76.5 71.6 71.1 68.9 
Early school-leavers (<16 years old) 51.9 50.3 46.0 45.2 44.6 
Regular employment 15.3 13.9 19.5 24.9 30.8 
Mean age first used any drug (excl. alcohol) 15.6 15.4 15.9 15.5 15.6 
Main drug - Heroin 54.5 63.2 58.4 56.1 58.2 
Main drug - Route of administration- inject 23.6 24.0 29.2 28.9 35.3 
Main drug - Route of administration- smoke 56.2 59.8 50.7 53.3 49.9 
Source: National Drug Treatment Reporting System (NDTRS), Drug Misuse Research Division, Health Research 
Board  
*NB changes, due to addition of extra data 
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Between 1995 and 1999 there was a fall in the proportion of clients living in 
the parental home (Table 3.1).  There was a decrease in those who left school 
before the age of 16 years from 52% in 1995 to 45% in 1999. There was a 
sizeable increase in the level of employment among problem drug users, from 
a very low 15% in 1995 to 31% in 1999, again reflecting more general 
changes in Irish society in relation to improvements in the economy, inter alia, 
over the same period.  The mean age of initial drug use was between 15-16 
years of age and did not change much over the five-year period.  Heroin was 
the main drug of misuse for over half of those presenting for treatment for the 
first time.  Over the five-year period there was an increase in the proportion 
injecting their main drug of misuse and a decrease in smoking (see discussion 
on risk behaviours at Section 2.3).   
 
There is great disparity in the pattern of drug use in different parts of the 
country.  Problematic opiate/heroin use is mainly in the eastern region of the 
country, around Dublin.  Seven out of ten Irish clients receiving drug treatment 
are residents of the Eastern Health Board area (now the ERHA) (O’Brien et al. 
2000).  Most of these clients (80%) are treated for heroin misuse (ibid.).  In 
other health board areas throughout the country cannabis is the drug for 
which the majority of people receive treatment (ibid.). Of course, the 
characteristics of clients using different types of drugs varied accordingly.  
Heroin users were must less likely to be still at school than cannabis users; 
and they were much more likely to be involved in behaviours with detrimental 
effects to their health, such as injecting, and sharing injecting equipment.  
  
b) Comments on different client profiles in different types of 
treatment 
 
The majority of people presenting for treatment for drug use problems in 
Ireland are treated at non-residential treatment centres.  Data from the 
NDTRS for 1999 show the following proportions presenting to different types 
of treatment services: 57% non-residential; 34% residential; 6% low threshold; 
3% medical doctors in general practice (National Drug Treatment Reporting 
System, personal communication).  It should be stressed that in 1999 not all 
GPs were reporting to the NDTRS and contacts in prisons were very poorly 
represented.  Men were more likely to be receiving treatment at residential or 
low threshold services, while women were more likely to present to non-
residential or GP services for treatment.  Clients living in the parental home 
were least likely to be attending low threshold services.  Unemployed clients 
were the most likely to be attending low threshold services; those in regular 
employment were more likely to be receiving treatment from a GP.   
 
Against a background of increasing encouragement of GPs to become more 
involved in the treatment of drug users, a study was carried out in a 
specialised drug treatment setting during August-September 1997, to assess 
the utilisation of primary care services for general health purposes, by 
injecting opiate users (n=77) (Smyth et al 1999a).  A structured questionnaire 
was used to interview clients.  The sample size was 139 with a response rate 
of 75 percent.  The sampling procedure was opportunistic.  Despite general 
policy changes, such as more emphasis on harm minimisation, the findings 
  57  
were similar to those of a similar study in 1991.  In particular, the relative 
frequency of GP and A&E (hospital accident and emergency department) 
attendances were unchanged.  Concern was expressed by the authors 
(Smyth et al. 1999a) at the high proportion who were being prescribed 
benzodiazepines (39%) by GPs.  They state that this indicated that there is 
‘clearly a wide gap’ between treatment approaches by psychiatrists 
specialising in substance misuse at treatment centres, and GPs, in the 
management of co-morbid disorders, such as anxiety and sleep disorders 
among drug users.  The need for improved communication and co-operation 
as well as explicit protocols relating to clarity, consistency and continuity in 
treatment approaches, was stressed.     
 
c) Comments on treatment demand for different drugs 
 
Heroin :  A majority of people (around 6 out of 10 new cases each year) 
presenting to the treatment services have problems with the misuse of heroin, 
i.e. it is the main drug of misuse (National Drug Treatment Reporting System).  
This is mainly confined to the Dublin area but in recent years pockets of 
heroin use in other parts of the country are being reported.  A sizeable 
proportion (59% in 1999) of those presenting to treatment services with 
problem heroin use for the first time are involved in intravenous drug using 
practices with very serious health and social consequences.  This is the 
highest level in the past five years (37% in 1995; 37% in 1996; 49% in 1997; 
50% in 1998) (EMCDDA Standard Table).  See discussion at Section 2.3b. 
 
Cannabis : Since the NDTRS was set up in 1990, the proportion of people 
presenting for treatment for cannabis use has not varied much: between 11% 
and 15%.  After heroin it is the next drug, at a much lower level, for which 
treatment is most commonly sought.  More than half (55%) started to use 
cannabis between 15-19 years of age, 37% started before the age of 15 years 
(Moran et al. 1997).   
 
Cocaine : Treatment demand for problem cocaine use has always been very 
low: between 1%-2%.  Apart from addiction counselling, there are no specific 
treatments for problem cocaine users in Ireland right now.  Of all those 
presenting for treatment for the first time in 1999 with multiple drug problems 
(more than one drug) (64%), 7% were seeking treatment for problem cocaine 
use.    
 
Synthetic drugs : Demand for treatment for problem ecstasy use has 
decreased somewhat in recent years (from 11% in 1995 to 8% in 1999).  The 
proportion of problem amphetamine users presenting for treatment for the first 
time has increased from 0.4% in 1995 to 2% in 1999.  A worrying 
development is that in 1999, 6% of these were injecting the drug.  The 
proportion presenting with problem LSD use has been falling (from 1.6% in 
1995 to 0.2% in 1999).  
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3.2 Drug-related mortality 
 
a) Drug-related deaths, direct and indirect, characteristics and 
trends 
 
Official Irish statistics on drug-related deaths from the General Mortality 
Register (GMR) are compiled routinely by the Central Statistics Office.  They 
are recorded according to the International Classification of Diseases, 
Version 9 (ICD-9), that is, the cause of death is designated as the underlying 
cause of death.  This is defined as - 
(a) the disease or injury which initiated the train of morbid events 
leading directly to death, or (b) the circumstances of the accident or 
violence which produced the fatal injury (WHO, 1977, p. 700) 
 
The underlying cause of death can be from natural or external causes.  The 
definition of external cause of death is as follows: 
 
…a supplementary classification that may be used, if desired, to code 
external factors associated with morbid conditions classified to any part 
of the main classifications.  For single-cause tabulation of the underlying 
cause of death, however, the E Code should be used as a primary code 
if, and only if, the morbid condition is classifiable to Injury and Poisoning     
(WHO, 1977, p. xxix) 
 
Data from the General Mortality Register at the Central Statistics Office show 
that drug-related deaths increased considerably between 1995 and 1997, and 
then levelled off in 1999 and 2000 (Table 3.2a).  It should be noted that data 
for 1999 and 2000 are provisional, and are likely to change as late returns are 
recorded.      
 
Table 3.2a.  Ireland 1990-1999.  Drug-Related Deaths** from Drug Dependence and 
Opiate Poisoning.  Numbers. 
 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999* 2000* 
Ireland 
(All ages) 
7 8 14 18 19 43 53 81 97 85 89 
Male 
Female 
 
6 
1 
8 
0 
11 
3 
16 
2 
18 
1 
37 
6 
44 
9 
67 
14 
70 
27 
64 
21 
71 
18 
Under 30 years 
old 
7 
 
4 
 
8 
 
8 
 
11 
 
22 
 
30 
 
51 
 
42 
 
39 
 
38 
15-49 years old 7 
 
7 
 
14 
 
16 
 
19 
 
39 
 
50 
 
75 
 
86 
 
75 
 
76 
Dublin 
(All ages) 
6 
 
8 
 
14 
 
16 
 
17 
 
39 
 
43 
 
70 
 
73 
 
68 
 
69 
Drug dependence 
(ICD-9 Code 304) 
(All ages) 
4 
 
5 
 
13 
 
13 
 
15 
 
38 
 
42 
 
69 
 
91 
 
80 
 
81 
Source: Central Statistics Office 
* provisional data 
** A drug-related death is defined here as one where the underlying or external cause of death was due to drug 
dependence (ICD-9 Code 304) or opiate poisoning (ICD-9 Code 965.0). 
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The highest number (N=97) was recorded in 1998.  It was in that year that an 
amendment was made to the information recorded, in the case of a sudden 
death, by the Garda Siochana (on Form 104): a question on drug/alcohol 
dependency was included on Form 104. This was as a result of the work of 
the National Task Force on Suicide (Department of Health and Children 1996; 
1998).  The increasing trend did not continue in 1999 and 2000 when the 
number of deaths was 85 and 89 respectively (Table 3.2a).  In terms of 
geographic location the vast majority of deaths each year were in Dublin.  The 
majority were males, between the ages of 15 and 49.   
 
Indirect as well as direct drug-related death was the subject of an ad hoc 
retrospective study carried out in 1999 (Keating et al. 1999).  Dublin City and 
County Coroners’ files were examined to study the number of drug-related 
(direct and indirect) deaths in 1997.  The criteria for inclusion were that the 
death had to have occurred in Dublin (city or county), between 1 January and 
31 December 1997, and have positive toxicological evidence of the presence 
of drugs, and where drugs were implicated in the cause of death - this is a 
much broader definition that that used for the purpose of the GMR.  
Toxicological screens included testing for alcohol, opiates, benzodiazepines, 
tricyclics, barbiturates and cocaine.  One-hundred-and-twenty cases were 
found to be toxicologically positive for drugs and 65 of these were known to 
be drug users.  The gender ratio was 3:1 (male:female) and more than half of 
the deaths were in the 20-39 year age group.  The drug most commonly 
identified was benzodiazepine (75 cases) mainly in combination with other 
drugs. The most common combination of drugs was opiates and 
benzodiazepines.  Methadone was found in 47 cases; alcohol was found in 47 
cases; cocaine in 7 cases; MDMA in 2 cases; and amphetamines in 2 cases.  
A similar study of coroners’ files in 1992 (in Keating et al. 1999) found no 
cocaine, MDMA nor amphetamines in drug-related deaths.  The 1992 study 
found a similar number of drug-related deaths recorded (in Dublin coroners’ 
files) to that recorded in the GMR for that year.  However, the total number 
(120) found in the 1997 study did not correspond with the number (49) 
recorded in the more narrowly defined GMR for the same year.  
 
A more recent study in Dublin in 1999 also found that statistics recorded in the 
GMR fell short of those found in the coroners’ records (Ward and Barry 2001).  
The study definitions, which included indirect as well as direct drug-related 
deaths, were somewhat different from the GMR definition.  One of the aims of 
the study was to determine the number of opiate-related deaths in Dublin city 
and county in 1999.  Eighty-four drug-related deaths were found: methadone 
and/or morphine were detected in 72; benzodiazepines in 52; alcohol in 26; 
codeine cocaine, amphetamines and ecstasy were found in 14 cases.  
Toxicological analyses showed that 2 or more drugs were identified in 73 of 
84 cases.  The majority was young males who had been involved in 
benzodiazepine or alcohol co-abuse.   
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Table 3.2b. Dublin 1999. Drug-related death by cause of death. Numbers. 
Cause of death ICD Code Number 
Drug dependence 304.0-304.9 63
Poisoning by opiates & related narcotics 965.0-965.2, 965.9 2
Violent & accidental (hanging, gunshot wound, fall etc.) 994.7, E922.0, E888 13
Miscellaneous 9not established, vasculitis, alcohol 
dependence, liver disease) 
799.0, 447.5, 303.0, 
571 
6
Total  84
Source: Ward & Barry 2001 
 
The cause of death was recorded as drug dependence in 75% of cases 
(N=63), and violence accounted for a sizeable minority (15%, N=15) (Table 
3.2b).   
 
These study findings show that polydrug use is a serious problem.  They also 
highlight the fact that the full extent of drug-related death is not evident from 
GMR statistics, suggesting the need for a Special Register to record indirect 
as well as direct drug-related deaths  
b) Mortality and causes of death in drug users, trends 
 
An outbreak of 24 cases of illness among injecting drug users in the Dublin 
area in Summer 2000 resulted in 8 deaths.  This was similar to an outbreak of 
the illness in Glasgow where the first cases were recognised.  While the 
definitive cause of death for all cases has not yet been established, the likely 
cause has been identified as a toxin-producing strain of Clostridium novyi, but 
other bacteria may be involved.  The ‘significance of the presence of 
clostridial species remains to be determined but it may suggest contamination 
of the drugs or other materials’ used by the intravenous drug users 
(Andraghetti et al. 2000).   
 
Research findings on mortality among drug users is not yet available, 
therefore it is not possible to discuss associated mortality trends.   
 
3.3 Drug-related infectious diseases – Lucy Dillon 
 
This section will summarise the Irish situation in relation to drug-related 
infectious diseases and report and comment on updated figures and any new 
research carried out in the area8. 
 
a) HIV and AIDS 
 
As described in the National Report for 2000, the majority of data collected on 
drug related infectious diseases in Ireland are related to HIV. Two sources of 
data exist: the routine data on HIV positive tests that are reported by the 
Department of Health and Children9; and special studies which have been 
                                                     
8 An in-depth account of the Irish situation in relation to drug-related infectious diseases was given as a 
Special Topic in the National Report for Ireland, 2000- this has subsequently been published in a 
collection of papers produced by the DMRD (Moran, Dillon, O’Brien, Mayock, Farrell & Pike, 2001). 
9 The National Disease Surveillance Centre (NDSC) took over statutory responsibility for sexually 
transmitted infections (STIs), including HIV/AIDS, from the Department of Health and Children (DOHC) 
on July 1st 2000. Data on HIV/AIDS are now provided directly to the NDSC by the Departments of Public 
Health of each health board. Quarterly STI reports for 2000 are now available on this website. The 
DOHC provided finalised data for quarter 1 (Q1) and quarter 2 (Q2), 2000. Data for quarter 3 (Q3) and 
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carried out estimating the prevalence of HIV among particular cohorts of drug 
users. 
 
Routine data on HIV testing 
Up until July 2000, the Department of Health and Children, in collaboration 
with the Virus Reference Laboratory, was responsible for producing statistics 
on HIV positive tests which are published every six months. On 1st July 2000, 
the Infectious Diseases (Amendment) Regulations, 2000 (S.I. No 151 of 2000) 
came into force. Under these regulations the National Disease Surveillance 
Centre (NDSC) was assigned responsibility for the collation and analysis of 
weekly notifications of infectious diseases, taking over from the Department of 
Health and Children. In their first six months of data collation (July 2000-
December 2000), data were collected in the same manner as previous years. 
However, in July 2001 a new HIV case-based reporting system has been 
developed. The aim of the new HIV case based reporting system has been 
noted as “to ensure the collection of accurate and complete epidemiological 
data on the distribution and mode of transmission of HIV infection” (O’Donnell, 
Cronin and Igoe 2001, p. 21). The socio-demographic data that will be 
collected within this new system are the patient’s age, gender, county of 
residence (if Dublin, then the postal code) and country of birth (if not Ireland 
then year of first arrival in Ireland). Furthermore, an expanded list of probably 
routes of transmission is included. The new list reads as follows: 
 
Probable route of transmission  
(please tick one) 
  Men who have sex with men (MSM)/Bisexual 
 Injecting Drug User (IDU) 
 IDU and men who have sex with men (MSN)/Bisexual 
 Heterosexual 
If heterosexual (please circle) 
1. From a country with a generalised HIV epidemic 
2. Sex with a bisexual male 
3. Sex with an injecting drug user 
4. Sex with a haemophiliac or a transfusion recipient 
5. Sex with a person from a country with a generalised HIV epidemic 
6. Sex with a person known to be HIV infected (not number 1-5 above) 
7. Infected through heterosexual transmission, no further information 
 Mother-to-child 
If mother-to-child please indicate status of mother (please circle) 
1. Injecting drug user 
2. From a country with a generalised HIV epidemic 
3. Infected through heterosexual contact (not number 2 above) 
4. Transfusion recipient 
5. Other/undetermined 
 Haemophiliac 
 Transfusion recipient 
 Nosocomial infection 
 Occupational 
 Other/undetermined (if other please state) 
Source: HIV/AIDS Surveillance Report Form, NDSC. 
                                                                                                                                                        
quarter 4 (Q4) 2000 was provided to NDSC by the Departments of Public Health. The figures for the Q3 
and Q4 2000 reports are provisional and will not be regarded as final until all returns are received and 
data has been validated.  
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This new system of data collection for HIV will be evaluated in Spring 2002, 
and any necessary changes made. 
 
In considering the data available for 2000, the remainder of this section refers 
to data gathered on positive test by the Virus Reference Laboratory and 
collated by the Department of Health and Children, and, from July 2000, the 
NDSC. Within this system figures relating to HIV tests are broken down 
according to risk category, one of which is injecting drug use. As noted in the 
National Report for 2000, while it is possible to get a breakdown of the 
number of positive HIV cases attributable to injecting drug use in a given year, 
there continue to be a number of limitations to this data source:  
It is limited to the tested population. Nothing can be inferred for those drug 
users who have not been tested. 
It is not possible to identify non-injecting drug users within the data set.  
No socio-demographic data is collected on those who are tested. 
There is only a limited geographical breakdown available. 
A gender breakdown has only been made available since 1997. 
Both risk behaviours (e.g. injecting drug use) and test locations (e.g. 
prison) are used as categories. This makes the data somewhat unclear. 
For example, it is not known through what risk activity those tested in the 
prison setting became infected with HIV.  
(National Report 2000) 
 
Despite these limitations, this data source provides the best information with 
which to examine the epidemiological profile of HIV in Ireland over the past 
decade and a half.  
 
The cumulative figures for the positive cases of HIV from the start of data 
collection in 1982 up until 1985, show that just over 60% (n=221) of all 
positive cases (n=363) were attributed to injecting drug use (see table 3.3a).  
Since 1985, injecting drug use has continued to be one of the main risk 
categories, accounting for 38.6% of the cumulative number of positive cases 
up until December 31st 2000 (see table 3.3a).  
 
As can be seen in Table 3.1 the proportion of positive HIV cases attributed to 
the intravenous drug user category generally decreased from 1992 through to 
1998. The proportion of positive HIV tests attributed to intravenous drug use 
fell from 49.7% in 1989, to a low of 17.6% in 1997 (see Table 3.3a). It was 
noted in the National Report for 2000 that 1999 had seen a significant rise in 
the numbers of injecting drug users testing positive for HIV. The number of 
positive tests has remained stable in 2000 with 70 positive tests being 
attributed to injecting drug use. Proportionately, in 2000 injecting drug use 
decreased to representing 20.5% compared to 33% of all positive tests in 
1999- this was primarily due to the significant increase in the number of 
positive tests attributable to the heterosexual sex/risk unspecified category- 
this more than doubled during 2000, increasing from 59 in 1999 to 129 in 
2000.  
 
  63  
Table 3.3a: Ireland 1985-1999. HIV positive cases by risk category. Numbers and 
percentages 
Year IVDUs  
n (%) 
Homosexual 
Sex 
n (%) 
Heterosexual Sex/ 
Risk unspecified 
n (%) 
Other 
n (%) 
Total 
n (%) 
1985* 221 (60.9) 39 (10.7) 0 103 (28.4) 363 (100.0) 
1986 112 (66.3) 11 (6.5) 21 (12.5) 25 (14.8) 169 (100.0) 
1987 72 (49.7) 21 (14.5) 26 (17.9) 26 (17.9) 145 (100.0) 
1988 58 (50.4) 17 (14.8) 20 (17.4) 20 (17.4) 115 (100.0) 
1989 57 (49.1) 33 (28.5) 0 26 (22.4) 116 (100.0) 
1990 50 (45.1) 25 (22.5) 24 (21.6) 12 (10.8) 111 (100.0) 
1991 34 (36.9) 27 (29.4) 25 (27.2) 6 (6.5) 92 (100.0) 
1992 82 (40.8) 58 (28.9) 50 (24.9) 11 (5.5) 201 (100.1) 
1993 52 (38.0) 48 (35.0) 21 (15.3) 16 (11.7) 137 (100.0) 
1994 20 (23.5) 31(36.5) 22 (25.9) 12 (14.1) 85 (100.0) 
1995 19 (20.9) 33 (36.3) 30 (33.0) 9 (9.9) 91 (100.1) 
1996 20 (18.9) 41 (38.7) 27 (25.5) 18 (17.0) 106 (100.1) 
1997 21 (17.7) 37 (31.1) 40 (33.6) 21 (17.7) 119 (100.1) 
1998 26 (19.1) 37 (27.2) 47 (34.6) 26 (19.1) 136 (100.0) 
1999 69 (33.0) 40 (19.1) 59 (28.2) 41 (19.6) 209 (99.9) 
2000 70 (20.5) 72 (21.1) 125 (36.4) 75 (22) 342 (100) 
Total 983 500 537 447 2537 
 Source: Department of Health and Children and National Disease Surveillance Centre.  
 
As discussed in the National Report for 2000, anecdotal evidence suggests a 
couple of explanations for the increase in the number of positive cases being 
attributed to injecting drug use during 1999 which may also offer an 
explanation for the 2000 figures. Firstly, leading on from the Protocol for the 
Prescribing of Methadone issued in 1993, guidelines were developed for GPs 
prescribing methadone within the general practice setting and for pharmacists 
in their dispensing of methadone. Following the completion and evaluation of 
a pilot programme, in January 1998 the Report of the Methadone Treatment 
Services Review Group made a number of recommendations on tightening 
control on both the prescribing and dispensing of methadone, in accordance 
with the 1993 protocol. Consequently, the Misuse of Drugs (Supervision of 
Prescription and Supply of Methadone) Regulations, 1998. The regulations 
aim to create a more controlled environment for the prescribing and 
dispensing of methadone. Within this context, all those who were receiving 
methadone in Ireland were integrated into a structured programme. 
Furthermore, drug users were integrated into a structured programme setting 
where there is an active policy of carrying out virology in relation to HIV and 
hepatitis. It is suggested therefore, that this may have resulted in an increase 
in the number of injecting drug users being tested for HIV and, in turn, an 
increase in the number of positive cases being attributed to injecting drug use 
during 1999 and 2000. Secondly, it has also been suggested anecdotally that 
perceptions may be beginning to change among the drug using population in 
relation to HIV. It is argued that the availability of new treatment (HAART) and 
the visibility of individuals in the community for whom treatment has been 
effective, has encouraged people to come forward for testing so that they can 
avail of treatment if necessary.  
 
                                                     
* Cumulative figures 
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Gender: As discussed in the National Report for 2000, gender is the only socio-
demographic data collected on those who are tested for HIV from the 
Department of Health and Children’s Data source, but has only been reported 
since 1997. An examination of the figures by gender suggests a possible 
change in the profile of those who are testing positive for HIV in Ireland (see 
Table 3.3b). In 1997, females only accounted for 3 of the 21 new positive cases 
attributed to injecting drug use. In 1998 this had increased to 10 of the 26 
positive cases among injecting drug users, and in 1999 it had increased further 
to account for 34 of the 69 positive cases. However, in 2000 only 29 of the 70 
new positive cases were women. Speaking in percentage terms, women had 
increased from representing 14.3% of the positive tests among injecting drug 
users in 1997, to 38.5% in 1998 and up to a high of 49.3% in 1999. However, in 
2000 they decreased proportionately to 41.4% of new cases. Due to the lack of 
information on gender prior to 1997, it is not possible to explore trends over a 
more extended period of time. Furthermore, research has not been carried out 
in the Irish context into the spread of HIV among female and male injecting drug 
users. As discussed in the National Report for 2000, anecdotal evidence 
suggests that the overall increase in the number of positive tests among women 
with a history of injecting drug use since 1997, may reflect a real increase in the 
number of female injecting drug users who are becoming infected with HIV. 
However, it is also suggested that these women may be becoming infected 
through their sexual behaviour rather than their injecting drug use. Once 
identified as an injecting drug user however, their infection will tend to be 
attributed to their injecting drug using behaviour. Anecdotal evidence also 
suggests that a growing number of women may be attending for testing in order 
to be able to minimise the risk of infection to their baby were they to become 
pregnant. 
 
Table 3.3b Ireland 1997-2000. HIV seropositive intravenous drug users by gender. 
Numbers and percentages.  
Year Male  
n (%) 
Female  
n (%) 
Total  
n (%) 
1997 18 (85.7) 3 (14.3) 21 (100) 
1998 16 (61.5) 10 (38.5) 26 (100) 
1999 35 (50.7) 34 (49.3) 69 (100) 
2000 41 (58.6) 29 (41.4) 70 (100) 
Source: Department of Health and Children and NDSC 
 
AIDS 
Since 1983 and up until December 31st 2000, there have been 707 AIDS 
cases reported in Ireland, and 362 AIDS related deaths (see Appendix 2, 
Table 3.3). It has been noted that injecting drug use has accounted for 
approximately 40% of the AIDS cases reported between 1983 and 1999 
(O’Donnell et al., 2000). In 2000 there were 21 new AIDS related cases 
recorded and 13 AIDS related deaths. Intravenous drug users continue to 
represent one of the main risk categories recorded in this data source. In 
2000, intravenous drug users accounted for 28.6% of new AIDS cases, and 
38.5% of the year’s AIDS related deaths.  
 
Special Studies 
A number of special studies have been carried out which have explored the 
prevalence of HIV among cohorts of drug users in a range of study locations. 
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The studies have included drug users located in: the community, drug 
treatment centres, needle exchange programmes and prisons. A summary of 
the research findings on the prevalence of HIV infection among particular 
cohorts of drug users is presented in Table 3.3c below. An in-depth 
description of these studies was presented in the National Report for 2000. 
There have been very few data made available since that report.  In a 
retrospective study of a sample of client records in a treatment setting, it was 
found that 16.7% had tested positive for HIV (Fitzgerald, et al., 2001). This 
prevalence rate is significantly higher than those found in recent studies. No 
explanation for the high prevalence rate is offered in the paper reporting this 
figure. However, it is noted that the study was primarily an audit of screening 
for infectious diseases and therefore was of “limited value in estimating true 
prevalence rates” (Fitzgerald et al., 2001: 33). In a study of a sample of those 
receiving methadone treatment within a general practice setting, 30 of 343 
clients were reported to have tested positive for HIV (Cullen et al., 2000). 
 
Table 3.3c Summary of research findings on the prevalence of HIV infection among 
particular cohorts of drug users 
Author Study 
period 
Sample 
Source 
Self 
Report/ 
Test 
Serum/ 
Saliva 
Sample 
size tested 
% infected 
of those 
tested 
Fitzgerald et 
al 
(2001) 
1997 Drug 
treatment 
centre 
n=138 
Test Serum n/a 16.7% 
Cullen et al 
(2000) 
1999 General 
practice 
n=571 
Test Not 
reported 
n=343 8.7% 
Long et al  
(2000) 
1999 Committal 
prisoners 
n=593 
Test Saliva IDUs10  
(n=173) 
 
IDUs   
5.8% 
 
Allwright et 
al  
(1999) 
1998 Irish Prison 
Population 
n=1178 
Test Saliva IDUs 
(n=509) 
 
IDUs 
3.5% 
 
Smyth et al  
(1998) 
1992-
1997 
Drug 
treatment 
centre 
n=735 
Test Serum IDUs  
(n=600) 
IDUs 
1.2% 
Dorman et 
al  
(1997) 
1992 Drug 
treatment 
centre & non-
treatment 
IDUs 
n=185 
Test Serum 
and 
saliva 
IDUs 
(n=180) 
IDUs 
8.4% 
O’Kelly et al  
(1996) 
1984-
1995 
IDUs in 
community 
n=82 
Test Serum IDUs 
(n=66) 
IDUs 
65% 
Johnson et 
al  
(1994) 
1991 Needle 
exchange 
n=106 
Test Saliva IDUs 
(n=81) 
IDUs 
14.8% 
 
In summary, injecting drug use continues to be one of the main risk categories 
to which HIV positive cases are attributed each year. Despite the rates of new 
HIV positive cases attributed to injecting drug use plateauing in the early and 
                                                     
10 IDUs: Injecting drug users 
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mid 1990s, recent figures suggest that there is an upward trend in the number 
of new HIV positive cases among Irish drug users. The information available 
on those who are testing positive for HIV remains limited. Analysis of the 
figures highlights the need for more information, in particular of a socio-
demographic and behavioural nature, to facilitate comprehensive 
epidemiological analysis of the trends. 
 
b) Hepatitis B and C 
 
Hepatitis B 
There is very little information in Ireland on the prevalence and incidence of 
hepatitis B among both the general population and the injecting drug using 
population. While data are collected on the number of positive tests carried 
out for hepatitis B by the Virus Reference Laboratory, no behavioural data is 
collected and therefore those infected through drug use cannot be identified. 
Information on prevalence rates is therefore confined to a small number of 
special studies that have been carried out in the field. A summary of the 
research findings is given in table 3.3d. Only one study has addressed the 
prevalence of hepatitis B among drug users since last year’s report. Cullen et 
al. (2000) found that 43 of 316 clients attending a general practice for 
methadone prescription had tested positive for hepatitis B. Overall, the 
prevalence rates of hepatitis B among samples of injecting drug users range 
from 1% to 18.5%. 
 
Table 3.3d Summary of research findings on the prevalence of Hepatitis B infection 
among particular cohorts of drug users 
Author Study 
period 
Sample 
Source 
Self 
Report/ 
Test 
Serum/ 
Saliva 
Sample 
size tested 
% infected 
of those 
tested 
Cullen et al 
(2000) 
1999 General 
practice 
n=571 
Test Not 
reported 
n=316 15.7% 
Long et al 
(2000) 
1999 Committal 
prisoners 
n=593 
Test Saliva IDUs 
(n=173) 
 
IDUs 17.9% 
 
Allwright et 
al (1999) 
1998 General 
prisoners 
n= 1178 
Test Saliva IDUs 
(n=509) 
 
IDUs 
18.5% 
 
Smyth et al 
(1998) 
1992-
1997 
Drug 
treatment 
centre 
n=735 
Test Serum IDUs  
(n=729) 
IDUs 
1% 
 
Hepatitis C 
In Ireland, there is no routine data collection in the area of hepatitis C. Only 
total numbers of individuals who tested positive in a given year are available- 
it is not possible to differentiate those who have become infected through 
injecting drug use. However, there have been a number of special studies 
carried out among samples of drug users in a variety of study settings (see 
table 3.3e). These were discussed in detail in the National Report for 2000. 
Three papers presenting findings of special studies have been published 
since last year’s report. In a study of a sample of clients (n=119) attending 
drug treatment services, of 48 injectors tested, 54% tested positive (Smyth, 
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2000). Another study of 138 clients in a treatment centre with a history of 
injecting drug use, found a prevalence rate for hepatitis C of 78.8% (Fitzgerald 
et al, 2001). Finally, Cullen et al (2000) found that of 372 clients attending a 
general practice setting for methadone treatment, 270 had tested positive for 
hepatitis C. In summary, prevalence rates among samples of injecting drug 
users have been found to range from 52.1% to 89%- clearly indicating 
hepatitis C among injecting drug users as an issue of concern for public 
health. 
  
While it is not possible from the available data to analyse infection trends over 
time, it would appear from the studies available that hepatitis C infection has 
been prevalent among Irish injecting drug users over the past decade. 
Anecdotal evidence suggests that the relative ease with which hepatitis C can 
be spread through injecting drug use, and a lack of knowledge among users 
about hepatitis C and the associated risks, have all contributed to its spread. 
In summary, the prevalence rate for hepatitis C has been found to be 
consistently high within the drug using population over the past decade. 
 
Table 3.3e Summary of research findings on the prevalence of Hepatitis C infection 
among particular cohorts of drug users 
Author Study 
period 
Sample 
Source 
Self 
Report/ 
Test 
Serum/ 
Saliva 
Sample 
size tested 
% infected 
of those 
tested 
Fitzgerald 
et al 
(2001) 
1997 Drug treatment 
centre 
Test Serum n/a IDUs  
78.8% 
Cullen et al 
(2000) 
1999 General 
practice 
n=571 
Test Not 
reported 
n=372 72.6% 
Smyth et al 
(2000) 
08/1996- 
01/1997 
Drug treatment 
centre n=138 
Test Serum IDUs 
n=48 
IDUs 
54% 
Long et al 
(2000) 
1999 Committal 
prisoners 
n=593 
Test Serum IDUs 
(n=173) 
Non IDUs 
(n=420) 
IDUs 
71.7% 
Non IDUs 
1.4% 
Allwright et 
al (1999) 
1998 General 
prisoners 
n=1178 
Test Serum IDUs 
(n=509) 
Non IDUs 
(n=669) 
IDUs 
81.3% 
Non IDUs 
3.7% 
Smyth et al 
(1999a) 
1993-
1996 
Drug treatment 
centre 
n=353 
Test Serum IDUs 
n=353 
IDUs 
52.1% 
Smyth et al 
(1999b) 
1997 Drug treatment 
centre 
n=84 
Self-report n/a IDUs 
n=84 
IDUs  
89% 
Smyth et al 
(1998) 
1992-
1997 
Drug treatment 
centre 
n=735 
Test Serum IDUs  
n=733 
IDUs 
61.8% 
Smyth et al 
(1995) 
1992-
1993 
Drug treatment 
centre 
n=272 
Test Serum IDUs 
(n=272) 
IDUs 
84% 
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c) Other drug related infectious diseases 
 
Data have not been collected on other drug-related infectious diseases in 
Ireland. Anecdotal evidence suggests however that tuberculosis may be 
increasing in prevalence among Irish drug users. 
 
Chronic drug effects: The most obvious consequences of HIV and hepatitis 
B and C are the impact these diseases have on the individual’s health. There 
are no data available on the number of drug users who develop chronic 
hepatitis C or require care for hepatitis B infection. The only routine data 
collected on the health consequences of drug related infectious diseases are 
those on AIDS related cases and deaths. Since 1983 and up until December 
31st 2000, there have been 707 AIDS cases reported in Ireland, and 362 AIDS 
related deaths. In 2000 there were 21 new drug-related AIDS cases recorded. 
Intravenous drug users continue to represent one of the main risk categories 
recorded in this data source. In 2000, intravenous drug users accounted for 
28.6% of new AIDS cases, and 38.5% of the year’s AIDS-related deaths (see 
appendix 2, Table 3.3).  
 
3.4 Other drug-related morbidity – Mary O’Brien 
 
a) Non-fatal drug emergencies 
 
NO INFORMATION AVAILABLE 
Information on non-fatal drug emergencies is not available in Ireland.   
 
b) Psychiatric co-morbidity 
 
NO NEW INFORMATION AVAILABLE  
National policy on the treatment of alcohol and drug misuse (Department of 
Health 1984) stipulates that the emphasis in the management of alcohol and 
drug-related problems be on community-based intervention, rather than on 
specialist inpatient treatment. Despite the general policy of providing 
treatment for problem drug use at non-residential services in the community, 
drug-related admissions to psychiatric inpatient hospitals are continuing to 
rise (Table 3.4a).  The proportion of drug-related admissions – with a primary 
or secondary diagnosis - increased from 2.2% in 1995 to 3.6% in 1999 for all 
admissions (National Psychiatric Inpatient Reporting System [NPIRS], 
personal communication).  For first admissions (admission for the first time 
ever) the proportion increased from 2.4% to 5.0% in the same period.  This is 
in contrast to the general trend of a decrease in overall admissions to 
psychiatric hospitals.   
 
The rates (per 100,000 population) increased from 16.2 in 1995 to 24.6 in 
1999 for all admissions, and in the case of first admissions the rate doubled 
between 1995 and 1999 from 4.7 to 9.8 per 100,000 population.  Admission 
rates for ‘drug dependence’ to inpatient psychiatric hospitals vary according to 
geographic location (Table 3.4a). This is not necessarily an indication of 
morbidity but may perhaps be linked to drug treatment provision in different 
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areas and/or more willingness in certain areas to admit people with drug 
problems to psychiatric hospitals.   
 
 3.4a.  Ireland 1997-1999. First Admissions to Inpatient Psychiatric Hospitals. Drug 
dependence diagnosis. Rates per 100,000 population aged 16 years and over. 
Health Board Area 1997 1998 1999 
Eastern 10.9 13.4 13.4 
Midland 10.1 8.0 17.4 
Mid-Western 10.6 10.2 13.2 
North-Eastern 6.3 6.8 8.6 
North-Western 6.5 6.5 2.6 
South-Eastern 7.1 8.0 8.7 
Southern 6.6 6.1 6.1 
Western 5.4 6.5 7.7 
Total 8.7 9.6 10.6 
Source: National Psychiatric Inpatient Reporting System, Mental Health Division, The Health Research Board. 
 
The NPIRS data from 1997 to 1999 did not show any noteworthy psychiatric 
co-morbidity (NPIRS, personal communication).  Close family ties and good 
family supports could be a factor in preventing people with psychiatric 
disorders from becoming involved in problematic drug use.   
 
In an attempt to draw attention to concerns of the Irish Council of Attention 
Deficit Disorder Support Groups (INCADDS) a submission was made on their 
behalf to the National Drugs Strategy Review which took place during 2000.  
The submission was made as a result of concern that attention deficit 
hyperactivity disorder (ADHD) may be a significant risk factor for involvement 
in substance misuse; and that people with ADHD are more likely to self 
medicate.  The aim was to highlight the need to identify drug users who suffer 
from ADHD and ensure the provision of appropriate treatment programmes 
for their care and management.   
 
c) Other important health consequences  
The Medical Bureau of Road Safety (MBRS) in collaboration with the Garda 
Siochana (police) has undertaken a study to determine current trends in 
driving under the influence of drugs in Ireland.  A survey being carried out in 
the year 2000 will investigate the presence of amphetamines, 
benzodiazepines, cannabis, cocaine, opiates and methadone in blood and 
urine samples taken by the Gardai under the Road Traffic Act, 1994.  One 
thousand samples will be randomly selected and another 1,000 from those 
who are under the legal alcohol limit for driving.  Preliminary results (Table 
3.4b) from 338 samples (under the legal alcohol limit) showed that cannabis 
was most frequently found (34%), followed by benzodiazepines (25%).  
Cocaine was the drug least commonly found at 4% of the sample (Moane et 
al. 2000).  
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Table 3.4b.   Drugs Driving in Ireland 2000.  Preliminary Study of Prevalence of Driving 
under the Influence of Drugs - for sample under legal alcohol limit. Type of Drug.  
Percentages 
Type of Drug Percentage 
Prevalence 
Cannabis 34 
Benzodiazepines 25 
Amphetamines 16 
Opiates 14 
Methadone 7 
Cocaine 4 
Total N=338  
Source: Moane et al. 2000 
 
These results indicate that there has been a significant increase in driving 
under the influence of drugs since 1987, when a similar study was carried out 
and 14.6% of samples (under the legal alcohol limit) tested were found 
positive for drugs.  The current preliminary study found that the percentage 
had risen to 37%.  The results of this survey, which will be available in 2002, 
will identify the types of drugs including alcohol, and their combination with 
other drugs, being used by Irish drivers. 
 
The MBRS is responsible for analysing blood and urine specimens taken from 
people suspected of driving under the influence of an intoxicant, for 
prosecution purposes.  The number of specimens analysed has been 
increasing for both alcohol and drugs.   
 
Table 3.4c. Ireland 1995-2000. Toxicological analysis of blood/urine specimens. 
Numbers. 
Year Alcohol Drug 
1995 4766 8 
1996 5514 16 
1997 6591 24 
1998 7812 32 
1999 8476 50 
2000 10134 78 
Source: Flynn et al. 2001 
 
Analyses of specimens for drug concentrations increased from 8 in 1995 to 78 
in 2000.  Of the 78 tested in 2000, 71 were found to be positive for drugs; 23 
for one drug; 48 for more than one drug.   
 
Table 3.4d. Ireland 2000. Toxicological analysis by type of drug found in blood and 
urine specimens*. Percentages. 
Type of Drug Percentage  
Cannabinoids 32 
Benzodiazepines 19 
Methamphetamine 18 
Amphetamine 15 
Methadone 8 
Other opiates 7 
Cocaine 1 
Total N=71  
Source: Flynn et al. 2001 
*using Cozart immunoassay kits. 
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The drug most frequently found was cannabis in almost a third of cases 
(32%), followed by benzodiazepines (19%). Amphetamine-type drugs were 
identified in 33% of cases.  This study of a small sample of blood/urine 
samples illustrates the occurrence of polydrug use among of Irish drivers.   
 
Summary: 
There is great disparity in patterns of drug use in different regions of 
Ireland.  Problematic drug use is mainly in the eastern region of the 
country, but in recent years heroin use is being reported in other areas.  
Cocaine use accounted for 7 percent of new treated drug users with 
multiple drug problems.  Demand for treatment for problem ecstasy use 
declined between 1995 and 1999. 
The most comprehensive data available on drug related infectious 
diseases in Ireland are for HIV. While the number of new positive tested 
cases for HIV, which were attributable to injecting drug use, appeared to 
stabilise in the mid-1990s, figures for 1999 showed an increase in the 
number of cases, which has remained stable in 2000. For both hepatitis B 
and C, analysis is dependent solely on data from special studies. Despite 
the absence of comprehensive data it appears from the evidence available 
that hepatitis C continues to be highly prevalent among Irish injecting drug 
users. Overall, it would appear from the data that is available that drug-
related infectious diseases continue to be an issue of concern in relation to 
Irish injecting drug users. Furthermore, this highlights the need for more 
comprehensive data collection in the area of all drug related infectious 
diseases in order to monitor changes in the trends over time. 
The sharp rise in the number of drug-related deaths in the 1990s was 
partly attributable to more accurate recording procedures, but undoubtedly 
there was also a real increase in drug-related deaths.  In the late 1999 and 
2000 the increases of earlier years levelled off.   
Findings of ad hoc studies show that the full extent of drug-related deaths 
is not apparent from the GMR data.  These studies also show that 
polydrug use is a problem among drug users and highlights the need to 
create more awareness of the risks involved and thereby prevent or at 
least reduce such deaths.  
Given that the full extent of deaths, in particular those related to opiate 
use, is not evident from official statistics, the need for a Special Register to 
record indirect as well as direct drug-related deaths has been recognised.  
Discussions, between the Department of Health & Children, the 
Department of Justice, Equality & Law Reform, and the Focal Point, are 
taking place about the establishment of such a Special Register.   
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4. Social and Legal Correlates and Consequences 
 
4.1 Social problems  
 
a) Social exclusion 
 
For several years, professionals working in disadvantaged communities and 
in the field of drug treatment have been aware that the development of long-
term and damaging drug careers is most often associated with social 
marginalization and exclusion (McCarthy and McCarthy 1995; Loughran 
1996).  Research in Ireland has, over the past two decades, consistently 
demonstrated a link between concentrations of drug use and various 
indicators of poverty and social exclusion, such as unemployment, poor 
housing, one-parent families and low educational attainment (Dean et al. 
1983; O’Kelly et al. 1988; McKeown et al. 1993; O’Higgins and O’Brien 1995; 
Coveney et al. 1999).  In 1996, Irish Government drug policy recognised the 
link between poverty and concentrations of serious drug problems in the First 
Ministerial Task Force on Measures to Reduce the Demand for Drugs.  As 
Butler (1991) has commented, the role of setting, that is the impact of 
environmental or contextual factors in the development of drug-related 
problems, was acknowledged for the first time.  The Irish National Drugs 
Strategy, which aims to provide an integrated response to the problems posed 
by drug misuse, can be characterised as supporting general initiatives to 
tackle social exclusion and specific initiatives targeted at drug related 
problems. 
 
The mid-1990s in Ireland witnessed increased attention to the plight of 
families, parents and children living in neighbourhoods with high 
concentrations of drug use and related illegal activity.  In 1996, community 
members engaged in direct action by marching on the homes of suspected 
drug dealers with the intention of intimidating them.  Media attention to the 
activities of resident anti-drug and vigilante groups increased substantially 
during this time, raising public awareness of drug-related activities as well as 
the link between drug use and crime. The murder of journalist Veronica 
Guerin in 1996, resulting in public outrage and heightened intolerance of drug-
related activities, forced the drugs issue to the top of the political agenda 
(Memery and Kerrins 2000).  In December 1996, the Government introduced 
the Housing (Miscellaneous Provision) Bill which was enacted in July, 1997.  
According to Section (1), (a) and (b) of the 1997 Act, anti-social behaviour 
includes either or both of the following : 
 
(a) the manufacture, production, preparation, importation, exportation, 
sale supply, possession for the purposes of sale or supply, or 
distribution of a controlled drug (within the meaning of the Misuse of 
Drugs Act, 1997 and 1984), 
(b) any behaviour which causes or is likely to cause and significant or 
persistent danger, injury, damage, loss or fear to any person living, 
working or otherwise lawfully in or in the vicinity of a house provided 
by a housing authority under the Housing Acts, 1966 to 1997, or a 
housing estate in which the house is situated and, without prejudice to 
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the foregoing, includes violence, threats, intimidation, coercion, 
harassment or serious obstruction of any person. 
 
This legislation, which gave powers to local authorities to evict tenants on 
grounds of anti-social behaviour, was and remains strongly criticised by 
several sectors involved in the care and rehabilitation of drug users, and is 
equally strongly supported by certain community activists.  According to the 
Merchants Quay Project, a voluntary service which provides a range of 
services to drug users seeking help, the Housing Act 1997 has contributed to 
an increase in homeless drug users in Dublin (Memery and Kerrins 2000).  
The Merchants Quay Project has noted an increase of young drug users 
sleeping rough in its recently published annual report.  They claim that “both 
homelessness and lack of experience of drug use make these drug users a 
particularly vulnerable group in terms of risk of infection and general health 
and well being” (Merchants Quay Project 2000, p. 1).  
 
Research evidence across a range of studies suggests that the Housing Act 
1997 has impacted negatively on drug users. The Costello and Howley (2000) 
qualitative study of fifteen homeless drug users found that several of their 
respondents perceived the 1997 Act as leading to their further exclusion in 
gaining access to independent housing.  The respondents’ perception that 
they are discriminated against by local authority and resident committees 
because of their drug use was reported as creating a considerable barrier to 
their seeking accommodation.  Similarly, Woods (2000), reporting on a study 
of female drug users’ experience of parenting, found that respondents 
described the Housing Act 1997 as “anti-woman” and “anti-family”.  
Respondents recounted several cases where drug users have been delivered 
the ultimatum to either access treatment or leave their communities. 
 
The Cox and Lawless (1999) study of homeless drug users in Dublin city 
highlights the extreme vulnerability of this group, among whom they found low 
levels of educational attainment, high unemployment and histories of serving 
prison sentences.  Fifty-six percent of the study’s respondents reported that 
their drug use had escalated as a result of being out of home.  This group of 
homeless drug users was found to engage in very high levels of risk 
behaviour, with 66% of clients injecting in public places, 49% reporting 
sharing injecting equipment and a further 24% stating that they recently 
borrowed used injecting equipment.  This highly marginalised group meet 
further exclusion at some of the homeless services due to a policy of non-
acceptance of active drug use in most direct access accommodation, such as 
hostels or shelters.  Costello and Howley (2000) note the numerous negative 
consequences of excluding drug users from accommodation services for 
homeless people, including increased likelihood of sharing needles, lack of 
safe places to store and dispose of needles, lack of access to clean injecting 
equipment, and the lack of a clean safe environment in which to inject. 
 
The impact of the Housing (Miscellaneous Provision) Act 1997 has been 
recently assessed by Memery and Kerrins (2000).  This report documents an 
increase in evictions related to anti-social behaviour by Dublin Corporation 
since the introduction of the Housing Act, 1997.  These authors conclude : 
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Instead of working to resolve the wider and complex drug issues for 
these communities and address the needs of drug users directly, a very 
blunt piece of legislation was put in place with the emphasis on excluding 
those involved with drugs from local authority housing. (ibid., p. 29). 
 
b) Public nuisance, community problems 
 
The links between local authority rental tenure and various forms of 
disadvantage are well-documented in Ireland (Nolan et al. 1998).  Less 
attention has been given to the investigation of the impact of social and 
environmental conditions on areas characterised by extreme deprivation, 
despite the susceptibility of such communities to a range of social problems, 
including drug misuse.  However, one recent study of living conditions in 
seven local authority estates in urban areas throughout Ireland (Fahey 1999), 
highlights a range of social order problems in the study’s estates.  O’Higgins 
(1999) notes that the nature of social order problems experienced in the 
seven estates varied.  At one end of the scale, social problems consisted of 
relatively minor “nuisance behaviour”, while at the other, a number of estates 
endured more serious problems, ranging from illegal drug use and dealing to 
intimidation and harassment.  This study found that the use of heroin and 
other “hard” drugs was confined mainly to Dublin estates, and was particularly 
acute in one large local authority flat complex located in Dublin’s south inner 
city.  The profound negative effects of concentrations of drug problems 
emerged strongly from the reports of children living in the estate, and 
interviewed for the purpose of the research.  Children in focus groups 
recounted routine encounters with drug users and made casual reference to 
the presence of drugs paraphernalia on the stairs, on balconies and in the 
stairwells.  Coupled with this, parents expressed extreme anxiety about the 
negative consequences of high level of exposure to drugs for their children.  
Drug use and activities related to the distribution of illegal drugs were 
considered to be among the most enduring problems on the estate, and one 
which impacted negatively on the quality of life of a high proportion of 
residents. 
 
In another study of a local authority estate, Corcoran (1998) similarly reported 
that all aspects of the drug problem, including drug-taking in public areas and 
the sale and distribution of drugs, were perceived as the biggest problem.  
Both Corcoran (1998) and O’Higgins (1999) note that the activities 
surrounding the distribution of drugs draw a steady stream of non-residents 
onto estates.  This among other factors, exacerbates the “palpable sense of 
tension” (Corcoran, 1998: 21) in the area.  There was a widespread belief 
among residents that the drug situation was out of the control of both 
residents and the Gardai (McAuliffe and Fahey 1999).  Reporting on research 
carried out in another large inner-city flat complex with a long history of social 
problems, Morley (1998) also highlighted the perceived negative impact of 
drug problems on the quality of life in the community.  The socio-economic 
profile of this estate revealed in the research - high rates of long-term 
unemployment, low educational attainment levels and high rates of early 
school leaving - is again indicative of a community struggling with the issues 
of social exclusion and marginalisation.  This estate also hosted a large 
number of problem opiate users. 
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The management of social order problems on local authority estates has 
involved, inter alia, evictions of problem tenants, particularly those individuals 
associated with drug dealing and related activities.  Fahey (1999) notes that 
while the use of exclusionary strategies has resulted in some improvements in 
social order in a number of estates, they can lead to further social problems 
which ultimately exacerbate social exclusion. 
 
4.2 Drug offences and drug-related crime – Mary O’Brien 
 
a) ‘Arrests’ for use/possession/traffic and trends 
 
The use per se of drugs, excluding opium, is not a criminal offence in Ireland.  
Under the Misuse of Drugs Acts, 1977 and 1984 (MDA), possession (MDA 
Section 3) and trafficking/dealing/supplying (MDA Section 15) are illegal 
activities.  In 2000 prosecutions for ‘possession’ of an illegal drug made up 
73% of total MDA prosecutions; 24% were prosecuted under Section 15 of the 
Misuse of Drugs Acts for drug-related trafficking offences (Table 4.2a).  A 
breakdown by Garda regions11 shows that most offences (34%) were 
committed in the Dublin Metropolitan area (N=2995), followed by 22% in the 
Southern region (N=1961).  The proportion of ‘possession’ offences was 
almost the same in these two areas: in Dublin 26% (N=1705); in the Southern 
region, 23% (N=1516).  Over half (53%, N=1116) of trafficking 
(supply/dealing) offences were in Dublin.   
 
Table 4.2a.  Ireland 200012.  Drug law offences by type of offence and region.  Numbers 
and percentages.  
Region/Offence 
Type  
Possession 
(Section3 MDA) 
Supply/Dealing 
(Section15 MDA) 
Obstruction 
(Section 21 MDA) 
Other 
offences 
Total 
      
Eastern 1376 222 0 1 1599 
17.9 
Dublin metropolitan 1705 1116 95 79 2995 
33.5 
Northern 514 117 11 10 652 
7.3 
South Eastern 749 156 28 7 940 
10.5 
Southern 1516 395 29 21 1961 
21.9 
Western 644 119 13 15 791 
8.8 
Total N 
% 
6504 
72.8 
2125 
23.8 
176 
2.0 
133 
1.5 
8938 
100.0 
Source: Annual Report of An Garda Siochána 2000 
 
With regard to the type of drug involved nationally, more than half (59%) were 
cannabis offences; in fact cannabis accounted for most of drug law offences 
in each region of the country (Table 4.2b).  Nationally, ecstasy accounted for 
25% of drug offences; after cannabis it was the drug implicated in most cases, 
except, that is, in the Dublin region where heroin accounted for over a quarter 
(28%) of offences.  This is in contrast to the national situation where heroin 
was implicated in 10 percent of cases.  In the Dublin region cocaine offences 
                                                     
11 Since 1996 a regional command structure has been in place in An Garda Siochana and the country is divided into six separate 
regions – Eastern, Dublin Metropolitan, Northern, South-Eastern, and Western. 
12 Provisional data 
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were 5 percent of the total; nationally cocaine accounted for 2 percent of 
offences.   
 
Table 4.2b.  Ireland 200013.  Drug law offences by type of drug and region.  
Numbers and percentages.  
Region/Drug  
Type  
 Cannabis Heroin LSD Ecstasy Amphetamine Cocaine Other Total14 
          
Eastern N 
% 
819 
51.2 
24 
1.5 
5 
0.3 
656 
41.1 
75 
4.7 
19 
1.2 
0 
0.0 
1598 
100.0 
 
Dublin  
metropolitan 
N 
% 
1481 
52.5 
778 
27.6 
0 
0.0 
346 
12.3 
47 
1.7 
128 
4.5 
41 
1.5 
2821 
100.0 
 
Northern N 
% 
372 
59.0 
4 
0.6 
7 
1.1 
234 
37.1 
11 
1.7 
2 
0.3 
1 
0.2 
631 
100.0 
 
South Eastern N 
% 
580 
65.2 
3 
0.3 
0 
0.0 
255 
28.2 
55 
6.1 
11 
1.2 
1 
0.0 
905 
100.0 
 
Southern N 
% 
1253 
65.6 
5 
0.3 
10 
0.5 
530 
27.7 
91 
4.8 
21 
1.1 
1 
0.1 
1911 
100.0 
 
Western N 
% 
551 
73.5 
2 
0.3 
7 
0.9 
156 
20.4 
36 
4.7 
7 
0.9 
4 
0.5 
763 
100.0 
Total  N 
% 
5056 
58.6 
816 
9.6 
29 
0.3 
2177 
25.2 
315 
3.7 
188 
2.2 
48 
0.5 
8629 
100.0 
Source: Annual Report of An Garda Siochána 1999 
 
Trends over the six-year period between 1995 and 2000 show an increase in 
the number of drug charges, from 4146 in 1995 to 8938 in 2000 (Table 4.2c).  
There was a rise in the number of cannabis offences in 1999 (N=4185) and 
again in 2000 (N=5056).  In 1998 cannabis offences (N=2190) made up 39% 
of total drug law offences, increasing to 59% in 1999: the proportion 
decreased a little to 57% in 2000.  Heroin offences which had been steadily 
increasing between 1995 and 1999 dropped slightly in 2000 (N=816), 
accounting for 9% of total drug law offences.  Amphetamine offences 
increased from 138 in 1995 to 464 in 1999 and dropped in 2000 to 315.  The 
most dramatic jump was in relation to ecstasy offences which more than 
doubled in 2000 to 2177, accounting for nearly a quarter (24%) of all offences.   
 
Table 4.2c.  Ireland 1995-2000.  Drug law offences by type of drug.  Numbers.  
Type of Drug 1995 1996 1997 1998 1999 2000 
       
Cannabis 2600 1834 2671 2190 4185 5056
Heroin 296 432 564 789 887 816
Cocaine 30 42 97 88 169 188
Amphetamine 138 152 239 273 464 315
LSD 70 24 39 13 26 29
Ecstasy 645 340 475 439 1023 2177
Other offences 385 454 65 1839 383 357
Total 4146 3278 4156 5631 7137 8938
Source: Annual Reports of An Garda Siochána 1990-1999 
 
In 2000 cannabis and ecstasy offences accounted for the majority (81%) of 
offences against the Misuse of Drugs Acts.  It is likely that the increase in 
cannabis and ecstasy offences in 1999 and 2000 was related to intensive 
                                                     
13 Provisional data 
14 Total for classification by drug type. There were 309 ‘other’ offences – obstruction etc.. 
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police activity, at large-scale music events at a number of venues in the 
country.  Heroin and cocaine offences were more likely to be detected in the 
Dublin region.   
 
b) Convictions and court sentences for drug offences 
 
NO INFORMATION AVAILABLE 
 
c) Drug-related crime 
 
THERE IS NO NEW INFORMATION AVAILABLE ON DRUG RELATED CRIME   
 
In a study of the general healthcare of the Irish prison population (sample size = 
777: 718 males, 59 females) Hannon et al. (2000) found that 51 percent of 
males and 69 percent of females stated that they were under the influence of 
drugs when they committed the crime for which they were incarcerated.   
 
A study to examine the association between drug use and crime in Dublin 
Metropolitan Area was carried out by the Garda Research Unit (Keogh 1997).  
The ‘population’ (N=4,105) was drawn from police records and from (police) 
local knowledge.  It included all those who had come in contact with the 
Gardai through being arrested, charged or suspected of criminal activity 
between August 1995 and September 1996.  The inclusion criterion was 
‘individuals involved in hard drug use’; opiates, stimulants, hypnotics and 
hallucinogens were included in the definition of ‘hard drugs’.  During the study 
period 19,046 serious crimes were detected and 7,757 individuals were 
apprehended for these crimes: of these 3,365 (43%) were identified as known 
hard drug users.  It was deduced that the drug users were responsible for 
12,583 (66%) of the crimes. 
 
A sample of (n=351) of these agreed to be interviewed to provide more 
detailed information. Over a third (37%) had left school before the official 
school leaving age of 15; and 84% were unemployed.  While three-quarters of 
the respondents had at some time sought treatment for problem drug use and 
most had received it, a number (n=81) had never sought treatment of any 
kind.  A majority said they had a poor understanding of the effects of drug 
use. It was found that 51% had been involved in crime before their 
involvement with drugs; 48% said family members were involved in crime.   
 
The authors of the National Crime Forum Report (1998, p. 74) stated that they 
were ‘deeply concerned with the impact of drug abuse on crime and the 
response of the criminal justice system to that issue’. The authors were 
impressed by suggestions to keep otherwise law-abiding young people out of 
the criminal justice system – that young experimental users of cannabis and 
ecstasy should be diverted to the Juvenile Diversion Programme.  (The aim of 
this programme, which was established by the Garda Siochana, is crime 
prevention and to provide an alternative for juvenile offenders.  Rather than 
being dealt with under criminal law, they enter the programme and thus are 
diverted from the formal criminal justice system). The case for the 
decriminalisation of certain drugs was presented to the Forum which agreed 
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that the issue was important and required more careful study.  Those against 
decriminalisation argued that public opinion was opposed to such a change.  
A general population survey (Bryan et al. 2000) to examine drug-related 
knowledge, attitudes and beliefs, could be interpreted to support this view – 
66 percent agreed that cannabis should be against the law.  Results from the 
same study found that drug-related crime is considered to be a major problem 
in Ireland by 94 percent (n=998) of those interviewed, and three-quarters of 
the sample felt that the drug problem was out of control.  
 
In 1998 a study was conducted by the Garda Research Unit to explore the 
links between alcohol/drug use and crime (Millar et al. 1998).  Gardai at 27 
stations throughout the country (12 in Dublin, 15 in the other 5 Garda 
divisional regions) were asked for their ‘informed opinion’ (ibid. p.2) as to 
whether alcohol or drugs were involved in offences where a person was 
‘arrested, charged, summonsed, or diverted under the Juvenile Diversion 
Programme’ (ibid. p.1).  Offences under the Misuse of Drugs Acts and the 
Liquor Licensing Acts were excluded.  A total of 4,334 offences (no indication 
is given as to whether these refer to individuals or incidents) were noted 
during the study period (March-May 1998).  Forty-two percent of cases were 
considered to be related to alcohol consumption, 17 percent to drugs and 4 
percent to alcohol and drugs (drugs were implicated in 913 cases).  Alcohol 
was most likely to be associated with public order offences, while drugs were 
most often linked to robberies.  In Dublin heroin was the drug most likely to be 
involved (83 percent of cases), while outside of Dublin cannabis (37 percent) 
and ecstasy (26 percent) were the drugs most commonly cited (see Table 
4.2d).       
 
Table 4.2d.  Ireland 1998.  Juvenile Diversion Programme. Drug-related crime by type of 
drug. Percentages & Numbers. 
Main drug involved Dublin Other areas 
   
Opiates 83.1 20.1 
Cannabis 13.5 37.4 
Ecstasy 0.9 25.9 
Amphetamines 0.9 1.1 
Barbiturates 0.6 0.6 
Cocaine 0.2 1.1 
Hallucinogens 0.2 0.0 
Other 0.6 13.8 
   
Valid N 534 174 
Missing N 136 69 
Total N 670 243 
Source: Garda Research Report No. 7/98 
 
Summary 
Most offences under the Misuse of Drugs Acts are committed under 
Section 3, that is, for possession of a controlled drug.  During 2000 
prosecutions involved ‘possession’ offences in almost three-quarter of 
cases (73%).   
One-third of all MDA offences were prosecuted in the Dublin metropolitan 
region of the country.  Cannabis accounted for the majority of drug law 
offences in each region of the country, varying from 51 percent in the 
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Eastern region, to 74 percent in the western region.  Nationally, ecstasy 
accounted for 25% of drug offences, and after cannabis it was the drug 
implicated in most offences committed under the MDA, throughout the 
country.  One exception to this was the Dublin region where heroin 
offences were more likely to be detected, accounting for over a quarter 
(28%) of offences in that region.  Nationally, heroin was implicated in 10 
percent of prosecutions.   
It is likely that the increase in cannabis and ecstasy offences in 1999 and 
2000 was related to police activity at large-scale music events in the 
country. 
 
4.3 Social and economic costs of drug consumption 
 
a) Studies and estimates of healthcare costs, other social costs 
 
Studies to estimate the healthcare or other social costs of drug consumption 
have not been carried out in Ireland.  Nor are estimates available on the 
economic costs to society from drug use.  Accepting that the “social costs” 
incurred by drug use can be defined and interpreted variously, and that no 
research has been undertaken in Ireland with the specific aim of estimating 
such costs, a number of research findings can be drawn upon to illustrate 
evidence of significant costs to individuals, families and communities as a 
result of drug use. 
 
As might be expected, this evidence arises primarily from research on a range 
of social problems associated mainly with disadvantaged communities.  
Numerous researchers have documented the perceived negative impact of 
high levels of drug misuse on communities where drug use is concentrated 
(O’Higgins 1999; Corcoran 1998; Morley 1998).  Residents of estates where 
drug use is concentrated consistently draw attention to the destructive effect 
of drug use and drug trafficking on community life.  Furthermore, they are 
acutely aware of the negative way in which their community is perceived by 
outsiders.  Mayock (2000), in a qualitative study of drug use by young people 
in a Dublin inner-city community noted that respondents made constant 
reference to the area’s drug problem.  Furthermore, these young people 
expressed resentment of outside representations of their neighbourhood.  
They were particularly critical of the negative effects of disparaging media 
reports of drug problems in their community, which they felt exaggerated the 
issue.  Many clearly felt stigmatised by virtue of living in a locality where drug 
use and associated activities are concentrated. 
 
There is relatively little research available pertaining to the consequences of 
drug problems for individual families.  For example, there is no available 
estimate of the number of individuals affected by familial drug use.  However, 
the issue of how children are affected by drug misuse has emerged as an 
issue of critical concern.  Hogan (1997), in an exploratory study of the social 
and psychological needs of children of drug using parents, found that the 
majority of children whose parent(s) were heroin users were experiencing 
difficulties at school.  Key workers interviewed for the purpose of the research 
  80  
expressed concern about the quality and consistency of care-giving by drug 
using parents. 
 
b) Estimates of total consumption/demand/expenditure on drugs 
 
In Ireland, there are no estimates of consumption nor demand nor expenditure 
on drugs available.   
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5. Drug Markets   - Mary O’Brien 
 
5.1 Availability and supply 
 
a) Availability of different drugs, trends and possible reasons 
 
The ESPAD 1999 nation- wide school survey of 15-16 year-old post-primary 
school pupils (Hibell et al. 2001) found that many illicit substances were 
perceived as being easy to obtain in Ireland.  However, in most cases 
perceptions of availability were lower in 1999 than in the previous ESPAD 
survey in 1995.  Throughout Europe the proportion that thought that inhalants 
were easy to obtain, was highest among Irish students (63%).  This was a 
decrease from 80 percent since the previous ESPAD study in 1995.  Fifty-nine 
percent of Irish students thought that cannabis was easy to obtain, this was 
less than the 1995 figure of 62 percent.  Irish students were at the top of the 
list in Europe for perceived availability of LSD (30%): this had diminished from 
43 percent in 1995.   
 
Table 5.1  Ireland 1995 & 1999.  Perceived availability of substances. Percentages 
Substance/Year 1995 1999 
Inhalants 80 63 
Anabolic steroids 15 19 
Marijuana 62 59 
Amphetamines 31 28 
LSD or other hallucinogens 43 30 
Crack 23 23 
Cocaine 20 21 
Ecstasy 54 35 
Heroin 28 21 
Magic Mushrooms - 38 
Tranquilisers 31 21 
Source: Hibell et al. 1995, 1999. 
 
Qualitative information from a survey in the north-east of the country (an area 
that is geographically proximate to Dublin), to explore the experience and 
knowledge of adolescents in relation to barriers and motivating factors to illicit 
drug use, found that drugs are readily available, in particular cannabis and 
acid (Department of Public Health 1999).  However, unlike the adult world of 
drug trafficking/dealing where distribution networks revolve around large 
quantities of money, ‘procurement of drugs in adolescent worlds, for the most 
part, revolves around friendship, reciprocity and sharing, where money is 
pooled and drugs are shared among friends.  The stakes involve friendship 
not profit’ (Department of Public Health 1999: 30).   
 
In a qualitative study of illicit drug use by young people in an inner city 
community, a sample (n=57) of 15-19 year olds considered to be particularly 
at risk were interviewed.  Thirty-nine were drug users and 18 did not use 
drugs (Mayock 2000).  Both users and non-users were exposed to the drug 
culture in the locality and for them ‘procuring drugs was a largely 
uncomplicated matter, provided they had the necessary financial resources at 
their disposal’ (Mayock 2000, p. 34).  They could identify specific areas in the 
locality where they could get a range of drugs with relative ease.   
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Another qualitative study in Mountjoy Prison involving 29 prisoners, found the 
prison atmosphere to be ‘characterised by a drugs culture’ (Dillon 2001, p. 3).  
While availability of drugs within the prison was said to fluctuate, it was 
reported in the Dillon study that when they are available the drugs are not sold 
for cash, but are distributed through a reciprocal network system (ibid.).  
 
Seizures may, with caution, be taken as an indirect indication of the 
availability of illicit drugs.  However, since the number of seizures and the 
amounts of illicit drugs seized can be affected by factors such as the 
resources committed to detection, changes in the quality of intelligence on 
illicit drugs trafficking etc., they cannot be used as a reliable indicator of trends 
in relation to the amount of drugs available on the market.  The fact also, that 
not all drugs seized in Ireland are destined for the Irish market, but are in 
transit elsewhere, complicates the issue even further (Garda Siochána, 
personal communication).   
 
In Ireland there was a sizeable increase in the quantity of drugs seized in 
1995 over previous years.  This can be partly attributed to the setting up of the 
Garda National Drugs Unit and the Customs National Drugs Team in 1995.  In 
that year there were two major seizures of cannabis, and one seizure of 
ecstasy contained 40,000 tablets.  More recently, the reported ban on opium 
production by the Taliban in Afghanistan does not appear to have had any 
impact on the availability of heroin at street level.   
 
Measuring the availability of drugs is a very difficult task given the illicit nature 
of the activity.  Special studies would need to be undertaken in order to 
explore the issues involved.  Given that no such studies have yet been 
conducted in Ireland it is not possible to comment on drug availability trends.   
 
b) Sources of supply and trafficking patterns within Ireland 
 
The sources of supply vary according to the type of drug.  Cannabis comes 
mainly from Morocco, while some smaller seizures are known to have 
originated in Pakistan, Afghanistan and Lebanon (Garda Siochána, personal 
communication).  Most of the trafficking in cannabis to Ireland takes place 
between Morocco, up through Iberian peninsula to the south coast of Ireland.  
It is transported in freight trucks using cross-channel ferries; and on sea-going 
yachts.  The south-west of Ireland is a major trans-shipment point.  In recent 
years some cannabis seizures were known to have originated in South Africa.  
Heroin seized in Ireland is thought to come from Asia, mainly Afghanistan, 
Pakistan, India and Laos. The bulk of heroin seizures are transported to 
Ireland through the UK and some through the Netherlands.  Individual drug 
couriers travelling by air, bring smaller amounts from Europe.  Cocaine traffic 
is believed to originate in South America.  The main place of origin for ecstasy 
seized in Ireland is the Netherlands and to a lesser extent Belgium (Garda 
Siochána, personal communication).   
 
The police believe that most of the drugs seized in Ireland in recent years are 
for the home market.  In the case of very large shipments it is speculated that 
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Ireland with its long coastline, isolated in many areas, is used as an access 
point for transit to the UK and Europe.  The police also believe that the 
distribution of drugs within the country is organised by networks of criminal 
gangs.  In some cases these gangs involve members of the same family.   
 
Sale patterns of drugs at street level in Dublin differ from location to location, 
with price and purity of drugs varying according to supply and demand factors.  
No research studies have been conducted on drug supply sources or patterns 
of trafficking as yet in Ireland.   
 
In recent times the nature of the cannabis market seems to have changed to a 
larger distribution network, involving smaller amounts of the drug.  In other 
words, there are many more carriers, trafficking smaller amounts of cannabis.   
 
5.2 Seizures  
 
Trends in quantities and numbers of seizures 
 
In Ireland it is not possible as yet to distinguish between police and customs 
seizures in relation to the quantities and numbers of drugs seized.  All 
seizures, by both police and customs, are included in published Annual 
Reports of An Garda Siochána (police).  Police and customs authorities 
increasingly work on a collaborative basis and data collection is being 
organised so that separate information on seizures will be provided in the 
future.    
 
Drug seizures are sometimes taken as an indirect indicator of the supply and 
availability of drugs, however they are more likely to reflect law enforcement 
resources, and police and customs activities.  The quantity of drugs seized 
fluctuates from one year to the next, sometimes due to a small number of 
large seizures.  The number seized is usually more useful as an indicator of 
trends at user level.   
 
Between 1996 and 2000 the total number of seizures increased steadily from 
5,244 to 7,706 (Table 5.2a).   
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Table 5.2a.   Ireland 1996-200015. Quantity (kgs) and number of seizures of illicit drugs. 
1996 1997 1998 1999 2000  
Type of Drug N* Q** N* Q** N* Q** N* Q** N Q** 
           
Cannabis 
 
3449 1935.4 4102 1282.7 4513 2201.7 4538 2577.3 4641 588 
Heroin 
 
664 10.8 599 8.2 884 38.3 767 17 598 24 
Cocaine 
 
93 642 157 11 151 333.2 213 85.6 206 18 
Amphetamines 
 
217 7.6 475 102.9 680 45 467 13.4 184 6 
Ecstasy*** 
 
534 23012 423 20434 509 609301 1074 229101 1910 558588 
LSD 
 
42 5901 48 1851 19 798 29 577 31 1127 
Benzodiazepines 
 
152 7146 219 4942 181 2885 175 15393 99 2626 
Other drugs 
 
93  159  93  55  37 674 
Total number 
seizures 
5244  6182  7030  7318  7706  
Source: Annual Reports of Garda Siochána 
*  N=Number of seizures 
** Q=Quantity seized in kilograms; number of tablets in the case of ecstasy, benzodiazepines; and number of doses 
in the case of LSD.  Q of ‘other drugs’ for 2000 refers to methadone and dihydrocodeine tablets.  
*** Ecstasy includes MDMA, MDEA, MDA, ephedrine, ketamine 
 
There are more seizures of cannabis than any other drug: the number 
increased from 3449 in 1996 to 4641 in 2000.  During the same period the 
number of heroin seizures remained fairly stable dropping to 598 in 2000 from 
767 the previous year.  Cocaine numbers increased to 213 in 1999 and 
dropped slightly in 2000 to 201.  The number of amphetamine seizures is 
falling, from the highest number seized (N=680) in 1998 to 184 in 2000.  The 
number of ecstasy seizures increased quite considerably from 534 in 1996 to 
1,910 in 2000.  It should be noted that ‘ecstasy’ can include various 
substances such as MDMA, MDEA, MDA, ephedrine or ketamine, and the 
user is not necessarily aware of the content.  There are no testing facilities at 
user level in Ireland.  In 2000 the number of cannabis, ecstasy and LSD 
seizures increased over those of the previous year; seizures of all other drugs 
decreased.   
 
The quantity of different types of drugs seized fluctuates from year to year. 
Between 1997 and 1999 the quantity of cannabis increased each year, but in 
2000 this dropped significantly from 2,577kg in 1999 to 588kg in 2000. The 
amount of heroin seized in 2000 increased slightly to 24kg from 17kg the 
previous year.  Except for the large amount seized in 1998, heroin seizures 
have remained fairly stable over the five-year period 1996 to 2000.  Cocaine 
quantities are down considerably, as are amphetamines.  The quantity of 
ecstasy seized in 2000 (558,588 tabs) increased over 1999 (229,101 tabs), 
but was less than the 1998 amount (609,301 tabs).  LSD also increased in 
2000 to 1,127 doses from 577 doses for 1999.   
 
In 1999 there was a large quantity of benzodiazepines (15,393 
tablets/capsules) seized.  The majority of these (13,389) were diazepam and 
                                                     
15 Provisional data for 2000 
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one seizure alone that year constituted 7,800 diazepam.  In 2000 the quantity 
of benzodiazepine seizures dropped to 2,626 tablets.  The number of seizure 
also fell from 175 in 1999, to 99 in 2000.  All benzodiazepines are controlled 
under Section 15 of the Misuse of Drugs Acts - it is illegal to supply or deal 
them other than by prescription.  However, in the case of flunitrazipam 
(Rohypnol) and temazepam they are controlled under both Section 15 and 
Section 3 of the Misuse of Drugs Acts - it is illegal to supply or possess them 
other than by prescription.  
 
NO NEW INFORMATION AVAILABLE ON PURITY OF DRUGS 
 
Drug seizures by the police are analysed at the Forensic Science Laboratory 
of the Department of Justice, Equality and Law Reform, to ascertain purity 
levels of heroin, cocaine and amphetamine.  Cannabis purity, for THC 
content, is not analysed.  Between 1995 and 1999 the purity levels of heroin 
decreased and in 1999 a minimum purity level of 0.25% was recorded.  Purity 
levels of amphetamine seizures have also decreased somewhat.  Cocaine 
purity levels have fluctuated in the five-year period but the trend is downward 
(Table 5.2b).   
 
Table 5.2b.  Ireland 1995-1999.  Purity of seized drugs.  Average percentages 
Type of Drug 1995 1996 1997 1998 1999 
      
Heroin 45 49 46 35 33 
Cocaine 47 62 54 38 41 
Amphetamine 4.7 9.8 3.5 6 3 
Source:  Forensic Science Laboratory, Department of Justice, Equality and law Reform 
 
Summary 
 
The limited information that exists on availability, suggests that drugs are 
perceived to be easily obtainable.  However, perceptions of availability 
among 15-16 year olds were lower in 1999 than in 1995.  
According to police the drug supply sources are the same as in the past – 
cannabis from Morocco, heroin from Asia and cocaine from South 
America. Ecstasy is believed to originate in the Netherlands, and to a 
smaller extent Belgium. 
Overall, the number of seizures in Ireland increased in 2000.  Cannabis 
and ecstasy account for 85% (6,551/7,706) of the total number.  Ecstasy 
seizures are increasing in both number and quantity.  In the case of 
cannabis, the number of seizures increased but the quantity dropped very 
significantly.  It is speculated that this may be due to a change in the 
nature of the cannabis market, which seems to have changed to a larger 
distribution network, trafficking in smaller amounts of the drug (Garda 
National Drugs Unit, personal communication).  Heroin seizures remained 
stable.  Cocaine and amphetamine seizures (number and quantity) were 
down in 2000. 
Special studies need to be undertaken in order to explore the issues 
involved in drug markets in Ireland, vis-a-vis availability, sources of supply 
and trafficking patterns.  
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6 Trends per Drug  - Mary O’Brien 
 
a) Information from different indicators and other sources plus 
comments on possible reasons and factors that may be associated to 
reported trends for each substance 
 
There is great disparity in the pattern of drug use in different parts of the 
country.  Overall cannabis is the most commonly used illicit drug.  Problematic 
opiate/heroin use is mainly in the eastern region of the country, around Dublin 
(cf. Section 2).   
 
b) Analysis for the following substances: 
 
Cannabis 
Cannabis remains the most widely available and the most commonly used 
illicit drug in Ireland.  Use is more experimental than habitual (see Section 
2.2).  Latest available survey results show that cannabis use is 
decreasing.  However, this is not borne out by the number of cannabis 
seizures which has been steadily increasing for several years. 
Around 20% of those aged between 18-64 years have tried cannabis at 
least once (see Section 2.2). 
Nine percent of those aged 18-64 have used cannabis in the past 12 
months; 5% in the past month (see Section 2.2). 
Cannabis use is most prevalent among young people between 18-24 
years; around a third have tried it at least once.  A quarter of this age 
group used it in the past 12 months; and 15% in the past month (see 
Section 2.2). 
The relatively high lifetime prevalence rate among 15-16 year olds, found 
in the ESPAD 1995 study, was not sustained in subsequent research (see 
Section 2.2).  
The proportion of all contacts presenting for treatment for problem 
cannabis use remained stable at around 15% between 1995 and 1999 
(EMCDDA Standard Table 4).    
Cannabis is the drug that features most frequently in prosecution and 
seizure data.  Cannabis offences account for 59% of drug law 
prosecutions.  The number of prosecutions increased from 1834 in 1996 to 
5056 in 2000 (see Section 4.2).  The number of cannabis seizures over 
the past five years has increased from 3449 in 1996 to 4641 in 2000 (see 
Section 5.2).  The quantities of cannabis seized fluctuated between 1996 
and 1999, and dropped considerably in 2000 to 588kg, from 2,577kg the 
previous year (see Section 5.2).   
Preliminary results from a study to determine current trends in driving 
under the influence of drugs found that cannabis was the drug most 
frequently found in 34% of cases (see Section 3.4c). 
Cannabis was the drug most frequently found (in 32% of cases) in 
toxicological analyses of blood and urine specimens for prosecution 
purposes (see Section 3.4c).  
 
 
 
  87  
Synthetic drugs (amphetamine, ecstasy, LSD, other/new) 
After cannabis, although much less prevalent, amphetamines and ecstasy 
are the second most commonly used drugs in the general population.   
Amphetamine use is slightly more common than ecstasy in general 
population studies.  Around 3 percent of those aged between 18-64 had 
used amphetamines in the past year (see Section 2.2).  Among younger 
people between 18 and 24 years old the annual prevalence was 9 percent.  
However, the picture among school pupils between 9 and 18 years of age 
is quite different: recent use of amphetamine, ecstasy or LSD is quite 
similar (under 2 percent); but prevalence of solvent misuse is higher at 5 
percent (see Table 2.2f at Section 2.2).   
The proportion presenting for treatment (for the first time) for ecstasy use 
has decreased, from 11% in 1995 to 8% in 1999 (EMCDDA Table 4). 
Treatment for amphetamine use is quite low but has increased a little; from 
0.4% in 1995 to 2% in 1999. 
After cannabis, ecstasy is the drug that features next in prosecutions and 
seizures data.  Up to 1998, the trend in ecstasy offences was fairly stable 
but in 1999 and 2000 the number of offences increased considerably (see 
Table 4.2c at Section 4.2).   
Ecstasy seizures come mostly from street or dance events, rather than 
from point of entry to the country.  Tablets tested are composed mainly of 
a combination of ketamine, ephedrine and caffeine.  Ketamine is due to be 
controlled in Ireland under the Misuse of Drugs Acts, as is 4MTA.  There 
have been no seizures nor reports of use of 4MTA in Ireland; nor have 
there been reports of ecstasy production in Ireland in recent years. 
Preliminary results from a study to determine current trends in driving 
under the influence of drugs found that amphetamine was found in 16% of 
cases (Moane et al. 2000). 
 
Heroin/opiates 
Heroin dependence is still mainly concentrated in and around the Dublin 
area, although this seems to be changing with diffusion to urban areas 
throughout the country.  The ‘visible’ users have serious health and social 
problems.  Unlike treated heroin users in other EU countries, they are a 
younger population: around 80% of all contacts presenting for treatment 
are between 15 and 29 years of age; up to 90% of those presenting for 
treatment for the first time are aged between 15 and 29.  There are no 
indications of serious psychiatric problems among treated drug users.  
Heroin is the least used drug in Ireland but it is the most problematic with 
serious health and social consequences. 
The trend some years ago (among treated heroin users) towards smoking 
rather than injecting heroin now seems to be changing. Smoking was the 
preferred route for people starting to use heroin, at least initially.  However, 
latest trends show that heroin is more likely to be injected.  It seems that 
people who originally preferred to smoke heroin are now no longer 
reluctant to inject (O’Brien et al. 2000).   
In 2000 heroin offences constituted 10% of total drug law offences (see 
Section 4.2).  The number of annual heroin seizures fluctuates from year 
to year but remains fairly stable. There were 598 heroin seizures in 2000, 
out of a total of 7,706 for all drug types.  In the five years between 1996 
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and 2000 the largest quantity was seized (38kg) in 1998.  For other years 
the amount fluctuated between 11kgs in 1996 and 24kgs in 2000 (see 
Table 5.2 in Section 5.2). 
Preliminary results, from a study to determine current trends in driving 
under the influence of drugs, found opiates in 14% and methadone in 7% 
of cases (Moane et al. 2000). 
 
Cocaine/crack 
Cocaine is used by about 2% of the general population in Ireland.    
Treatment demand for problem cocaine use has always been very low: 
less than 2%.  Apart from addiction counselling, there are no specific 
treatments for problem cocaine users in Ireland right now.  Of all those 
presenting for treatment for the first time in 1999 with multiple drug 
problems (64%), 7% were seeking treatment for problem cocaine use. 
Up to 1999 the number of cocaine seizures was increasing.  However, in 
2000 there was a slight drop: there were 206 seizures of cocaine out of a 
total of 7,706 for all drug types.  In 2000 there was also a considerable 
decrease in the quantity of cocaine seized from 86kgs in 1999 to 18kgs in 
2000.  
A small-scale (N=10) qualitative study of recreational cocaine users found 
that cocaine is more easily available in Ireland than previously, and that 
more people are perceived to be using it.  It is used in private social 
settings, such as home-based parties, rather than in public settings (I 
Moran et al.  2001). 
Preliminary results from a study to determine current trends in driving 
under the influence of drugs found that cocaine was present in 4% of 
cases (Moane et al. 2000). 
 
Multiple use 
In 1999, 64% of clients presenting for treatment for the first time were 
using two or more drugs.  Heroin was the primary drug for which the 
majority of people sought treatment.  Cannabis was the most frequently 
cited (26%) secondary drug of misuse followed by ecstasy (21%); 
benzodiazepines (10%); amphetamines (9%); cocaine (7%); and 
methadone (7%) (National Drug Treatment Reporting System, personal 
communication). 
Concern was expressed from a number of quarters regarding the over-
prescribing of benzodiazepines, in general, and in drug treatment settings.  
Benzodiazepines continue to be widely prescribed particularly to women, 
the elderly, the chronically ill, and other groups of people socially and 
educationally disadvantaged (Quigley 2000).  Quigley states that 
‘benzodiazepine regulation is a crucial public health responsibility’, and 
goes on to say that the medical profession should acknowledge its central 
role ‘in the creation, as well as the solving, of drug problems’.  In 2000 a 
Committee was established by the Minister for Health and Children to 
explore the nature and extent of benzodiazepine prescribing in Ireland. 
This Committee will examine current trends and make recommendations 
on good prescribing practices, paying particular attention to the 
management of drug users. The Committee is due to make its report to the 
Minister at the end of 2001.   
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A study on drug-related death in 1999 found that benzodiazepine was the 
drug most commonly identified (in 75 cases), and was mainly in 
combination with other drugs.  The most common combination of drugs 
was opiates and benzodiazepines (Keating et al. 1999). 
Preliminary results from a study to determine current trends in driving 
under the influence of drugs found quite a high prevalence of 
benzodiazepines – in 25% of cases (Moane et al. 2000).   
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7. Conclusions 
 
7.1 Consistency between indicators  
 
The five key indicators of drug misuse are at different stages of development 
as tools to measure the drug situation in Ireland.  For example,  
Estimates of national and local prevalence of problem drug use are at 
initial stages of development, and studies on prevalence of problem drug 
use are limited  
General population surveys on the use of all types of illicit drugs are very 
scarce, which makes it very difficult to make comparisons or discuss 
trends in drug use.  Where they are available comparability can be a 
problem. 
A number of ad hoc studies on the prevalence of infectious diseases 
among drug populations of drug users have been carried out, but no 
systematic monitoring of such populations for disease prevalence is 
currently taking place. 
Statistics on drug-related death, which are obtained from the General 
Mortality Register at the Central Statistics Office, are not, by their nature, 
all-inclusive of death related to drug use.  Research on mortality among 
drug-using populations is only just beginning to be carried out in 
collaboration with the EMCDDA. 
Treatment demand monitoring, the most developed of the indicators, has 
been adversely affected in recent years, mainly due to lack of 
commitment/priority given to data collection by drug treatment service 
providers. 
Drug seizures over a number of years can indicate trends in drug use Law 
enforcement data tend to be more of a reflection of police and customs 
activities than good indicators of drug use  
 
Despite all these drawbacks, there have been improvements in data collection 
and monitoring, for example, GMR data collection, law enforcement data, data 
on infectious diseases.   
 
From the limited information that is available there does seem to be some 
consistency between indicators of drug misuse. For example, in the case of 
more problematic opiate use a number of indicators – treatment demand, 
deaths, HIV and survey data – point to a stabilisation in use.  In the case of 
cannabis use, consistencies are not so evident: population surveys point to a 
decrease or a stabilisation in use; whereas law enforcement data, particularly 
the number of drug seizures, indicate increasing use.  The quantity of 
cannabis seized, however, did drop very considerably in 2000. 
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7.2 Implications for policy and interventions 
 
a) Possible hypotheses and reasons for main trends and new 
developments in drug use 
 
Against the background outlined above, the difficulties involved in attempting 
to make interpretations from the data that are available can be understood.  
Even taking the improvements in monitoring, data collection and institutional 
procedures, which initially partially contributed to increasing trends, into 
consideration, these trends have not been sustained. The rising trend in drug 
use seen over several years, now seems to be stabilising. 
 
It is difficult to offer reasons, and explanations can only be speculative.  
Several factors are likely to be involved, such as the availability of drugs at 
street level, drug prevention policies.  However in the absence of consistent, 
comparable and regular data collection, it is impossible to make meaningful 
interpretations.   
 
b) Relevance to policy issues or interventions for policy makers and 
professionals 
 
The gaps in available information, particularly in relation to the main indicators 
of drug misuse, do not help in the formulation of good policies.  Therefore the 
development of the five key indicators is vital.  As well as this, more in-depth 
qualitative research studies are needed in order, for example, to understand 
more about different user groups, different patterns of use e.g. drug users 
involved in risky behaviours. This would help towards making prevention 
strategies more effective. 
 
Data from different indicators over several years show high levels of social 
deprivation among problem drug users.  Economically, Ireland is relatively 
better off than in previous times but not all its people have access to the 
means of benefiting from the economic boom.  Certain sectors of society have 
been excluded from participating in the benefits of the so-called ‘Celtic tiger’.  
Lack of material and cultural capital such as having a job, having a decent 
place to live, access to education, having good skills, even having 
expectations, prevents people from availing of the current opportunities.  This 
is not just confined to so-called marginalised urban areas.  Key policy areas, 
which require attention in this context are; economic and fiscal policy, housing 
policy, education policy, employment policy, and the operation of the criminal 
justice system.  New policies and strategies in the context of the National 
Drug Strategy, the National Development Plan and Local Drugs Task Forces 
(see Parts 1 & 3 of this report) aim at addressing the drug problem in the 
broader socio-economic context and will help towards the alleviation of such 
adverse social conditions.   
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7.3 Methodological limitations and data quality 
 
Methodological limitations, evaluation of data quality, new information 
needs and priorities for future work 
 
General population surveys to study the extent of drug use in Ireland vary 
in objectives, methodologies, focus of data collection, questionnaire 
design, age groups studied etc..  Comparisons are therefore tentative and 
must be viewed with these variations borne in mind.  If meaningful 
interpretations and comparisons are to be made a priority for future work 
should be that prevalence surveys are carried out using comparable 
methodologies.  Information on recent and annual use should be available 
as well as lifetime experience of drug use.  Surveys should be comparable 
nationally as well in the wider European sense where possible.  It is also 
important that these surveys be replicated at frequent interval if trends 
over time are to be available.   
More work needs to be carried out on the improvement and evaluation of 
data quality, particularly in relation to the five key indicators of drug 
misuse. 
More in-depth qualitative research studies are needed to understand more 
about at-risk groups, such as injecting drug users, and thus help towards 
making prevention strategies more effective. 
Interest in the availability of drugs has been growing.  However, measuring 
this is a very difficult task given the illicit nature of the activity.  Special 
studies would need to be undertaken in order to explore the issues 
involved in drug markets in Ireland, vis-a-vis availability, sources of supply 
and trafficking patterns.  
In Ireland, there are no estimates of consumption or demand, or 
expenditure on drugs available.  Nor are there any estimates of healthcare 
or other social costs available.  This is an area that will need to be 
developed.  
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PART 3 
 
DEMAND REDUCTION INTERVENTIONS 
 
8.  Strategies in Demand Reduction at National Level – Martin Keane 
 
Demand reduction comprises interventions, which are aimed at decreasing 
the demand for drugs at an individual or at a collective level. Interventions 
aimed at reducing the harmful consequences of drugs are also included. The 
scope of demand reduction intervention is wide and consists of many facets. 
(EMCDDA 1996)  
 
8.1 Major strategies and activities 
 
The Irish Government's approach to combating drug misuse in the coming 
years has been set out in the National Drugs Strategy 2001-2008. The 
strategy includes four key areas that will receive focused attention from 
government and other relevant agencies, namely the areas of supply 
reduction, prevention, treatment and research. In terms of demand reduction, 
the areas of prevention, treatment and research are of particular relevance.  
 
Prevention  
A number of government departments are involved in delivering a range of 
education, prevention and awareness measures that aim to reduce the 
demand for drugs. For example, the Department of Education and Science 
oversee a number of initiatives, which are aimed at addressing the link 
between drug misuse and educational disadvantage. Such initiatives include 
The Disadvantaged Area Scheme, The Stay in School Retention Initiative and 
the Home-School Liaison Scheme. The rationale underlying these initiatives is 
that by seeking to improve educational opportunities for disadvantaged young 
people, a corresponding decrease in the demand for illicit drugs may 
materialise. The Department of Education and Science also oversee the 
provision of two key national prevention programme which specifically aim to 
prevent school going individuals from engaging with illicit drug misuse. The 
Substance Misuse Prevention Programme "Walk Tall" is delivered to primary 
school pupils, while the Substance Misuse Prevention Programme "On My 
Own Two Feet" is provided to secondary school students.  
 
The Department of Health and Children focuses on the need for education 
and prevention in terms of equipping young people with the skills and 
resources that may prevent engagement with illicit drug misuse. The 
Department through the Health Promotion Unit is responsible for 
disseminating information on drug misuse to the general public and in 
particular to groups that are designated at risk. The Department, through the 
regional Health Boards has developed extensive links with the Community 
and Voluntary sectors and is in a position to contribute to the provision of 
prevention, outreach and harm reduction programmes throughout the state.  
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Treatment 
The Department of Health and Children has primary responsibility for 
developing aspects of drug misuse policy related to treatment, through the 
Drugs/AIDS/HIV Services Unit which is a sub-division of the Primary Health 
Care Division.  Responsibility for the provision of treatment and rehabilitation 
services for drug misusers is vested in the ten Regional Health Boards. In 
particular, the Eastern Regional Health Authority (ERHA) which includes the 
Greater Dublin area has been involved in developing an expansive range of 
services, covering prevention, harm reduction and treatment/rehabilitation 
(See Section 9.3).  In addition the health boards outside the ERHA region 
have also bee involved in providing treatment services through the services of 
addiction counsellors, psychosocial therapy programmes and family support. 
Also, It must be noted that representatives from the voluntary sectors provide 
a range of services and supports in the areas of prevention and treatment of 
drug misuse.  
 
Local Drug Task Forces 
A key part of the National Drug Strategy is the development of the Local Drug 
Task Forces (LDTFs). The LDTFs were set up to provide a strategic local 
response to drug misuse in priority areas. There are currently 14 LDTFs 
operating under the direction of the National Drug Strategy. Twelve task 
forces operate in the Greater Dublin Area in what have been termed priority 
areas where drug misuse has been identified as an issue that merits attention. 
The remaining task forces are located in North Cork in the South of Ireland 
and in Bray, Co. Wicklow an area close in proximity to Dublin. Both areas 
have been linked with a serious drug misuse problem. Each task force is 
comprised of representatives from statutory, voluntary and the community 
sector. It is planned to develop the task force model by having a task force in 
each region by the end of 2001. (See section 8.2)  
 
Each Task Force is involved in developing local action plans that are 
designed to respond to the issue of drug misuse at area level. Such 
responses include a range of measures such as treatment, education, 
rehabilitation and prevention. Funding is provided at government level to 
support the implementation of local initiatives under the respective task 
forces, for example, a sum of €154908045 has been provided in the National 
Development Plan to support the work of the Local Drugs Task Forces up to 
2006.  
 
Research 
The National Advisory Committee on Drugs  (NACD), that was established in 
July 2000, has collaborated with other groups and individuals on preparing a 
three-year research programme in the drug area. It is anticipated that the 
outcomes of research will contribute significantly to the development of policy 
on drugs, in particular in the field of demand reduction. For instance, priority 
areas for research have been identified to include prevalence, treatment 
outcomes and research into drug use and also marginalised groups in an Irish 
context. (See section 10.3)  
 
 
  95  
The Drug Misuse Research Division (DMRD) of the Health Research Board 
(HRB) continues to be the designated central point to which all drug research 
data and information should be sent. In order to facilitate this process, the 
DMRD is developing a National Documentation Centre which will contain all 
relevant and up-to-date information and research in the field of drug misuse in 
Ireland and internationally. The centre when established will be accessible to 
the public and facilitate ease of access and retrieval of drug related research 
for policy makers and researchers with an interest in the field.  
 
In addition the Eastern Regional Health Authority plans to conduct a number 
of evaluations during 2001 into the addiction services that they provide. For 
instance it is planned to carry out: 
• An evaluation of the drug treatment services investigating adherence of 
service providers to prescribing protocols, assessment and referral 
procedures, methadone users'  perception's of the quality of service, and 
the experience of heroin users not currently in treatment 
• A review of the drug treatment waiting list to validate the numbers awaiting 
treatment, to profile clients on the waiting list and to assess treatment 
personnel's views of the efficiency of the waiting list procedures.  
 
8.2  Approaches and New Developments 
 
a) New and Innovative Approaches 
 
Rehabilitation 
In recent times there has been an increasing focus on developing the role of 
rehabilitation provision for recovering drug misusers. This is in part due to the 
increasing number attending treatment (See Section 9.3) plus the recognition 
that individuals who have been through or are progressing through primary 
treatment services very often require further support and intervention in order 
to access mainstream education and employment opportunities. The 
definitional boundaries between treatment and rehabilitation can quite often 
appear blurred. However, in relation to opiate addiction one approach can be 
to view treatment as the pre-stabilisation stage involving detoxification, and 
methadone maintenance.  Whereas rehabilitation can be seen to occur in the 
post-stabilisation stage, covering the period when an individual is encouraged 
to engage with educational/training activities for instance. In both the 
treatment and rehabilitation phases, there is also a range of therapeutic 
options available.  
 
The emphasis on rehabilitation has received a more focused approach in 
recent times, particularly within the Eastern Regional Health Authority area 
(ERHA). This is not surprising given that, by far the greatest number of 
individuals reporting for treatment is drawn from the ERHA region. (See 
NDTRS Data) In response, a blueprint was drawn up in 2000 to guide the 
development of rehabilitation services within the remit of the ERHA.  Central 
to the measures set out in the aforementioned blueprint, was the creation of 
"re-integration centres" in the three health board areas under the ERHA. It 
was proposed that these centres would provide a base for integration workers 
to support individual clients towards re-integration into mainstream social 
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activity. In pursuit of this aim the centres would provide career guidance and 
counselling, personal skills development, and educational/training 
opportunities. The latest information would seem to suggest that the 
development of these centres is still on track in two of the three health board 
areas. In the Northern Area Health Board (NAHB) where the idea of a re-
integration centre has been sidelined, a re-habilitation manager has been 
appointed to work in each of the five task force areas within their remit. In 
addition, the NAHB have appointed three re-habilitation co-ordinators to 
oversee policy creation, quality assurance and strategic planning for the area. 
Two facilitators will assist each co-ordinator.  
 
Further recognition of the important role of rehabilitation for people recovering 
from drug misuse is evidenced by the recently produced recommendations 
from the South-Eastern Health Board's Regional Treatment and Rehabilitation 
Working Group 2001. Some of the key recommendations that have been 
documented by the Treatment and Rehabilitation Working Group are: 
 
• That a Substance Misuse Unit should be established in each Community 
Care area. Such a unit would primarily play a co-ordinating role regarding 
substance misuse activities in each area.  
• That a regional counselling policy is developed which would be community 
based and easily accessible, particularly to under eighteen-year-olds.  
• That outreach services are developed to target at risk community 
members.  
• That locally based treatment services should include harm reduction, 
counselling, support aftercare, rehabilitation and detoxification.  
• That 'one-stop shops' be established where different services are 
represented and young people feel relaxed about making inquiries.  
• The Health Board should support the development of supervised 'Halfway 
Houses'.  
• The difficulties in accessing treatment for drug users who are homeless, in 
prostitution or pregnant need to be addressed.  
• All hospitals in the South-East region should have clear protocols for the 
management and referral of drug misusers admitted hospital.  
• A system of on-going evaluation needs to be developed for treatment 
services. 
• A partnership approach should be developed for the provision of 
prevention, treatment and aftercare programmes.  
(South Eastern Health Board Regional Treatment and Rehabilitation Working 
Group Recommendations 2001; South Eastern Health Board Drug Co-
ordinating Unit) 
 
Regional Drug Task Forces 
A key recommendation contained in the National Drugs Strategy Programme 
for 2001-2008 is the creation of a number of Regional Drug Task Forces 
(RDTFs) to be established in each of the ten regional health board areas. The 
RDTFs will consist of representatives from the statutory, voluntary and 
community sectors and are being set up: 
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• To ensure the development of a co-ordinated and integrated response to 
tackling the drugs problem in their region; 
• To create and maintain an up-to-date database on the nature and extent of 
drug misuse and to provide information on drug-related services and 
resources in the region; 
• To identify and address gaps in service provision having regard to 
evidence available on the extent and specific location of drug misuse in 
the region; 
• To prepare a development plan to respond to regional drugs issues for 
assessment by the NDST and approval by the Inter-Departmental Group 
(IDG);  
• To provide information and regular reports to the NDST in the format and 
frequency requested by the team; and  
• To develop regionally relevant policy proposals, in consultation with NDST.  
(Building on Experience: National Drugs Strategy 2001-2008, Department of 
Tourism, Sport and Recreation)  
 
Social Inclusion Initiative 
The Northside Partnership is an area-based company working in a designated 
area on the Northside of Dublin. The work of the partnership is primarily 
engaged in combating social exclusion and promoting social integration: the 
target area comprises over 100,000 people. The partnership has identified a 
number of specific priority groups that experience social exclusion. Through 
consultation with relevant agencies and organisations ex-drug misusers have 
been identified as a social group that have tended to be marginalised in terms 
of accessing education and employment opportunities. The partnership has 
recognised that an estimated 4,000 drug misusers are resident in the 
partnership area (New Frontiers 2000-2006). In response, the partnership has 
outlined a series of measures that aim to support existing social integration 
initiatives with ex-drug misusers. In addition, the partnership has developed a 
number of innovative initiatives that aim to assist ex-drug misusers in the 
process of reintegration. For example, The Labour-Market Inclusive Project 
(LIP) is designed to target recovering drug misusers referred by treatment 
centres. It aims to support participants before and after placement in 
employment. Additional work with ex-drug misusers will take place through 
the Targeted Outreach Initiative which aims to make contact with ex-drug 
misusers who are not contactable through treatment centres; and the 
Business Network Initiative which comprises of local business contacts that 
work to reintegrate ex-drug misusers into employment  
 
Drug misuse and young homeless people 
A new development to emerge in recent times has been the focus on service 
provision for young homeless people who misuse drugs. The Eastern 
Regional Health Authority (ERHA) has recently appointed a Director of 
Homelessness, and the three area health boards under the auspices of the 
ERHA have each appointed an Assistant Chief Executives for Child Care and 
Homelessness. The ERHA have identified a core of approximately 23 young 
people who continually present for emergency accommodation.16 Behavioural 
                                                     
16 See http://www.erha.ie 
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problems and substance misuse among these young people are seen as 
further obstacles to them securing accommodation.  
 
Under the ERHA a large property in the north inner city of Dublin capable of 
providing a day treatment programme for up to a 100 young local drug 
misusers has been purchased. In addition, proposals are being formulated by 
the ERHA to provide a detoxification centre for young homeless people. Also 
a 12 bed residential service and two additional day services for drug users 
under 18 from the south inner city of Dublin is to be established at Cherry 
Orchard Hospital.17 According to the Service Development Plan of the ERHA 
for 2001, an allocation of €380921 is provided to enable initiatives to be 
developed for homeless young people who are drug misusers. It is envisaged 
that specific facilities will be developed in each of the three area health boards 
to ensure access by young homeless persons to the relevant drug services.  
 
b) Socio-cultural developments relevant to demand reduction 
 
In recent year's social policy analysis and the construction of policy in an Irish 
context has witnessed an increase in the usage of the term 'social exclusion'. 
In particular, policy developments in the drug area have come to embrace the 
idea that 'problematic drug users' primarily tend to experience high levels of 
'social exclusion'.  According to the Combat Poverty Agency of Ireland 18 
 
" Social exclusion is a process which pushes people out to the 
edge of society and distances them further and further from the 
chance of a job or an adequate income, from social and 
educational opportunities, from social and community networks 
, and from power  and decision making." 
 
It could be argued that one of the strengths of seeing the drug problem, as 
being influenced by social conditions, is that in responding the emphasis is as 
much on society as on the individual engaged in drug misuse. In terms of Irish 
society, in recent times the response has been to counteract the negative 
effects of social exclusion by focusing on the merits of social inclusion. A 
particular model of partnership has underpinned this move towards a more 
socially inclusive socio-cultural framework in the drug field. This has 
manifested itself, whenever possible, in promoting a coordinated approach 
between the statutory, voluntary and community sectors in pursuit of creating 
the social conditions that will enhance the chances of those involved in drug 
misuse to rehabilitate and reintegrate as far as possible into mainstream 
society. Much of this activity has taken place within a policy framework greatly 
influenced by the idea that it is necessary to support social inclusive initiatives 
if marginalised groups such as drug users are to be reintegrated. For 
example, the Cabinet Committee on Social Inclusion as part of its wide remit, 
has political responsibility for reviewing trends in the drugs problem, for 
assessing progress in implementing the National Drugs Strategy and for 
resolving policy or organisational difficulties which may inhibit effective 
responses to the problem.  
                                                     
17 See http://www.erha.ie 
18 See http://www.cpa.ie 
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c) Developments in Public Opinion 
 
The data referred to in this section comes from two studies that investigated 
public attitudes towards, and perceptions of, aspects of the drug issue in 
Ireland (Bryan et al, 2000, 2000 data unpublished). Both studies touched on 
many aspects of public opinion that have a bearing on how measures to 
reduce the demand for illicit drugs are perceived in Irish society. For example, 
both studies investigated public attitudes and perceptions towards: 
 
• drug users and drug addicted individuals; 
 
• drug treatment for individuals engaged in drug misuse; 
 
• and aspects of current drug policy including drug prevention, harm 
reduction, drug education 
 
A majority of the Irish people does not view drug addicts as criminals, and 
there has been little change to this viewpoint between the years 1998 and 
2000. (Table 8.2a) This attitude could be taken as one indicator that the Irish 
public would be supportive of measures taken by the state to treat individuals 
who present for drug misuse treatment. Also, a further interpretation may be 
that a majority of people in Irish society has begun to question the links 
between drug addiction and criminality.  
 
Table 8.2a. Changes in attitudes towards drug addicts, 1998-2000 
Statement Survey year (number 
of responses) 
Agree 
% 
Disagree 
% 
Don't 
Know % 
I would see drug addicts more 
as criminals than victims 
1998 (n=999) 
2000 (n=998) 
42.6 
37.8 
45.2 
45.6 
12.1 
16.6 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
In supporting the view that drug addicts are more victim than criminal (Table 
8.2a) it could be argued that a majority of the Irish people are implicitly 
questioning the efficacy of the use of prison as a criminal justice sanction for 
drug addicts. Indeed, this interpretation is given additional support by the 
findings recorded below. (Table 8.2b) This shows a majority of the Irish public 
agrees with the statement that drug addicts charged with a petty offence 
ought to be allowed to choose between treatment and prison.  
 
Table 8.2b. Changes in the support for alternative policy interventions, 1998 and 2000 
Statement Survey year (number 
of responses) 
Agree 
% 
Disagree 
% 
Don't 
Know % 
Drug addicts charged with 
petty offences should be given 
a choice between treatment 
and prison service 
1998 (n=997)  
2000 (n=994) 
71.9 
72.9 
17.2 
15.2 
10.9 
11.9 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
However, as (Table 8.2c. Below) shows an increasing proportion of Irish 
society agrees with the view that treatment should only be given to drug 
addicts who intend to give up drugs for good. Perhaps in some quarters this 
could be interpreted as a hardening of public attitude towards some drug 
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addicts whose intentions regarding drug treatment may sometimes be open to 
question. Nevertheless it would seem the case that the public is very much in 
favour of treatment provision for drug addicts (Table. 8.2c) and that treatment 
for drug addiction has become a legitimate and integral part of the demand 
reduction response in Irish society.  
 
Table 8.2c. Changes in the support for drug treatment strategies, 1998 and 2000 
Statement Survey year (number of 
responses) 
Agree 
% 
Disagree 
% 
Don't 
Know  % 
Treatment should only be 
given to drug addicts who 
intend to give up drugs for 
good 
1998 (n=999) 
2000 (n=997) 
64.5 
73.8 
27.3 
18.4 
 
8.2 
7.8 
Treatment should be available 
to all drug addicts according to 
their needs 
1998 (n= 999) 
2000 (n=999)  
90.2 
90.5 
3.7 
3.1 
6.1 
6.4 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
There is widespread public approval towards the view that money spent on 
prevention of drug use is money well spent (Table 8.2d).  In addition it would 
appear from that the Irish public express positive affirmation regarding drug 
education as a viable preventative strategy, whilst agreeing with the view that 
primary level in school is the most appropriate social location for the 
beginning of drug education.  
 
Table 8.2d. Changes in the support for drug prevention strategies, 1998 and 2000 
Statement Survey year (number of 
responses) 
Agree 
% 
Disagree 
% 
Don't 
Know % 
Money spent in the prevention 
of drug use is money well 
spent 
1998 (n=997)  
2000 (n=998)  
91.6 
87.3 
4.1 
3.8 
4.3 
8.9 
Drug education in school 
should start at primary level 
1998 (n=996) 
2000 (n=999)  
94.5 
93.5 
2.3 
2.9 
3.2 
3.6 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
Public support for the use of medically prescribed heroin substitutes such as 
methadone or physeptone among drug addicts has increased. (Table. 8.2e) 
However it should be noted that 29% of the Irish public either disagree with 
this position or are unsure of their attitude towards the issue. Public support 
for the provision of syringes and needles has also increased (Table 8.2e) but 
again there is a notable opposition and uncertainty on the part of the public 
regarding this aspect of harm reduction.  
 
A further analysis (Table 8.2e.) raises some important questions regarding the 
dissemination of drug related information to the public which is crucial in 
gaining public support for demand reduction interventions. For example, it 
could be argued that the provision of methadone as a heroin substitute has 
been, to some extent at least, a relatively effective tool in reducing the 
commission of criminal acts by drug addicts. Yet, almost 30% of the public are 
either opposed to its provision or are uncertain of their position on the issue. 
This could be due to the fact that the public is not being made aware of the 
links between the use of methadone and a reduction in crime. Similarly, the 
provision of syringes and needles to drug addicts usually means that there is 
an exchange for 'dirty' needles, thereby reducing the risk of the spread of drug 
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related infectious diseases. Yet, almost 28% of the public either disagree or 
express a 'don't know' position regarding the provision of syringes and 
needles to drug addicts. This again suggests that the quality of information for 
public consumption may need some revision if harm reduction measures are 
to gain similar levels of public support as the provision of drug treatment and 
education enjoy.  
 
Table 8.2e. Changes in the support for harm reduction strategies, 1998 and 2000 
Statement Survey year (number 
of responses) 
Agree 
% 
Disagree 
% 
Don’t 
Know % 
Medically prescribed heroin 
substitute (such as methadone, 
physeptone) should be available to 
drug addicts 
1998 (n=933) 
2000 (n=963) 
64.8 
70.9 
16.1 
14.3 
19.1 
14.7 
Society should provide syringes 
and needles free of charge to drug 
addicts to avoid the spread of 
HIV/AIDS 
1998 (n=998) 
2000 (n=998)  
66.7 
72.3 
17.3 
14.4 
15.9 
13.2 
Source: 1998 data Bryan et al 2000, 2000 data unpublished 
 
In the final analysis, it could be argued that by embracing drug treatment, and 
drug education as viable methods in addressing drug addiction, the Irish 
public is indicating their strong support for some of the key strands of official 
demand reduction strategy. The Irish public appear amenable to embracing 
aspects of harm reduction with similar enthusiasm and perhaps a more 
effective means of disseminating information to the public will enhance this 
process.  
 
d) New Research Findings 
 
People sleeping rough in Dublin and using drugs: 
The Dublin Simon Community in partnership with the Merchant’s Quay 
Project, initiated a feasibility study to explore the possibility of setting up a 
direct access hostel in Dublin, for people who are sleeping rough and using 
drugs (Costello and Howley 2000). As part of the study 15 people who were 
sleeping rough in Dublin and using drugs were interviewed in depth using a 
semi-structured interview. The interviews were conducted qualitatively with 
the focus on the experience of drug use and homelessness among the 
interviewees. Twelve of the sample was accessed while they were begging on 
the streets, and a €6.35 payment was offered as payment for their time. The 
three remaining interviewees were accessed through hostels.  
 
All 15 interviewees reported injecting heroin on a daily basis. The extent of 
drug use varied from injecting twice a day to injecting eight times a day, with a 
daily cost varying from €101.50 to €254 per day. In terms of maintaining their 
drug use, the two primary options utilised were stealing or begging.  
 
In addition, sixteen hostels, five transitional housing projects and two refuges 
were included in a survey of policies relating to illicit drug use in homeless 
services in Dublin (IBID). The study found that hostels and night shelters 
tended to limit access to people who were identified as active drug users. 
Additional factors such as charging high rents and barring individuals, who are 
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found to be drug users for long periods of time, contribute to many homeless 
people who are using drugs having no other options but to sleep rough on the 
streets. It was found that few transitional housing projects were willing to 
accommodate people who were using or had a history of using drugs. Overall, 
the authors of the study concluded that there is an urgent need for a direct 
access hostel which would overcome access barriers for homeless people 
using drugs and provide relevant support needs for residents.  
 
e) Specific events during the reporting year 
 
Perhaps the most significant event in terms of developing the field of demand 
reduction in an Irish context was the launch of the new National Drugs 
Strategy 2001-2008. This strategy has already been referred to in Section 8.1.  
 
One of the key developments emerging from the Drugs Strategy in terms of 
providing tangible support for demand reduction was the announcement 
during the year of €4444083 in capital funding for Local Drug Task Force 
Projects. This money has been allocated primarily for the purpose of 
refurbishing premises being used by local drug projects. In total 16 separate 
projects have benefited through funding under the new Community Based 
Premises Initiative which has been underpinned to the value of €12697380 to 
cover the next three years.   
 
f) Dissemination of information on demand reduction among 
professionals (networks, Internet, etc) 
 
DrugNet Ireland 
The Drug Misuse Research Division of the Health Research Board publishes 
and distributes the newsletter “Drugnet Ireland” twice yearly. This newsletter 
fulfils an important role in the distribution of information, news and research 
among health professionals and other interested parties involved in the drugs 
area in Ireland. Its readership includes community groups, policy makers, 
treatment providers and academics. The newsletter contains information on 
research, recent publications, and upcoming events. It also looks at 
developments in the drugs area within the EU, as well as local and world 
news.  
 
EDDRA 
The EDDRA project plays a key role in the demand reduction field by raising 
awareness on the different types of demand reduction activities that operate 
throughout the country. In order to facilitate this process further, an “EDDRA 
column” will be included in Drugnet Ireland, with effect from the next 
publication in November 2001. This column will include regular up to date 
information on developments relating to demand reduction initiatives at 
national level. Also included will be an assessment of ‘best practice’ models of 
demand reduction at national level, while the importance of impact/outcome 
evaluation of interventions will be emphasised. Significant attention will be 
given to encouraging local projects/initiatives to explore and develop the 
theoretical foundations on which their interventions are grounded.  
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9. Intervention Areas 
 
a) Typologies of interventions with synthetic description of: objectives, 
target groups, settings and results.  
 
9.1 Prevention 
 
The field of prevention is very much dominated by interventions that target 
children ‘at risk’ and also the provision of initiatives to support parents by 
providing drug awareness courses, and in general seeking to improve the 
content of information on drugs that parents receive. A key source of funding 
for many initiatives in the preventative field has been the Young People’s 
Facilities and Services Fund (YPFSF). This fund was established by the 
Government in 1998 to assist in the development of preventative strategies in 
a targeted manner through the development of youth facilities, including sport 
and recreation facilities and services in disadvantaged areas, where a 
significant drug problem exists or has the potential to develop. The aim of the 
fund is to attract “at risk” young people in disadvantaged areas into these 
facilities and activities, thereby diverting them from the dangers of substance 
misuse. Listed below is an example of some of the initiatives that are 
prominent in the prevention field.  
 
9.1.1 Infancy and Family 
 
(a) Intervention in different fields 
 
During pregnancy and for future parents: 
A number of drug liaison midwifes have been appointed to work in three major 
hospitals in Dublin. The hospitals in question are the Coombe, the Rotunda 
and Holles St. hospital, with each providing an extensive maternity service. A 
large part of the workload of each midwife entails visiting the various drug 
treatment centres located around the city of Dublin, and making contact with 
women who are pregnant and misusing drugs. This work occurs on an almost 
daily basis and is viewed as being essential in building trust and positive 
relationships with the women involved. No evaluation has been carried out on 
this service yet and the limited amount of statistical information available 
indicates that in the case of one midwife during the first seven months of her 
work she worked directly with 40 women who were pregnant and misusing 
drugs.  
 
Families with adolescent children/’children at risk’.  
Category:   Primary prevention 
 
Name of project:  The Springboard Initiative 
 
Projects aims:  To support families with children ‘at risk’ 
 
Activities:   Community supports 
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Category:  Drugs information provision 
  
Name of project: Mid Tipperary Drugs Initiative Parenting Programme 
   
Projects aims: To inform local parents on drug misuse issues 
  
Activities:  Group discussion led by facilitators 
 
Category:  Drugs information provision 
 
Name of project: Carlow Community Awareness of Drugs (CCAD) 
 
Projects aims: To create awareness among local parents, children and 
teachers on drug misuse related issues 
 
Activities: Drug information courses for parents, drug projects for 1st 
year students in local schools, running Addiction Studies 
courses, presenting talks on drug issues in local schools 
 
Category:  Parent support programme 
 
Name of project: Fas Le Cheile 
 
Projects aims: To encourage inter-family dialogue, to provide accurate 
information on drugs and alcohol and to enhance 
parenting skills and confidence 
 
Activities: Group discussion, peer led facilitation, training parents to 
run courses for other parents 
 
Category:  Parenting education and support programme 
 
Name of project: Family Communication and Self-Esteem 
 
Project aims: The enhancement of parents and children’s self-esteem, 
develop responsibility for family health and raise 
awareness of drug related issues and provide accurate 
information on drugs 
 
Activities: Tutors receive specialised training to run health education 
and drug awareness courses for parents and children 
 
(b) Intervention in crèche, kindergarten and other specific 
interventions 
 
Crèche facilities are provided in association with drug treatment services on a 
limited based at present. For example, a pilot study (Moran 1999) that looked 
at the availability, use and evaluation of the provision of crèche facilities in 
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drug treatment locations found that when the study was being carried out in 
late 1998, 20% of the 45 treatment centres in Dublin provided crèche facilities.  
 
(c) Statistics and evaluation results 
 
Project Statistics Evaluation Results 
Springboard Initiative No statistics available No evaluation carried out 
Mid Tipperary Drugs Initiative 
Parenting Programme 
No statistics available No evaluation carried out 
Carlow Community Awareness 
of Drugs 
No statistics available No evaluation carried out 
Fas Le Cheile No statistics available a) improvement in parents 
communication and 
listening skills with 
children  
b) parents report relevancy 
of course content 
c) improvement in overall 
parental skills and in 
dialogue between 
partners/spouse 
(Evaluation of Medium 
Term Impact of Fás Le 
Cheile 1999)  
Family Communication and 
Self Esteem 
No statistics available a) positive response to the 
programme by tutors 
and parents with 
parents reporting 
learning outcomes 
b) parents reporting 
relative satisfaction with 
information provided by 
programme 
c) parents reported the 
usefulness of being in 
contact with other 
parents and indicated 
that they would 
recommend programme 
to other parents (Ruddle 
1993)  
 
(d) Specific training 
 
Some of the initiatives mentioned above encapsulate specific training 
programmes which aim to train parents to act as group leaders/facilitators and 
in some cases parents are trained to become trainers themselves.  
 
 
9.1.2 School Programmes 
 
The following are an example of prevention programmes operating in schools 
throughout the country.  
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(a) Mandatory, recommended or voluntary at different school levels 
 
Category:  Drug education/awareness 
 
Name of project: The Awareness FC Drugs Prevention Programme 
 
Target group: 5th and 6th class pupils in schools in Finglas and Cabra 
 
Projects aims: To increase awareness on drug misuse, to encourage 
participants to make informed decisions about drugs and 
to increase self-esteem in participants 
 
Activities: Weekly half-hour drug education/awareness classes in 
school setting during seven/eight weeks per programme 
 
Category:  Drugs information/awareness programme 
 
Name of project: The Changeling Project 
 
Target group: 5th and 6th class in primary school 
 
Project aims: To stimulate awareness of substance misuse within a 
framework of individual and social responsibility where 
choices, decisions and consequences are explored 
 
Activities: Utilising a series of metaphors a drama production 
performed in schools explores themes such as peer 
pressure, personal responsibility and the adverse 
consequences of substance abuse. A pre-show workshop 
and a post-show workshop accompanied each 
performance with teachers being encouraged to 
participate. An information pack is also prepared for 
teachers and is designed as a support mechanism for 
them to handle substance misuse related issues as they 
arise 
 
Category:  Substance misuse prevention project 
 
Name of project: On My Own Two Feet:  
 
Target group: Secondary school students 
 
Project aims: To provide accurate information on drugs and drug 
misuse, to equip young people with the necessary skills 
to withstand social pressures to engage in substance 
misuse and to instill confidence in young people to make 
informed decisions which benefit them in the long run 
 
Activities: Special classes are delivered by specially trained 
teachers/trainers that explore issues such as substance 
misuse and personal decision-making on a thematic 
basis 
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(b) General (health promotion, life skills) or specific (directed to high risk 
groups) and type of approaches 
 
Category:  Health Promotion 
 
Name of project: The Healthy Schools Project 
 
Target group: Second level students in the North Eastern Health Board 
area 
 
Project aims: To enable young people to accept responsibility for their 
own health and behaviour, to facilitate the enhancement 
of self-confidence, self-esteem, decision making and 
assertiveness skills. To provide factual information on 
matters that can impact on their health, including 
substance misuse.  
 
Activities: Provides specialised training for all teachers involved in 
health education. All members of staff who receive 
special training deliver classes to students in schools. 
Classes last 35-40 minutes and are held once a week. 
Classes are presented under a thematic framework and 
group discussion is encouraged at all times.   
 
Category: Alternative Lifestyle Approach 
 
Name of project: The Give Kids A Choice Project 
 
Target group: Young people ‘at risk’ of early school leaving and of 
substance misuse and anti-social behaviour 
 
Project aims: The overall aim of the project is to involve young people 
at risk of early school leaving in a positive school based 
programme that will provide them with opportunities to 
develop their personal and inter-personal skills. It is 
hoped that participation in the project may contribute to 
the young people remaining in formal education for longer 
and decreasing the chances for engaging with drug 
misuse and anti-social behaviour. 
 
Activities: The project incorporates various activities such as a 
Tuesday/Thursday group, which involve young people 
participating in developmental, social and recreational 
activities for approximately 1.5 hours each week. A dance 
programme that involves young people developing their 
dance and movement skills. An Amigos programme 
involving 5th year students befriending 1st year students. 
In addition the project provides a homework club, one-to-
one counselling and a parenting for prevention drugs 
awareness programme for local parents. 
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Category:  Drug awareness/education 
 
Name of Project: Killinarden Drug Primary Prevention Group 
 
Target group: Primary and secondary school students considered ‘at 
risk’ of early school leaving in the area and of becoming 
involved in drug misuse and anti-social behaviour.  
 
Project aims: The aims to contribute to the personal development of 
participants as well as increasing awareness of drug 
related issues 
 
Activities: The project is run through eight trained facilitators who 
deliver a number of programmes and courses to pupils in 
schools throughout the area 
 
(c) Involvement of teacher, parent and community 
 
NO INFORMATION AVAILABLE 
 
(d) Guidelines for school policy 
 
NO INFORMATION AVAILABLE 
 
(e) Specific research results, statistics and evaluation results 
 
Project Statistics Evaluation Results 
Awareness FC 
Drug Prevention 
Programme 
No information 
available 
a) An evaluation of this programme (Morgan 1999) 
reported a link between improvements in the 
accuracy of drugs information held by participants 
and their participation in the programme 
b) participants less likely to rely on ‘myths’ about 
drugs and more likely to make informed decisions 
c) participants reporting more confidence in making 
personal decisions about the use of drugs 
 
Killinarden Drug 
Primary 
Prevention 
Group 
No statistics 
available 
a) A recent project report (Rourke 1999) has revealed 
that high participation rates and a generally positive 
response from young people are indicators that the 
project is well received. 
b)  An additional development has been that local people 
such as parents have been trained in facilitation skills 
for the purpose of delivering the programme, this has 
enabled them to make a positive contribution to the 
community and in the process develop their own self-
esteem.  
 
The Changeling 
Project 
No statistics 
available 
An evaluation of the project found that the response from 
teachers and pupils was positive with a lot of voices 
echoing the message that this was a welcome intervention 
as relatively little educational work on substance abuse 
had been done previously in the targeted schools.(Kiely et 
al 2000) 
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The Healthy 
Schools Project 
No information 
available 
An evaluation of the programme indicated that there were 
significant differences between the pilot and the control 
group on items relating to acceptance of responsibility, 
self-esteem, and positive outcomes in adulthood and 
attitudes to substance abuse (Morgan 1997). 
 
The Give Kids A 
Choice Project 
 
No information 
available 
Main results of the project indicate that a total of 104 
people have participated in the various activities which 
have been organised and delivered through the project. 
Initial indications would suggest that young people are 
benefiting from their participation in the activities of the 
project. Participants have displayed enthusiasm for the 
activities and have also demonstrated consistently high 
attendance rates at various activities. In addition 
improvements in self-esteem among participating young 
people have been noted, also school attendance among 
project participants has shown signs of improvement. 
(Rourke 2000)  
 
On My Own Two 
Feet 
No information 
available 
An outcome evaluation of ‘On My Own Two Feet’ found 
that compared to a control group, students who 
participated in the programme had less positive attitudes 
to drug/alcohol use, and stronger beliefs in the negative 
outcomes of such use (Morgan et al. 1996). 
 
9.1.3 Youth Programmes outside schools 
 
(a) Types, settings of activities 
 
Project name:   St Michael’s Parish Youth Project 
Type of project: The project is a community-based intervention 
designed to provide a number of services for 
young people in the Inchicore area of Dublin, who 
are engaged in substance misuse or are at risk of 
becoming involved.  
 
Settings of activities: The project operates in an area of Dublin 
characterised by high unemployment and an acute 
drug misuse problem. Main activities/services 
provided by the project include outreach work, a 
drop-in centre, a Teenage Health Initiative, a 
referral service and working with local schools to 
develop preventative strategies.  
 
Project name:  Finglas Action Now (FAN)  
Type of project: The FAN project is a multi-agency initiative funded 
by the Department of Justice, Equality and Law 
Reform and run by the Finglas Youth Service with 
support from the Garda, the Probation and Welfare 
Service and the local community. The project aims 
to engage young people in alternative constructive 
activities in the hope that such pursuits may 
provide an alternative lifestyle to that of crime and 
drugs which are endemic in the local community  
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Settings of activities: The project operates in an area with high 
unemployment, low educational attainment levels, 
a high crime rate and an acute drug misuse 
problem.  Participants of the project can avail of 
activities such as camping, fishing, football, rock 
climbing, canoeing, music, computers, 
photography, drama and community awareness 
training.  
 
Project name:  The Clondalkin Teen Counselling Project 
Type of project: Provides counselling to young people in the 
Clondalkin area of Dublin, who are experiencing 
difficulties with substance misuse, domestic 
problems, issues at school, and behavioural 
difficulties.  
 
Settings of activities: The Clondalkin area is characterised by high levels 
of socio-economic disadvantage in particular there 
is acute inter-generational unemployment attached 
to the area. The project primarily provides a 
counselling service that operates four days a 
week.  
 
Project name:  The STAY project 
Type of project: The project is an integrated community response 
that aims to work with young people at risk of early 
school leaving and of engagement with drug 
misuse and anti-social behaviour. The project 
endeavors to support young people to stay in 
school and to engage with health and constructive 
activities.  
 
Settings of activities: The project operates within the St. Aengus parish 
area in Tallaght, Dublin. Participants in the project 
tend to reside in the most disadvantaged parts of 
Tallaght. The project’s activities include drug 
awareness courses, swimming, homework support 
club, art, cooking, computers, canoeing, and a 
host of other outdoor pursuits.  
 
Project name:  The Bluebell Youth Initiative 
Type of project: The initiative seeks to develop the confidence, self 
esteem and personal skills of young people at risk 
of early school leaving and engagement with 
substance misuse through a programme based 
around recreational and social activities.  
 
Settings of activities: The project operates in an area where social 
disadvantage and problematic drug use is high. 
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Activities offered by the project include the 
summer project, football tournament, a media 
group for 11-14 year olds, an after schools group 
and a drop-in facility for young people. The project 
works with parents of young people and in 
particular run’s a women’s group to assist mothers 
of children at risk of early school leaving and 
substance abuse. 
 
Project name:  The Carline Project of Learning 
Type of project: The Carline Project provides day-to-day support 
and training for young people in the Clondalkin 
area who are unable to access existing training 
programmes. The project aims to target young 
people who are at risk of becoming involved in 
drug misuse or crime, and who are without training 
and qualifications. 
 
Settings of activities: The project is located in Clondalkin, a large suburb 
of Dublin. The area is characterised by high levels 
of unemployment. The project provides training in 
educational and social skills, computers, 
mechanics, woodwork/glasswork, horticulture, arts 
and crafts and various sporting pursuits. The 
project has developed extensive links with local 
companies and training agencies. 
 
Project name:  National Youth Health Programme 
Type of project: This programme is a partnership between the 
National Youth Council of Ireland, the Health 
Promotion Unit of the Department of Health and 
Children and the Youth Affairs Section of the 
Department of Education. The aim of the 
programme is to provide broad based flexible 
youth health education within the non-formal 
education sector.  
 
Settings of activities: The programme assists youth workers, leaders 
and volunteers working within youth services and 
community groups nation-wide in addressing the 
health needs of young people. The service 
provides training at an organisational, regional and 
national level in the health promotion area. The 
project has developed a Youth Work Support Pack 
dealing with the drugs issue. The pack covers a 
number of issues and is divided into four sections; 
1) Youth work in a drug using society; 2) Youth 
work responses to drug use; 3) Policy 
development and 4) Supporting information 
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Project name:  Sound Decisions 
Type of project: The project is designed to raise awareness of the 
dangers of drugs among young people and 
nightclub staff.  It was also designed to increase 
the competence of nightclub staff in dealing with 
drug related issues 
 
Settings of activities: The programme primarily operates in the North 
Eastern region and consists of training sessions to 
inform nightclub staff about the legal implications 
relating to drug use, to enable them to recognise 
signs of drug use and to respond effectively to 
drug related emergencies.  Promotional materials 
such as pins, posters, leaflets, stickers and t-shirts 
are used to highlight for club-goers the dangers 
associated with drugs 
 
Project name: The Staying Alive Campaign – A Dublin Safer 
Dancing Initiative 
Type of project: This initiative introduced in 1997 in the Eastern 
Health Board area is designed to provide training 
and support to night club staff in order to allow 
them to respond more effectively to drug related 
situations in night clubs 
 
Settings of activities: This initiative operates primarily in the Eastern 
region and activities include training programmes 
for club owners/managers and door supervisors 
focusing on increasing participants knowledge 
about drugs, exploring their attitudes towards 
drugs and examining legal, health and safety 
issues. Information about drugs in the form of a 
small credit card sized booklet known as the Vital 
Information Pack (VIP) are being distributed 
through a number of venues including third level 
colleges and clubs for the benefit of young people 
who frequent nightclubs. A one-day conference 
was organised to gain support from the 
music/dance industry for the development of 
acceptable policies in dance venues across the 
Eastern region.  The project will eventually involve 
standardising training for door supervisors where 
different training elements will be provided in 
modular form. 
 
Project name:  Health Advice Café 
Type of project: The main aim of the café is to offer young people 
direct access to health services and to health 
information and advice. 
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Settings of activities:  The café is located in Galway’s city centre in the 
Western region of Ireland. The café incorporates a 
range of drug prevention and education strategies 
and provides information about available treatment 
services.  It also places an emphasis on ‘fun drug 
free activities’ to illustrate to young people that it is 
possible to have a good time without using drugs 
 
 
b) Peer to Peer Approaches 
 
Mid Tipperary Peer Education Programme 
 
The Mid Tipperary Drugs Initiative began to implement A Peer Education 
Programme in January 2001. The programme intends to cater for teenagers 
in the 13-18 age group. The programme generally works with groups of ten 
young people at a time, and participants are recruited through request and 
referral. The programme operates a flexible approach where the participating 
young people are encouraged to contribute to the development of the 
programme. The initial stages of the programme are very much regarded as 
the pre-induction stages and in general have been focusing on building 
awareness and confidence levels among young people and encouraging 
discussion on drug related issues. From September 2001 it is planned to 
develop the Peer Education Programme to stage two where young people 
who have completed stage one will be trained to become Peer Educators of 
other young people on drug related issues. So far the programme has worked 
with approximately 70 young people.  
 
c) Target groups 
 
Project Target group 
St Michael’s Parish 
Youth Project 
Young people in the Inchicore area of Dublin between the age of 8-
25, who are at risk of early school leaving and who may be 
experimenting with illicit drugs 
Finglas Action Now 
(FAN) 
Young people aged between 12-18 and living in Finglas, Dublin who 
are experiencing difficulties in school, at home and in the community 
resulting from aspects of their behaviour.  
The Clondalkin Teen 
Counselling Project 
Young people aged between 12-18 who are resident in Clondalkin, 
Dublin and are engaged in substance misuse to some extent 
The STAY Project Young people between the age of 10-15 who have been identified as 
potential early-school leavers, and who reside in Tallaght, Dublin 
The Bluebell Youth 
Initiative 
Young people aged between 12-18 resident in the Bluebell area of 
Dublin who have identified as at risk of engaging in substance misuse 
and anti-social behaviour 
Mid Tipperary Peer 
Education 
Programme 
Young people in the 13-18 age group from the Tipperary region who 
could be at risk of engaging in substance misuse and other anti-social 
pursuits 
The Carline Project of 
Learning 
Young people from Clondalkin, Dublin aged between 13-18 who are 
at risk of becoming involved in drug misuse and crime, and who are 
without training and qualifications. In particular young people who are 
unable to access existing training programmes are focused on 
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National Youth Health 
Programme 
 
Targets all young people nationwide through individuals at 
community, voluntary and statutory levels who work with young 
people in a health enhancement context 
The Staying Alive 
Campaign – A Dublin 
Safer Dancing 
Initiative 
 
Young people who frequent disco’s and nightclubs in Dublin are 
targeted through a campaign that trains nightclub staff to deal with 
the issue of drug misuse in nightclubs and to inform teenagers of the 
risks involved 
Sound Decisions 
 
Both young people who frequent nightclubs in the North Eastern 
region and nightclub staff who work in this region are targeted with 
information and awareness training on the risks of substance misuse 
in nightclubs 
Health Advice Café 
 
Young people from Galway in the West of Ireland, who may benefit 
from advice, advocacy and information on health related matters in 
particular drug misuse 
 
d) Specific research results, statistics and evaluation results 
 
Project Research results and statistics Evaluation results 
St. Michael’s Parish 
Youth Project 
The project has reported to be 
catering for the needs of over 200 
young people since inception 
(Quinn 2000, Project Report)  
No information available 
Finglas Action Now 
(FAN) 
No information available No information available 
Clondalkin Teen 
Counselling Project 
No information available No information available 
The STAY project No information available The project reports that all 
young people who joined the 
project since March 1998 are 
still within the mainstream 
education sector. Attendance 
levels at various activities in 
the project are around 90% 
with a high level of positive 
feedback from participants 
(Rourke 2000) 
Bluebell Youth Initiative Since the inception of the project 
it is estimated that over 250 
young people have benefited 
from contact with the project 
(Quinn 2000 Project Report)  
No information available 
Mid-Tipperary Peer 
Education Programme 
So far it is estimated that the 
programme has worked with over 
70 young people (Internal 
communication)  
No information available 
The Carline Project of 
Learning 
Many young people on the project 
have been placed in jobs or 
further training and some have 
chosen to return to school full-
time (Interim Report)  
No information available 
National Youth Health 
Programme 
No information available No information available 
Staying Alive 
Campaign-Dublin Safer 
Dancing Initiative 
No information available No information available 
Sound Decisions No information available No information available 
The Health Advice Cafe No information available No information available 
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e) Specific Training 
 
NO INFORMATION AVAILABLE 
 
9.1.4 Community Programmes 
 
a) Drug-specific/drug non-specific 
 
The bulk of Community Programmes operating in Ireland can be considered 
as drug non-specific interventions. Although some programmes emerged in 
response to an opiate problem, most have developed to include the misuse of 
all illicit drugs. For example, programmes that prescribe methadone to 
recovering opiate misusers run a urine analysis to screen for the presence of 
other drugs. Below is a list of some community programmes that operate as 
Drug Non-Specific programmes.  
 
Fettercairn Drug Rehabilitation Project 
The Community and Prison Link Service 
The Candle Community Trust: Training Workshop and Day Centre 
Cabra Community Positive Living Year 
Kilbarrack Community Coast Programme (KCCP)  
Ballyfermot Star Community Support Group.  
Edenmore Drugs Intervention Team (EDIT)  
Clondalkin Addiction Support Programme (CASP) 
Drugs Information Community Education Project (D.I.C.E.) 
The Advance Project 
Darndale/Belcamp Drugs Awareness Group (DAG) 
St. Dominics Community Response Project 
The Community Addiction Programme (CAP) 
Clonmel Community Based Drugs Initiative (CCBDI) 
Co. Waterford Community Based Drugs Initiative (CWCBDI) 
Southside Communities Drugs Initiative (Waterford) 
Crew Network 
DAP – Crosscare 
Community Addiction Response Programme (CARP) 
Ballymun Youth Action Project 
Ballymun Community Action Programme 
Adult Substance Misuse Education Programme 
Jobstown Assisting Drug Dependency (JADD) 
Cabra Resource Centre 
The Crinian Project 
 
b) Cities/Rural areas 
 
The vast majority of community programmes operating in Ireland are based in 
Dublin. (See Table below) There is also a limited amount of community 
interventions operating outside Dublin. However, when the city/rural divide is 
referred to in an Irish context, it usually means that includes all areas outside 
Dublin. Based on this definition a selection of the main Community 
Programmes operating in Dublin and outside Dublin are presented below.  
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Community Programmes based in Dublin  
Fettercairn Drug Rehabilitation Project 
The Community and Prison Link Service 
The Candle Community Trust: Training Workshop and Day Centre 
Cabra Community Positive Living Year 
Kilbarrack Community Coast Programme (KCCP)  
Ballyfermot Star Community Support Group.  
Edenmore Drugs Intervention Team (EDIT)  
Clondalkin Addiction Support Programme (CASP) 
Drugs Information Community Education Project (D.I.C.E.) 
The Advance Project 
Darndale/Belcamp Drugs Awareness Group (DAG) 
St. Dominics Community Response Project 
Crew Network 
DAP – Crosscare 
Community Addiction Response Programme (CARP) 
Ballymun Youth Action Project 
Ballymun Community Action Programme 
Community Addiction Programme (CAP) 
Jobstown Assisting Drug Dependency (JADD) 
Cabra Resource Centre 
The Crinian Project 
 
Community Programmes based outside Dublin that can be considered rural 
interventions 
 
Adult Substance Misuse Education Programme 
Clonmel Community Based Drugs Initiative (CCBDI) 
Co. Waterford Community Based Drugs Initiative (CWCBDI) 
Southside Communities Drugs Initiative (Waterford) 
 
c) Cooperation Structures 
 
NO INFORMATION AVAILABLE 
 
d) Statistics and evaluation results 
 
Project Statistics Evaluation results 
Fettercairn Drug 
Rehabilitation 
project 
The project has worked with a 
total of 70 clients since 1997, in 
the year 2000 there were 31 
active clients involved with the 
project (Rourke 2000) 
A number of clients with the project 
have progressed onto employment, 
training and further education. 
Clients have also set up their own 
drama group and produced a play, 
whilst others are competing in a 
competitive football league. The local 
community has also noted the 
benefits from the activities of the 
project (Rourke 2000) 
Community and 
Prison Link 
Programme 
Over 20 people enrolled for 
regular meetings with the liaison 
worker when he visited the 
prison during the initial phase of 
the programme(Personal 
communication) 
No information available 
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The Candle 
Community Trust 
Programme 
 57 young men and 7 young 
women registered with the 
workshop in the year 2000. In 
addition, the project offered 33 
programmes throughout that 
year In total, the attendance 
figures for the day centre in the 
year 2000 were 2,423, however, 
some of these figures may relate 
to the attendance of an 
individual on more than one 
occasion (Candle Community 
Trust Annual Project Report) 
Subsequent to their participation in 
the workshop programme, 14 have 
found employment, 5 went into 
further education and 20 are still with 
the project (Candle Community Trust 
Annual Project Report) 
The Cabra 
Community 
Positive Living 
Year Project 
No information available An increase in numbers attending 
youth club activities in the area with 
many clubs operating a waiting list. 
Recent surveys in the area indicate 
an increase in drug awareness in the 
community. (Personal 
Communication)  
 
Kilbarrack 
Community Coast 
Programme 
(KCCP 
The Kilbarrack Community 
Coast Programme is primarily 
operated through the FAS 
Community Employment 
Scheme. Currently The project 
caters for 10 recovering drug 
misusers through a FAS 
Community Employment 
Scheme. (Personal 
Communication) 
No information available 
Ballyfermot Star 
Community 
Support Group.  
No information available No information available 
Edenmore Drugs 
Intervention Team 
(EDIT)  
The project caters for 13 clients 
through a FAS Community 
Employment Scheme. . In 
addition to this, the programme 
offers a short therapeutic service 
to a further 12 clients, who are 
unable to engage with the 
structural requirements of the 
FAS scheme. In addition the 
programme currently facilitates 
eighteen parents or co-
dependents on the 10-week 
drugs education/support course. 
(Personal Communication)  
 
No information available 
Clondalkin 
Addiction Support 
Programme 
(CASP) 
At present the treatment phase 
of the project has 40 clients in 
full time treatment  
(Personal Communication) 
No information available 
Drugs Information 
Community 
Education Project 
(D.I.C.E.) 
No information available No information available 
The Advance 
Project 
No information available The project has created over 20 full-
time jobs that have been filled by 
twenty local people. All of those 
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employed are over 35 and have 
been unemployed for at least five 
years. Most have a history of drug 
misuse (Personal Communication)  
Darndale/Belcamp 
Drugs Awareness 
Group (DAG) 
No information available No information available 
St. Dominics 
Community 
Response Project 
A drop-in centre is provided five 
days a week. The centre 
recorded 2,155 visits by clients 
to the drop-in centre from 1997 
to 2000 (Rourke  2000)  
 
No information available 
Crew Network No information available No information available 
DAP – Crosscare No information available No information available 
Community 
Addiction 
Response 
Programme 
(CARP) 
No information available An evaluation report (Bowden 1997) 
showed that participants generally 
viewed the programme in positive 
terms and the programme allowed 
participants to develop the ability to 
resist heroin.  
 
Ballymun Youth 
Action Project 
No information available No information available 
Ballymun 
Community Action 
Programme 
No information available No information available 
Adult Substance 
Misuse Education 
Programme 
The programme is delivered to 
groups of between 6 and 12 
participants at a time and 
consists of between two and five 
sessions that are two hours in 
duration and cover various 
aspects of substance misuse 
(Personal Communication)  
 
No information available 
Jobstown 
Assisting Drug 
Dependency 
(JADD) 
No information available A recent evaluation (O’Rourke 2000) 
found that participants generally 
viewed the programme in positive 
terms and that JADD had made a 
significant contribution to the quality 
of life and provision of opportunities 
for many people living within the 
Jobstown area.  
 
Cabra Resource 
Centre 
No information available No information available 
The Crinian 
Project 
No information available No information available 
The Community 
Addiction 
Programme (CAP 
The programme caters for 15 
clients at a time through a 
special FAS Community 
Employment Scheme that runs 
over a 12-month period ( CAP 
Project report)  
 
 
Clonmel 
Community Based 
Drugs Initiative 
(CCBDI 
The maximum number of people 
in a group is 20 and the 
minimum is 8. The course runs 
for eight weeks and the each 
Internal assessments of participants’ 
perception of the course indicate the 
following. All respondents report it to 
be informative, useful and 
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session lasts about two hours. 
The course is undergoing 
continuos evaluation and after 
four courses had been 
completed for a total of 44 
people initial feedback indicates 
the following.  
 
interesting. 53.28% reported that the 
most important idea they learned 
from the course was to get more 
involved in their child’s life. All 
respondents agreed that the course 
should be offered again and that 
they would willingly promote a 
repeat. 70% of respondents reported 
that they would be interested in 
becoming a facilitator on the course 
and 86.58% of respondents reported 
that they felt their skills, confidence 
and ability were enhanced by their 
participation on the course. (Annual 
Report  2000)19 
Co. Waterford 
Community Based 
Drugs Initiative 
(CWCBDI) 
Included is a 4-week drug 
awareness programme for 
parents in the local communities. 
To date 5 such programmes has 
been completed. The Parent to 
Parent programme conducted 
under the guise of the CWCBDI 
now has 7 trained facilitators. 
For the programme, which runs 
for a period of eight weeks at a 
time. Extensive work with young 
people has also been 
undertaken by the CWCBDI with 
a total of 5 Drug Awareness and 
Education Programmes being 
run with young people from the 
Co. Waterford area. (Internal 
Communication)  
No information available 
Southside 
Communities 
Drugs Initiative 
(Waterford) 
No information available No information available 
 
e) Specific Training 
 
NO INFORMATION AVAILABLE 
 
9.1.5 Telephone Help-lines  
 
a) Interventions at national/regional/local: their characteristics (type of 
information, costs) 
 
The Northern Area Health Board, the SouthWestern Area Health Board and 
the East Coast Area Health Board each provide a Freephone Drugs Helpline. 
The Midland Health Board has recently set up a new 24 hour Helpline service, 
entitled “Don’t Get Down-Get Help”. It can be accessed from anywhere in 
Ireland for the price of a local call regardless of the duration of the call. The 
service operates 7 days a week, 365 day a year. The helpline was set up to 
primarily target the 15-24 age group, who may be experiencing emotional 
                                                     
19 Hayes, M. (2000) Yearly Report of Clonmel Community Based Drugs Initiative( Draft Report)  
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distress and suicidal thoughts. Although this helpline is not specifically aimed 
at drug related matters, it is felt that the service can also capture individuals 
who may be experiencing alcohol and drug related problems.  
 
b) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
c) Specific training 
 
NO INFORMATION AVAILABLE 
 
9.1.6 Mass Media Campaigns 
 
a) Types and characteristics of mass media campaigns (TV, radio, 
posters…)  
 
The Health Promotion Unit of the Department of Health and Children 
disseminates information on drugs and their effects on people on an on-going 
basis. This information primarily comes in the form of booklets, posters and 
leaflets and is distributed through local health centres, clinics, schools and 
hospitals. The South Eastern Health Board has recently produced a number 
of videos on drugs. The videos are primarily aimed at teenagers and parents 
and are based on prevention and education.  
 
HYPER 
 ‘HYPER’ was launched in 1999 by the project promoter – Soilse which is a 
rehabilitation programme in the Northern Area Health Board area. HYPER 
which is an acronym for Health, Youth, Promotion, Education and 
Rehabilitation acts as a voice for young people affected by drugs.  HYPER 
was initially funded through a combination of Eastern Health Board and 
European funding, however, recently the project has been mainstreamed and 
is now being funded solely by the Northern Area Health Board. Initially the 
project targeted 18-20 year olds, however, it has now been decided to 
increase the age profile of prospective clients to the 18-25 age group. The 
magazine is produced by former drug users as part of a rehabilitation project 
and aims to bring young people a magazine which they can relate to and 
which critically addresses their lifestyles without preaching or scare-
mongering.  The magazine includes interviews, book and theatre reviews, 
cartoons and articles that challenge peoples’ attitudes towards drugs, young 
people and health. In July 1999, HYPER won an award in the British based 
Total Publishing Awards competition for design innovation.  The magazine 
was selected from over 400 entries. The magazine is due to be re-launched in 
October 2001 under a new editorial team.  
 
b) Cooperation with mass media (cost and cost sharing with media) 
 
NO INFORMATION AVAILABLE 
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c) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
d) Specific training 
 
NO INFORMATION AVAILABLE 
 
9.1.7 Internet 
 
a) Use of Internet for: prevention (type of intervention, target, other relevant 
characteristics) – dissemination of prevention know-how among 
professionals 
 
http://dnedrugstaskforce.ie/ 
This website has been set up by the Dublin North East Drug Task Force and 
outlines various activities which have been initiated in response to the 
problem of drug misuse in the local areas under the task force. It also 
contains information on treatment centres and rehabilitation initiatives in the 
local areas.  
 
http://www.mqi.ie 
Merchant’s Quay Ireland is a voluntary organisation which provide treatment, 
rehabilitation and harm reduction methods to people who misuse drugs. Their 
website, which was recently launched, contains extensive information on their 
service provision.  
 
http://www.kildare.ie/drugsawareness/ 
This website covers the areas of Kildare and West Wicklow, which are 
situated around 20 miles from Dublin. The site offers information on services 
in the area, as well as seeking to engage visitors to the site to reflect on the 
issues pertaining to drug misuse.  
 
http://www.kildare.ie/outreach/index/htm 
This site offers extensive information on outreach services in the areas 
covered by the Eastern Regional Health Authority, which cover most of the 
areas which have the most serious problems of drug misuse.  
 
http://www.drugawareness.ie 
This site offers information on education programmes that teaches local 
community activists to respond to local drug problems in a measured and 
informed manner.  
 
http://www.coolchoices.ie 
This is a government-sponsored website seeking to offer information to young 
people on the dangers of drug and alcohol abuse.  
 
http://www.rutlandcentre.org/ 
This website introduces the treatment programme that is provided by the 
Rutland Centre. The centre provides treatment for addiction, to drugs, alcohol 
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gambling and other recognised conditions. The programme provides 
residential treatment and extensive aftercare programmes.  
 
http://www.clubscene.ie/ 
Merchants Quay Ireland has launched a unique and innovative new website 
aimed at clubbers, containing advice and information in relation to dance drug 
use, harm reduction etc.  
 
b) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
9.2 Reduction of drug related harm 
 
9.2.1 Outreach work 
 
a) Strategies (youth work approach, family/community approach, “catching 
clients”, public health model, self help initiatives, etc) 
 
Outreach workers employ various strategies in order to make contact with 
target groups. Essentially the bulk of work carried out by outreach workers in 
the Dublin/Kildare area consists of the following: 
 
• Providing support to local communities and individuals who are not in 
contact with established services 
• Promoting awareness of HIV/AIDS, drugs and sexual health through the 
provision of  education and information 
• Advocating on behalf of identified target groups 
• Attempting to link people into treatment centres for heroin detoxification 
and maintenance 
• Providing detoxification options as alternatives to methadone maintenance  
 
b) Target groups 
 
• Homeless people engaged in drug misuse  
 
• Individuals engaged in male and female prostitution 
 
• Individuals engaged in illicit drug misuse who are not in contact with 
established services 
 
 
c) Synthetic description of actors and instrument 
 
The Eastern Regional Health Authority (ERHA) is responsible for providing 
the bulk of outreach services to drug misusers in the Dublin-Kildare area. The 
ERHA are instrumental in providing outreach workshops that promote safe 
sex practices, and which cover hepatitis A/B/C and substitution services in the 
form of methadone distribution for instance. Workshops are also provided for 
people working with drug users and precautions are outlined for individual 
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workers regarding the dangers of needlestick injuries. The ERHA also provide 
an extensive range of services through street work, these include  
 
• Reaching out to people who are not presently receiving help or advice. 
Providing information on contaminated heroin.  
Monitoring preferred drug use and current price in the area.  
Providing HIV information and hepatitis information.  
 
d) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
e) Specific training 
 
NO INFORMATION AVAILABLE 
 
9.2.2 Low threshold services 
 
a) Organisational framework: structures (public service, NGO, co-
operation schemes), tasks and special services 
 
The Mobile Clinic was established in the Eastern Regional Health Authority 
area in 1996. The mobile clinic service is designed for low threshold work and 
provides initial services to the more chaotic drug users, who are not stabilised 
on  methadone maintenance and who benefit by such intervention. By 
definition low threshold services place increased emphasis on harm reduction 
than on abstinence from opiates. Part of the service is the provision of a 
needle exchange facility and in some cases the administration of low doses of 
methadone. The clinic also provides a specific service for women engaged in 
sex work. Currently there are four mobile clinics operating on a seven day a 
week basis.  
 
b) Target groups 
 
• Chaotic drug users, who are primarily injecting opiates and are not 
stabilised on a methadone maintenance programme 
• Women and men using drugs and engaged in sex work 
 
c) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
d) Specific training 
 
NO INFORMATION AVAILABLE 
 
9.2.3 Prevention of infectious diseases 
 
a) Synthetic outline on organisations, strategies and actors 
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The prevention of the spread of drug-related infectious diseases in Ireland 
falls under the general auspices of treatment services, in the context of Irish 
drug policy’s emphasis on harm reduction. Under the treatment pillar of the 
National Drugs Strategy (2001-2008) one of the two main objectives of 
treatment provision in Ireland is “to minimise the harm to those who continue 
to engage in drug-taking activities that put them at risk” (Department of 
Tourism Sport and Recreation 2001, p.6). Each health board is responsible 
for the provision of services for drug users that will facilitate them in 
minimising the spread of drug-related infectious diseases. The concentration 
of injecting drug use in the ERHA has meant that these services have tended 
to be focused heavily in this region. Both voluntary and statutory agencies are 
involved in the provision of services and programmes aimed at preventing the 
spread of drug-related infectious diseases. 
 
b) Principal interventions: 
 
Needle and syringe exchange 
Approximately 12 needle exchange sites are in operation in Ireland-, all of 
which are located in the ERHA where the vast majority of known injecting 
drug users resides (O’Brien et al. 2000). There are three main ‘types’ 
programme contexts in which an exchange programme is provided: 
 The Merchant’s Quay Project is a voluntary organisation that, among other 
services, provides a needle exchange programme. 
 There is a mobile clinic which provides low threshold services to drug 
users including a needle exchange and a low dosage methadone 
programme. This clinic services four areas in Dublin City and the 
surrounding suburbs on a Monday to Friday basis. 
 The remaining programmes are all statutory services run by the ERHA. 
These are located in health centres and drug treatment centres around the 
city. 
 
Safer sex/safer education 
In Ireland condoms are distributed free of charge to ‘at risk’ groups, including 
drug users, through both voluntary and statutory agencies. However, it should 
be noted that condoms are not made available to prisoners in Ireland. 
 
Testing, vaccination 
Drug users who present for treatment at any of the statutory drug treatment 
services are routinely offered HIV and hepatitis C testing, and a similar 
service is also available through voluntary agencies. Testing is available free 
of charge and users are encouraged by service providers to have a test 
carried out. However, two prison studies on the prevalence of hepatitis C 
(Allwright et al.1999; Long et al. 2000) of all prisoners and committal prisoners 
respectively, found that only 59.3% of all prisoners who had a history of 
injecting drug use had been tested for hepatitis C (Allwright et al. 1999), and 
65.7% of the committal population (Long et al. 2000). 
 
Another form of testing is antenatal testing. A nationwide routine linked 
antenatal HIV testing programme has been established which can reduce 
perinatal transmission through the use of antenatal treatment of HIV positive 
  125  
women with anti-retroviral drugs and careful management at delivery 
(Department of Health 2000). 
 
Hepatitis B vaccination is available free of charge to drug users from drug 
treatment clinics, hospitals and general practitioners. In theory all drug users 
are routinely offered vaccination when in contact with services, but the 
proportion who are fully vaccinated is not known. A study of clients attending 
the Merchant’s Quay project found that only 19% of clients reported having 
been vaccinated for hepatitis B (Cox & Lawless 2000). Furthermore, a study 
of HIV and hepatitis B/C prevalence among committal prisoners (Long et al. 
2000) found that of 175 prisoners who reported a history of injecting drug use, 
only 23% (n=41) reported that they had been fully vaccinated for hepatitis B. 
This would suggest that to date the services have not been effective in 
providing a comprehensive vaccination programme. 
 
Treatment 
Treatment for both HIV and hepatitis C are available free of charge to people 
infected through drug use.  
 
HIV treatment/HAART is available to IDUs through referral through GUM and 
Infectious Disease clinics in Ireland. The selection of patients for HAART is 
based on medical criteria as set out by international recommendations, and 
the motivation of the individual to undergo the treatment. The first three 
treatment sites are in Dublin based hospitals, and the fourth in Cork:  
 St. James’s Hospital  
 Beaumont Hospital 
 Mater Misericordiae Hospital 
 Cork University Hospital 
 
Treatment for hepatitis C is also available. While there are no written selection 
criteria for acceptance onto a hepatitis C treatment programme, in practice 
certain criteria need to be met. It is generally agreed among service providers 
that a potential client should be ‘drug stable’ (i.e. free from street opiates and 
injecting drug use) for a minimum of a year prior to starting treatment. It is 
argued that an individual needs to be drug stable in order to maximise the 
chances of compliance with the treatment regime. Therefore, while a person 
with a history of injecting drug use may access treatment for hepatitis C, an 
active IDU may not. Treatment for hepatitis C is therefore not offered to active 
IDUs. 
 
c) Providing equipment 
 
As described above injecting drug users are provided with access to clean 
injecting equipment through a number of needle exchange services. 
 
d) Statistics and evaluation results 
 
Statistics are not routinely collected in the area of programmes for the 
prevention of the spread of drug-related infectious diseases and evaluations 
are rare. On a general basis according to the report of the National AIDS 
Strategy Committee, recent HIV statistics indicate that interventions with 
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intravenous drug misusers are effective in reducing transmission rates among 
this ‘at risk’ group (Department of Health and Children 2000). However, 
between 1998 and 1999 there was a major increase in the numbers of drug 
users with HIV which stabilised in 2000 (see Section 3.3 of this report). Smyth 
et al. (1999) attempted to explore the impact harm reduction programmes in 
Ireland had on the spread of hepatitis C by carrying out tests for hepatitis C 
among a cohort of drug users. The cohort included those who had begun their 
injecting drug use both before and after the expansion of harm reduction 
programmes in Ireland. Smyth et al. (1999) argue that the findings suggest 
that those injecting drug users who began their injecting drug use after the 
introduction of harm reduction strategies, demonstrated a reduced risk of HCV 
infection. However, Smyth et al. (1999) emphasise that it was not possible to 
control for other factors that may explain the decline in the HCV infection rate, 
such as a possible reduction in overall injecting frequency among more recent 
injectors.  
 
Health Promotion Unit – Merchants Quay Project 
The largest needle exchange in the country is operated by a voluntary agency 
– Merchants Quay. The Health Promotion Unit within Merchants Quay operate 
the needle exchange which is aimed at drug users who inject heroin and offers 
a drop-in service which is open Monday to Friday, 2.00pm until 4.30pm. The 
Health Promotion Unit offers a range of services to its clients. It provides a 
range of needles and syringes, sterile water, filters, swabs, citric acid and 
condoms. The Unit also acts as a source of referral to other drug treatment 
services and offers a nursing service. This service provides clients with basic 
wound care, and deals with other health issues such as scabies, athlete’s foot 
and any other conditions that clients present. When appropriate, referrals are 
made to other services and clients may also apply for a medical card. 
Encouraging clients to engage in specialist contact such as having an HIV test 
and receiving the hepatitis B vaccination is also considered an integral part of 
the Health Promotion Unit. A recent evaluation (Cox and Lawless 2000) found 
that the Health Promotion Unit had a positive impact on clients’ drug using 
behaviour. There was a reduction in the frequency of injecting and the 
incidence of sharing and an increase in condom use reported by clients at the 
three month follow up visit. 
 
e) Specific training 
 
Training is made available to midwives and others involved in the routine 
linked antenatal HIV testing mentioned above. This is provided in all health 
boards by a team including expert clinicians, a midwife and a social worker. 
 
9.3 Treatments 
 
9.3.1 Treatments and health care at national level 
 
a) Services offered and their characteristics (typology, staffing, monitoring 
and other relevant aspects) 
 
According to the recent National Drugs Strategy Report (2001)  
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“…The provision of a comprehensive range of drug treatment options was 
a crucial component in a number of submissions relating to treatment…” 
(p 86)  
 
In recognising the diverse nature of individuals who engage with drug misuse, 
and in response to concerns raised through community networks, the 
response has been to implement as far as possible a comprehensive range of 
treatment options. These can include detoxification, treatment in therapeutic 
communities, methadone maintenance, counselling and harm reduction 
methods such as needle exchange. Throughout the 1990s there has been an 
emphasis on the provision of methadone maintenance for opiate misusers, 
however, in recent times the role of rehabilitation for drug misusers has been 
explored. This emphasis on rehabilitation is reflected in the 
rehabilitation/reintegration blueprint devised by the Eastern Regional Health 
Authority (ERHA) and the appointment of three rehabilitation co-ordinators by 
the ERHA. (See section 8.2)  
 
b) Objectives: drug free treatment, not drug free treatments 
 
NO INFORMATION AVAILABLE 
 
c) Criteria of admission 
 
NO INFORMATION AVAILABLE 
 
d) Involvement of public health services and GPs 
 
Drug treatment services are provided through a network of treatment locations 
with the emphasis on the provision of local based treatment where possible. 
Within the Eastern Regional Health Authority, 54 treatment locations have 
been developed over the last number of years and at the end of August 2001 
5,605 clients were receiving treatment with methadone. By the end of August 
2001 there were 166 general practitioners involved in the prescribing of 
methadone for opiate addiction and by the end of August 2001 there were 237 
community pharmacies dispensing methadone to opiate addicts.  
 
e) Co-ordination between public health services and GPs 
 
NO INFORMATION AVAILABLE 
 
f) Special services 
 
NO INFORMATION AVAILABLE 
 
g) Financing 
 
One of the difficulties in assessing expenditure on treatment in the drug area 
is that of locating a definition of treatment from which to measure expenditure. 
This difficulty has been identified for some time, as according to the 
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Government Strategy to Prevent Drug Misuse (1991) the treatment, care and 
management of drug misuse does not lend itself to a ‘one-solution’ approach. 
Consequently treatment of drug misuse in an Irish context can involve a 
diverse set of responses which seek to intervene at different stages of the 
treatment process. These can range from detoxification to the provision of a 
pre-employment training programme. Therefore it is difficult to arrive at a 
reliable estimate of costs associated with the treatment of drug misuse. 
However there is some data available for the year 2000 on Government 
expenditure on drug misuse initiatives, from which it is accepted that a 
proportion of this expenditure was directed towards treatment initiatives. The 
National Drug Strategy Review Group has calculated the following 
expenditure estimates based on the available data.  
 
Table 9.3a.  Government expenditure on drug misuse initiatives, 2000 
Department/Agency Expenditure € Millions 
Dept. of Health and Children €31997400 
Dept. of Enterprise, Trade and Employment €5967770 
Dept. of Education and Science €7491455 
Dept. of Tourism, Sport and Recreation €11554617 
Source: Department of Tourism, Sport and Recreation 2001-2008: 63  
 
The expenditure for the Department of Education and Science includes the 
Young Person’s Facilities and Services Fund. This fund was set up to provide 
sport and recreational facilities in disadvantaged areas where a significant 
drug problem exists. The expenditure for the Department of Enterprise, Trade 
and Employment represents funding for the Special Drugs Community 
Employment Programme run by FAS for recovering drug misusers. This is an 
integral component of the rehabilitation/reintegration approach being 
implemented through the local projects funded through the Local Drugs Task 
Forces. The Department of Health and Children and the Department of 
Tourism, Sport and Recreation are primarily responsible for the funding of 
recognised treatment centres through the area Health Boards and the Local 
Drug Task Forces respectively.  
 
One of the areas identified as in need of immediate expenditure was the 
provision of funding for adequate premises from where to run treatment 
programmes. A specific sum of €4444083 million was provided by the 
Department of Tourism, Sport and Recreation through the National Drugs 
Strategy for the Capital funding of 16 separate premises. This was the first 
allocation of funding under the new community based Premises Initiative, 
whereby €12697380 million is being provided over 3 years to assist 
community based drug projects to meet their accommodation needs.  
 
The Eastern Regional Health Authority (ERHA) in their Service Development 
Plan for 2001 has drawn up the following proposals as part of their Opiate 
Addiction Services. An allocation of €2841673 has been received for the 
development of new drug demand reduction initiatives. It is planned to provide 
for the following new developments with this allocation:  
• to develop three pilot projects in A&E Departments in acute hospitals to 
liase with the drug services - €76185 
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• to develop a pilot project in each Area Health Board to utilise 
community pharmacists in the area of health promotion for persons 
with an addiction and who are still using needles - €50790 
• to appoint a Hepatitis C Co-ordinator for each Area Health Board to 
ensure that the links are maximised with the acute hospitals to ensure 
that persons who are drug using and have hepatitis C access services 
and attend treatment and follow up - €95230 
• to provide three additional Consultant Psychiatrists with a particular 
expertise in youth and adolescent addiction problems - €190460.  
• to establish a dedicated 12 bed unit for adolescents who require 
treatment in Cherry Orchard Hospital - €317435 
• to provide 2 specialist day programmes for young people who wish to 
access treatment - €380920 
• to continue the provision of treatment services in areas of greatest 
need and in particular those areas which have waiting lists for 
treatment - €733910 
• to open a new 20-bed rehabilitation unit in St. Mary’s Hospital (Phoenix 
Park) early in 2001. This will have the benefit of providing greater 
access to rehabilitation services and will also allow for a greater 
number of clients to be detoxed in the Cuan Dara unit as the overall 
length of the programme in Cuan Dara will be changed to allow clients 
to move to the residential unit - €380920 
• to establish a drop-in centre for drug free clients who are in recovery in 
the inner city - €63486 
• to establish a further clinic for women involved in prostitution who have 
a drug addiction problem - €95230 
• to provide dedicated counselling services for general practitioners who 
are involved in treating clients in the community - €126973 
• to commission a number of research projects particularly in relation to 
outreach services and counselling services - €63486 
• to address the capacity problems that has emerged from the number of 
additional patients in treatment and the need for more detailed 
reporting of urinalysis and screening programmes  
• to provide additional laboratory staff to ensure that specimens are 
reported on in a timely manner - €126973 
• to appoint a Co-ordinator for the development of drug services to the 
prison population. A separate development plan is being prepared 
which will be the subject of a separate funding application to the 
Department of Health & Children and the Department of Justice, 
Equality & Law Reform – cost in 2001 €50789 
• to appoint a Senior Administrative person in each Area Health Board to 
ensure that the projects are mainstreamed, funded and evaluated on 
an on-going basis - €88880 
The decision of the National Drugs Strategy Team to mainstream a large 
number of projects, which were being funded by the Drug Task Forces, 
has resulted in significant additional responsibility for the Area Health 
Boards in the funding and management of projects. The total additional 
cost of providing these developments in 2002 is €321245  
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h) Statistics and evaluation results 
 
National Drug Treatment Reporting System Statistics 
 
The National Drug Treatment Reporting System (NDTRS) data for 1999 (the 
latest year for which published data are available) indicate that there was an 
increase in the numbers reporting for treatment for drug related problems, 
compared to the 1998 figures. Similarly there has been a corresponding 
increase in the numbers recorded as first time treatment contacts. (Table 
9.3b)  
 
Table 9.3b: Ireland 1998-1999.  Number of all recorded and first time treatment 
contacts.  
 1998 1999 
Number of all recorded treatment contacts 6043 6443 
Number of first time treatment contacts 1652 1852 
Source: NDTRS Data, 1998-99 
 
75.2% of all recorded treatment contacts in 1999 indicated that their main 
drug of misuse was heroin, and 57.9% of first time treatment contacts in 1999 
also gave heroin as their main drug of misuse. 83.5% of all recorded 
treatment contacts for 1999 were treated in the then Eastern Health Board 
area. This Health Board area caters for the Greater Dublin area, which has 
been identified as having the most severe cases of drug misuse in Ireland. 
The fact that this area contains 13 of the 14 established Local Drug Task 
Forces is testament to the response that was required to address the drug 
misuse issue.  
 
According to the data collected in 1999, there was a slight increase in those 
reporting to having injected drugs at some point in their lives. (Table 9.3c)  
 
Table 9.3c: Ireland 1998-1999 All recorded treatment contacts reporting to have 
injected drugs at some point in their drug use. Percentages. 
 1998 1999 
All recorded treatment contacts reporting to have 
injected drugs at some point in their drug use 
66% 68.9% 
Source: NDTRS Data, 1998-99 
 
A gender breakdown of all recorded treatment contacts for 1999 show that 
69% were male which shows little variation on the 70.2% recorded as male 
contacts in 1998. It would appear that there has been a decrease in the 
numbers reporting for treatment in 1999 who report living with either 
parents/family, in contrast to the 1998 figures. (Table 9.3d). A decrease in the 
numbers reporting for treatment that is under age 25 has also been recorded. 
(Table 9.3e)  
 
Table 9.3d: Ireland 1998-1999. All recorded treatment contacts living with either 
parents/family. Percentages.  
 1998 1999 
All recorded treatment contacts living with either 
parents/family 
65% 62.7% 
Source: NDTRS Data, 1998-99 
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Table 9.3e: Ireland 1998-1999. All recorded treatment contacts under 25 years of age. 
Percentages. 
 1998 1999 
All recorded treatment contacts under 25 years of age 58% 52.6% 
Source: NDTRS Data, 1998-99 
 
A number of questions arise as a result of the data collected, on the 
employment/unemployment status of clients reporting for treatment. An 
emerging trend is apparent in the increase in the numbers reporting for 
treatment that are in gainful employment (Table 9.3f)-gainful employment 
meaning paid employment. Some of the questions that can be posed are to 
what extent does Ireland experience this increase due to the positive 
economic climate in recent times, which has seen a steady growth in 
employment figures? What role has the use of prescribed methadone played 
in increasing the employment opportunities of individuals attending for 
treatment? Or can this increase be partly explained by a greater and more 
visible availability of treatment?  
 
Table 9.3f: Ireland 1997-1998-1999. All recorded drug treatment contacts reporting to 
be in gainful employment. Percentages  
 1997 1998 1999 
All recorded drug treatment contacts 
reporting to be in gainful employment 
14% 20% 26% 
Source: NDTRS Data, 1998-99 
 
i) Specific training 
 
General practitioners – GPs who are the primary substitution service 
providers in Ireland, are required to undergo specific training before they are 
permitted to prescribe methadone. This requirement has been in place since 
the introduction of the Methadone Prescribing Protocol in 1998. The Irish 
College of General Practitioners provides this training in conjunction with the 
local health boards. There are two training levels that GPs can complete. The 
level attained will dictate the nature of the contract the GPs will have with the 
health boards in terms of the substitution services he/she can provide within 
their general practice.  
 
Level 1: This level permits GPs to prescribe methadone only for clients that 
have been stabilised on a methadone programme in a clinic setting. These 
stabilised clients are referred to the GP from the health board treatment 
centres. GPs in this group are limited to providing services to a maximum of 
15 clients per GP.  
 
Level 2: This level of training permits GPs to initiate the treatment of opiate 
dependent persona. Doctor’s must have worked for a minimum of one year in 
a clinic based setting before they can undergo this training. A GP in this group 
may treat up to 35 clients in their own practice. If a GP is involved in a 
practice with two or more doctors, they may cater for a maximum of 50 clients.  
 
The number of GPs providing this service has increased over the year. In 
1996 there were 58 GPs registered as prescribing methadone in the setting of 
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their practice. This number increased to 97 in 1998, 143 in 1999, and 158 in 
2000 and to 166 by the end of August 2001.  
 
The Irish Council of General Practitioners (ICGP) collaborates with the Drug 
Misuse Research Division (DMRD) in encouraging GPs to participate in the 
National Drug Treatment Reporting System (NDTRS), by providing a slot in 
GP training sessions for briefing on the NDTRS. Training in NDTRS data 
collection is subsequently provided to GPs on an individual level by the 
DMRD.  
 
j) Other national specifications 
 
NO INFORMATION AVAILABLE 
 
9.3.2 Substitution and maintenance programmes 
  
a) Organisation and delivery of substitution drugs: 
 
NO INFORMATION AVAILABLE 
 
b) Criteria of admission 
 
During the early 1990’s substitution services in Ireland were expanded and 
became more widely available to the opiate using population. In accessing 
maintenance programmes preference has always been given to pregnant 
women and those who have AIDS or is HIV positive. However, in 1998 the 
Eastern Health Board produced an ‘Inventory of Policies’ which lays down 
criteria for admission to substitution programmes.  
 
Methadone Maintenance 
The following are the criteria for inclusion of a person on a methadone maintenance 
programme. 
 
 They must meet physical emotional and behavioural criteria for addiction as set 
down by the 10th edition of the International Classification of Diseases. 
 They must be aged over 18, but those between the ages of 18 and 20 will require 
a more extensive investigation before being commenced on methadone. This 
would require an extensive drug history going back more than two to three years, 
which will need careful clarification. 
 They must have an extensive one-year history of intravenous drug use. 
 
Special cases that need not meet the above criteria for admission will include the 
following: 
 
 patients who are HIV positive; 
 partners; and 
 patients who are pregnant. 
 
These patients will be offered detoxification, maintenance or inpatient services as 
appropriate. 
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Young people, 18 years or younger 
Young persons under the age of 18 will need their parents to attend and give parental 
consent. There should be a history of at least one failed detoxification, usually two or 
three preferably at inpatient level. However, where patients have a very long history 
that can be verified, this condition may be waived. 
 
Young persons 18 years or younger will require very careful assessment and 
consideration at team meetings and will need the formal decision of a consultant 
psychiatrist before commencing methadone maintenance. 
 
Dosages above 80mg can only be offered after consultation with the consultant 
psychiatrist. 
Source: Barry (2000) 
 
Prior to the introduction of these guidelines, the criteria of admission onto 
maintenance programmes were generally left to the discretion of an individual 
GP or particular clinic. As such, there may have been extensive variation 
between programmes in terms of the criteria used for admission.  
 
c) Mode of prescription 
 
Legal Basis for Substitution 
Prior to October 1998 there was no policy in relation to GPs prescribing of 
methadone. There are no data available on the extent to which GPs 
prescribed methadone up until this point, as the provision of such a service 
was up to the discretion of individual GPs. However, in the early 1990s there 
was a move away from the centralised specialist model toward a more 
decentralised model of service provision. This called for the involvement of 
community based GPs and pharmacists in the prescribing and dispensing of 
methadone. Although some individual GPs were already involved in providing 
this service, the aim was to establish a structured and co-ordinated approach 
to the provision of services. An Expert Group was set up to develop a suitable 
treatment protocol. In March 1993, the Protocol for the Prescribing of 
Methadone was issued which set out guidelines for GPs prescribing 
methadone within the general practice setting, and for pharmacists in their 
dispensing of methadone. Guidelines set out in a review of this protocol 
produced in 1997 were implemented in October 1998. Consequently, the 
Misuse of Drugs (Supervision of Prescription and Supply of Methadone) 
Regulations were published in 1998.  
 
The guidelines aim to create a more controlled environment for the 
prescribing and dispensing of methadone. Under the Regulations the 
prescribing medical practitioner must register each client in receipt of a 
methadone prescription on the Central Methadone Treatment List.  The 
guidelines aim to restrict the number of clients for whom individual GPs can 
prescribe methadone. While there is no specific licence required by GPs in 
Ireland to provide substitution programmes, they are required to undergo 
training and must be approved by the relevant health board. Approval is only 
forthcoming after the GP has undergone the training programme organised by 
the Irish College of General Practitioners. Methadone itself is a licensed 
prescription drug controlled under Schedule 2 of the Misuse of Drugs 
Regulations, 1988. Methadone is currently prescribed in a number of service 
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settings: drug clinic setting and GP setting. Furthermore, it is also dispensed 
from community pharmacies. 
 
Clinic Setting 
Clinics have been developed specifically to meet the needs of drug users. 
Expansion in the clinic services has been overwhelmingly in the area of 
substitution programmes, including methadone detoxification, stabilisation and 
maintenance. The number of clinic locations where methadone is prescribed 
has grown from two in 1991 to 45 in 1999 and 62 in August 2001. Fifty-six of 
the sixty-two clinics are based in the Eastern Regional Health Authority Area 
where the large majority of opiate users reside.  
 
Clinics fall in to one of two categories. First is the category referred to as 
‘addiction centres’ where a range of services are available to clients, including 
methadone programmes. The majority of the clients attending these clinics 
are dispensed their methadone on-site on a daily basis, this means they 
consume the methadone under the supervision of a member of staff. 
Supervised urine samples are taken on a regular basis. When clients have 
demonstrated a certain level of stability by providing opiate-negative samples 
over a period of time, they may be dispensed ‘take home’ doses. This means 
less frequent attendance at the clinic is required.   
 
The second category of clinic is referred to as ‘satellite clinics’. These are 
clinics based in communities identified as having a significant opiate using 
population. These clinics provide methadone prescribing services, although it 
is not dispensed on site. Rather, clients attend a designated community 
pharmacy where their methadone is dispensed. 
 
General Practice Setting  
As mentioned above, in 1993 a protocol was published for the prescribing of 
methadone in the GP setting. The basic premise outlined in the 1993 Protocol 
is that GPs should take on responsibility for the care of opiate dependent 
people once they have been stabilised in either an addiction centre or a 
satellite clinic. GPs and clients should then have the continued support of that 
centre. A protocol review committee was established which produced a report 
in 1997, the recommendations of which were implemented through legislation 
in October 1998. The main changes this had on the organisation and delivery 
of methadone services in the GP context were: 
 GPs had to register with the health board to enable them to prescribe 
methadone. 
 GPs were restricted in the number of drug users they could treat, 
depending on their level of training. 
 Only GPs having undergone specialised training could initiate the 
prescription of methadone in the treatment of drug addiction. Other GPs 
could only treat those already stabilised in a clinic setting. 
 GPs were no longer allowed to prescribe methadone to patients in a 
private capacity but had to provide the service free of charge to the patient 
under the General Medical Scheme. 
 All patients in receipt of a methadone prescription had to be registered on 
a Central Methadone Treatment List. 
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As with the number of clinics providing substitution services, the number of 
GPs offering the service has increased dramatically over recent years. In 
1996 there were 58 GPs registered as prescribing methadone in their practice 
setting, this grew to 143 in 1999 and in August 2001 was 166.  
 
Community Pharmacists 
As substitution programmes have become more decentralised the role of the 
community pharmacist has become increasingly important. Pharmacies are 
responsible for dispensing methadone to clients attending a GP based 
substitution programme and those attending satellite clinics. Each client is 
assigned to a particular pharmacy in the local community, from which his or 
her methadone will be dispensed. Pharmacists are involved in dispensing 
take home doses and also provide a supervised administration service. The 
Pharmaceutical Association of Ireland recommends that pharmacists agree a 
written contract with clients upon initiating these services. Contracts detail the 
pharmacy service and the expected standards of behaviour of clients. The 
number of pharmacies involved in dispensing methadone has increased 
significantly over recent years. As of August 2001 there were 237 pharmacists 
involved in dispensing methadone, 167 of these were based in the Eastern 
Regional Health Authority area. 
 
Specialised Prescription Forms 
 
It is required that methadone be prescribed using specialised prescription 
forms. These prescription forms must be correctly written and allow for a 
single supply or supply on installment. The prescription form must also 
indicate whether or not the administration of the dose should be supervised by 
the pharmacist (Department of Health 1997).  
 
d) Objective (gradual detoxification, maintenance) 
 
The objectives of substitution programmes vary depending on the type of 
programme. While the ultimate aim of the services is to facilitate the individual 
to return to a drug free lifestyle, a variety of programmes are available. While 
some programmes aim to detoxify the individual on a short-term programme 
others offer a longer term maintenance which is not subject to a specific time 
limit.  
 
e) Substitution drug/s, mode of application 
 
The only substitution drug currently prescribed in Ireland is oral methadone. 
The average dose of methadone prescribed is 55mg (Barry 2000). Prior to 
1996 the only form of methadone available in Ireland was Physeptone Linctus 
(2mg methadone per 5mls of syrup). As part of a move in the reorganisation 
of the methadone treatment services, the health board decided to transfer 
patients on to methadone mixture (5mg methadone per 5mls syrup). This 
change was first implemented in treatment clinics and then in GP surgeries. 
This methadone mixture is the only form currently available from treatment 
services.  
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The Pharmaceutical Society of Ireland has proposed that the use of non-
opioid alternatives to methadone for the management of addiction, such as 
Lofexidine, be considered in the future.  
 
f) Psycho-social counselling (requirements and practice) 
 
Counselling is available on-site to those attending a clinic-based programme. 
Interim programmes have counsellors available to clients on an ad hoc basis. 
Access to counselling is provided where there are complex/acute issues 
involved. Clients of maintenance programmes are allocated a full time 
counsellor. While participation is recommended within the programme, it is 
ultimately voluntary. In the GP setting clients can be referred to local 
counsellors if so required. Attendance is also voluntary.  There is no data 
available on the level of uptake of counselling services or the number of visits 
made per client from either treatment setting. 
 
g) Drug testing  
 
Both clinic and GP based programmes require clients to give regular 
supervised urine samples that are tested for the presence of prohibited 
substances. In the clinic settings, urine samples are taken on a twice-weekly 
basis during stabilisation, and on at least a weekly basis once clients are 
stabilised. These samples are all screened for opiates and methadone. On a 
monthly basis all clients are screened for other substances such as 
benzodiazepines and cocaine. Where clients are identified as having a 
specific ‘problem’ with such substances they are screened for them on at least 
a weekly basis. Where clients are transferred to a GP based programme, 
urine screening is organised between the Eastern Regional Health Authority 
and the GP, and carried out on a weekly basis. All samples are currently sent 
to the Trinity Court Drug Treatment Centre for analysis.  
 
h) Diversion of substitution drugs  
 
No research has been carried out to date in Ireland looking specifically at the 
extent to which substitution drugs are diverted. However, the National Drug 
Treatment Reporting System data show that of those who presented to drug 
treatment services with problem drug use during 1998 (N=5076), 6.3% 
reported ‘street methadone’ as their main drug of misuse. This suggests that 
at the time, methadone continued to be diverted from the treatment service 
environment.  However, it will be necessary to examine these figures as they 
become available to asses the impact of the tighter regulations on methadone 
prescribing on the diversion of methadone to the street market. 
 
i) Statistics (measure point) 
 
At the end of August 2001 there were 5,605 clients registered as receiving 
substitution treatment in Ireland. Clients of both GP and clinic based 
programmes are all registered on a Central Methadone Treatment List. As 
mentioned in previous sections, opiate use in Ireland is overwhelmingly based 
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in the Eastern Regional Health Authority Area, therefore most substitution 
programme clients are resident there. In August 2001 163 of a total of 5,605 
clients registered on the Central Methadone Treatment List were receiving 
substitution services outside the Eastern Regional Health Authority area. Data 
gathered through the Central Methadone Treatment List is confidential and is 
not available for analysis.  
 
j) Specific research results 
 
Most research carried out in Ireland with clients of substitution programmes 
has focused on their identity as injecting drug users rather than their 
experiences of substitution programmes. In addition this has been limited to 
sample populations from one particular clinic (Smyth et al. 1998; Smyth et al. 
1995; Dorman et al. 1997; Williams et al. 1997). Little research has been done 
looking at substitution programmes per se. However, this gap is due to be 
addressed by the National Advisory Committee on Drug  (NACD), which has 
called for tenders to evaluate opiate addiction treatment services.  
 
A nation-wide general population survey on ‘Drug-Related Knowledge, 
Attitudes and Beliefs in Ireland’ (Bryan et al. 2000) has been carried out by 
the Drug Misuse Research Division of the Health Research Board. In this 
study one thousand members of the public were asked about a range of drug-
related issues, including drug treatment services. In relation to substitution 
services specifically, respondents were asked to what extent they agreed with 
the following statement:  
 
‘Medically prescribed heroin substitutes [such as 
methadone/physeptone] should be available to drug addicts.’ 
 
Only 16.1% disagreed with this statement while 63.5% agreed and 20.3% 
responded ‘don’t know’. These views appear to contradict the negative 
attitudes expressed by communities in relation to the establishment of 
treatment centres in their localities. 
 
k) Evaluation results 
 
The following evaluative studies have been reported to be underway at the 
time of writing, most are nearing completion (Barry 2000):  
 an evaluation of the first 150 inpatients in the detoxification unit; 
 a five year follow-up of the first 350 patients in outpatient methadone 
maintenance; 
 a four-year follow-up of the first 150 patients in inpatient detoxification and 
stabilisation; 
 an assessment of the care process for 700 patients referred to health 
board services as a result of regulatory changes in 1998; 
 an analysis of the first decade of  first-time needle-exchange patients; 
 a review of the level of care of female users at a city centre clinic; 
 an evaluation of outpatient satellite clinics; and 
 a study of seroprevalence of blood-borne viral infections in methadone 
patients. 
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9.4 After-care and re-integration 
 
a) Organisation 
 
NO INFORMATION AVAILABLE 
 
b) Accessibility for different target groups (after treatment, after prison, for 
long term substitution clients) 
 
Project Target Group 
The Fusion Project 
 
After Treatment: Stabilised methadone users 
The Turas Project 
 
After Treatment: Stabilised methadone users 
The Millennium Carving 
Project 
 
Recovering drug misusers 
Aislinn Addiction Treatment 
Centre 
 
For individuals aged 15-21 requiring treatment for addiction 
The Cavan Centre 
 
Young people aged 16-19 who are at risk of early school leaving 
and of engaging in substance misuse 
Tallaght Rehabilitation 
Project 
 
Recovering/stable drug misusers from the Tallaght area who 
specialist intervention in pursuit of mainstream social integration 
Rehabilitation and Support 
Programme (RASP)  
 
After Treatment: Stabilised methadone users 
The Pathways Post-Release 
Centre 
 
Ex-prisoners: including those recovering from drug misuse 
The Merchant’s Quay Re-
integration Programme 
 
Former drug misusers who have been through residential 
treatment and are seeking to access mainstream employment 
and educational options 
Arbour House Treatment 
Centre 
 
Individuals seeking to recover from addiction plus the families of 
individuals using the service 
Hesed House: Counselling 
and Family Therapy 
 
Individuals engaged in drug misuse and their families, where the 
need for counselling and therapy has been identified 
Soilse/Rutland Centre 
Partnership for Treatment 
 
Individuals from the North Inner City of Dublin who are 
recovering from drug misuse 
 
9.4.1 C) Education and training 
 
Project Medium through which education/training is delivered 
The Fusion Project 
 
FAS Community Employment training programme 
The Turas Project 
 
Training programme 
The Millennium Carving 
Project 
 
FAS Community Employment training programme 
The Cavan Centre 
 
Training programme 
Tallaght Rehabilitation Project 
 
FAS Community Employment training programme 
Rehabilitation and Support 
Programme (RASP)  
FAS Community Employment training programme 
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The Pathways Post-Release 
Centre 
 
Education centre 
The Merchant’s Quay Re-
integration Programme 
 
Training centre 
Soilse/Rutland Centre 
Partnership for Treatment 
 
Partly-an education/training programme 
 
9.4.2 D) Employment 
 
The Merchant’s Quay Re-integration Programme: 
The Merchant’s Quay Project (MQP) in its capacity as a drug service provider 
identified the need for a programme that would assist former drug users who 
had completed residential treatment to gain entry to the mainstream 
employment market. The needs of this client group were given priority 
because the lack of employment opportunities had been identified as a factor, 
which contributed to the relapse of former drug users. In response to this gap 
in service provision, the MQP with initial funding from the EU Integra project 
established the reintegration programme called ‘From Residential Drug 
Treatment to Employment’ in September, 1997. The operational phase of the 
programme began in January 1998 with the first client admitted in February of 
the same year. The overall objective of the programme was to ‘develop, 
evaluate and disseminate a model of good practice in relapse prevention, 
using a locally based, holistic programme which facilitates the integration of 
former drug users into mainstream training, educational and employment 
opportunities’. The MQP identified three main target groups to work with. 
These were former drug users who had completed residential treatment, local 
employers and state training agencies. Former drug users were the primary 
target group and therefore the intervention was primarily aimed at enhancing 
their chances of social integration. It was also felt that employers could be 
encouraged to facilitate former drug users by offering them employment or job 
training. Whilst it was though that training agencies could benefit by receiving 
some drug awareness training to equip them to understand the needs of the 
client group. The work with former drug users comprised two six-week 
phases. Phase one the residential phase, focuses on enabling clients to ‘let 
go’ of the therapeutic environment that many had just left and to facilitate 
movement back into the community. The second phase of the programme 
concentrates on obtaining employment/job placements or educational 
opportunities for clients. During this phase clients are also encouraged to give 
at least one day per week to the attention of personal matters such as 
housing and social welfare issues and to maintain links already forged. The 
programme is underpinned by the belief that clients needs are best 
approached in a holistic manner. An evaluation of the programme found that 
there has been a good deal of success in reaching the target group with 49 
client admissions over a two year period of 1998-99. In particular, the 
programme has attracted female clients with 31% of clients being female. 
65% of admissions have completed the programme. For the year 1999 94% 
of those who embarked on job placement completed the task. While 83% 
secured full-time employment and 13% went on to pursue full-time 
educational opportunities. Of those participants surveyed in 1999, 94% 
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reported that they had acquired important new skills while 65% indicated that 
existing skills had been improved. A majority of participants during 1999 
reported that relationships with family and friends had improved. 89% of 
clients agreed that the programme provided the necessary skills to avoid 
relapsing into drug use. The programme also ran a Drug Education course for 
state training agencies. All participants who attended reported positive 
changes with many reporting less anxiety at the prospect of dealing with 
former drug users in the future. Also they reported that they now had a greater 
understanding of the reasons why some people turn to drugs and the 
consequences that ensue. A majority of employers who accepted clients on 
work placement reported that they rated the work by former drug users as 
either good or very good. All employers noted that clients were very energetic 
and highly motivated. 
 
9.4.3 E) Housing 
 
There are no specific interventions that directly address the housing needs of 
former drug users. However, The Merchant’s Quay Re-Integration 
Programme (referred to above) highlighted the extreme difficulty former drug 
users experienced in accessing accommodation, specifically in Dublin. The 
project found that former drug users who had been through residential 
treatment, and had also been through the social and educational re-
integration programme were particularly affected by accommodation 
problems. Two key factors tend to predominate against former drug users 
seeking to avail of accommodation.  
 
1) Many former drug users have been evicted from the family home during 
the active stages of their drug-using career. Under legislation prohibiting 
anti-social behaviour (Housing Miscellaneous Provisions Act 1997), they 
remain barred from residing in the family home and their local community, 
even when they enter treatment programmes. In some cases, some 
former drug users are allowed back into the family home but only when 
local community activists and the local corporation have vetted their re-
entry.  
2) Due to escalating property prices and a general shortage of 
accommodation in Dublin, property owners charge exhoribant rents that 
cannot be afforded by former drug users as most of them are not in gainful 
employment and are usually reliant on subsidisation to meet their rent.  
 
f) Other national specifications 
 
NO INFORMATION AVAILABLE 
 
g) Statistics and evaluation results 
 
Project Statistics Evaluation results 
The Fusion Project 
 
In the initial year of the project, 39 
people in drug treatment developed 
links with the Fusion project. 24 
were placed in Community 
Employment or training, 8 were 
The following outcomes have 
occurred for participants on the 
Fusion project.  
• 2 individuals are now in full-time 
employment 
  141  
placed in preparation for 
employment or training and 7 opted 
not to accept a place. (Internal 
communication) 
• 10 participants have acquired 
NCVA level 2 in Media and 
Radio Production 
• 7 participants have completed a 
course in pre-enterprise training 
• 3 participants have completed a 
full drug detoxification process 
• 10 have been referred to other 
services in Ballyfermot 
Of the 7 individuals who did not 
accept a place the latest information 
indicated that 1 had gone abroad, 2 
are in full-time employment, 1 is drug 
free and attending NA, 1 is in touch 
with Fusion and 1 has returned to 
active drug use. (Personal 
Communication)  
 
The Turas Project 
 
The project accommodates 20 
trainees, 10 men and 10 women per 
year. (Personal  Communication)  
No information available 
The Millennium 
Carving Project 
 
When the project started a total of 
78 applications were submitted, 
from which a total of 24 places 
allotted to recovering drug misusers 
through a FAS Community 
Employment Scheme. (Project 
report)  
No information available 
Aislinn Addiction 
Treatment Centre 
 
Since it opened in October 1998, 
the centre has worked with over 
200 individuals who reported with 
addiction problems.(Personal 
Communication)  
 
The South Eastern Health Board is 
currently evaluating the centre 
(Personal Communication)  
The Cavan Centre 
 
The number of people using the 
centre each year since 1990 has 
been approximately between 2 and 
3 thousand each year. Figures for 
2000 show that 2,832 people used 
the centre and this was made up of 
182 groups. However, it must be 
noted that an individual’s 
attendance may be counted more 
than once in these figures. (Project 
report)  
 
No information available 
Tallaght 
Rehabilitation 
Project 
 
The project involves the 
participation of 15 clients (at any 
one time) on a Special Community 
Employment Project. Clients attend 
the project for four hours each day. 
The project offers numerous 
education/training activities and 
seeks to build social skills and self-
esteem among clients. During the 
year 2000, the age of participants 
ranged from 22 years to 35 years. 
69% of participants were women, 
with 31% men. Initial reports 
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suggest that clients are responding 
positively to the challenges of the 
project. (Rourke 2000 Project 
Report)20 The Tallaght Drugs Task 
Force, FAS and the Eastern Health 
Board provide funding of the 
project. An extensive evaluation is 
currently being carried out on the 
project.  
 
Rehabilitation and 
Support 
Programme 
(RASP)  
 
No information available No information available 
The Pathways 
Post-Release 
Centre 
 
 However, an evaluation of the centre 
found that when participants begin to 
attend the centre they are either on a 
maintenance programme or drug 
free. The centre offers the services 
of professional drug counsellors and 
the evaluation noted that in over a 
two-year period there were 167 
appointments between clients and 
counsellor, the number of sessions 
completed with one client ranging 
from one session to twenty-five (25) 
sessions. The Department of 
Education, FAS and the City of 
Dublin Vocational Educational 
Committee (CDVEC) provide funding 
for the centre.  
 
The Merchant’s 
Quay Re-
integration 
Programme 
 
 An evaluation of the project’s 
outcomes found that 65% of clients 
managed to complete the 
programme, 94% of clients who 
undertook job placements completed 
these placements and 83% of clients 
secured full-time employment on 
completing the programme. 13% of 
clients secured full-time educational 
opportunities, while a high proportion 
of clients reported improved family 
relations, and an improvement in 
skills and education. The programme 
was also attributed with providing the 
necessary relapse prevention skills 
for 89% of clients. This data relates 
to the years 1998 and 1999, when a 
total of 49 clients were admitted to 
the re-integration programme over 
the two year period.  
 
Arbour House 
Treatment Centre 
 
  
                                                     
20 Rourke, S. (2000) Tallaght Rehabilitation Project, Project Report,  
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Hesed House: 
Counselling and 
Family Therapy 
 
Since receiving Task Force funding 
the Counselling and Family Therapy 
services of Hesed House have 
worked with 208 clients and all of 
these have been touched in some 
way through drug misuse.  
 
 
Soilse/Rutland 
Centre Partnership 
for Treatment 
 
 An evaluation of the programme 
carried out in 1999 revealed that 7 
out of 10 participants reported 
successful outcomes through 
engagement with the programme. 
The evaluation identified three core 
components of the programme, 
which influenced successful 
outcomes as reported by 
participants. These were 1) the 
experience of living in a safe 
environment and feeling part of a 
therapeutic community 2) building 
peer networks and having opinions 
validated and 3) the existence of a 
continuum of care from detox to 
treatment to rehabilitation. In addition 
12 participants were interviewed for 
the evaluation. 11 reported that they 
felt they had been prepared for 
independent living and work through 
their participation with the project. Of 
these, three were in jobs, one on a 
Community Employment Scheme, 
two involved in a Community Drama 
Group and two had applied for an 
Access Group. (Morgan 2000) 21 
 
 
h) Specific training 
 
NO INFORMATION AVAILABLE 
 
9.5 Interventions in the Criminal Justice System 
 
(a) Interventions 
 
 Medical (detoxification, drug substitution) 
In Ireland any individual held in custody has the right to request to see a 
general practitioner (Criminal Justice Act). Where a drug user wishes, he/she 
may request to see a general practitioner who will tend to them while they are 
being held in custody and assess whether to provide the individual with 
medication, e.g. methadone, to alleviate withdrawal symptoms. However, data 
are not currently collected on either the number of people held in custody who 
avail of this service or the proportion who do so as a consequence of their 
drug use. 
                                                     
21 Morgan, M. (2000) Soilse/Rutland Centre: Partnership for Treatment, Process Evaluation.  
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Upon imprisonment there is a standard twenty-day methadone detoxification 
programme offered to prisoners who are found to test positive for opiates. 
This service however is not available in all prisons around the country and 
tends to be based in the Dublin prisons. In what has been the main committal 
prison in Ireland up until recently (i.e. Mountjoy Prison, Dublin), there were an 
estimated 1,200-1,500 cases of prisoners receiving methadone detoxification 
per year (Department of Justice, Equality and Law Reform, 1999).  
 
The following is the detoxification regime followed in Mountjoy Prison, Dublin. 
This is a methadone based detoxification programme, in which Zimovane is also 
offered for the first seven nights during detoxification. In the context of Mountjoy 
prison this programme has been described as being provided in an “essentially 
unstructured and unsupervised fashion, with no follow-up or medium to long 
term planning” (Department of Justice, Equality and Law Reform 1999). The 
programme is the same for each prisoner, irrespective of the quantity of opiates 
being used prior to imprisonment. The doses involved are as follows: 
Day 1-2 35mls methadone mixture  
Day 3-5 30mls methadone mixture  
Day 6-8 25mls methadone mixture  
Day 9-11 20mls methadone mixture  
Day 12-14 15mls methadone mixture  
Day 15-17 10mls methadone mixture 
Day 18-20 5mls methadone mixture 
Zimovane 25mgs each night on day 1-7 of this programme 
 
The provision of methadone maintenance within the Irish prison system 
remains limited. Methadone maintenance is available to prisoners who are 
HIV positive or who have AIDS and to those who were on a maintenance 
programme prior to imprisonment. Currently, methadone maintenance is only 
commenced in Irish prisons in the case where a prisoner is HIV+. However, it 
is currently being planned to expand the provision of methadone maintenance 
to include initiation for those who at some stage in the past have participated 
on a methadone maintenance programme in the community.  
 
Drug-free programmes 
The Probation and Welfare Service provides a Drug Awareness Programme 
in a number of Dublin based prisons. This is a four-week programme 
consisting of one session per week. The principal aim is to educate 
participants about their drug use and the associated risks. It is aimed at all 
prisoners with a history of drug use, including those who have ceased their 
drug use and those who are continuing to use within the prison setting. The 
programme is run regularly in a couple of prisons but staffing shortages 
prevent it from being a more widespread service.  
 
A seven-week ‘Drug Detoxification and Rehabilitation Programme’ is run by 
probation and welfare officers, and is based in the Medical Unit of Mountjoy 
prison. The programme caters for nine male prisoners at a time. There is no 
equivalent service available to female prisoners. To access the programme 
prisoners are interviewed by probation and welfare officers and assessed for 
suitability. Only prisoners with less than 26 months to serve or with a court 
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sentence review date less than 26 months away can apply for the 
programme. Participation entails an initial methadone detoxification followed 
by an intensive rehabilitation programme. A multi-disciplinary team that 
includes both medical staff and counsellors from outside agencies delivers 
this programme. Participants who remain drug free during the seven-week 
period are then transferred to a designated drug free unit (the Training Unit). 
While workers from a therapeutic community are involved in service provision 
for this particular programme, there is no therapeutic community type 
programme available to drug users in the Irish prison system. A similar 
programme with more of a focus on factors associated with imminent release 
into the community is run over an eleven-week period. This is also based in 
Mountjoy Prison Dublin and will be discussed in the section on ‘Release’ 
below. 
 
Self-help groups 
Self-help groups within the Irish criminal justice system are based within the 
prison setting. The only structured self help group available to prisoners which 
specifically addresses the issue of drug use is Narcotics Anonymous (NA).  
 
HIV/Hepatitis prevention (needles and syringe exchange) 
Needle and syringe exchanges are not provided to drug users in the Irish 
prison system. Furthermore, there is no structured access to cleaning 
materials for injecting equipment. However, a recent report of the Group to 
Review the Structure and Organisation of Prison Health Care Services, 
established by the Minister for Justice, Equality and Law Reform (2001) has 
recommended that disinfectant tablets should be introduced into the Irish 
prison system “without further delay” (p.11) as a method of limiting the spread 
of communicable diseases- this continues to be problematic due to on-going 
objections of prison officers. The group did not go so far as to recommend the 
introduction of a syringe exchange programme in Irish prisons, arguing that 
“the risk of attacks on staff and prisoners with syringes supplied by the state 
would appear to be unacceptable” (p.46). 
 
As mentioned above the Probation and Welfare Service in Mountjoy prison 
Dublin have developed a Drug Awareness Programme which is also run to 
some extent in other prisons. This is a four-week programme consisting of 
one session per week. The principal aim is to educate participants about their 
drug use and the associated risks. It is aimed at all prisoners with a history of 
drug use, including those who have ceased their drug use and those who are 
continuing to use within the prison setting. Included in this programme is a 
session on HIV and Hepatitis. 
 
(b) Drug testing 
 
In the community, probation and welfare officers as a condition of an 
offender’s Supervision Order sometimes use drug testing (urinalysis).Routine 
randomised drug testing is only carried out within the prison system in the 
designated drug free area of the Training Unit in Mountjoy Prison. A drug free 
environment is ensured by the requirement for all prisoners, irrespective of 
whether they have a drug using history or not, to undergo random urinalysis. 
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Where a prisoner tests positive for a prohibited substance, he is moved either 
to another prison or another area of Mountjoy. Drug testing is also used to 
monitor those prisoners who are receiving methadone on a maintenance 
basis in the prison setting. 
 
(c) Release: referral to treatment, aftercare, probation 
 
In Ireland there is no formal referral scheme for drug using prisoners to 
treatment upon release. The need to develop a structured through-care 
programme from the prison system to the community has been identified 
within the Irish criminal justice system (Irish Prisons Service 2000). The 
Probation and Welfare Service of the Department of Justice, Equality and Law 
Reform carry out group work programmes in the prison setting. These aim to 
promote desired behavioural changes in terms of risk behaviour and drug 
addiction, and to help prisoners cope with imprisonment and to prepare them 
for life demands following release from prison.  
 
There are also a couple of specific projects underway which are targeted 
specifically at dealing with the issues surrounding release: 
 
As mentioned above, the Probation and Welfare Service of Mountjoy Prison 
run an eleven week drug rehabilitation programme that focuses on factors 
associated with imminent release into the community. The programme 
facilitates prisoners in developing a Community release Plan through contact 
with his probation and welfare officer. After the initial eleven week period 
prisoners are released subject to Temporary Release Rules. Prisoners then 
contact their probation and welfare officer and link in with therapeutic, 
education, training and employment contacts in the community. 
 
There is also a rehabilitation programme for ex-prisoners based in Cork 
(southern Ireland), that has as its aim the integration of ex-prisoners back into 
mainstream society and stop them re-offending. This is a collaborative project 
managed by a partnership of voluntary and statutory bodies, part funded by 
the Cork Drugs Task Force. Key roles in the development of the project have 
been played by: the Probation and Welfare Service of the Department of 
Justice, Equality and Law Reform, the Cork Prison’s Governor, the prison staff 
and the Education Department in the prison. The project serves prison 
inmates, ex-prisoners, those who are on probation and family members of 
prisoners. The project provides a counselling and referral service to clients 
referred by the Probation and Welfare Service. In addition the project provides 
a counselling service within the prison and an ‘Addiction Education and 
Awareness Programme’. Since it started, the project’s counsellor has had 
some form of contact with 181 people.  
 
The CONNECT project was established in Mountjoy under the European 
DESMOS project which is supported by the European Social Fund under the 
Integra Employment Initiative. The main objective of its work is ‘to encourage 
the (re) integration of offenders in society through employment as a support.’ 
Each country has developed its own national programme which has as its 
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base the guidelines on employment recommended by the Council of Europe, 
which have at its core four aims: 
 Improving employability 
 Developing entrepreneurship 
 Encouraging adaptability of businesses and their employees 
 Strengthening the policies of equal opportunities for women and men. 
 
In Mountjoy, the CONNECT project is an action-research project led by the 
Department of Justice Equality and Law Reform and run by the National 
Training and Development Institute. Initially the project carried out research to 
identify the education and training gaps in programme provision in Mountjoy 
Prison and the Training Unit. In response, the project has developed and 
implemented pilot strategies and systems to fill the gaps identified and 
improve the employability of offenders while in custody. Included in the pre-
vocational training is training in job seeking skills and work-related social 
skills. The process at the centre of the project is described as the ‘transition 
from custody, through training, on to reintegration in the community and more 
specifically, on to labour market participation’. Each course caters for up to 
fourteen male prisoners. 
 
(d) Statistics and evaluation results  
 
There has been little evaluation carried out of programmes aimed at drug 
users in the Irish criminal justice system. Crowley (1999) provided a medical 
review of the seven-week Drug Detoxification and Rehabilitation Programme 
in Mountjoy prison, Dublin. Up to February 1999, 187 prisoners had entered 
the programme, 173 completed the detox and 14 failed to complete the detox. 
While this implies a 93% success rate, Crowley (1999) highlights the need for 
the success of this intervention to be determined by the 6 and 12 month 
relapse figures. Overall it was found that there was a twelve monthly relapse 
rate of 78%. Crowley argues that while this may appear high, it compares 
favourably to outcome rates of other inpatient detoxification programmes.  
 
(e) Specific training 
 
There is little specific training of those working within the Irish criminal justice 
system in relation to drug use and the specific needs of drug users. 
 
As part of their training, members of the Irish police force (An Garda 
Siochana) receive instruction in the area of drug misuse. The programme 
includes training in: 
the enforcement of drug-related laws;  
the procedures for dealing with drug cases;  
health and safety issues. 
As part of its proposals for the staff development the Steering Group on 
Prison Based Drug Treatment Services (Irish Prisons Service 2000), it is 
proposed that a special Prisons Service Training Officer be appointed. It is 
proposed that this Assistant Training Officer would work in tandem with the 
Area Health Authority’s training department of the Drugs/AIDS services. The 
Officer would have responsibility for implementing a full training package for 
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all staff within the prison who are working with drug users. The proposed 
training would consist of two levels. The first level would cover general 
education, basic skills training and awareness training of drug problems for all 
prison staff in relevant institutions. The second level would be more specific 
training for a core group of staff who would be working directly with drug 
users, within prison treatment units. 
 
Interventions outside the prison system but remaining within the remit 
of the Criminal Justice System.  
 
Project Name:  Harristown House 
 
Target Group:  Male offenders with drug and alcohol problems 
 
Aims of project:  To serve as an alternative to prison for offenders with 
drug and alcohol problems that have been identified by 
the courts as people who would benefit from an 
intervention of this kind 
 
Activities of project: A self sufficient residential drug free unit offering a 
treatment programme that includes a blend of cognitive 
and behavioral therapy underpinned by the principles of 
the Minnesota Model of addiction treatment.  
 
Project Name:  Copping On: National Crime Awareness Initiative 
 
Target Group:  Early school leavers and young people ‘at risk’ 
 
Aims of Project:  To reduce the risk and incidence of offending behaviour 
among young people and to decrease harmful and 
damaging behaviour such as bullying, alcohol and drug 
misuse 
 
Activities of Project: Training for professionals who work with young people ‘at  
risk’ and training and instruction for young  ‘at risk’ 
 
Project Name: The Tower Programme 
 
Target Group: Young offenders aged 18-30 
 
Aims of Project: To serve as an alternative to custody for young offenders 
 who are deemed suitable to for inclusion on the project 
 
Activities of Project: A FAS sponsored vocational training programme plus 
evening classes for those waiting to join the full-time 
programme and sports and leisure activities are 
organised for participants on weekends. 
 
Project Name: The Garda Youth Diversion Project 
 
Target Group: Young people between 10-18 who are deemed ‘at risk’ of  
becoming involved in drug misuse and crime.  
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Aims of Project: To prevent crime and drug misuse among the target 
group 
through community and multi-agency cooperation and to 
improve the quality of life within a community.  
 
Activities of Project: Training and educational upgrading including literacy and 
numeracy, training in job skills, work experience and job 
placement.  
 
b) Drug Testing 
 
NO INFORMATION AVAILABLE 
 
c) Release: referral to treatment, aftercare, probation 
 
NO INFORMATION AVAILABLE 
 
d) Statistics and evaluation results 
 
Project Statistics Evaluation results 
Harristown House Since the inception of the project 
in November 1998, 102 young 
men have been placed on the 
project 
No information available 
Copping On: National 
Crime Awareness Initiative 
Over a 1,000 people have been 
trained to implement the 
programme.  
An evaluation by Bowden 
1998 recorded a positive 
reaction from trainers and 
participants.  
The Tower Programme No information available Evaluation in progress 
The Garda Youth 
Diversion Project 
No information available A recent evaluation revealed 
that the programme is 
beginning to have an impact 
on offending and anti-social 
behaviour among the target 
groups.  
 
e) Specific Training 
 
NO INFORMATION AVAILABLE 
 
9.6 Specific targets and settings 
 
a) Description of new trends and developments 
 
The National Advisory Committee on Drug (NACD) has tendered for research 
to be carried out with a number of marginalised groups. For instance, 
homeless drug users, drug users working in the sex industry and drug use 
among travellers. The nature of the research will predominantly be explorative 
in order to shed some light on ‘hidden’ aspects of social life. However, it is 
hoped that the research and the conclusions that is anticipated from the 
research will provide a background from where policy interventions in the 
areas outlined can be influenced.  
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b) Specific services and interventions (prevention, treatment 
programmes, etc.)  
 
The Renewal Project/ A Gender Specific Programme 
The Renewal Project was set up by Tabor Lodge in respose to a need for a 
residential supportive environment for women who are in the early stages of 
recovery from addiction. The project offers accommodation for 10 women 
aged 18 years and over. The project demands that entrants are free of alcohol 
and drugs for 72 hours prior to admission. The project offers a three-month 
programme based on the Hazledon model of total abstinence. Services 
provided include group therapy, one to one counselling and parenting skills 
and training in relapse prevention. Residents are encouraged to work outside 
on a part-time basis and some attend training courses and FAS schemes. At 
weekends residents return home when appropriate and those who remain at 
the project are encouraged develop their drug free lifestyle by socialising in 
social settings where the use of alcohol and drugs is minimal. The South 
Eastern Health Board primarily funds the project, and clients are encouraged 
to pay a small sum towards their keep. As well the Southern Corporation 
under section 10 give funding to cater for homeless recovering drug users. 
The centre caters for women only who are over 18 of age.  
 
The Lorien Project/ Targeting the Children of drug users 
The Lorien Project is a family support project that aims specifically to work 
with the families of drug using parents. The project also works with parents 
who are using drugs and in this context operates a holistic and integrated 
approach. The project is located in Tallaght, a large suburb of Dublin. So far 
the project has worked with over 63 families since it was established in 1997. 
On the basis of 2-3 per family it is estimated that the project has impacted on 
approximately 150 people (drug users, their children and siblings).  
 
Ethnic Minorities/The Traveller Specific Drugs Initiative 
Pavee Point received funding through the National Drug Strategy in 2000 to 
establish the Traveller Specific Drugs Initiative. Pavee Point is a national non-
governmental organisation, which is committed to the attainment of human 
rights for Irish Travellers. The organisation is a partnership of Travellers and 
settled people working together to address the needs of Travellers as a 
minority ethnic group who experience exclusion and marginalisation. From the 
outset, representatives from the Travelling community made clear that this 
initiative was not about the development of a separate segregated service for 
Travellers but rather about the promotion of Traveller inclusion in existing 
mainstream services and other services that are being developed. The 
Traveller Specific Drugs Initiative is run by a co-ordinator. To date the work of 
the co-ordinator within the initiative has concentrated on: 
 
• Developing and disseminating information to Travellers and Traveller 
organisations on a variety of issues specific to Travellers and drug use. 
This includes information on the Traveller Specific Initiative itself, The 
National Drugs Strategy, The Local Drugs Task Forces and basic 
information on drug misuse.  
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• Support to Traveller organisations in assisting them to explore the drugs 
issue within their area and examine responses that may be developed. 
• Raising the issues of Travellers and drug use and the distinct needs of the 
travelling community with the Local Drugs Task Forces. This work has 
centered on raising awareness of the issues of Travellers and drugs use 
and working with the structures to promote Traveller inclusion.  
• The need for more research into drug use and the traveller community has 
been a central concern of the initiative to date. In order to forward this aim 
the initiative has made contact with the National Drugs Strategy Team and 
the National Advisory Committee on Drugs regarding the funding and 
development of research into Travellers and drug use.  
 
To date there has been little research conducted into drug use in the travelling 
community. However, a recent exploratory study (Hurley 1999) has confirmed 
that: 
 
• There is a growing drug problem among the Traveller community 
throughout the country. 
• There are no specific services targeted to meet the needs of Travellers 
who misuse drugs.  
• Service providers identified the need to develop an outreach/targeted 
dimension to their work in order to facilitate Traveller access to and uptake 
of existing services.  
• Owing to on-going discrimination of Travellers in society, it is easier for 
Travellers to access cannabis and other illegal drugs than to gain access 
to a public house to purchase alcohol legally.  
 
Alternatives to prison and prosecution  
In Ireland, where drugs are involved in an offence, the police have no 
discretionary powers to issue a caution [informal or formal] nor to impose an on-
the-spot fine. Therefore, officially, charges will be brought against any individual 
found to have committed an offence against the Misuse of Drugs Act. An 
exception is made in the case of a juvenile offender [under 18 years old] found 
in possession of a small amount of drugs, where drug trafficking is not an issue. 
In such a case, the Juvenile Diversion Programme is brought to bear. The 
Garda Juvenile Diversion Programme was introduced in 1963 with the aim to 
divert juvenile offenders from criminal activity. The Programme allows that if 
certain criteria are met, a juvenile offender may be cautioned as an alternative to 
being prosecuted. The programme operates on the basis of the common law 
principle of police discretion (An Garda Siochana 1999). While this programme 
is specifically aimed at juvenile offenders committing first offences, it can be 
adapted/extended to include juveniles committing subsequent offences.  A 
juvenile offender who is eligible for inclusion in the programme is dealt with by 
way of a caution, as opposed to being prosecuted for a criminal offence. 
Cautions may be either formal or informal. A Juvenile Liaison Officer [JLO] 
becomes involved with the offender and the family.  While an informal caution 
may be given by the JLO, the Garda Superintendent of the district where the 
offender lives must give a formal caution. There is no provision for a similar 
system of cautioning for adults. 
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In terms of alternatives to prison there is a range of non-custodial options 
available to sentence those who plead guilty or are found guilty through the 
courts. The decision of the court in relation to the imposition of a custodial or 
non-custodial sentence may be influenced by a Pre-Sanction Report where 
available. This report is compiled by the Probation and Welfare Services and 
includes information on factors such as addiction that may have contributed to 
the individual’s offending. Pre-Sanction Reports are often not available, 
however a judge may request that one be provided. The non-custodial options 
available in the Irish criminal justice system were overviewed in a report on 
the Irish Probation and Welfare Services (Expert Group on The Probation and 
Welfare Services 1999) and include:  
• A suspended sentence* 
• Supervision during deferment of penalty*/ Intensive Supervised Probation: 
This facility was designed to increase restraints on offenders in the 
community. Offenders are required to report for frequent urine testing. The 
type and levels of demand placed on offenders differ enormously by 
jurisdiction.  
• A Community Service Order: Community Service Order requires offenders 
to perform unpaid work for between 40 and 240 hours. There is a 
perceived lack of suitability of community service for offenders with 
addictions (Expert Group on The Probation and Welfare Services 1999). 
This can be due to the Probation Service’s inability to provide occupational 
insurance in the event of an accident due to known disability in the 
offender i.e. addiction. 
• A fine: A fine has statutory limits, fixed for a particular offence. The money 
goes to Central Funds and if unpaid can be enforced by committal to 
prison. 
• A Compensation Order: A Compensation Order has a specific statutory 
format as laid out in the Criminal Justice Act, 1993 and is related to the 
wrong done. The money goes to the victim as opposed to Central Funds. 
• A fine and Compensation Order 
• Release under the Probation of Offenders Act, 1907: In this instance a 
decision is made not to proceed to convict 
• Probation Order (Probation of Offenders Act 1907): The purpose of a 
probation order is to secure the rehabilitation of the offender, to protect the 
public and to prevent the offender from committing further offences. This is 
used for drug users by imposing conditions. Conditions may include 
attendance for treatment and the provision of urine for analysis. This is the 
preferred procedure in the District Court when dealing with drug users. 
• Order of Recognisance (Misuse of Drugs Act 1977, Section 28 as 
amended by the Misuse of Drugs Act, 1984): This is an order requiring an 
offender to undergo treatment for his/her drug condition in a residential 
centre or in the community. 
 
The ‘Order of Recognisance’ would appear to be an important non-custodial 
option for drug users who offend in Ireland. However, in practice the courts do 
not generally use this order. The necessary rules and regulations have not 
                                                     
* Both these options have no statutory basis but are widely used by the Courts 
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been made. Furthermore, the provision of a statutory place of treatment has 
always been problematic. The Expert Group on the Probation and Welfare 
Services has recommended that the necessary Courts Rules and Regulations 
be updated by the various Court Rules Committees to facilitate wider use of 
the ‘Order of Recognisance’ (Expert Group on the Probation and Welfare 
Services 1999).  
 
A Drug Court was established in Ireland in January 2001 on a pilot basis in 
one area of Dublin City. The Court has as its primary aim “the reduction of 
crime through rehabilitation of the offender but not excluding punishment 
should the circumstances so warrant. The purpose of the proposed Drug 
Court is to provide a scheme for rehabilitation, under the auspices and control 
of the court, of persons who are convicted of, or who have pleaded guilty to, 
drugs offences, relating to possession for own use or for supply to others on a 
minor scale, and crimes triable in the District Court22 which are related to the 
drug misuse of the offender” (Drug Court Planning Committee 1999, p.15). In 
order to access the court the person must be seventeen years of age or older, 
and either have pleaded guilty or been convicted in the District Court of a drug 
or drug-related offence which would warrant a prison sentence. The offender 
must express a wish to be admitted to the Drug Court and at the 
recommendation of either the police, the Probation Service, a drug treatment 
professional or the defending solicitor the individual will be assessed as to 
their suitability for engagement in the Drug Court process (Drug Court 
Planning Committee 1999). To date 44 offenders have been referred to the 
Drug Court, of those 15 were deemed either to be unsuitable or their 
involvement was terminated due to non-compliance with the Court’s 
requirements- the remainder are currently ‘in front of the Court’ (personal 
communication, Drug Court Planning Committee). The pilot phase is being 
evaluated over its initial twelve-month period, with a focus on ‘success’ in 
terms of changes in offending behaviour; cost; and feasibility of expansion to 
cover the remaining areas of the city. The evaluation is due for completion in 
May 2002 (personal communication, Drug Court Planning Committee). 
 
c) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
d) Specific training 
 
NO INFORMATION AVAILABLE 
                                                     
22 “The jurisdiction of the District Court extends to offences which are triable summarily or indictable 
offences where the judge accepts jurisdiction to hear the case summarily after election by the accused 
or at the direction by the Director of Public prosecutions (DPP). The maximum sentence the District 
Court may impose on any one charge cannot exceed 12 months imprisonment and an overall total of 24 
months on a combination of more than one offence” (Drug Court Planning Committee 1999, p.13). 
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10. Quality Assurance 
 
10.1 Quality assurance procedures 
 
NO INFORMATION AVAILABLE 
 
a) Formal requirements for quality assurance 
 
NO INFORMATION AVAILABLE 
 
b)  Criteria and instruments applied in quality assurance 
 
Evaluation of Local Drug Task Force Funded Projects 
 
A recent evaluation of Local Drug Task Force Projects (Ruddle et al 2000) 23 
revealed that according to the perceptions of project managers, the 
emergence of local drug projects had contributed to improvements in the lives 
of participants and in the local community. In the main, project managers 
reported perceptions of positive outcomes emanating from the various 
projects. These observations were primarily due to the dedication and 
commitment shown by clients/participants towards the projects, plus the self-
development of clients/participants and the positive recognition of the project 
at community level.  
 
The overall aim of the evaluation was to examine the manner in which each 
project has managed to handle the first two stages of project development, 
i.e. the planning and implementation stages. This satisfies the criteria for 
process evaluation. At the time of evaluation approximately 220 projects had 
received funding. Of these 142 projects were covered for the evaluation, a 
profile breakdown of projects reveals that: 
 
• 51 % are educational/prevention projects 
• 36 % treatment/rehabilitation 
• 7 % combination of both of above 
• 3 % supply control 
• 3 % research and information 
 
The fieldwork was done over a three-month period by a panel of 13 
evaluators, primarily consisting of an in-depth interview with project 
managers. The evaluation served two main purposes, on the one hand it 
enable successful projects to be identified for “mainstream funding”. This 
meant that responsibility for funding such projects could be transferred on a 
permanent basis to the state agency from through which funding for the 
project was initially channeled. The evaluation revealed a number of key 
insights into the operation of projects under the Local Drug Task Forces, such 
as:  
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• The majority of project managers (82%) admit that pitfalls were 
experienced or narrowly avoided. Main pitfalls being a lack of suitable 
premises, community hostility and staffing issues.  
• The main factors identified as enabling project delivery include the 
commitment and qualities of the project staff and support and networking 
opportunities with other bodies.  
• Main factors identified in constraining project delivery include unsuitable 
premises, lack or loss of trained staff and funding issues.  
• Over two thirds of project managers 68% believed that the original 
objectives of their projects had been reached. This was based on their 
perceptions.  
• The key indicators which project managers use to assess achievement are 
the numbers of clients availing of or staying with the project. Or the client’s 
personal progress. Main method used to gather information on this is the 
client’s participation records.  
• Main factors identified in enabling attainment of projects include the quality 
and commitment of staff and support from other agencies and bodies.  
• Main factors identified in constraining attainment of objectives include lack 
or loss of staff and inadequate premises.  
 
10.2 Treatment and prevention evaluation 
 
a) Evaluation policy 
 
NO INFORMATION AVAILABLE 
 
b) Requirements for evaluation 
 
To date in Ireland the bulk of evaluation that has been carried out on 
interventions in the field of demand reduction has been process evaluations. 
These tended to concentrate on the planning and implementation stages of 
projects/initiatives. In preparation for the next stage of evaluation, the 
outcome and impact assessment, and a number of requirements have been 
outlined.24 For example, it is recommended that: 
 
• At project level, the project manager has the responsibility of ensuring that, 
from the outset, evaluation of outcomes and impact is built into the 
projects information systems and is taken into account when determining 
the funding and resources required 
• Support in the form of resources, funding, expertise, guidance and training 
must be provided to the projects by the National Drug Strategy Team and 
the Local Drug Task Forces 
• A means to explore ways of obtaining consumer feedback from the 
project’s clients be explored 
• The need for research into the many dimensions of local drug issues be 
explored to assist in the contextualisation of impact and outcome 
assessments from local projects 
                                                     
24 For further information see Evaluation of Local Drug Task Forces, Ruddle et al 2000 
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• And, that each Local Drug Task Force have a trained research worker 
dedicated to the research function 
 
c) Use of evaluation results 
 
Review of Eastern Health Board (EHB) Drugs and AIDS services 
 
A review of the EHB’s Drugs and AIDS services was conducted during 1999 
(Farrell et al. 2000)25. The review was designed to examine the service 
development over the 5 years since the last review was undertaken, to assess 
the current service provision and service mix and to make recommendations 
about policy development and the evolution of policies in the context of 
services and practices elsewhere. The report concluded that the EHB has 
achieved a major expansion in drug services over the last five years and has 
developed innovative services. A number of recommendations were made in 
the report. It was suggested that an audit of benzodiazepine use be 
conducted and that the current needle exchange facilities be expanded.  
 
Review of Current Alcohol and Drug Problem Service Provision in Kilkenny 
 
A review of the Current Alcohol and Drug Problem Service Provision in 
Kilkenny was conducted during 2001 (Farrell and Marsden 2001) 26 The 
review was designed to assess the current levels of service provision and to 
make recommendations about future development of service organisation and 
service delivery. The report concluded that the current service, which primarily 
operated from a single floor in an outpatient building of St. Luke’s Hospital in 
Kilkenny, gave the impression of being underfunded. There was a distinct lack 
of administrative support that meant the workload of counsellors 
overburdened. The overall level of activity over the previous three years was 
120 to 130 new cases per year. The report concludes that perhaps there is 
pockets of the community that would benefit from contact with the services. 
However, given the demands of the current workload on the service, the 
limited amount of counsellors and private rooms and the lack of administrative 
support, perhaps the wider community is unable to access treatment options. 
The authors make some key recommendations, which state that: 
 
• The development of an integrated community based service is the best 
way to harness new resources and develop and innovate on the basis of 
current funding opportunities.  
• Service delivery can be improved if people with alcohol and drug problems 
in the area can access services appropriate to their needs, that the service 
can deliver access to a range of primary, secondary and tertiary health 
                                                     
25 Farrell, M. Gerada, C. and Marsden, J. (2000) External Review of Drug Services for The Eastern 
Health Board. London; National Addiction Centre, Institute of Psychiatry, London.  
 
26 Farrell, M and Marsden, J. (2001) External Review of Current Alcohol and Drug Problem Service 
Provision in Kilkenny. Commissioned by the Drug Co-ordination Unit of the South Eastern Health 
Board.  
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and social care options and the delivery of care is based on a continuing 
assessment of presenting and evolving treatment and support need.  
• That a working group is established to oversee the development and 
implementation of enhanced arrangements for monitoring the delivery and 
impact of treatment.  
 
d) Evaluation training 
 
NO INFORMATION AVAILABLE 
 
10.3 Research 
 
a) Demand Reduction research projects: objectives, structure and 
organisation 
 
A National Advisory Committee on Drugs (NACD) comprising of experts from 
the research, voluntary, community and statutory sectors was established in 
1999 to co-ordinate and commission research on drug problems in Ireland. 
The primary objective of the NACD is to advise the Government, in relation to 
the prevalence, prevention, treatment and consequences of problem drug use 
in Ireland. The Committee has set out a detailed three-year plan of research, 
which includes an examination of the areas of prevention, treatment and 
rehabilitation. These are three key areas in the field of demand reduction and 
it is anticipated that a valuable insight into the strengths, weaknesses and 
gaps in these areas will materialise upon completion of this research 
programme. In particular the programme will endeavour to do the following:  
 
Prevention 
• To examine the effectiveness in terms of impact and outcomes of existing 
prevention models and programmes, with particular regard to evaluation 
instruments developed at European level 
• To undertake comparative studies of different models with particular 
reference to those in operation in task force areas 
 
Treatment/Rehabilitation 
• To examine the effectiveness in terms of impact and outcomes of existing 
treatment and rehabilitation models and programmes 
• To undertake longitudinal studies of the effectiveness of existing treatment 
and rehabilitation models 
• To examine the context in which relapse occurs 
• To examine the impact of the treatment setting 
 
b) Relations between research and drug services 
 
The following are some examples of relatively recent research that has been 
carried out with individuals attending drug treatment services in Dublin.  
 
A document outlining a blueprint for rehabilitation services for opiate addicts in 
the Eastern Health Board area (Dorman et al 1999) drew on the findings of a 
research project commissioned by the Drug Rehabilitation Committee of the 
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Eastern Health Board. The research was carried out in order to facilitate the 
informed planning of rehabilitation services in the future. The research was 
qualitative in design and looked at three distinct perspectives, those of the 
clients, the staff in drugs services in the health board areas and the local 
community. 94 opiate addicts, attending rehabilitation services funded and/or 
operated by the Eastern Health Board were interviewed. Focus groups were 
held for staff and for those representing the community. The report made the 
following recommendations. Rehabilitation should be; comprehensive, client 
centred, delivered through an integrated multi-disciplinary service and offering 
a range of responses. In addition, it should be well resourced with fast access 
and every opportunity given for addicts to contribute to the design and 
delivery of programmes.  
 
Smith et al (1999) claimed that while there was evidence of a reduction in the 
rates of unsafe injecting practices among opiate users while injecting, there 
had not been much published evidence to show that harm reduction 
programmes helped to reduce the occurrence of the hepatitis C virus. The 
study aimed to explore whether or not, among intravenous drug users with 
short injecting histories, the prevalence of hepatitis C was lower in those who 
started injecting after an expansion in harm reduction services in Dublin. The 
study was set in Trinity Court addiction treatment centre.  
 
In the context of the relatively high prevalence rate of hepatitis C among 
injecting drug users (IDUs), (Smyth et al, 1999) sough to explore and assess 
the understanding of hepatitis C among IDUs attending an addiction clinic. In 
total 105 IDUs were interviewed. It was found that respondents were better at 
identifying activities that carried a risk of hepatitis C transmission than at 
identifying activities that posed no threat. Understanding of the long-term 
nature of hepatitis C was found to be poor, and respondents in recent contact 
with a GP performed less well than those without contact. The authors 
concluded that understanding of hepatitis C among IDUs in contact with 
health professionals was poor and in need of major improvements.  
 
c) Funding of demand reduction research 
 
The bulk of funding being provided for research in this field comes from the 
Department of Tourism, Sport and Recreation the Department of Health and 
Children, the National Advisory Committee on Drugs, the National Drug 
Strategy Team through the Local Drugs Task Forces and the regional health 
boards. Representatives from the community sector who identify a gap in 
research can also apply for funding through the Local Drugs Task Forces. 
While a limited amount of research is carried out in the voluntary sector and is 
usually funded by a mixture of statutory and private subsidies.  
 
d) Training in demand reduction research 
 
Trinity College, Dublin, incorporates a research component into both the 
Diploma in Addiction Studies and the M.Sc. in Drug and Alcohol Policy.  
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10.4 Training for professionals 
 
a) Training in quality assurance and evaluation: type and structures 
 
NO INFORMATION AVAILABLE 
 
b) University training, Non-University Vocational training, in-service 
training 
 
UNIVERSITY TRAINING NON-UNIVERSITY TRAINING IN-SERVICE TRAINING 
Diploma In Addiction 
Studies 
Alcohol and Drug Abuse Awareness Teen Community Addiction 
Studies Course 
M.Sc in Drug and Alcohol 
Policy 
Drugs and Addiction Peer Support Training 
Programme 
National Diploma/Degree 
in Community Drug 
Prevention Studies 
 
Peer Education Drug Awareness 
Programme 
Probation and Welfare 
Service Training 
 Peer Leadership Training Garda Training 
 Substance Abuse Prevention 
Programme 
Drug Education and 
Awareness for Pharmacists 
 Social, Personal and Health 
Education 
Substance Abuse Training 
Course 
 Training for Community Drug 
Workers 
Certificate in Drug 
Counselling and Intervention 
Skills 
 Certificate Course in Community 
Leadership and Substance Misuse 
Awareness 
Drug Response and the 
Traveller Community 
 Community Addiction Studies 
Course 
Learning Together, Working 
Together 
 Drug Information and Community 
Education (DICE) 
Drug Awareness for 
Voluntary Leaders 
 Further Training in Community Drug 
Work 
Drug Questions, Local 
Answers 
 Leadership Training for Prevention 
of Drug Problems 
Foundation Level Training in 
Drugs and Addiction 
Education 
 Parenting for Prevention Working with clients: 
Motivational Interviewing and 
Brief Counselling Skills 
 Certificate in Addiction Studies  
 Addiction Studies Certificate  
 Social and Health Education 
Facilitation Training 
 
 
c) Statistics and evaluation results 
 
NO INFORMATION AVAILABLE 
 
Conclusion:  
 
Plans for the future development of the demand reduction field in Irish drug 
policy is embedded in the National Drugs Strategy 2001-2008. In particular, 
the fields of prevention, treatment and rehabilitation are well covered in this 
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regard. However, there are a number of issues across the three areas that 
warrant special attention. The strategy recognises the tackling of povery, poor 
housing conditions and inadequate educational opportunities all have a role to 
play in the prevention and management of drug misuse and drug related 
harm. The point can also be made that prevention strategies like school 
based drug programmes need to take account of the probability that those 
most ‘at risk’ may not be benefitting from the provision of mainstream drug 
education programmes. For instance, the school prevention programmes may 
be missing early school leavers, while the content and delivery of drug 
programmes in schools may be to difficult for some children with learning 
difficulties to understand. 
 
In terms of treatment, the strategy aims to increase the number of treatment 
places to a minimum of 6,500 by the end of 2002. A noble aspiration one 
might say, however, an issue that needs constant attention is the use of 
prescription drugs by those in treatment, primarily benzodiazepines. The 
efficacy of the treatment process runs the risk of being seriously undermined 
both in medicinal and cultural terms. In particular, the cultural element 
requires attention as if local community members witness people in treatment 
being ‘stoned’ on a regular basis, this can have implications for the status of 
treatment among the community.  
 
Finally, perhaps the biggest challenge facing the drug strategy and the key 
players in the drug field is the area of rehabilitation. The development of 
effective models of rehabilitation is crucial to the future of the drug strategy 
and the overall Irish drug policy in general. Programmes delivering personal 
development, training and educational services for former drug uses need to 
be developed around the needs of individuals. These programmes need to 
combine preparation for mainstream activities like the job market, while 
recognising the special needs of recovering drug users.  
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PART 4 
 
KEY ISSUES 
 
11. Polydrug Use: Drug Set and Setting – Martin Keane 
 
Despite an increased research focus on drug misuse related issues in Ireland 
over recent years, an area that has received little attention has been that of 
polydrug use. However, a review of the literature on drug misuse in Ireland 
has revealed ‘pockets’ of evidence indicating some levels of polydrug use 
among individuals engaging in drug misuse. In the majority of these studies 
which will be referred to throughout this chapter, polydrug use is reported as a 
part of the drug-using career of individuals with little focus on the nature, 
effects, extent or rationale behind the polydrug using behaviour.  
 
The purpose of this chapter is to explore the issue of polydrug use in an Irish 
context by looking at different combinations of drugs used and effects sought, 
historical and new patterns of polydrug use, user groups, and the health and 
social consequences of polydrug use. Differences in routes of administration, 
gender, age, rural/urban and sexual orientation among polydrug users will be 
discussed.   
 
There different approaches were taken to examine the issue of polydrug use 
in Ireland, namely: 
 
• A comprehensive search of the Irish literature on drug use and misuse; 
 
• An analysis on data collected by the National Drug Treatment Reporting 
System (NDTRS) for 1999 (last year of complete national data); 
 
• A survey of small convenient sample of ‘confirmed’ polydrug users using a 
self-completed questionnaire. This data was collected at three separate 
locations in Dublin using a self-completed questionnaire. Two of the 
locations were Health Promotion Clinics, the other a Post-Release Centre 
for ex-prisoners. Individuals were asked to respond to a filter question, 
which inquired “Have you ever used two or more of the following drugs 
during the same 24-hour period”. A list of 14 different drugs and a 
separate category for ‘other drugs’ were presented. In the event of 
responding in the affirmative, individuals were asked to complete the 
remainder of the questionnaire. In total 41 respondents completed the 
questionnaire, 3 additional questionnaires that were partially completed 
were dismissed. This study will be referred to throughout the remainder of 
this chapter as the “exploratory survey on polydrug use”.  
 
Defining polydrug use 
Polydrug use can prove an elusive term to define. Broadly speaking, the 
phenomenon of polydrug use primarily involves the use of different 
substances and different combinations at different times (Keup 1990, 
Bergmark 1998).  Some of the issues that render polydrug use a difficult term 
to define are deciding on whether to include the use of legal and prescribed 
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drugs in addition to the use of illicit drugs. Also deciding on the timeframe 
within which polydrug use can be examined. For instance, is it the use of a 
number of drugs (usually two or more) during an individual users lifetime, or 
within the last year/month/week? An additional point to consider is deciding on 
whether to look at how often does the usage of a number of drugs occur, is it 
daily/weekly/monthly? Also do users take particular combinations of drugs in 
order to achieve specific effects?   
 
For the purpose of preparing this chapter a number of different definitions of 
polydrug use were employed in the process of data collection and data 
analysis. A literature search of material on aspects of drug misuse in an Irish 
context revealed that most of the studies that touched on polydrug use 
referred to it in broad terms. For instance, in the majority of studies where 
polydrug use was indicated, respondents reported the ‘use of two or more 
drugs during their lifetime’. The second source of data referred to in this 
chapter comes from the National Drug Treatment Reporting System 
(NDTRS), specifically the year 1999. In this instance, polydrug use is defined 
as the ‘use of two or more drugs on a daily basis in the month prior to 
treatment’. Finally, the exploratory survey on polydrug use utilised the 
definition of polydrug use as the ‘use of two or more drugs during the same 
twenty-four hour period’.  
 
11.1 Patterns and Users Groups 
 
a) Combinations and effects sought 
 
In recent times in Ireland an emerging tendency has been noted for drug 
users to combine ecstasy and heroin (Table 11.1a). In most cases the 
indications are that individuals aimed for a desired effect in using this 
combination. It appears that smoking heroin or ‘chasing the dragon’ as it’s 
often referred to is seen as effective in helping to ‘come down’ from the high 
of ecstasy (Gervin et al. 1998). What is not made clear is why individuals 
required the intervention of another drug in ‘coming down’ from ecstasy. For 
instance, does this mean that individuals are smoking heroin to conceal the 
high of ecstasy from parents, or is heroin smoked to alleviate the short term 
‘negative effects’ that withdrawing from ecstasy is reported to bring on (Bissett 
1997).  The studies referred to (Table 11.1a) looked at ecstasy use over 
lifetime usage of drugs by individuals, but the studies do not reveal the 
number of times that individuals may have used this combination of heroin 
and ecstasy. The limitations of this lifetime usage definition are discussed in 
(Section 11.5). However if individuals report to using to counteract the effects 
of ecstasy then it can be inferred that this form of usage is more likely to take 
place within the same 24-hour period, thereby indicating a more intense form 
of polydrug use.  
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Table 11.1a: The combination of heroin and ecstasy among some drug using 
individuals in Ireland 
Author Sample source Data 
collection 
Definition of  
Polydrug use 
Combinations and 
effects sought 
Gervin et al 
(1998) 
Treatment 
Centre 
(n=46) 
Interviews Lifetime usage Almost 50% reported  
smoking heroin to 
“come down” off 
ecstasy 
Dorman and 
Jones (1999)  
Treatment 
Centre 
(n=94) 
Interviews Lifetime usage 
 
 
 
Smoking heroin to 
counter ecstasy use 
 
 
Crowley 
(1999) 
Prison Detox 
Programme 
(n=187) 
Self 
Completed 
Questionnaire 
Lifetime usage 100 heroin 
60% ecstasy 
(effects sought not 
known 
 
Another combination of drugs that has been picked up by some studies is the 
link between heroin and benzodiazepines and in some cases the use of 
methadone (Table 11.1b). The word ‘combination’ is being used loosely here 
as it must be noted that it is not clear from the studies referred to (Table 
11.1b) whether the use of these drugs were combined during the same 24 
hour period. Neither is it clear what effect individuals were seeking to induce 
by using these types of drugs.  It could be argued that the combining of heroin 
and benzodiazepines has implications for the efficacy or otherwise of opiate 
treatment programmes. Clearly, if individuals opiate use is being addressed 
while their co-existing benzodiazepine use is being neglected then there is 
potential for the undermining of drug specific treatment programmes such as 
methadone maintenance and methadone substitution.  
 
Table 11.1b: The combination of heroin and benzodiazepines among some drug using 
individuals in Ireland 
Author Sample Source Data Collection Definition of 
polydrug use 
Combinations and 
effects sought 
Rooney et al 
(1998) 
Treatment 
Centre (n=63) 
Interviews and 
urine/analysis 
Lifetime usage Over two thirds of 
sample tested positive 
for opiate and 
benzodiazepine use 
(effects sought not 
known) 
Hutchinson 
et al (1995) 
A&E 
Departments 
(n=141) 
Self completed 
questionnaire 
Lifetime usage Reported use of 
opiates, prescribed 
methaone and 
benzodiazepines 
(effects sought not 
known) 
Browne et al 
(1997) 
Treatment 
Centre (n=107) 
Urine/analysis Drug use in 30 
day prior to 
test 
45% tested positive for 
using benzodiazepins 
while using methadone 
(effects sought not 
known) 
Farrell 
(2000) 
Treatment 
Centres 
Urine/analysis Drug use in 30 
days prior to 
test 
65% tested positive for 
benzodiazepine use 
while taking methadone 
(effects sought not 
known) 
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Polydrug use among those treated for problem drug use was examined using 
data from the National Drug Treatment Reporting System (NTRS) for the year 
1999 (last year of complete national data).  A total of 6443 treatment contacts 
were made in 1999 of which 956 (14.8%) reported using two or more drugs, 
on a daily basis, in the month prior to treatment. Where polydrug use was 
reported on a daily basis by all treatment contacts 740 (77.4%) reported 
taking two drugs only, 188 (19.7%) reported taking three drugs only, and 28 
(2.9%) reported taking four drugs only. No information was available on a fifth 
(or subsequent) drug. 
 
Where two drugs only were reported as being used on a daily basis Heroin 
and Cannabis, and Heroin and Benzodiazepines were the most common 
combinations, accounting for 45 per cent of all two drug combinations (Table 
11.1c). A daily Methadone and Benzodiazepine combination was used by a 
further 15 per cent. 
 
Table 11.1c. The combinations of drugs used by all treatment contacts reporting daily 
use of two drugs only in the month prior to treatment  
Drug Combination (2 drugs only) N   (%) 
Heroin + Cannabis 174 (23.5) 
Heroin + Benzodiazepines 159 (21.5) 
Methadone + Benzodiazepines 108 (14.6) 
Heroin + Methadone 85 (11.5) 
Heroin + Cocaine 34   (4.6) 
Other Combinations 180 (24.3) 
Total 740 (100) 
Source. National Drug Treatment Reporting System (NDTRS), Drug Misuse Research Division, Health Research 
Board. 
 
Where three drugs only were reported as being used on a daily basis Heroin, 
Methadone and Benzodiazepines was the most common combination, 
accounting for over 31 per cent of all three drug combinations (Table 11.1d).  
A daily Heroin, Benzodiazepine and Cannabis combination was used by a 
further 16.5 per cent. 
 
Table 11.1d. The combinations of drugs used by all treatment contacts reporting daily 
use of three drugs only in the month prior to treatment 
Drug Combination (3 drugs only) N  (%) 
Heroin + Methadone + Benzodiazepines 59 (31.4) 
Heroin + Benzodiazepines + Cannabis 31 (16.5) 
Heroin + Methadone + Cannabis 13   (6.9) 
Methadone + Benzodiazepines + Cocaine 9   (4.8) 
Methadone + Benzodiazepines + Cannabis 6   (3.2) 
Other Combinations 70 (37.2) 
Total 188 (100) 
Source. National Drug Treatment Reporting System (NDTRS), Drug Misuse Research Division, Health Research 
Board. 
 
Where four drugs only were being taken on a daily basis the most common 
combination of drugs used was Heroin, Methadone, Benzodiazepine and 
Cannabis. A total of 7 (25.0%) of the 28 treatment contacts reported taking 
this combination of drugs. 
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A total of 1852 first treatment contacts (i.e. clients who had never been 
previously treated for drug misuse) were made in 1999 of which 207 (11.2%) 
reported using two or more drugs, on a daily basis, in the month prior to 
treatment. Where polydrug use was reported on a daily basis by first 
treatment contacts 168 (81.2%) reported taking two drugs only, 33 (15.9%) 
reported taking three drugs only, and 6 (2.9%) reported taking four drugs only. 
No information was available on a fifth (or subsequent) drug. 
 
Where two drugs only were reported as being used on a daily basis Heroin 
and Cannabis was the commonest combination, accounting for 34 per cent of 
all two drug combinations (Table 11.1e). A daily Heroin and Benzodiazepine 
combination was used by a further 21 per cent.  
 
Table 11.1e. The combinations of drugs used by first treatment contacts reporting daily 
use of two drugs only in the month prior to treatment  
Drug Combination (2 drugs only) N  (%) 
Heroin + Cannabis 57 (33.9) 
Heroin + Benzodiazepines 35 (20.8) 
Heroin + Methadone 16   (9.5) 
Cannabis + Alcohol 10   (6.0) 
Cannabis + MDMA 7   (4.2) 
Other Combinations 43 (25.6) 
Total 168 (100) 
Source. National Drug Treatment Reporting System (NDTRS), Drug Misuse Research Division, Health Research 
Board. 
 
Where three drugs only were reported as being used on a daily basis Heroin, 
Methadone and Benzodiazepines was the commonest combination 
accounting for 15 per cent of all threedrug combinations (Table 11.1f). A daily 
Heroin, Benzodiazepine and Cannabis combination was used by a further 12 
per cent.  
 
Table 11.1f. The combinations of drugs used by first treatment contacts reporting daily 
use of three drugs only in the month prior to treatment  
Drug Combination (3 drugs only) N  (%) 
Heroin + Methadone + Benzodiazepines 5 (15.2) 
Heroin + Benzodiazepines + Cannabis 4 (12.1) 
Heroin + Benzodiazepines + Benzodiazepines 2   (6.9) 
Heroin + Methadone + Cannabis 2   (6.1) 
MDMA + Cannabis + Alcohol 2   (6.1) 
Other Combinations 18 (54.5) 
Total 33 (100) 
Source. National Drug Treatment Reporting System (NDTRS), Drug Misuse Research Division, Health Research 
Board. 
 
In the six cases where first treatment contacts reporting taking four drugs only 
on a daily basis during the month prior to treatment no discernible pattern or 
drug combinations could be established. 
 
Findings from the exploratory survey on polydrug use show that 41 individuals 
reported to engaging in polydrug use where this meant using two or more 
drugs during the same 24-hour period. In terms of looking at the combinations 
used and effects sought on the FIRST occasion individuals used two or more 
drugs in the same 24-hour period, the following emerged from the survey. 
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Alcohol and cannabis was the most likely combination to be used, and was 
reported by 36.5% of respondents.  
 
The survey utilised two open-ended qualitatively focused questions in order to 
ascertain why people engaged in polydrug use on the FIRST occasion and 
what effects they were seeking on this occasion. The following is a breakdown 
of the findings: 
 
• Around 25% of the sample indicated that their desired effect was to forget 
their worries.  
• Around 20% reported that they first engaged in polydrug use in order to 
intensify their high and get “really out of it”.  
• Most of the remainder submitted mixed responses primarily indicating that 
they wanted to “feel good” and that the drugs were available and they 
used they opportunity to experiment. 
• Around 60% of respondents indicated that “peer pressure” played some 
part in their first engagement with polydrug use.  
 
The open-ended questions that elicited these responses were part of a self-
completed questionnaire and therefore it was not feasible for the researcher 
to explore the meanings of terms such as “really out of it” and “peer pressure”.  
 
b)   Patterns and user groups: historical perspective and new patterns 
 
 A review of the literature on drug related activities in Ireland shows that as far 
back as 1983, when the first prevalence study of opiate use in Ireland was 
carried out (Bradshaw 1983) polydrug use was evident in the drug using 
activities being reported by individuals engaged in drug misuse. Table 11.1g 
shows that polydrug use, utilising different definitions, can be detected in a 
range of studies on drug related issues in Ireland throughout the 1980s and 
1990s. When lifetime usage is referred to, this means the use of more than 
one drug during the lifetime of an individual, however it cannot be inferred 
from this that more than one drug was used at the same time during lifetime 
usage. It must be noted that there is no evidence on patterns of polydrug use 
available through the literature.  
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Table 11.1g: Some instances of polydrug use among drug using individuals in Ireland 
in the 1980s and 1990s  
Author Sample 
Source 
Data 
Collection 
Definition of 
polydrug 
use 
Evidence of polydrug use 
Carr et al 
(1980) 
Treatment 
Centre 
(n=100) 
Interviews Use of 2 or 
more drugs in 
past month 
excluding 
opiates 
25% reported polydrug use 
in previous month 
Bradshaw 
(1983) 
Opiate Users 
in the 
community 
(n=82) 
Interviews Lifetime 
Usage 
Almost 75% use heroin + 
other drugs 
Dean et al 
(1984)  
Opiate Users 
in the 
community 
(n=36) 
Interviews Drug usage 
in 12 months 
prior to 
interview 
92% using heroin and 
cannabis + other drugs 
Lavelle 
(1985) 
Opiate Users 
in the 
community  
(n=74) 
Interviews Lifetime 
Usage 
Almost third using heroin 
and other drugs 
McCarthy 
et al 
(1997)  
Opiate Users 
in the 
community 
(n=26) 
Interviews Lifetime 
Usage 
32% report daily use of 
heroin and physeptone 
Keogh 
(1997) 
Garda 
Records 
(n=352) 
Garda 
Interviews 
Lifetime 
Usage 
96% report heroin use, of 
this group 35% report use of 
methadone, 33% cannabis, 
20% ecstasy and 13% 
cocaine 
O’Mahony 
(1997) 
Men’s Prison 
(n=108) 
Interviews Lifetime 
Usage 
76% report usage of drugs 
other than cannabis and 
heroin 
Cassin et 
al 
(1998) 
Health 
Promotion 
Unit 
(n=770) 
Self Report 
Questionnaire 
Drug Use in 
previous 
month 
67.4% under 25s and 63.5% 
over 25s reported polydrug 
use in previous month 
Coveney et 
al 
(1999) 
Treatment 
Centre 
(n=16) 
Interviews Lifetime 
Usage 
40% reported using nine 
drugs, 35% reported use of 
five drugs 
Crowley 
(1999) 
Prison 
Detoxification 
Programme 
(n=187) 
Self Report 
Questionnaire 
Lifetime 
Usage 
100% heroin 
98% cannabis 
90% benzodiazepines 
85% cocaine 
60% ecstasy 
Centre of 
Health 
Promotion 
(2000) 
Irish Prisons 
(n=777)  
Self Report 
Questionnaire 
Drug Use in 
previous 3 
months = 
 
Drug Use in 
previous 12 
months 
63% male and 83% female 
report using other drugs in 
addition to cannabis 
 
In addition to heroin, 47% 
male and 52% female used 
amphetamines. Usage of 
cocaine and LSD also 
reported 
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Gender and rural/urban differences 
 
Gender and rural/urban differences in polydrug use among those treated for 
problem drug use were examined using data from the National Drug 
Treatment Reporting System (NTRS) for the year 1999 (last year of complete 
national data).  A total of 6443 treatment contacts were made in 1999 of which 
956 (14.8%) reported using two or more drugs, on a daily basis, in the month 
prior to treatment.  Of these the majority were male (67.5%) and living in 
urban areas (88.0%). A total of 1852 first treatment contacts (i.e. clients who 
had never been previously treated for drug misuse) were made in 1999 of 
which 207 (11.2%) reported using two or more drugs, on a daily basis, in the 
month prior to treatment.  Of these the majority were again male (76.6%) and 
living in urban areas (79.4%). 
 
11.2 Health and Social Consequences 
 
A review of the files of drug and alcohol related deaths investigated by the 
Dublin City coroner for the year 1998 reveals that 520 inquests were held in 
1998, 108 or 20.76% were identified as having drugs or alcohol implicated in 
the death.27 The majority was male and under 44. (Byrne 1999)  
 
Of the 108, 28 cases, which were deemed to be primarily alcohol related, 
were eliminated plus a further 10 that were deemed to be suicides or possible 
suicides. This left a cohort of 70 that were deemed to be primarily drug related 
deaths and this revealed that only 7 of these deaths had a singular drug 
implicated in their death. One person tested positive for five separate drugs, 
13 were positive for four, 25 were positive for three, and 24 people for two. 
Benzodiazpines were implicated in 69% of cases, methadone in 53%, heroin 
in 51.4% of cases and alcohol in 42.8%.  
 
Between 1st January 1998 and the 31st of December 2000 the Dublin City and 
County Coroners conducted 2063 inquests into deaths due to unnatural 
causes within their jurisdictions. A recent study by (Byrne 2000) examined 
these files and identified 254 (12.3%) as being related to the use of opiates. 
These were extracted for the purpose of conducting further analysis. The 
research shows that a singular drug was implicated in only 6.7% of drug 
related deaths.  
                                                     
27 A drug is deemed implicated when it has proven positive at toxicology or when evidence was 
presented that the drug had been consumed prior to death. This is not to infer that the drug is the cause 
of death, although it may have been. However, it may imply that the drug/drugs was a contributory 
factor in the death.  
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Table 11.2: Number of drugs implicated in deaths due to unnatural causes. Frequency 
and Percentages 
Number of Drugs Frequency Percentage % 
0 5 2.0 
1 17 6.7 
2 53 20.9 
3 70 27.6 
4 60 23.6 
5 36 14.2 
6 9 3.5 
7 3 1.2 
10 1 0.4 
Total 254 100 
(Source: Byrne, 2000)  
 
Benzodiazepines were implicated in the highest number of fatalities 70.5%, 
with Diazepam the drug most cited (68%) in this regard. Heroin was 
implicated in 61.8% of fatalities and methadone was implicated in 56.7% of 
fatalities. There were six ecstasy-related deaths during the three-year period.  
 
Note: A drug is deemed implicated when it has been proven positive at 
toxicology or when evidence was presented that the drug had been consumed 
prior to death. This is not to infer that the drug is the cause of death, although 
it may have been. It may imply that the drug/drugs was a contributory factor in 
the death.  
 
11.3 Risk assessment and local market 
 
a) Products and physical description 
 
NO INFORMATION AVAILABLE 
 
b) Combination of different substances on the local market 
 
 NO INFORMATION AVAILABLE 
 
 
11.4 Specific approaches to the intervention 
 
a) Approaches to polydrug use  
 
NO INFORMATION AVAILABLE 
 
b) Evaluation results 
 
NO INFORMATION AVAILABLE 
 
11.5 Methodological issues 
 
a) Limitations in data availability 
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The data referred to in this chapter comes from three main sources, a 
literature search, an exploratory survey on polydrug use and an analysis of 
the data collected by the National Drug Treatment Reporting System. All three 
sources contain their limitations regarding the exploration of polydrug use. For 
instance, the literature search of Irish drug related literature revealed a gap in 
research on the issue of polydrug use. In essence this meant that the 
phenomenon of polydrug use had not been investigated in an Irish context. 
However, some studies picked up ‘pockets’ of polydrug use among drug using 
individuals. In most cases polydrug use in these studies referred to lifetime 
usage of two or more different drugs. It could be argued that this definition has 
severe limitations for describing or explaining polydrug use as there is often 
little indication of the time gap between the use of one drug and another and 
how often these drugs are consumed.  
 
The main limitations of the exploratory study were a) it was confined to a 
small sample (n=41) and by virtue of this its findings cannot be attributed to 
any individual or group outside the sample. And b) the definition employed 
was the use of two or more drugs during the same 24-hour period, and this 
failed to capture whether drugs were combined concurrently or whether there 
was a time gap and if so how long and for what reasons?  
 
In terms of the National Drug Treatment Reporting System (NDTRS) the main 
limitation in this data is that it is confined to people who report for treatment. 
Therefore, it’s not often useful to attribute findings to the wider population. The 
NDTRS data does reveal some useful information on polydrug use among 
individuals reporting for treatment, it may be the case that this is merely a 
snapshot of the real extent of polydrug use among drug using individuals in 
Ireland.  
 
b) Future needs/ Methodological proposal 
 
Exploration of the polydrug using habits, social settings, influences and 
aspirations of recreational/problematic polydrug using groups 
 
It would appear from the data available that at least two different categories of 
polydrug users are to the fore in an Irish context. These can be broadly 
referred to as ‘recreational polydrug users’ and ‘problematic polydrug users’, 
however, it must be noted that these categories are not always clearly 
demarcated in terms of their use and often there are overlaps between the 
different drugs used. For instance, some of the issues that confound the 
definitional boundaries are, heroin use, which is primarily referred to in 
‘problematic’ terms, can be said to have crossed the boundary into 
‘recreational’ use when combined with ecstasy. In addition, is it feasible to 
refer to drug users in treatment as ‘problematic’ given that their drug use is 
being treated?  
 
It could be argued that a key distinguishing feature dividing both categories is 
the use of heroin by intravenous injecting by ‘problematic polydrug users’. 
There does not appear to be any evidence to suggest that ‘recreational 
polydrug users’ engage in injecting behaviour. What seems to be the case in 
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an Irish context is that ‘recreational polydrug users’ in the main tend to reject 
the use of heroin by intravenous injecting. For example, individuals attending 
the Gay Men’s Health Clinic whom were surveyed as part of the exploratory 
survey on polydrug use, all identified themselves as ‘recreational polydrug 
users’ and all expressed a clear anti-heroin mentality. This mentality appeared 
to be part of their individual belief system and also part of their social settings 
in pubs, clubs and house parties. Nevertheless, there are some ‘recreational 
polydrug users’ who may smoke heroin as part of their ecstasy use 
(O’Gorman 1998, Gervin, et.al 1998, Dorman and Jones 1999).  
 
It would be useful to carry out further exploratory research into the some of 
the comparisons and contrasts between problematic and recreational 
polydrug users. Such research could go a long way to profiling both sets of 
polydrug users in a more refined definitional sense. In addition, some key 
questions that need to be addressed are; 
 
• Why do recreational polydrug users in the main reject heroin use by 
intravenous injection and why do problematic polydrug users embrace this 
method 
• What regulations govern the social settings of both groups when it come to 
polydrug use and what is the social origins of these regulations 
• What are the primary expectations underpinning each groups polydrug 
use, for example, do recreational polydrug users aspire to liberation and 
sexual freedom and do problematic polydrug users seek to enhance their 
coping mechanisms by the use of narcotics 
• What are the socio-economic aspirations of each group and to what extent 
does their polydrug use and the culture surrounding same manage to 
satisfy or defer these aspirations 
• What are the economic incentives for both groups to engage in different 
forms of polydrug use 
 
Knowledge of the Health risks of polydrug use among 
recreational/problematic groups 
 
There can also be a misconception that recreational polydrug users are better 
equipped to handle their drug use. For example, there may be a perception 
that the ‘recreational’ category is more responsible and better informed and 
aware of the risks involved in their polydrug use. Whereas, those in the 
‘problematic category’ can be viewed as ignorant, irresponsible and requiring 
more intense intervention. However, when it comes to polydrug use so little is 
known about the health risks and psychological effects of combining different 
drugs that it is implausible to suggest that one group has a monopoly on 
information.  
 
In this regard it would be useful to carry out a comparative study between 
both groups to ascertain the level of awareness and information on the effects 
and health of engaging in polydrug use. To put this research gap in 
perspective a comparison of two recent studies into cocaine use highlights the 
potential misconception of health risks among recreational drug users. 
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(Mayock 2001) reported that the recreational drug users whom she 
interviewed described how  
 
“ Their cocaine use was strongly linked with alcohol consumption. [with 
emphasis on] the compatibility of alcohol and cocaine…” p, 124 
 
Furthermore, they respondents did not appear to have any reservations about 
mixing cocaine and alcohol and also reported combining cannabis and 
ecstacy on occasions. However, according to Andrews (1997) there are acute 
health risks associated with the combination of cocaine and alcohol.  
 
“Use of cocaine and alcohol at the same time the effects are experienced 
together results in another psychoactive substacne being made in the 
body. ‘Cocaethylene’ …is associated with seizures, liver damage and 
compromised functioning of the immune system. It has also been argued 
to have an 18-25 fold increase over cocaine alone in risk of immediate 
death”.  
 
Survey into the polydrug using habits of young clubbers under 18 
 
A survey needs to be carried out on young people under the age of 18 
attending clubs/discos to ascertain what the polydrug using habits of young 
people are. A survey such as this would go some way to capturing information 
on people not attending treatment or needle exchanges and not in regular 
contact with hospitals. The survey could be carried out using a short 
questionnaire containing closed text questions. The location for the survey 
could be inside the entrance of clubs/discos with some incentive being offered 
for participating in the survey.  
 
Data collection on polydrug using habits of sections of the drug using 
population 
 
It would be useful if the current Eastern Regional Health Authority (ERHA) 
needle exchange programmes included a section in their data collection 
system for the purpose of recording polydrug use among clients. This could 
be done in a similar way to the National Drug Treatment Reporting System 
(NDTRS) where primary and secondary drug use on a daily/weekly/monthly 
basis during the last month is recorded. It may be useful for the needle 
exchange to record information for the previous 24/48/72 hour’s period prior to 
attending the needle exchange. In addition the Hospital In-Patient Enquiry 
System (HIPE) could include a similar method for capturing information on 
polydrug use among individuals reporting for treatment (not drug related) in 
general hospitals.  
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12. Successful Treatment: The effectiveness of the interventions – 
Lucy Dillon 
 
Defining what constitutes ‘drug treatment’ can prove problematic. For the 
purpose of data collection for this section the definition of treatment used in 
the National Drug Treatment Reporting System [NDTRS]28 has been adopted. 
As defined in the NDTRS, treatment is: 
 
“any activity which is targeted at people who have problems with their drug 
use, and which aims to ameliorate the psychological, medical or social state 
of individuals who seek help for their drug problems. The activity will often 
take place at specialised centres for drug users, but may also take place in 
general services offering medical/ psychological help to people with drug 
problems. 
Treatment is broadly defined and includes: 
 Interventions aimed at reducing drug-related harm amongst active users, 
as well as those whose primary goal is detoxification and abstinence 
Non-medical as well as medical interventions 
Short-term crisis interventions, counselling or support, as well as more 
structured longer-term programmes. 
However treatment excludes: 
Contacts with services which involve requests for social assistance only 
Contacts where drug use is not the reason for seeking help 
 Imprisonment per se (although admissions to drug treatment programmes 
in prison or to treatment as an alternative to prison are included) 
 Interventions solely concerned with the physical complications of drug 
misuse (e.g. overdoses or infections treated at hospital0 
Contacts by telephone or letter only 
Requests for practical information only 
Contact with family only”  
(National Drug Treatment Reporting System 2001). 
 
12.1 The approaches to treatments and the related concepts of 
success 
 
a) The concept and criteria for success considering: Intervention 
approaches, target groups, drugs used 
 
Underlying Approach to Treatment 
In the absence of an agreed definition of ‘successful treatment’ in the Irish 
service context, this section will describe the approach underlying treatment 
provision in Ireland and the implications of this for defining the ‘success’ of the 
various programmes. Prior to the early 1990s, drug treatment services in 
Ireland were based on a centralised-specialist model, with abstinence 
considered to be the only acceptable aim of treatment programmes (Butler 
1991). However, as happened elsewhere in Europe, the advent of HIV/AIDS 
in Ireland in the early 1990s, and its connection with injecting drug use, 
signaled a change in the structure and focus of treatment services. In 
addition, there was public pressure on the government to address the drugs 
issue because of a perceived escalation of drug-related crime. The 1991 
                                                     
28 The NDTRS is a national database of all those receiving treatment for illicit drug use in Ireland- the 
database is held in the Drug Misuse Research Division of the Health Research Board.   
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Government Strategy to Prevent Drug Misuse reflected the central role that 
the advent of HIV, and its prevalence among injecting drug users, had in the 
development of government policy in relation to drug treatment services.  
 
“Insofar as HIV infection is concerned, of the 1049 cases 
identified, 582 (or 57%) are drug misuse related….. It is clear 
from the foregoing that the prevention of transmission of HIV 
virus in this country must include strategies developed to deal 
with the drug misuse problem.” (Department of Health 1991, 
p.17) 
 
The report called for a heavier focus on a “multiplicity” of treatments in order 
to ensure services were appropriate to the individual user’s needs. A two-
pronged service programme aimed at both harm minimisation and abstinence 
was identified as the ideal. This called for changes in treatment programmes 
both in terms of the services they provided, and the manner in which they 
were delivered. 
 
“These strategies must be community-based, client orientated and, 
given the serious nature of the problem, of necessity, innovative. They 
must include emphasis on outreach programmes involving 
counselling, methadone maintenance and needle exchange. Advice 
on risk reduction services generally must form an essential part of any 
such strategies to minimise the spread of the disease.” (Department of 
Health 1991, p.17) 
 
In addition to abstinence based programme, services were to include 
treatment modalaties based on an ethos of harm minimisation. Furthermore, 
treatment was to be provided on a more decentralised, community-based 
model.  
 
A ‘Ministerial Task Force to Reduce the Demands for Drugs’ was established 
that subsequently produced two reports (Ministerial Task Force on Measures 
to Reduce the Demand for Drugs 1996 & 1997). Both dealt with treatment 
and, in particular, the development of the community-based model. The first 
report highlighted methadone maintenance services as having a “crucial role 
in stabilising injecting addicts, whose behaviour threatens families and whole 
communities” (Ministerial Task Force on Measures to Reduce the Demand for 
Drugs 1996, p.41). The second report saw the Task Force as having 
developed “a strong philosophy of harm reduction and treatment of the 
consequences of drug abuse-stabilisation, methadone maintenance, 
detoxification, rehabilitation and re-integration” (Ministerial Task Force on 
Measures to Reduce the Demand for Drugs 1997, p.7). Despite this emphasis 
on harm reduction, the report reiterated that the ultimate aim of all treatment 
programmes, including substitution programmes, was abstinence.  
 
More recently the National Drugs Strategy 2001-2008 has highlighted the two-
pronged approach to the provision of drug treatment services in Ireland. 
Treatment forms one of the four pillars (supply reduction, prevention, 
treatment and research) of the government’s drugs strategy- the objectives of 
which are: 
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 “To encourage and enable those dependent on drugs to avail of 
treatment with the aim of reducing dependency and improving overall 
health and social well-being, with the ultimate aim of leading a drug-
free lifestyle; and 
 To minimise the harm to those who continue to engage in drug-taking 
activities that put them at risk.”  
(Department of Tourism, Sport and Recreation 2001, p.6) 
 
Target Groups and Drugs Used 
A range of treatment services has developed to meet the needs of drug users 
in Ireland and a variety of treatment modalities constitute Irish drug treatment 
service provision. These include substitution services, counselling, and 
therapeutic communities. The types of treatment services available to drug 
users in Ireland are categorised in the NDTRS under the following headings 
according to the treatment centre type: 
 
“Specialised Residential  
Hospital inpatient unit 
Therapeutic community 
Other specialised residential treatment 
 
Specialised Non-Residential 
Hospital outpatient treatment centre 
Day centre/day hospital 
Local health care/ social service centre 
Low threshold/drop-in/street agency/mobile clinic 
Other specialised non-residential 
 
Based in general services 
Inpatient psychiatric hospital/unit 
Outpatient mental health care centre 
General Practitioner 
Residential social care facility 
Non-residential social care facility 
Other non-specialised non-residential 
Primary care” 
(NDTRS, 2001) 
 
It is important to note that there are distinct geographical variations in the 
nature of drug use in Ireland, reflected in the profile of those attending 
treatment for their drug misuse. This also means that there are geographical 
variations in the treatment services available. As can be seen from Table 
12.1a the vast majority of those reported to be receiving treatment were 
resident in what was called the Eastern Health Board29 (EHB) area in 1998, 
incorporating counties Dublin, Kildare and Wicklow. Furthermore, there is 
significant variation in the profile of those receiving treatment depending on 
geographic location (see Table 12.1b). The variation is particularly acute 
between the EHB and the rest of the country- opiate use being based 
predominantly in the EHB. 
 
                                                     
29 Now the Eastern Regional Health Authority (ERHA). 
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Table 12.1a Clients (by residence) receiving treatment for drug misuse by Health Board 
Area in 1998 
Residence Number % 
Eastern Health Board 5,076 85% 
Southern Health Board 303 5.1% 
North Western Health Board 48 0.8% 
Midland Health Board 96 1.6% 
Western Health Board 14 0.2% 
Mid Western Health Board  96 1.6% 
North Eastern Health Board 128 2.1% 
South Eastern Health Board 201 3.4% 
Total (includes residence not known) 6,043 100% 
Source: National Drug Treatment reporting System 
 
Table 12.1b Treatment by main drug of misuse in Regional Health Boards areas in 1998 
Area Total 
No. 
Heroin 
 
Cannabis Ecstasy Cocaine LSD Other 
National 6,043 4,297 71.1 642 10.6 196 3.3 88 1.5 14 0.2 806 13.3 
EHB 5,076 4,121 81 211 4.2 45 0.9 58 1.1 4 0.1 637 12.7 
SHB 303 14 4.6 120 39.6 89 29.4 12 4 4 1.3 64 21.1 
NWHB 48 10 20.8 21 43.8 10 20.8 0 0 1 2.1 6 12.5 
MHB 96 23 24 51 53.1 5 5.2 0 0 2 2.1 15 15.6 
WHB 14 6 42.9 2 14.3 1 7.1 1 7.1 0 0 4 28.6 
MWHB 96 7 7.3 57 59.4 11 11.5 3 3.1 1 1.0 17 17.7 
NEHB 128 32 25 52 40.6 15 11.7 2 1.6 2 1.6 26 19.5 
SEHB 201 22 10.9 119 59.2 19 9.5 9 4.5 0 0 32 15.9 
Source: National Drug Treatment reporting System 
 
Attempts have been made to meet the needs of all those requiring treatment 
for their drug use. However, the needs of two specific target groups have 
been highlighted in particular within the Irish context- young drug users and 
prisoners. The age profile of Irish drug users presenting for treatment has 
received some attention. Data on clients presenting for treatment for the first 
time in the period in 1995-1999 show that over 70% of those presenting for 
treatment for the first time were under the age of 25. This is younger than in 
other EU countries and reflects the demographic situation of Ireland, where 
the median age of the Irish population is much younger than the EU average- 
48% of the Irish population is under 30, whereas the median age in other EU 
countries is between 35 and 40 years (Moran et al. 2001). The relatively 
young age at which Irish drug users present for treatment has meant the 
identification of young drug users as a specific target group for treatment. A 
number of programmes have been established specifically for younger users 
and the development of a specific protocol for their care within established 
programmes is to be undertaken (National Drugs Strategy 2001-2008).  
 
The provision of treatment services for prisoners in Ireland is particularly 
complex. While the care of drug users in the community falls under the remit 
of the Department of Health and Children, that of prisoners is the 
responsibility of the Department of Justice, Equality and Law Reform. Unlike 
in the community where there is a focus on harm reduction in the treatment 
services through the provision of treatment services such as substitution and 
needle exchanges- harm reduction programmes are confined to restricted 
substitution services and there is no provision of access to clean injecting 
 177
equipment of cleaning materials30. Recently, efforts have been made to 
improve treatment provision for Irish inmates through increased co-operation 
between the Health Boards and the prisons. Within the context of ‘successful’ 
treatment the National Drugs Strategy, 2001-2008 has called for an 
independent evaluation to be carried out of the overall effectiveness of the 
Prison Strategy by mid 2004- including a focus on treatment services- 
although it is not clear what will be considered an appropriate definition of 
‘success’. 
 
A number of other specific groups considered to be ‘at risk’ and in need of 
specially targeted services have been identified, these include: the homeless 
population, members of the travelling community and persons involved in 
prostitution (National Drugs Strategy, 2001-2008). As with other treatment 
programmes in Ireland, none of the programmes developed for these groups 
have been evaluated for ‘successful treatment’. 
 
In conclusion, Irish drug treatment services have evolved in response to the 
developing drug problem in Ireland. They have progressed from being based 
on a principal of abstinence as the only acceptable outcome of treatment, to 
considering the reduction of drug-related harm as a crucial aim of treatment 
provision. However, while the provision of services has progressed this has 
not accompanied by the development of either concepts or measures of 
‘successful treatment’. 
 
b) Political and professional choices and principles behind the 
approaches 
 
As discussed above, while the objectives of the government policy on drug 
treatment have been laid out (Department of Tourism, Sport and Recreation 
2001), measures of success for the services have yet to be defined on both a 
political and professional level. However, it would appear that the two-pronged 
approach taken to treatment (i.e. a joint focus on harm reduction and 
abstinence) in the government’s policy would encompass the principles 
guiding individual treatment services if used as the basis for developing a 
definition of ‘successful treatment’.  
 
Consistency, or lack thereof, between the political strategy and professional 
choices in terms of definitions of successful treatment in Ireland should 
become more apparent in the context of a major piece of research on 
treatment outcomes currently being commissioned by the National Advisory 
Committee on Drugs31 (NACD). The National Drugs Strategy 2001-2008 
recommended that the NACD should commission outcome studies to 
establish the impact of methadone programmes on individual client’s health 
and offending behaviour. Furthermore, the remit of the NACD includes that 
they look at how best to determine the effectiveness of existing models and 
programmes in the area of drug treatment. A call has been made by the 
                                                     
30 For a full discussion on the situation in Irish prisons see section 13 of this report. 
31 The National Advisory Committee on Drugs (NACD) was established in July 2000 to advise the 
government in relation to prevalence, prevention, treatment/rehabilitation and consequences of problem 
drug use in Ireland, based on analysis of research findings and information available to it. 
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NACD for proposals to carry out a national longitudinal study (to be carried 
out over a period of 3 years) that would evaluate the effectiveness of 
treatment and other intervention strategies used in the care of adult (i.e. over 
18 years) opiate users. Substitution programmes form the basis of treatment 
provision for opiate users in Ireland. In August 2001 there were 5,605 people 
registered as receiving methadone in Ireland (Central Methadone Treatment 
List, personal contact). It is expected that the methods used will be similar to 
those of the National Treatment Outcomes Research Study (NTORS) in the 
UK. This piece of research should go some way to filling the gap in 
information on ‘successful treatment’ in the Irish context and also open up the 
debate on what constitutes ‘success’ in the treatment of drug use. 
 
12.2 Evaluation of the treatments 
 
a) Research findings and used methodologies 
 
As mentioned above, the number of Irish treatment programmes to examine 
their success is extremely limited. To date, no success criteria have been 
defined on a national basis, nor have any national level evaluations been 
carried out that allow for comparisons between either individual programmes 
or different treatment modalities. However, there have been a number of 
small-scale studies that have aimed to ascertain the ‘success’ of particular 
programmes. These will be described in the following sections.  
 
Substitution programmes: 
While substitution programmes (i.e. methadone programmes) form the basis 
of drug treatment services for opiate users in Ireland, no formal evaluations 
have been carried out of the service. In their review of drug services in the 
then Eastern Health Board region, Farrell et al. (2000) reported that within 5 
treatment clinics the results of urinalysis, carried out as a routine part of the 
treatment programme, showed a 70% reduction in heroin consumption among 
clients once on the programme. While this finding may indicate that the 
programmes are ‘successful’ in reducing clients’ intake of street opiates, data 
are not collected as a formal measure of ‘success’ and other outcomes were 
not measured.  
 
‘Drug Detoxification and Rehabilitation Programme’ in Mountjoy Prison, 
Dublin:  
Treatment services within Irish prisons have tended to be very limited, 
although they are currently under expansion. Other than limited substitution 
prescribing the Drug Detoxification and Rehabilitation Programme provided in 
Mountjoy Prison Dublin has been the only dedicated drug treatment 
programme available to prisoners. Crowley (1999) provided a medical review 
of the seven-week programme. Up to February 1999, 187 prisoners had 
entered the programme, 173 completed the detoxification and 14 failed to 
complete the detox. While this implies a 93% ‘success’ rate (i.e. where 
success is taken to be abstinence), Crowley (1999) highlights the need for the 
success of this intervention to be determined by the 6 and 12 month relapse 
figures. Overall it was found that there was a twelve-month relapse rate of 
78%. Crowley argues that while this may appear high, it compares favourably 
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to outcome rates of other inpatient detoxification programmes, although these 
are not presented. 
 
In-patient detoxification unit:  
An audit was carried out between July 1995 and July 1996 of the performance 
of the in-patient detoxification unit at Cuan Dara (Smyth and Lane 1997). The 
programme consists of a detoxification with methadone over approximately 
10-12 days and intensive counselling and rehabilitation for an additional 4 
weeks. ‘Success’ of the unit was explored by looking at (i) the proportion of 
patients completing methadone detoxification, (ii) the proportion completing 
the full six-week inpatient programme and (iii) the proportion of patients 
remaining drug free after discharge. 
 
Data were collected on all clients admitted to the programme between July 4th 
1995 and 30th June 1996. One hundred and five admissions were included in 
the data analysis. Details on demographics and drug using history were 
collected from patient notes and/or referral forms. Attempts were made to 
contact clients who had been discharged for more than two weeks, to collect 
data on the outcome variables (i-iii above) on three occasions during the year 
(Dec 1st 1995, Mar 1st 1996 & Aug 1st 1996).  Three sub-groups were formed 
depending on clients’ date of discharge. 
 
Twenty-nine per cent of patients (n=30) left hospital on or prior to day fourteen 
of the programme, i.e. before detoxification was complete. In terms of status 
on follow-up (average time gap over 10 weeks): 18% drug free, 5% 
undergoing another methadone detoxification, 12% on methadone 
maintenance, 33% had relapsed, 3% were in prison and contact could not be 
made with 29%. Therefore, of those for whom data were available, 26% were 
drug free and 49% had relapsed. The authors conclude that “the success 
rates from the point of view of detox completion and program completion 
approximate to those reported in similar centres around the world” (Smyth and 
Lane 1997, p. 11). 
 
Harm minimisation strategies: 
As discussed above, harm minimisation programmes constitute one of the two 
prongs of drug treatment in Ireland. A number of harm reduction strategies 
have been developed which specifically aim to prevent the spread of HIV and 
other drug-related infectious diseases among injecting drug users in Ireland. 
However, the impact of these programmes on infection rates among injecting 
drug users is unclear. A number of research papers have explored the 
‘success’ of these programmes according to certain criteria. Smyth et al. 
(1999a) attempted to explore the impact these programmes had on the 
spread of hepatitis C by carrying out tests for hepatitis C among a cohort of 
drug users. The cohort included those who had begun their injecting drug use 
both before and after the expansion of harm reduction programmes in Ireland. 
Data were collected on the results of HCV tests as recorded in clients’ 
medical files in one treatment centre, categorising them according to the date 
when they initiated injecting drug use. Smyth et al. (1999a) argue that the 
findings suggest that those injecting drug users who began their injecting drug 
use after the introduction of harm reduction strategies (post 1993), 
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demonstrated a reduced risk of HCV infection. However, they emphasise that 
it was not possible to control for other factors that may explain the decline in 
the HCV infection rate, such as a possible reduction in overall injecting 
frequency among more recent injectors. 
 
Smyth et al. (1999b) also carried out a study of knowledge regarding hepatitis 
C among a sample of injecting drug users (n=84) in a treatment setting in 
Dublin. Included in the sample were individuals who were on a methadone 
maintenance programme and those who were on a short-term detoxification 
programme. The study aimed to explore the ‘success’ of the programme by 
assessing clients’ understanding of hepatitis C and the associated risks. Data 
were gathered by a researcher, who was independent of treatment services, 
through a structured interview with clients. The authors developed a series of 
questions and scoring system designed to assess clients’ knowledge 
regarding hepatitis C. Smyth et al.’s basic hypothesis was that those injecting 
drug users with increased contact with medical services would demonstrate 
better understanding of hepatitis C and associated risk behaviours, i.e. a 
‘dose-response’ type effect. The hypothesis was not confirmed. Seventy-three 
of the sample recognised the four main infection routes, i.e. injecting drug 
use, sex, transfusion and vertical. However, only 44% recognised activities 
with no recognised risk, i.e. injecting without sharing, smoking heroin and 
kissing. Smyth et al. (1999b) expressed concern about the finding that 
substantial minorities believe that there is a risk of exposure even when not 
sharing injecting paraphernalia. They argued that perceived personal 
vulnerability to infections such as hepatitis C is likely to be a factor in leading 
individuals to avoid practising unsafe injecting behaviour. Where this 
vulnerability is diminished by false beliefs about already having been exposed 
to infection when actually engaging in ‘safe’ practices, then the preparedness 
to share injecting equipment may well increase. 
 
Local Evaluations 
Evaluations of specific programmes in Ireland have tended to focus on 
process evaluation rather than evaluations based on defined success criteria. 
However, a small number of programmes have also explored changes in 
clients’ behaviour and circumstances since starting on the programme- these 
will be explored in this section. Evaluations of the largest needle-exchange 
programme in Ireland and two community-based initiatives that aim to 
address the needs of drug users within their local communities will be 
discussed. Methadone prescribing is provided as part of the treatment service 
offered within the two latter programmes. Each programme has been 
evaluated and certain success criteria measured. None of the evaluations 
identified a specific definition of ‘successful treatment’, rather they tended to 
look at a variety of aspects when considering the impact of participation on 
the programme on the individual client. Furthermore, they are evaluations of 
individual programmes rather than a treatment modality per se. Aspects 
considered, included a reduction in illicit drug use, changes in criminal 
behaviour and general physical and social well-being. Each evaluation will be 
considered individually. 
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Merchant’s Quay Health Promotion Unit: Merchant’s Quay provides the 
biggest needle-exchange service in Ireland. The syringe exchange 
programme is located within the agency’s Health Promotion Unit which 
“provides a model for working with people who engage in both injecting and 
sexual risk behaviour. This model concentrates on reducing or eliminating 
these risks in so far as is possible” (Cox and Lawless 2000, p. vii). Five 
specific aims of the Unit were identified: 
 To enable clients to gain access to sterile injecting equipment and 
condoms; 
 To reduce the risk of contracting HIV, hepatitis B and C and other STDs; 
 To increase knowledge of safer injecting and sexual practices; 
 To improve health care and; 
 To evaluate changes and trends in drug use. 
(Cox and Lawless 2000, p. 4) 
 
While the provision of clean syringes is the central activity of this service, the 
unit also provides harm reduction orientated information and education for 
drug users. An evaluation of the service was carried out between 1997 and 
1998 (Cox and Lawless, 2000). Self-report data were collected on the 
following outcome domains: drug use, injecting risk behaviour, sexual risk 
behaviour, contact with services and health and well-being. Data were 
gathered during clients’ first visit and then at a three-month follow up visit.  
The evaluation found the Health Promotion Unit to be effective in meeting its 
aims on a number of levels. Specific findings included:  
 An 11% reduction in IV drug use among those who reported doing so at 
first visit (n=341). 
 Sixty-seven per cent of respondents who reported injecting in excess of 4 
times a day (n=104) reported less frequent IV use at their three month 
follow-up visit. 
 Fifteen per cent (n=56) of clients reported lending their used injecting 
equipment at first visit compared with only 9% (n=33) of clients at follow-
up. 
 Twenty three per cent (n=85) of first visit clients reported borrowing 
injecting equipment compared with 15% of follow-up clients (n=55).  
 At follow-up there was a 44% increase in the number of clients who 
reported cleaning their injecting site before administration. 
 
Jobstown Assisting Drug Dependency (JADD): The objective of the 
programme is stated to be “to provide realistic care and support for persons 
with an established opiate addiction resident in the Jobstown electoral district” 
(Bourke, unknown, p. 1). The main services offered by JADD are methadone 
maintenance and a gradual detoxification programme. The evaluation of the 
programme was carried out a year after the programme started. At the time 
the evaluation was carried out 28 people had approached the programme, 26 
of whom had started treatment. The evaluation focused on a process 
evaluation but it was found that the programme was ‘successful’ in effecting 
change under a number of criteria. In summary it was found that after a period 
of time on the programme employment rates increased, involvement in 
criminal behaviour was reduced and there was a significant reduction in the 
intake of illicit drugs.  
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Addiction Response Crumlin (ARC): The evaluation of ARC included a 
more detailed  assessment of the impact of participation on ARC on its clients 
than the previous evaluation discussed. A survey was carried out in October 
1998 of 91 out of a total caseload of 100 clients who used ARC in December 
1997 (McKeown and Fitzgerald 1999). Once on the programme, all of the 
clients had been prescribed methadone and had access to further 
rehabilitative services including counselling, a drop in service and various 
forms of group work. The following are some of the measures of success that 
were found in the evaluation: 
 At the time of interview, approximately 73% of clients were still receiving 
methadone and 27% were drug-free.  
 Significant improvements in clients’ self-assessed state of health were 
reported. In total, 86% of clients reported that their health had improved 
since starting on the programme. 
 Eighty-nine per cent of respondents reported an improvement in their 
quality of life since starting on the programme. They also reported 
improvements in the quality of their relationships with various significant 
others including their mothers (76%), fathers (59%), children (73%) and 
partners (69%).  
 Sixty-nine per cent of clients were unemployed when they first began on 
the programme, this fell to 44% at the time of the evaluation. 
 Prior to starting on the programme, 68% of the sample admitted to being 
involved in theft to finance their drug use and 66% that they had been ‘in 
trouble with the law’ before starting on the programme. Since starting on 
the programme only 23% reported being involved in criminal activity. 
 
In conclusion, while the number of Irish treatment programmes that have 
undergone evaluation remain limited, there appears to be a focus on similar 
outcomes of success i.e. reduced illicit drug use, reduced criminal behaviour 
etc. However, these evaluations highlight the need for ‘successful treatment’ 
to be properly defined and the concepts to be discussed in order that 
outcomes can be measured effectively. 
 
b) Comparison between treatments and related approaches 
Due to the lack of evaluations carried out in the Irish context and the absence 
of a definition of ‘successful treatment’, there is currently no information 
available that would allow for comparisons to be made between treatments 
and related approaches.  
 
12.3 Methodological issues 
 
a) Limitations in data availability 
 
Irish data on ‘successful treatment’ remain extremely limited. The gaps in data 
are apparent on an individual programme basis, across treatment modalities 
and across the Irish treatment service programme as a whole.  
 
b) Future needs 
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Extensive work needs to be carried out in the area of exploring ‘successful 
treatment’ in Ireland. It is important that a definition of ‘successful treatment’ 
be developed that could be adapted to the objective of particular programmes 
and/or treatment modalities, i.e. harm reduction or abstinence. It is important 
that a definition of ‘successful treatment’ incorporates the interests of all 
stakeholders (i.e. policy makers, service providers and service users). On the 
basis of a suitable definition of ‘success’ outcome variables may then be 
established that can be used to measure the ‘success’ of particular treatment 
programmes and/or modalities.  
 
c) Methodological proposal 
 
As mentioned above (12.3 (b)) there is a need for a definition of what 
constitutes ‘successful treatment’ in the Irish context to be established. It is 
proposed that initial research in this area should include an exploration of the 
views of all the stakeholders in drug treatment services (policy makers, 
service providers and service users) to establish their perceptions of success. 
Once established it would then be necessary to develop measures that would 
reflect the definition of success that could be used in longitudinal analysis of 
‘successful treatment’ in the Irish context.  
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13.  Drug Users in Prison – Lucy Dillon 
 
Introduction 
This paper aims to provide an overview of the issues related to drug use 
among prisoners in Ireland. A number of sources have been used to access 
the relevant information, and an attempt made to draw together these 
disparate sources of information in as comprehensive a manner as possible. 
In accordance with the EMCDDA guidelines, the main areas covered in this 
paper are: 
13.1 Epidemiological situation 
13.2 Availability and supply 
13.3 Contextual information 
13.5 Demand reduction policy in prison 
13.6 Evaluation of drug users treatments in prison  
13.7 Methodological issues     
 
 
13.1 Epidemiological Situation 
 
a) Drug use before and within prison 
 
Ireland has a daily prison population of approximately 3,000, located in 
sixteen prisons (www.irishprisons.ie). It has been found that within the Irish 
prison population a significant proportion of these individuals have a history of 
illicit drug use (Allwright et al. 1999; Long et al. 2000; Hannon et al. 2000). 
However, studies carried out have tended to look at prison populations as a 
whole, rather than the experiences of specific groups such as ethnic 
minorities or juvenile offenders. This section will explore the data available on 
the prevalence of drug use among prisoners, noting the experiences of 
specific groups where available. 
 
Prevalence of prisoners with a history of drug use 
In estimating the prevalence of drug use among Irish prisoners it has been 
argued that an analysis of drug-related convictions and committals largely 
underestimates the extent of the problem (O’Mahony 1997a). Research has 
shown that when comparing the number of Irish prisoners reporting a history 
of drug use with the number imprisoned because of a drug-related crime, the 
former significantly outnumbers the latter (O’Mahony and Gilmore 1983; 
Carmody and McEvoy 1996; O’Mahony 1997b).  
 
National: In their study Allwright et al. (1999) found that 52% of a national 
sample of prisoners (n=1,205) reported a history of opiate use, and 43% 
reported a history of injecting drug use. In what were designated ‘medium-risk’ 
prisons the rate of ‘ever injected’ was 21%, compared to 58% in the ‘high-risk’ 
prisons.32 A subsequent study that used the same methodology (Long et al. 
                                                     
32 Prisons in the study (Allwright et al., 1999) were categorised as high, medium or low risk according to 
expected prevalence rates for infection with drug related infectious diseases (hepatitis B, C and HIV), 
this was mainly based on estimates of the proportion of injecting drug users within each prison’s 
population. 
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2000) found that 35% of a sample of committal prisoners (n=607) had a 
history of opiate use and 29% reported a history of injecting drug use.  
 
Local- Mountjoy Prison, Dublin: Drug use has been identified as an issue of 
concern among populations in various prisons around the country- particularly 
those based in the Dublin area. Other research carried out in the Irish prison 
context has been limited to Mountjoy Prison in Dublin, which cannot be 
considered representative of the overall prison population in relation to drug 
use. At the time the research below (see Table 13.1) was carried out 
Mountjoy was the main committal prison in the country. It had an average 
population of 650 prisoners on any one-day, approximately a quarter of the 
total Irish prison population. Owing to the concentration of Ireland’s 
problematic drug use in the Dublin area (O’Brien et al. 2000), and estimates 
that approximately 66% of indictable crimes in the Dublin metropolitan area 
were attributable to ‘known hard drug users’ (Keogh 1997), Mountjoy was 
likely to have a higher proportion of drug users in its population than other 
prisons.  
 
Gender: Hannon et al. (2000) explored the drug-using history of a sample of 
prisoners (n=777)- reporting results separately for male and female 
respondents. They found that 68% of the sample of female prisoners (n=59) 
reported using heroin in the last twelve months, compared to 38% of male 
prisoners. Overall, 72% of male prisoners and 83% of female prisoners 
reported some lifetime drug use. Sixty-three per cent of the male sample and 
83% of the female sample had used drugs other than cannabis. Allwright et al. 
(1999) found a less distinct gender difference. They found that approximately 
60% of the female prisoners in the sample (n=57) and 45% of the male 
sample (n=1,130) had smoked heroin in the last year. Only approximately 3% 
of the Irish prison population are female (ww.irishprisons.ie), but these 
findings suggest that drug use may be particularly acute among this portion of 
the prison population. 
 
While the data collected through the available research are not directly 
comparable, owing to variations in methodology, they give a clear picture of 
illicit drug use as prevalent among Irish prisoners (see Table 13.1a). 
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Table 13.1a: Summary of Irish Research Findings on Prisoners with a History of Illicit 
Drug Use 
Sample 
Location 
Authors  (Publication 
Date) 
Year of  
Fieldwork 
Sample 
Size (n) 
Ever Used 
Opiates (%) 
 O’Mahony & Gilmore  
(1983) 
1981 
 
22* 73 
 
Mountjoy: 
Male Section 
O’Mahony  (1993) 1986 
 
95 32 
 O’Mahony (1997) 1996 
 
108 66 
 
Mountjoy: 
Monaghan  (unpublished) 1989 
 
34 31 
Female Section Carmody & McEvoy  (1996) 1994 
 
100 57 
 Allwright et al. (1999) 1998 1,205 52 
                           Male 1998 1130 45❋ 
                           Female 1998 57 59❋ 
National Surveys Long et al. (2000) 1999 607✤ 35 
 Hannon et al. (2000) 2000 777 32❋ 
                          Male  718 38❋ 
                          Female  59 68❋ 
• Sample made up solely of prisoners who described themselves as ‘drug abusers’. 
8 Sample made up solely of committal prisoners. 
9 Used heroin in last twelve months. 
 
Drug use within the environment of Irish prisons 
Studies have shown that a significant proportion of Irish prisoners have a 
history of drug use (see Table 13.1a). However, most of these studies have 
not considered the extent and nature of drug use engaged in by these 
prisoners while incarcerated. Four studies have looked at the extent to which 
prisoners use drugs while incarcerated and the risk behaviours in which they 
engage; two studies were carried out on a national basis (Allwright et al. 1999; 
Long et al. 2000) and two in Mountjoy Prison, Dublin (O’Mahony 1997b; Dillon 
2001).  
  
Imprisonment has been found to impact on an individual’s pattern of drug use. 
Both O’Mahony (1997b) and Dillon (2001) found that prisoners continue to 
use drugs while in the prison environment. O’Mahony (1997b) found that 42% 
(n=45) of a sample of 108 prisoners had used heroin while in prison serving 
their current sentence. This was 63% of those who had ever used heroin. 
Dillon (2001) reported that of a sample of 29 respondents selected through 
network sampling, 24 had a history of illicit drug use, all had used drugs at 
some stage while in prison and 17 reported that they were using drugs in the 
prison at the time of interview. However, both studies found that respondents 
reduced the quantity of drugs they used once imprisoned and the frequency 
with which they used them. Based on the qualitative data gathered in both 
studies a lack of access to drugs appeared to be the main reason for the 
lower frequency of use.  
 
On a national basis Allwright et al. (1999) found that 45% of the 334 
respondents who reported a history of injecting drug use and had been in 
prison for longer than three months, stated that they had injected drugs in the 
month prior to interview.  
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Another issue addressed in these studies was initiation into drug use while in 
prison. Initiation into first ever use of an illicit drug in the prison was found to 
be very rare, slightly less rare was initiation into the use of ‘new’ drugs. Six 
prisoners in O’Mahony’s (1997b) sample (n=108) reported that their first-ever 
experience of heroin had been in prison. Dillon (2001) also found evidence 
that a small number of prisoners are initiated into heroin use while in prison.  
 
It would appear, therefore, that entering prison in Ireland does not necessarily 
mean a cessation of drug use. 
 
Injecting Drug Use and Risk Behaviours  
Studies have found that Irish prisoners engage in injecting drug use while 
incarcerated and that they tend to share injecting equipment (O’Mahony 
1997b; Allwright et al. 1999; Long et al. 2000; Dillon 2001). Research has 
highlighted two main issues- initiation into injecting drug use while in prison 
and sharing injecting equipment while in prison. Furthermore, qualitative work 
has explored people’s motivations for engaging in these behaviours. 
 
A study carried out by Allwright et al. (1999) focused on the risk behaviours 
engaged in by prisoners in relation to the spread of hepatitis B, hepatitis C 
and HIV. One-fifth (104/506) of those reporting a history of injecting drug use 
said they had first begun injecting drugs while in prison. In considering the risk 
behaviours engaged in by these prisoners, it was found that injecting drug 
users were more likely to share injecting equipment while in prison than when 
they were in the community. Fifty-eight per cent of injecting drug users said 
they had shared all injecting equipment (needles, syringes, filters, spoons) 
while in prison, compared to 37% who reported sharing in the month prior to 
being incarcerated. 
 
Qualitative evidence offers an insight into the motivations behind these 
practices. Dillon (2001) found that injecting was the dominant route of heroin 
administration among a sample of prisoners based in Mountjoy Prison, Dublin. 
Relatively small quantities of the drug were available within the prison setting 
and prisoners reported a culture in which the drug needed to be used in what 
was perceived to be the most ‘economical’ way possible- this meant using the 
smallest amount of heroin to the largest effect for the most people. In this 
context, respondents reported that smoking heroin was perceived to be 
wasteful, whereas injecting was seen as an ‘efficient’ use of heroin. However, 
it was also reported that injecting drug use within the prison was synonymous 
with the sharing of injecting equipment. All of those who had injected heroin 
within the prison setting had shared injecting equipment. 
 
From these studies it is clear that prisoners continue to use drugs while in 
prison in Ireland. It appears that the quantity of drugs used and the frequency 
with which they use them is greatly reduced, when compared to drug using 
behaviour while in the community. However, the evidence also suggests that 
an injecting culture exists within at least one Irish prison (Dillon 2001). 
Prisoners appear to adapt their drug-using behaviour to suit their 
environment- in the absence of access to clean injecting equipment and the 
small quantity of drugs available to them prisoners engage in risky injecting 
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practices. This raises issues of particular concern for public health in relation 
to the spread of drug-related infectious diseases (HIV, hepatitis B and C). 
However, it has also been noted (Dillon 2001) that the reduction in the 
quantity and frequency of use suggests that imprisonment may provide an 
important opportunity for prisoners to address their drug use and that there is 
a need for the appropriate services to be developed to capitalise on this 
opportunity.  
 
b) Health status in prison, social and legal consequences among drug 
users in prison 
 
This section will explore the consequences of drug use in prison for inmates in 
two areas: the health-related consequences and legal consequences. 
 
Health-related consequences 
Three aspects of the health-related consequences of drug use among 
prisoners will be considered: drug-related infectious diseases, mortality and 
morbidity. 
 
Drug-related infectious diseases: Prevalence of HIV, hepatitis B and C 
In a context where drug-related infectious diseases have been found to be 
prevalent among injecting drug users in the community33, a number of studies 
have explored the prevalence of these diseases within cohorts of the prison 
population. 
 
Two national studies (Allwright et al. 1999; Long et al. 2000) have been 
carried out on drug-related infectious diseases among prisoners. Both studies 
found that the needle-sharing practices engaged in by prisoners appeared to 
have serious implications for their health status.  In Allwright et al.’s study, of 
those who had shared equipment inside the prison, 89.1% had tested positive 
for hepatitis C, compared to 62.2% of those who had not shared injecting 
equipment while in prison. While Long et al. (2000) found that a smaller 
proportion of committal prisoners had a history of drug use, they found similar 
risk behaviours occurring and similarly high rates of infection, particularly of 
hepatitis C (see Table 13.1b). 
 
Table 13.1b  Number and percentage of injectors testing positive for HIV, hepatitis B 
and hepatitis C. 
Study Injectors in 
sample (n) 
% of injectors 
tested positive 
for HIV  
% of injectors 
tested positive 
for hepatitis B 
% of injectors 
tested positive 
for hepatitis C 
Allwright et al. 1999 509 3.5 18.5 81.3 
Long et al. 2000 173 5.8 17.9 71.7 
 
Smaller scale qualitative studies have found evidence that even where 
prisoners were aware that they were infected with a drug-related infectious 
disease, some continued to engage in needle sharing practices while in the 
prison (Dillon 2001; O’Mahony 1997b). Unlike in the community, Irish 
prisoners do not have access to clean injecting equipment through structured 
                                                     
33 See Dillon & O’Brien (2001) for an overview of the data available on drug-related infectious 
diseases among Irish injecting drug users. 
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programmes. This contributes to an environment in which injectors are at risk 
of contracting drug-related infectious diseases. 
 
Mortality 
The number of deaths recorded in prisons in Ireland is shown in Table 13.1c 
below. Between 1990 and 1997 17% of the deaths that occurred in custody 
were due to natural causes; 27% due to overdose or the prisoner choking on 
his/her own vomit; and, 56% due to hanging. The number of prisoners dying 
of natural causes has increased in recent years, this is in part attributed to an 
increase in the number of older people being committed to prison (particularly 
for sex offences) (National Steering Group on Deaths in Prisons 1999). It is 
not clear how many deaths were directly related to drug use. However, 
between 1991 and 1997 at least one death a year was attributed to overdose. 
 
Table 13.1c Number of deaths in Irish Prisons. 1990-2000. 
Year ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 ‘00 
Deaths 4 5 5 3 5 3 9 7  7 9 
Source: National Steering Group on Deaths in Prisons 1999; Irish Prisons Service, personal communication.  
 
Suicide among prisoners has become a major issue of concern within the 
prison service. However, as with deaths in the prison in general, it is not clear 
how many of these are related to drug use. In 1999, six people committed 
suicide while in custody (see Table 13.1d). As a response to growing concern 
about suicides in prisons, local Suicide Awareness Group were established in 
each institution in the early 1990s that are chaired by the prison Governor and 
include members from the relevant prison services (National Steering Group 
on Deaths in Prisons 1999). Further measures have also been introduced in 
an attempt to minimise the risk of suicide among prisoners, e.g. the 
development of a suicide prevention policy in each prison and increased 
awareness among prison staff of the risk of suicide among prisoners. 
However, despite these measures the numbers of suicides recorded have not 
reduced. Furthermore, it should be noted that where death is caused by an 
overdose this is not recorded as a suicide and therefore the actual number of 
prison suicides may be greater. 
 
Table 13.1d: Number of suicides in Irish Prisons. 1985-1999. 
Yr ‘85 ‘86 ‘87 ‘88 ‘89 ‘90 ‘91 ‘92 ‘93 ‘94 ‘95 ‘96 ‘97 ‘98 ‘99 
S* 2 1 1 4 5 3 4 3 1 3 1 5 3 3 6 
 *Number of suicides 
Source: National Steering Group on Deaths in Prisons 1999; Irish Prisons Service, personal communication 
 
Morbidity 
Studies carried out on the health of prisoners have found that they suffer from 
a relatively high level of morbidity, both in terms of their physical and 
psychological health. In their study of female prisoners in Mountjoy, Carmody 
et al. (1996) found that almost half (n=49) of the women in their sample 
(n=100) had received psychiatric treatment at some time- 26 of whom had 
spent time as an in-patient in a psychiatric hospital. Furthermore, 37 reported 
that they suffered from a specific physical illness, these were mainly 
respiratory complaints. 
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Hannon et al. (2000) carried out a study of the general health care of 
prisoners in Ireland. They found that compared to a sample of the general 
Irish population, prisoners tended to suffer from a higher level of morbidity.  
Twenty-two percent of male prisoners (compared to 7% of males in the 
general population survey) and 29% of female prisoners reported that they 
had a long-standing illness or disability that limited their activity.  They also 
reported experiencing a number of other medical conditions, a sample of 
which can be seen in table 13.1e below. 
 
Table 13.1e: Self-reporting of male and female prisoners and of males from general 
population survey on the frequency of occurrence of having (A) any of 14 medical 
conditions in the previous twelve months and (B) ever having been told by a doctor 
that they had any of the same 14 conditions. 
 In the last twelve months Ever been told 
Condition Male 
prisoners 
Female 
prisoners 
Male 
prisoners 
Female 
prisoners 
Males 
general pop. 
Depression 22 42 14 44 4 
Asthma 10 36 11 33 na 
Anxiety 14 11 8 16 3 
High blood 
pressure 
5 11 11 12 4 
Skin diseases 12 15 8 11 na 
Source: Hannon et al. 2000, p. 25 
 
Legal consequences 
It is prohibited for prisoners to have in their possession drugs or the 
paraphernalia required to use them. Prisoners caught in possession of drugs 
within the prison are normally dealt with and punished under the Rules for the 
Government of Prisons, 1947- possession of drugs or paraphernalia are dealt 
with under the rules related to possession of an unauthorised article. Other 
offences such as sharing a toilet cubicle to use drugs (see Table 13.2) are 
dealt with as an offence against good order and discipline. The punishments 
include: 
 
13.2 Availability and supply 
 
a) Availability of illicit drugs in prison 
 
Due to the illicit status of drug use within the prison setting and the covert 
nature of that use which continues within this environment, little is known 
about the actual availability of drugs and their routes of supply into Irish 
prisons. However, the measures invoked by prison authorities to prevent 
drugs being smuggled into prisons suggest that prison visits may provide the 
main access route and that drugs sometimes are thrown to inmates over the 
prison walls (Cork Prison Visiting Committee Report, St. Patrick’s Prison 
Visiting Committee).  
 
The findings from an exploratory study of drug use among prisoners in 
Mountjoy Prison Dublin (Dillon 2001) offer some insight into aspects related to 
the availability of illicit drugs in prison. The findings of the study suggest that 
the types of drugs used in prison reflect those used by the prison population 
while in the community. Therefore, the Dublin based prison population 
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focused on accessing heroin and cannabis, whereas in a prison elsewhere 
cannabis and stimulants were reported to be the main drugs accessed and 
used. This reflected the main drugs of use reported by clients attending for 
treatment in the respective community (O’Brien et al. 2000). 
 
Prisoners in Dillon’s study (2001) argued that the quantity of drugs available 
within the prison was greatly exaggerated by media reports, and that they 
were significantly more difficult to access than was generally perceived by 
those outside the prison.  
 
Dillon’s (2001) study focused on the distribution networks established to 
distribute drugs once they had been smuggled into the prison. It was found 
that the sale of drugs within the prison was not reported to be a common 
practice at the time the study was carried out. Rather a ‘favour’ network was 
reported to be the main distribution tool. The distribution process invoked by 
inmates was seen to impact on the quantity of drugs used, the frequency of 
use and the risk behaviours engaged in by those using drugs in the prison 
setting.  
 
The principal means of drug distribution in Mountjoy Prison was found to be 
through networks set up between prisoners. Networks were generally 
established between prisoners who had known each other in the community. 
Fellow prisoners were often people with whom respondents had mixed 
outside prison, either through their drug use, their criminal activity or simply 
because they came from the same community. Distribution was based on a 
reciprocal arrangement between those who had access to drugs from the 
community. One person would access drugs by smuggling them into the 
prison, and then he/she would distribute them within his/her network. Another 
member of this network would then access drugs in a similar way and 
distribute them to the members of this network. As such, members of this 
group were assured that they would continue to receive drugs from other 
people’s visits, as long as they continued to receive drugs that they could then 
distribute. 
 
No information is available on the means through which drugs are distributed 
in prisons other than Mountjoy. Anecdotal evidence suggests that drugs may 
be sold for cash elsewhere, although there is no information on prices 
available.  
 
b) Smuggling into prison 
 
The prison authorities invoke a number of measures to prevent prisoners from 
smuggling drugs and the relevant paraphernalia into prisons. These include: 
 
 monitoring all visits (both by prison officers in the visiting hall and a closed 
circuit television system); 
 prohibiting physical contact between visitors and prisoners during visits; 
 internal and external body searches of prisoners suspected of smuggling 
drugs or paraphernalia into the prison; and 
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 carrying out searches of cells where it was suspected that drugs or 
paraphernalia were being kept. 
 
Other measures are taken in some of the prisons. For example, in some 
prisons netting has been installed over the exercise yards- this is to prevent 
drugs from being thrown over the prison walls to inmates.  
 
In the period from April 1998 to April 2000 there were 622 seizures of drugs in 
Irish prisons. Furthermore, a number of visitors were successfully prosecuted 
for attempting to supply drugs to inmates (Irish Prisons Service, personal 
communication). Some more detailed data are included in the Visiting 
Committee reports for each prison. In their 1999 annual report, Mountjoy 
Prison’s Visiting Committee reported a number of incidents in which prisoners 
were found to be contravening prison regulations in relation to drugs and their 
use (see table13.2). 
 
Table 13.2: Cases of informal offences reported in Mountjoy Prison, Dublin. 1998-1999. 
Informal Offence 1998 1999 
Receiving drugs on visits 152 112 
Possession of drugs in cells 78 88 
Possession of syringe 191 161 
Using drugs in prison 7 35 
Sharing a toilet cubicle to use drugs 82 91 
Giving a false name to receive medication 9 35 
 Source: Mountjoy Prison Visiting Committee Report, 1999. 
 
13.3 Contextual information 
 
This section will describe the general structure of the Irish prison system, 
including the organisational structure, the relevant legislation and a general 
profile of the prison population and places of detention. Furthermore, an 
overview of data available on the culture within Irish prisons and the 
relationships that exist within this setting will be presented. 
 
Structure of the Irish prison system 
The structure of the Irish prison system is currently undergoing significant 
changes- the Irish prison service is undergoing a transition from being a 
functional area of the Department of Justice, Equality and Law Reform, to an 
independent executive agency status (www.irishprisons.ie). In November 
1996, on foot of recommendations from various reports (Commission of 
Inquiry into the Penal System 1985; Department of Justice 1994), the Irish 
Government approved the establishment of an independent prisons agency to 
take on responsibility for the day-to-day running of the prison service. The 
agency will be overseen by an independent Prison Board to ensure that it is 
operationally independent in performing its day-to-day functions and activities. 
The Minister for Justice, Equality and Law Reform however, will continue to 
be politically accountable for the prison system. 
 
A Prisons Authority Interim Board was appointed by the Minister for Justice, 
Equality and Law Reform in April 1999 and the first Director General of the 
Irish Prisons Service was appointed in July 1999. The Service is to be 
established on a statutory basis, requiring the preparation of the necessary 
legislation in the form of a Prison Service Bill. This Bill has yet to be enacted 
despite plans to do so during 2000. The structure of the new system can be 
seen in diagram 13.3 below. 
 
Diagram 13.3: Reporting Structure of Irish Prison System 
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On a day-to-day basis each institution is managed by a prison governor. 
Governors are appointed by the Minister for Justice, Equality and Law 
Reform, and come from a variety of backgrounds. Within the new structure it 
is planned that greater authority, responsibility and accountability will be given 
to Governors in the management of their own prisons. 
 
Prison Visiting Committees: An important structure within the Irish prison 
system, and a valuable source of information on prisoners’ experiences of this 
system, are the annual reports of the Prison Visiting Committees. Prison 
Visiting Committees were established under the Visiting Committee Act, 1925, 
and a statutory instrument of 1972 (S.I. No. 217/1972: Prisons (Visiting 
Committees) Order, 1972). They are independent statutory bodies that act on 
behalf of the public to oversee the treatment of prisoners and to ensure that 
the prison system operates humanely (Vaughan 2001). Prisoners are able to 
access the committees and make complaints to them about any aspect of 
their treatment by the prison authorities. The Visiting Committees of the 
various institutions carry out a statutory role under the Prisons (Visiting 
Committees) Act, 1925 to: 
 
(a) from time to time and at frequent intervals to visit the prison…. To hear 
any complaints which may be made to them by any prisoner…..; and 
(b) to report to the Minister any abuses observed or found by them in such 
prison; and 
(c) to report to the Minister any repairs to such prison which may appear to 
them to be urgently needed; and 
Independent 
Prisons Board
Irish Prisons 
Service
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(d) to report to the Minister on any matter relating to such prison on which the 
committee shall think it expedient or shall have been requested by the 
Minister so to report. 
 
The Visiting Committee for each prison is required to make a report to the 
Minister on an annual basis to which the public may have access. The 
Committees however have been subject to some criticism for not being wholly 
impartial (Commission of Inquiry into the Penal System 1985; Vaughan 2001). 
 
Legislative Framework 
The legislation governing the operation of the prison system is made up of a 
variety of Prison Acts dating from the 19th century, with the principal Acts 
being: the Prisons (Ireland) Act, 1826; the Prisons (Ireland) Act, 1856; the 
General Prisons (Ireland) Act, 1877; the Visiting Committee Act, 1925; the 
Criminal Justice Act, 1960; the Criminal Justice (Miscellaneous Provisions) 
Act, 1997; and the various statutory Rules and Regulations- the most 
important of which are the Rules for Government of Prisons, 1847 (S.I. 
number 320 of 1947). The Rules of Government for Prisons, which were last 
updated in 1947, are to be replaced with a new set of Prison Rules drawn up 
in line with EU-formulated prison rules- the new rules have been signed off by 
the Irish Prisons Service and the Department of Justice, Equality and Law 
Reform, and are currently being studies by the Office of the Attorney General.  
 
Profile of Prisoners and Places of Detention 
As mentioned above Ireland has a daily prison population of approximately 
3,000 housed in 16 prisons around the country. Box 13.3a provides a brief 
profile of the Irish prison population on June 1st 2000. 
 
Box 13.3a: Profile of Prisoner Population on 1st June 2000 
97% of prisoners are male 
90% of prisoners are under sentence 
44% of sentenced prisoners are aged between 17 and 25 
65% are aged under 30 years of age 
8 out of 10 (80.5%) are serving sentences of more than one year 
64% of sentenced prisoners are serving sentences of two or more years 
25% are serving sentences of between 5 and 10 years and 10% more than 10 
years. 
Source: www.irishprisons.ie 
 
The Irish prison system is made up of what are termed ‘open’, ‘semi-open’ 
and ‘closed’ prisons. The type of institution reflects the level of security 
considered necessary for the cohort of prisoners housed there. The variation 
between the different institutions is best reflected in the daily regime of each 
type of institution (see Box 13.3b). 
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Box 13.3b: Structure of Daily Routine in Irish Prisons.  
Daily Timetable “closed” Institutions. 
The timetable in closed institutions is generally as follows; 8.15am unlock, breakfast, 
return to cell. 9.15am unlock, tidy cell, go to place of employment/training, 
course/school. 12.15pm collect dinner, return to cell. 2.15pm unlock, tidy cell, return 
to employment/training/education activities. 4.15pm collect tea, return to cell. 5.30pm 
unlock go to recreation. 7.30pm collect supper, return to cell. 8.00pm final lock up. It 
should be noted however that not all prisoners in these institutions have access to 
the employment/training/education activities. Therefore, the hours when they are 
‘unlocked’ prisoners engage in the limited recreational activities available to 
prisoners. 
 
Daily Timetable Semi-open Institution (Training Unit) 
The Training Unit located in the Mountjoy Prison Complex is the only institution within 
the Irish prison service to have the status of a semi-open institution. Here the 
traditional lock-unlock regime does not apply. A prisoner rises at about 8am and is 
not obliged to return to his cell until he goes to bed at about 10pm. Most of the day 
(9am to 5pm) is spent in one of the workshops or at education classes, with meal 
breaks in the course of the day. From 5-10pm approximately, there is recreation time 
during which prisoners may engage in a full range of activities including watching 
television or playing snooker, squash, volleyball etc. 
 
Daily Timetable Open Institutions  
The daily regime in an “open” centre is more relaxed, reflecting the lower security 
rating. From the time the prisoner rises until he/she goes to bed, prisoners have 
practically full-time association with other prisoners. Furthermore, they have access 
to a wide range of activities- both indoor and outdoor. The traditional lock up system 
associated with closed prisons does not apply in “open” institutions. 
Source: www.irishprisons.ie 
 
Prison Culture 
Little is known about the culture that exists within different Irish prisons. 
Prisons tend to house inmates resident in the locale of that prison wherever 
possible, i.e. offenders normally resident in Cork tend to be imprisoned in 
Cork Prison. However, some prisons deal with specific categories of 
prisoners. For example, the population of the Curragh prison consists mainly 
of sex offenders, while the Portlaoise Prison population includes offenders 
convicted by the Special Criminal Court of “subversive-type offences” 
(www.irishprisons.ie), mainly members of various paramilitary organisations 
(e.g. IRA, UVF) who are considered by the prison service to pose a high 
security risk. Therefore, each prison will probably have a different culture 
depending on the profile of prisoners it houses.  As mentioned above, little 
research has been carried out to explore these different cultures. However, in 
the context of drug use among prisoners some work has been carried out on 
the culture that exists within at least one prison in which drug use ahs been 
found to occur. 
 
Mountjoy Prison in Dublin is an institution in which studies have shown that a 
large proportion of the population has a history of opiate use (O’Mahony 
1997b; Allwright et al. 1999), most having engaged in daily use right up to the 
time they entered the prison. The Department of Justice, Equality and Law 
Reform has estimated that Mountjoy has to cope with detoxifying 1,200 – 
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1,500 opiate users each year (Department of Justice, Equality and Law 
Reform 1999). In his commentary on the prison system, O’Mahony has 
argued that Mountjoy is ‘totally dominated by a drugs culture embodied in 
prisoners’ attitudes, values and behaviours’ (1997a, p.42). Mountjoy is the 
only prison in which effort has been made to explore the culture that exists in 
the prison. For the purpose of this Special Topic the findings of Dillon’s (2001) 
exploratory study in relation to the culture that existed within Mountjoy Prison 
will be overviewed. While this study in no way purported to provide a 
comprehensive profile of prison culture in Ireland, it offers an overview of a 
prison culture where drug use was a central feature of daily life. 
 
Overall, respondents in Dillon’s (2001) study (n=29) reported that life in prison 
was characterised by tension, monotony and that being in prison was a 
depressing experience. Where respondents with a history of illicit drug use 
were not engaged in structured activities, the boredom experienced was seen 
to reinforce the perceived positive aspects of illicit drug use. Furthermore, 
other than in the designated drug-free wing of the Training Unit, respondents 
perceived Mountjoy Prison to be characterised by a drugs culture, manifest in 
the attitudes and behaviour of prisoners. Irrespective of the drug-using history 
of prisoners, or their current drug-using status, there was an overall 
consensus that drug use was an issue they faced on a daily basis. 
Respondents reported that they saw significant variation between different 
areas of the prison in terms of the visibility of the activities involved in illicit 
drug use, i.e. distribution, administration and being under the influence of 
drugs. While it was reported that drug use was not seen in one area of the 
prison (the designated drug free wing- Training Unit), it was reported to be 
particularly acute in others (main Male Prison, Female Prison). Prisoners 
currently using drugs, and those who were not, reported that drugs were one 
of the main topics of conversation among prisoners. Accessing them, using 
them and past experiences of them were talked about on a frequent basis. 
Respondents identified drug use as visible, depending on which area of the 
prison they were housed in, rather than whether they were engaged in illicit 
drug use in the prison or had a history of illicit drug use. They reported that 
the overall atmosphere of the prison was affected by drug use. In an 
environment where the availability of drugs fluctuated, tensions among those 
depending on drugs also fluctuated. This resulted in a volatile atmosphere in 
most areas of the prison. Respondents argued that drugs impacted on all of 
those in the prison setting, including prisoners with a history of drug use, 
prisoners with no history of drug use, and prison staff. Prisoners with a history 
of drug use argued that the perceived benefits of drug use were reinforced in 
the prison environment. Drugs were seen to alleviate some of the problems 
associated with prison, such as boredom and depression. To stay or become 
drug-free in an environment characterised by a drugs culture was not 
perceived as feasible by those with a history of drug use. The prisoners with 
no history of drug use, who were housed outside the designated drug free 
area of the Training Unit, reported that, at least initially, the presence of drugs 
made the prison environment more threatening for them. Respondents felt 
that the presence of drugs in the prison made for a more threatening working 
environment for prison officers. 
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While this study provides a valuable insight into the culture within one of 
Ireland’s prisons, it is likely that prison cultures will vary across the country. 
Furthermore, where different types of drugs are used by different populations 
this is likely to impact on the nature of the drug culture in each institution. 
Further research needs to be carried out in this area. 
 
Prison Relationships 
As with prison culture, little research has been carried out on the relationships 
that exist between those in the Irish prison system. Dillon’s (2001) qualitative 
study again provides the main source of information on this subject from one 
of Ireland’s prisons. Relationships developed within the prison both between 
prisoners and between prisoners and staff. Prisoners’ perceptions of these 
relationships were explored in the interviews carried out by Dillon (2001). 
 
Another study had established that prisoners in Mountjoy tend to be from a 
limited number of areas in Dublin that are characterised by relative deprivation 
(O’Mahony 1997b). Dillon (2001) found that prisoners who had been living in 
Dublin prior to imprisonment tended to come from these same areas. 
Furthermore, they tended to know each other not only through being 
members of the same community but also through their drug use. Where 
relationships had already been established in the community, they were 
maintained in the prison. Relationships were also based on an individual’s 
drug-using status. In general, prisoners tended to select those whom they 
spent time with based on their drug-using status. For those currently engaged 
in drug use, social affiliations tended to be with other prisoners who were part 
of the drug distribution network in which they were involved. On the other 
hand, prisoners who were not engaged in drug use tended to spend their time 
with other non-users. Overall, as in the community, individuals selected a peer 
group of ‘like-minded’ individuals. The divisions in terms of drug-using status 
were highlighted by the experience of those housed in the Training Unit, 
which was a designated drug-free area. Respondents generally felt that, 
owing to the lack of a drug-using culture in this area, there was less 
differentiation between those prisoners with a history of drug use and those 
with no history of drug use. In this environment the tensions around drug use 
were removed. This was seen to encourage mutual respect between 
prisoners, and removed divisions based on drug-using status. There was a 
much higher level of interaction between prisoners, irrespective of drug-using 
history.  
 
This study (Dillon 2001) did not aim to examine prisoner–staff relationships in 
depth and data on this aspect of prison life are limited. Staff were not 
interviewed and therefore data were restricted to the perceptions of prisoners. 
While there was a range of different staff in the prison, respondents focused 
almost exclusively on their relationships with prison officers. Prisoners had 
daily contact with prison officers, who were perceived to play a key role in 
their day-to-day experience of prison life. Respondents had mixed attitudes 
towards prison officers. A small number held particularly negative attitudes 
about them and categorised them all as ‘being the same’, emphasising a 
‘them’ and ‘us’ relationship between officers and inmates. Overall, however, 
while the majority of prison officers were viewed in a generally negative way 
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by interviewees, a significant minority were viewed more positively. As with 
other aspects of prison life there appeared to be variations in the relationship 
between prison officers and inmates in different areas of the prison. Overall, 
prison officers tended to be seen as more of a source of support by female 
respondents than by male respondents. In summary, prisoners had mixed 
views of prison officers and this was reflected in their relationships with them. 
While a significant minority were seen in a positive light, prisoners generally 
maintained a distance between themselves and the prison officers.  
 
None of the respondents in Dillon’s (2001) study made allegations of ill-
treatment against prison officers. However, on a more general level, the 
European Committee for the Prevention of Torture and Inhuman or Degrading 
Treatment or Punishment (ECPT, 1999), reported that a number of Irish 
prisoners interviewed alleged that they had been mistreated by prison staff. 
Where a prisoner feels he/she has been mistreated while in prison, he/she 
can make a complaint to the prison’s Governor, the Visiting Committee, the 
Department of Justice, Equality and Law Reform, a solicitor or a member of 
the police force (An Garda Síochána) (Vaughan 2001). In response to the 
ECPT’s report, the Department of Justice, Equality and Law Reform published 
the following table 13.3a outlining the number of complaints made by 
prisoners, the number referred on to the Gardaí and those that were not 
pursued. In none of the cases there was sufficient evidence to sustain a 
charge of ill-treatment. However, there is currently one case pending against 
a prison officer for the ill-treatment of a prisoner (personal communication, 
Irish Prisons Service). 
 
Table 13.3a No. of complaints by prisoners 1996-1998 
Year Ill-treatment 
complaints 
Referrals to Gardai Withdrawals/ not 
pursued 
1996 27 6 2 
1997 18 6 6 
1998 44 14 13 
Source: Department of Justice, Equality and Law Reform 
 
In exploring the quality of life of prisoners Hannon et al. (2000) asked 
prisoners about their perceptions of their environment and the threat they felt 
it presented them with. They found that inmates tended to perceive the prison 
to be threatening environment, but the experiences varied depending on what 
type of an institution they were based (see Table 13.3b). Table 13.3b below 
indicates the extent to which male prisoners felt they had been subjected to 
one of a number of threatening experiences within the prison setting. 
 
Table 13.3b Aspects of prison life among male prisoners 
 Closed (%) Semi-open (%) Open (%) 
Physical harm from prison officers 31 25 15 
Verbal abuse from prison officers 59 44 28 
Feeling very/extremely safe in daily life 32 69 70 
Physical harm from other prisoners 14 15 10 
Verbal abuse from other prisoners 26 35 13 
Source: Hannon et al. (2000) 
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13.5 Demand reduction policy in prison 
 
a) Drug user needs assessment in prison 
 
Although limited, research carried out to date has consistently found drug use 
to be an issue of concern among prisoners (Allwright et al. 1999; Long et al. 
2000; Hannon 2000; O’Mahony 1997; Dillon 2001). Furthermore, the needs of 
drug users within prison have been noted both by the Department of Justice, 
Equality and Law Reform and the Irish Prisons Service. Despite evidence that 
a significant number of Irish prisoners engage in problematic drug use, and 
recognition on the part of the relevant authorities of the necessity of providing 
the appropriate services to meet their needs, no research has formally been 
carried out that has aimed to assess drug users’ needs within the prison 
environment. 
 
b) Organisation of the drug services in prison 
 
In 1994 the Department of Justice clearly stated that equivalence of care and 
continuity of care of prisoners were among the objectives of the prison 
medical services in Ireland: 
 
To provide primary health care (prevention, treatment and health 
rehabilitation) to offenders of at least an equivalent standard to that 
available to citizens in the general community; this involves as a 
minimum an adequate reception, medical assessment and 
examination, through-care while in prison and making appropriate 
arrangements for the continuation of health care following release. 
(Department of Justice 1994, p. 51) 
 
This stance was reiterated in a 1999 document concerned with developing 
drug treatment provision in the prison setting (Department of Justice, Equality 
and Law Reform, 1999), the Report of the Group to Review the Structure and 
Organisation of Prison Health Care Services (2001), and in a recent speech 
by the Minister for Justice, Equality and Law Reform (speech given on July 4th 
2001).  
 
The care of drug users in the community falls under the remit of the 
Department of Health and Children, whereas in the prison setting, it is the 
responsibility of the Department of Justice, Equality and Law Reform. This 
situation creates inherent problems for the continuity of care of drug users. A 
draft action plan drawn up in 1999 (Department of Justice, Equality and Law 
Reform) sought to reflect a medical policy agreed between the Department of 
Justice, Equality and Law Reform, the Department of Health and Children and 
the Eastern Health Board.34 It proposed the development of a range of 
treatment services within the prison setting including methadone maintenance 
programmes, detoxification programmes and addiction counselling. In 
addition, it was proposed that drug-free wings be introduced.  
 
                                                     
34 Now the Eastern Regional Health Authority. 
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There was also a recommendation that by 1 July 1999 prisoners be provided 
with access to bleach for sterilising injecting equipment, in an attempt to 
prevent the spread of communicable disease. The provision of bleaching 
tablets has also been recommended in a more recent report of the Group to 
Review the Structure and Organisation of Prison Health Care Services – at 
the time of writing these have yet to be provided in Irish prisons.  
 
The provision of a needle exchange programme is not currently being 
considered by the Irish Prisons Service and has not been identified 
specifically as a point of action within current drug policy. However, an action 
point within the National Drugs Strategy 2001-2008 states that the health 
boards should “review the existing network of needle-exchange facilities with 
a view to ensuring access for all injecting drug misusers to sterile injecting 
equipment” (Department of Tourism, Sport and Recreation 2001, p.118). 
While not specifically targeted at the prison context, this may have 
implications where there continues to be evidence of injecting drug use 
occurring within the prison setting. However, in the more recent Report of the 
Group to Review the Structure and Organisation of Prison Health Care 
Services it is stated that the Group is not recommending the introduction of 
syringe exchange programmes into the Irish prison system because “the risk 
of attacks on staff and prisoners with syringes supplied by the state would 
appear to be unacceptable” (p.46). 
 
Following on from the draft action plan (Department of Justice, Equality and 
Law Reform 1999), a Steering Group on Prison-Based Drug Treatment 
Services was established at the end of 1999, under the chairmanship of the 
Director General of the Prisons Service. The group consists of senior prison 
staff, representatives of the Department of Justice, Equality and Law Reform, 
the Prisons Psychology Service, the Probation and Welfare Service, the 
Prisons Education Service, the Director of Prison Medical Services and 
several nominees from the Eastern Regional Health Authority. In a report by 
the group, a further commitment to the provision of drug treatment services 
based on the principle of equivalence of care was given (Irish Prisons Service, 
2000). Furthermore, the report proposed a ‘new treatment ethos’ (Irish 
Prisons Service 2000, p.3) for a number of prisons in which prisoners with a 
history of drug use were concentrated. In October 2000 the government 
approved the implementation of recommendations contained in this report 
(Irish Prisons Service 2001). Furthermore, the implementation of the report’s 
recommendations has been identified as a priority within the new National 
Drugs Strategy 2001-2008 (2001). 
 
On foot of the Steering Group’s report, methadone maintenance service 
provision was expanded within the prison setting. All prisoners entering the 
remand prison Cloverhill, all new committals to Mountjoy, and prisoners 
transferring from Cloverhill Prison who are on approved methadone 
maintenance treatment programmes, were to continue to receive methadone 
maintenance while in prison (Irish Prisons Service, 2001).  
 
Furthermore, the Minister for Justice, Equality and Law Reform announced a 
directive to the Irish Prisons Service to develop drug free regimes, wings and 
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facilities across the prison system, and build up detoxification and counselling 
services for prisoners with a history of drug use, within a three-year time 
frame from July 2001 (Department of Justice, Equality and Law Reform press 
release July 4th 2001). While a range of drug treatment services are available 
in Irish prisons (see Table 13.5), and the recent developments suggest a 
more innovative approach on the part of the Irish prison system to drug 
treatment, the principle of equivalence does not currently prevail in the Irish 
prison system in its care of drug users.  
 
Table 13.5 : List of dedicated drug treatment services available in Irish prisons35 
Prison Dedicated Drug Treatment Services 
St. Patrick’s Institution Short-term methadone detoxification   
Methadone maintenance 
Monitored drug-free wing 
Mountjoy female prison Short-term methadone detoxification 
Methadone maintenance 
Mountjoy Training Unit Monitored drug-free wing 
Mountjoy Main Prison Short-term methadone detoxification 
Methadone maintenance 
Drug detoxification and rehabilitation programme 
Wheatfield Short-term methadone detoxification 
Methadone maintenance 
Cork Prison No dedicated drug service 
Limerick Prison Short-term methadone detoxification* 
Portlaoise Prison Short-term methadone detoxification* 
Arbour Hill Short-term methadone detoxification* 
Castlerea No dedicated drug service 
Cloverhill Short-term methadone detoxification 
Methadone maintenance 
Fort Mitchel No dedicated drug service 
Loughan House No dedicated drug service 
Shanganagh Castle No dedicated drug service 
Shelton Abbey No dedicated drug service 
Curragh No dedicated drug service 
‘No dedicated detox programme but will continue detox for those transferred in who need it. 
Source: Personal communication, Irish Prisons Service. 
 
c) Link with the community services outside the prison 
 
The care of drug users while in the community falls under the remit of the 
Department of Health and Children, while that of drug users in prison is the 
responsibility of the Department of Justice, Equality and Law Reform. This 
has meant that there have been persistent problems with providing continuity 
of care for drug users moving between the community and prison. Recently 
however, there has been a concerted effort on the part of those involved to 
form stronger links between services provided within the prison and the 
community- the importance of establishing links between prison and 
community based services has been highlighted by the Irish Prisons Service: 
 
“The Service acknowledges that it has an essential role and duty to 
perform in tackling drug misuse and that this role must be undertaken in 
                                                     
35 It should be noted that within Ireland there are variations between Health Boards in terms of 
what they will provide in the area of drug treatment, therefore it is to be expected that these 
variations will impact on what services are provided within each prison. 
 203
a co-operative and co-ordinated way with other government 
departments, statutory agencies, prisoners and their families and the 
wider community.”  
(Irish Prisons Service 2000, p.1)  
 
Strengthening links with community services has been identified as a priority 
in the National Drugs Strategy 2001-2008. It is recommended that the 
involvement of community and voluntary sectors in prison drug policy be 
expanded. It is proposed that this be done through the development of Local 
Prison Liaison Groups and formal meetings held between the relevant sectors 
and the Steering Group on Prison Based Drug Treatment Services. 
 
In Ireland there is no formal referral scheme for drug using prisoners to 
treatment upon release. The need to develop a structured through-care 
programme from the prison system to the community has been identified 
within the Irish criminal justice system (Irish Prisons Service 2000; Mountjoy 
Complex Redevelopment Group 2001; Group to Review the Structure and 
Organisation of Prison Health Care Services 2001). In the absence of formal 
links between the community and the Irish prison service, a number of 
programmes aimed at preparing prisoners for release or meeting their needs 
upon release have been developed on an ad hoc basis. The Probation and 
Welfare Service of the Department of Justice, Equality and Law Reform carry 
out group work programmes in the prison setting. These aim to promote 
desired behavioural changes in terms of risk behaviour and drug misuse, and 
to help prisoners cope with imprisonment and to prepare them for life 
demands following release from prison.  
 
There are also a couple of specific projects underway which are targeted 
specifically at dealing with the issues surrounding release including: a 
programme that facilitates prisoners in developing a Community Release 
Plan; a programme aimed directly at ex-prisoners to facilitate their 
reintegration back into society; and, training and education based 
programmes aimed at providing ex-prisoners with an alternative to crime upon 
release. 
 
13.6 Evaluation of drug users’ treatments in prison 
 
a) State of the art evaluation in prison  
 
To date there has not been a tradition of evaluation within the context of 
service provision for drug users in the Irish criminal justice system. However, 
evaluation has been identified as an important aspect of future service 
development within the prison context (Irish Prisons Service 2000). In their 
report, the Steering Group on Prison Based Drug Treatment Services said 
“the Steering Group strongly recommends that review and evaluation systems 
for the new prison based drug treatment services be established from the 
outset” (Irish Prisons Service 2000: 4). Furthermore, within its Action Plan, the 
National Drugs Strategy 2001-2008 (2001) proposes to have carried out an 
independent evaluation of the overall effectiveness of the Prison Strategy by 
mid-2004. 
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b) Main findings and evaluation results 
 
As mentioned above, generally evaluation has not been carried out on drug 
treatment services within the prison. Crowley (1999) provided a medical 
review of the seven-week Drug Detoxification and Rehabilitation Programme 
in Mountjoy prison, Dublin. Up to February 1999, 187 prisoners had entered 
the programme, 173 completed the detoxification and 14 failed to complete 
the detox. While this implies a 93% success rate, Crowley (1999) highlights 
the need for the success of this intervention to be determined by the 6 and 12 
month relapse figures. Overall it was found that there was a twelve monthly 
relapse rate of 78%. Crowley argues that while this may appear high, it 
compares favourably to outcome rates of other inpatient detoxification 
programmes. 
 
Despite the potential for the spread of HIV and hepatitis among intravenous 
drug users in prison, a report evaluating services in this field found that at the 
time there were no harm reduction strategies in place in the Irish prison 
system (O’Brien and Stevens 1997). An award-winning booklet and video, 
containing information for prisoners on HIV discrimination, infection and 
prevention, had been produced and were supposedly available to all 
prisoners. However, focus group interviews with prisoners and former 
prisoners found that HIV-positive individuals in the focus groups had seen 
neither of these materials (O’Brien  and Stevens 1997). 
 
It is hoped that the emphasis on evaluation in recent policy development will 
result in a tradition of evaluation within the context of prison based drug 
treatment services. 
 
13.7 Methodological issues 
 
a) Limitations in data availability 
 
The data available on drug use among prisoners in Ireland remains limited. 
However, there does appear to be an interest on the part of the Irish prison 
service to encourage and facilitate research on the issue. This is encouraged 
alongside policy and practice developments in the area of drug use among 
prisoners in Ireland. 
 
b) Future needs 
 
Among the implications of the findings of Dillon’s (2001) study was that there 
is a need for further research to be carried out on the subject of drug use 
among prisoners. It is argued that with only a few exceptions (O’Mahony 
1997b; Allwright et al. 1999; Long et al. 2000), there has been little 
information available to guide policy and practice in the area of drug use 
among prisoners in Ireland. The need to base policy and service 
developments on a sound knowledge base is identified. Research needs were 
identified on both a general and specific level: 
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On a general basis, there is a need for routine data on prisoners to be 
collected, so that trends and changes in the prison population can be 
monitored. The lack of routine statistics on those in custody should be 
addressed.36 Furthermore, the prison services should encourage and facilitate 
the collection of data for the National Drug Treatment Reporting System. This 
reporting system will provide important epidemiological information on those 
prisoners who access drug treatment in the prison, and could be used to 
identify trends over time, as well as changes in patterns of drug use. 
 
Routine data collection needs to be complemented by special surveys, which 
would provide more detailed information on sub-groups and specific issues of 
particular concern. Some of the areas in need of further research, which arose 
from Dillon’s (2001) study were: 
 
 the extent to which a drugs culture exists in other Irish prisons, the 
perceived impact of different prison environments on prisoners’ drug-using 
behaviour and their overall experience of prison; 
 the drug–crime relationship in the Irish context; 
 the extent to which drug users change their drug-using behaviour in the 
prison setting and the nature of these changes; 
 the risk behaviours engaged in by those using illicit drugs in the prison 
setting, the context in which these occur and how they compare to those in 
the community; 
 the processes surrounding initiation into injecting drug use, with a 
particular focus on initiation in the prison setting; 
 perceptions and knowledge among prisoners of the health risks involved in 
sharing injecting equipment; 
 on-going monitoring and evaluation of prison-based drug treatment and 
healthcare services; and 
 prison officers’ perceptions of the drug situation within the prison and their 
attitudes toward a comprehensive service provision profile. 
 
c) Methodological proposal 
 
A range of methodologies would need to be adopted to carry out research in 
the areas identified in section 13.7 (b). Both qualitative and quantitative would 
need to be used and a variety of sampling methods invoked including 
randomised sampling and techniques such as network sampling. 
Methodologies developed must also take consideration of the particular 
ethical issues that arise from carrying out research within the prison setting.  
 
In her exploratory study on drug use among Irish prisoners Dillon (2001) 
carried out in-depth qualitative interviews with a sample of prisoners. A 
network/snowball sampling method was used for sample selection. 
‘Categories’ of prisoners were developed based on general characteristics 
relating to an individual’s drug-using history.  Initial contacts were made 
through probation and welfare officers and respondents selected according to 
these categories. Respondents located in this way were asked to refer the 
                                                     
36 The last annual report on prisons and places of detention was for the year 1994 (Department of 
Justice, Equality and Law Reform, 1998). 
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researcher on to other potential study participants in the prison. Interviews 
were tape-recorded, with participants’ consent, and fully transcribed for 
analysis. The methodology used in this study (Dillon 2001) was found to be 
very effective in facilitating an exploration of the particularly sensitive subject 
of drug use among prisoners. 
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Databases – Software – Internet Addresses 
 
a) Databases used in this report: 
 
• General Mortality Register 
Principal Use – Contains data on mortality statistics 
Users – politicians, policy makers, police, medical practitioners, researchers, 
the public. 
 
• Hospital Inpatient Enquiry database 
Principal Use – A computer based health information system designed to 
collect medical and administrative data regarding discharges from acute 
hospitals (excluding private hospitals). 
Users – politicians, policy makers, medical practitioners, hospital and health 
services staff, researchers. 
 
• National Drug Treatment Reporting System 
Principal Use – The national epidemiological database on treated drug misuse 
in Ireland 
Users – politicians, policy makers, researchers, drug treatment services, local 
drug task forces, the public. 
 
• National Psychiatric Inpatient Reporting System 
Principal Use – Provides information on the activities of the inpatient 
psychiatric service (admissions, discharges and deaths) in Ireland 
Users – politicians, policy makers, psychiatric and health services staff, 
researchers, the public 
 
 
Software Used: 
 
• Microsoft Word 
• Microsoft Excel 
• SPSS 9.0  (1999).   Statistical Package for the Social Sciences. USA: 
SPSS Inc. 
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b) Internet Addresses:  
 
www.clubscene.ie Club scene website 
www.coolchoices.ie Cool choices website 
www.cpa.ie Combat Poverty website 
www.dnedrugstaskforce.ie Dublin North East Drugs Task Force 
www.drugawareness.ie Drug Awareness website 
www.erha.ie Eastern Regional Health Authority 
www.incb.org/e/cpnv International Narcotics Control Board 
www.irishprisons.ie Irish Prisons website 
www.kildare.ie/drugsawareness Drug Awareness website for Kildare  
www.kildare.ie/outreach/index/htm Outreach website for Kildare 
www.mqi.ie Merchants Quay Ireland website 
www.nehb.ie North Eastern Health Board 
www.penal-reform.ie Penal Reform website 
www.rutlandcentre.org Rutland Centre website 
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ANNEX 
 
Drug monitoring systems and sources of information – Mary O’Brien & 
Lucy Dillon 
 
The core information systems, used to monitor the drug problem and to inform 
policy making, are in the health and law enforcement areas. 
 
• National Drug Treatment Reporting System [NDTRS] 
The Drug Misuse Research Division [DMRD] of the Health Research Board 
(HRB) operates the National Drug Treatment Reporting System [NDTRS].  
The NDTRS is an electronic database providing information on people who 
present to drug treatment services nationwide.  The data are collected by 
health services personnel at regional health board level, and are co-ordinated 
by the DMRD.  Data co-ordinators are in the process of being appointed at 
regional level.   
 
• Infectious diseases data 
The National Disease Surveillance Centre (NDSC) took over statutory 
responsibility for reporting on sexually transmitted infections (STIs), including 
HIV/AIDS, from the Department of Health and Children (DOHC) on July 1st 
2000. On 1st July 2000, the Infectious Diseases (Amendment) Regulations, 
2000 (S.I. No 151 of 2000) came into force. Under these regulations the 
National Disease Surveillance Centre (NDSC) was assigned responsibility for 
the collation and analysis of weekly notifications of infectious diseases, taking 
over from the Department of Health and Children. This includes responsibility 
for reporting on drug-related infectious diseases. While hepatitis B is a 
notifiable disease but it is generally accepted that there is under-reporting in 
Ireland and that the notification system is not a good indication of the true 
incidence of infection. Furthermore, while data are collected on the number of 
positive tests carried out for hepatitis B by the Virus Reference Laboratory, no 
behavioural data is collected and therefore those infected through drug use 
cannot be identified. There is no routine data collection in the area of hepatitis 
C. Only total numbers of individuals who test positive in a given year are 
available- as with hepatitis B it is not possible to identify those who have 
become infected through injecting drug use. 
 
The most complete data available on drug-related infectious diseases are 
those on HIV. Up until July 2000, the Department of Health and Children, in 
collaboration with the Virus Reference Laboratory, was responsible for 
producing statistics on HIV positive tests which are published every six 
months. Data on HIV/AIDS are now provided directly to the NDSC by the 
Departments of Public Health of each health board. In their first six months of 
data collation (July 2000-December 2000), data were collected by the NDSC 
in the same manner as previous years. However, in July 2001 a new HIV 
case-based reporting system has been developed. The aim of the new HIV 
case based reporting system has been noted as “to ensure the collection of 
accurate and complete epidemiological data on the distribution and mode of 
transmission of HIV infection” (O’Donnell, Cronin & Igoe, 2001: 21). The 
socio-demographic data that will be collected within this new system are the 
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patient’s age, gender, county of residence (if Dublin, then the postal code) 
and country of birth (if not Ireland then year of first arrival in Ireland). 
Furthermore, an expanded list of probably routes of transmission is included 
on the form (for further information see section 3.3 of the report)..  
 
• General Mortality Register 
Data on drug-related mortality are currently obtained from the General 
Mortality Register operated by the Central Statistics Office.  Mortality data are 
collected by regional Registrars of Births and Deaths, from a number of 
sources (medical practitioners, police, coroners) and returned centrally to the 
Registrar General's Office.  These data are reported upon (Report on Vital 
Statistics) by the Central Statistics Office (CSO).  Data on drug related deaths 
are not routinely published.  A new development is that the possibility of 
setting up a Special Register to record drug related death is being explored.  
This came about as a result of discussions, which took place at Workshops 
organised by the DMRD, in the context of the harmonisation of key indicators 
of drug misuse. 
 
• National Psychiatric In-patient Reporting System 
The National Psychiatric In-patient Reporting System [NPIRS], which provides 
information on the activities of the inpatient psychiatric service in Ireland, is 
maintained by the Mental Health Research Division of the Health Research 
Board.  This monitoring system collects data on admissions to and discharges 
from public and private psychiatric hospitals and units in Ireland.  It provides 
information on the activities of the inpatient psychiatric service (admissions, 
discharges and deaths).  Primary and secondary psychiatric diagnoses are 
recorded.  An annual report provides information on gender, age, marital 
status, socio-economic group, legal status, diagnosis (ICD-10) and length of 
stay.   A review of changes over time is also provided by the system, from 
computerised data going back to 1971. 
 
• Hospital In-Patient Enquiry System 
The Hospital In-Patient Enquiry System [HIPE], records details on discharges 
and deaths for all acute public hospitals in Ireland.  The database is 
maintained by the Economic and Social Research Institute.  It is a computer 
based health information system designed to collect medical and 
administrative data regarding discharges from acute hospitals (excluding 
private hospitals).  Data on principal diagnoses and principal procedures 
performed are collected.  Each discharge record represents one episode of 
care and patients may have been admitted to hospital more than once with 
the same or different diagnoses.  These records facilitate analyses of hospital 
activity rather than incidence of disease, with information on primary and 
secondary diagnoses (ICD-9). 
 
• Central Methadone Treatment List 
The Central Methadone Treatment List is a register of all clients who receive 
prescribed methadone.  The information collected consists of:  
the operative/issue date  
client’s name  
client’s date of birth  
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void date  
reason for void. 
These data, which are used to avoid duplication of methadone prescription, 
are confidential and are not published. 
 
• Police data 
In the area of law enforcement, national data are collected by the Garda 
Síochána and published annually. These data are a reflection of police activity 
and include the number of criminal charges for drug offences.  The published 
data refer to drug-related offences under the Misuse of Drugs Acts where 
proceedings are commenced. Breakdown is given by drug and whether it was 
intended for possession or traffick/supply. The data are event-based, 
individuals cannot be identified so the number of individual persons involved 
is not known.  
 
Collection of drug seizures data is carried out by the Gardaí and the Customs 
Service.  Information includes the quantity (by weight) and the number of 
seizures of illegal drugs as well as type of drug involved.  These data are inter 
alia a reflection of the activity of the police and the Customs authorities.  
Methods of detection, for example the number of personnel involved in the 
detection of such crimes, the availability of detection equipment or sniffer 
dogs, could influence the consistency of the data over time. Information on 
drug product purity is collected by the police from seizures of drugs. The 
purity of drugs is analysed by scientists at the Forensic Science Laboratory 
and tests are carried out on samples of all products seized, except in the case 
of cannabis where tests are carried out on random samples of seizures.  
 
Information on the price of drugs is collected by the police at street level. The 
quality of the latter data is difficult to ascertain. Price and purity information is 
not included in published Garda reports. 
 
• Prison data 
An annual report of prisons and places of detention is supposed to be 
produced which includes data on those imprisoned under the Misuse of Drugs 
Acts. However, the most recent statistics providing such a breakdown relate 
to 1994- from 1995 to date no such data have been produced by this source. 
A new computer system was to be established within the prison system from 
January 2001, but at the time of writing (September 2001) there continues to 
be problems with the practice of routine reporting and the publication of 
annual statistics from this source. Furthermore, two categories of law offences 
have been used in the statistics produced up until 1994: sale or supply of 
drugs; and, possession/production/cultivation/import/export of drugs. These 
do not correspond with data collected by the Gardai, as they are categories 
according to the offence under the Misuse of Drugs Act. 
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